ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0035166;post-embryonic hemopoiesis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;35.890675140735624;8.67846133901236;0.0012012285974498564;0.7669372290569613;[KLF4]
GO:1902311;regulation of copper ion transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;56.266460488832536;9.777073627680469;0.0018831877960343868;0.875;[SLC31A2]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[TNF, HAVCR2, IL18, ACTN4, GREM1, IL23A, IL1B, CHI3L1, TLR7, TLR6, TLR4, TLR2, NOD2, CCL19, CD14, TNFSF14, TNFRSF10B, EIF2AK2, NLRP12, CD27, IL18R1]
GO:1901223;negative regulation of NIK/NF-kappaB signaling;8.0;1.0;0.875;9.628524252492122;239.1998693179246;6.686031174322154;0.008005804360164796;0.7169239451870815;[NLRC3, NLRP12, NLRP3]
GO:1904976;cellular response to bleomycin;7.0;1.0;0.8509193652572005;9.628524252492122;332.1079197183639;9.083926447120524;0.011115353195250678;0.8154717862087246;[TIMELESS]
GO:0002244;hematopoietic progenitor cell differentiation;4.0;0.811012628672052;0.655506314336026;8.935377071932177;21.066225782797595;5.395046993006588;7.050676185779127E-4;0.5259029541176994;[TOP2A, SPI1, TNFRSF13B, PLEK, SOX4, PDGFRA, ESCO2, TAL1, KIT, HOXB4, HOXB3, RBM47, PRKDC, PLD4, GATA3, JAM3, TGFB1, ACE, INHBA, ANLN, PTPRC, BCL2, PTPN6]
GO:0002479;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;6.0;1.0;0.8231203125901445;9.628524252492122;33.24930607151726;6.518977089658987;0.0011128243517809471;0.6565011041187423;[CHUK, ITGB5, HLA-B, TAP1, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E, CD36, FCGR1A, FCGR1B]
GO:0030947;regulation of vascular endothelial growth factor receptor signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;67.94038154209638;6.409777797693995;0.002273903427840277;0.6509166472493662;[PRKCB, ITGB3, MYOF, HHEX, HGS, IL1B, NEDD4, EMILIN1]
GO:0000060;protein import into nucleus, translocation;9.0;1.0;0.896240625180289;9.628524252492122;93.4429707305496;6.444869117505266;0.0031274521371376313;0.7258315315665724;[TGFB1, RANBP6, PHB2, TNF, NFKBIA, POLA2, BCL6, IFNG, BCL3, AKT1, RAN]
GO:2001204;regulation of osteoclast development;9.0;0.8933024483968273;0.8428918493787028;9.510741216835738;200.3946012839482;7.292166977892469;0.006707026961541477;0.769162383550154;[TYROBP, TNFSF11, LILRB1, LTF, FBN1]
GO:2001205;negative regulation of osteoclast development;10.0;1.0;0.9152410118609203;9.628524252492122;1250.359070569308;8.16763571524637;0.041848392841848644;0.8329342821725234;[LILRB1, LTF, FBN1]
GO:0071499;cellular response to laminar fluid shear stress;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;52.23891675539742;7.8311634786251565;0.0017483895318303475;0.6907270763441554;[KLF4]
GO:0071258;cellular response to gravity;5.0;1.0;0.7902410118609202;9.628524252492122;37.20981579086828;9.777073627680469;0.0012453790478602876;0.7902410118609202;[PTAFR]
GO:2000110;negative regulation of macrophage apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;256.26138950429646;7.9853141584524145;0.008576838086431384;0.8046099625986299;[GHSR, CCL5, IRF7, NOD2, CCR5]
GO:2000117;negative regulation of cysteine-type endopeptidase activity;11.0;0.8259837884571596;0.845420846558242;9.538912093802434;565.4444864912041;5.076593261888053;0.018924918095861203;0.6920461678283469;[TNFAIP8, ARRB1, ARRB2, AQP1, LAMP3, RPS6KA1, AKT1, GPX1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, BIRC2, LTF, BIRC3, LEF1, IFI6, NLRC4, PTGS2, CST7, THBS1, CST3, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4, FABP1, VIL1, CD27]
GO:0036006;cellular response to macrophage colony-stimulating factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;8.16763571524637;0.0027327542132076126;0.7408135829017477;[CSF1R]
GO:2001202;negative regulation of transforming growth factor-beta secretion;10.0;1.0;0.9152410118609203;9.628524252492122;670.9356820924863;9.083926447120524;0.02245561347672384;0.8797934328124444;[FN1, LILRB1]
GO:2000373;positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity;7.0;1.0;0.8509193652572005;9.628524252492122;112.16415423977526;7.9853141584524145;0.0037540333012201187;0.7592887026755414;[PLSCR1, UHRF1, NCAPH]
GO:1905832;positive regulation of spindle assembly;10.0;1.0;0.9152410118609203;9.628524252492122;380.05421777584075;8.16763571524637;0.012720072642367639;0.8329342821725234;[GPSM2, SPAG5]
GO:0006612;protein targeting to membrane;10.0;0.811012628672052;0.8207473261969463;9.414950152194063;149.73401455281405;4.753193106834193;0.0050114627152184205;0.6583195283905053;[NCF1, SEC63, SRP9]
GO:0048012;hepatocyte growth factor receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;7.292166977892469;0.0010376185600805164;0.747921758369865;[NRP1, PAK1, STMN1]
GO:0051653;spindle localization;4.0;0.7866048967936545;0.6433024483968273;9.223059144383958;22.024791997814198;5.9928839937622085;7.371499671409332E-4;0.5564763661386056;[GPSM2, CENPA, NUSAP1, SPAG5, NDC80, ASPM, ESPL1, LLGL2]
GO:0000077;DNA damage checkpoint;8.0;0.811012628672052;0.780506314336026;9.456673995565463;85.75736069739153;5.486614186532078;0.002870221685927797;0.655585704652903;[BLM, BRIP1, CHEK1, E2F1, TOPBP1, CLSPN, FANCI, TIPIN, H2AFX, DONSON, RPA2, MAPK14, MSH6, MSH2, CDK2, CDK1]
GO:0048011;neurotrophin TRK receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;58.19790639729547;6.781341354126479;0.0019478315524021762;0.7217981122146513;[SORT1]
GO:0000076;DNA replication checkpoint;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;54.456905800140625;6.8867018697843045;0.0018226236290973575;0.7271862538851576;[CDT1, TIPIN, CDC45, TIMELESS, CDC6, TOPBP1, NAE1, CLSPN, DNA2]
GO:0048010;vascular endothelial growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.186691500213083;31.002284443533863;5.572381008289503;0.0010376185600805164;0.6599718239061428;[CYFIP1, NRP1, NRP2, NCF1, NCF2, ITGB3, NCF4, CYBB, VAV1, SH2D2A, NCKAP1L, FYN, MAPK14, SULF1, PTK2]
GO:0071480;cellular response to gamma radiation;7.0;1.0;0.8509193652572005;9.628524252492122;60.39874674087868;6.444869117505266;0.0020214916980741903;0.6805102716434839;[YAP1, EGR1, CDKN1A, H2AFX, NOX4, BCL2L1]
GO:0048015;phosphatidylinositol-mediated signaling;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;5.649939242635378;8.845336528452411E-4;0.6398575208746181;[CSF1R, PTAFR, PIK3CD, GATA3, PIK3C2A, PIK3R5, AKT1, KCNH1, PDGFRB, PDGFRA, EDN1, GSN, GAB2, IGF1, RPS6KB1, PIK3C3, EXOC1]
GO:0097411;hypoxia-inducible factor-1alpha signaling pathway;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;8.390779266560578;7.75488093814194E-4;0.7193458537639684;[CYBB]
GO:0006606;protein import into nucleus;9.0;0.8933024483968273;0.8428918493787028;9.551563211355994;277.5355368998559;5.288437257948329;0.009288864654271135;0.6666915524892495;[NUP107, CSE1L, NUP62, NUP133, SYK, TSC2, MMP12, NUP54, NUP85, NUP88, RANBP2, RANBP1, NUP155, RANBP6, PML, NUP35, RAN]
GO:0072332;intrinsic apoptotic signaling pathway by p53 class mediator;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;80.0523555558605;5.734022359845919;0.002679280298012042;0.64415753539903;[CDKN1A, BRCA2, PYCARD, PERP, TP53BP2, E2F1, E2F2, SIRT1, POU4F1, PML, MSH2, JMY, BCL3]
GO:0048255;mRNA stabilization;10.0;0.8933024483968273;0.861892236059334;9.577230958104572;1968.7172834448895;6.088194173566533;0.06589119574637584;0.7265915450270957;[RBM38, SLC11A1, AXIN2, MAPK14, E2F1, MYD88]
GO:0071243;cellular response to arsenic-containing substance;4.0;0.8653626801206646;0.6826813400603323;9.377209824211215;38.7152913866576;7.138016298065211;0.0012957659612112835;0.6150384854347593;[HMOX1, MAPK13]
GO:0046078;dUMP metabolic process;11.0;0.8933024483968273;0.8790801765280758;9.566003895510788;882.6830739380919;7.8311634786251565;0.029542608121515816;0.8329150168128974;[TYMS]
GO:0000070;mitotic sister chromatid segregation;6.0;1.0;0.8231203125901445;9.628524252492122;56.84344269090966;6.311337724880743;0.0019024988710876387;0.6458824173477649;[SPAG5, MIS12, PLK1, CDCA8, SMC1A, TUBG1, SMC4, ZWINT, NDC80, KIF18A, KIF18B, ESPL1, KIFC1, NUSAP1, NEK2, RAN, MAD2L1]
GO:2000121;regulation of removal of superoxide radicals;7.0;0.8259837884571596;0.7639112594857803;9.4949928598676;93.21217700056023;7.474488534686424;0.003119727678695759;0.7331650565203278;[DHFR, GCH1, CD36, TNF]
GO:2000363;positive regulation of prostaglandin-E synthase activity;6.0;1.0;0.8231203125901445;9.628524252492122;43.017486512842105;8.67846133901236;0.001439756560360439;0.7669372290569613;[ITGAM, ITGB2, NOD2]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CSF3, CD80, PIK3CD, ARRB2, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, GPX1, IGFBP5, GAB1, IL18, F3, VAV1, EREG, BTC, LCK, KIT, CHI3L1, HCLS1, ADAM8, HBEGF, ENG, PDGFA, GATA3, THBS1, PIK3R5, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK, HPSE]
GO:0051898;negative regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;6.063501560976162;0.00799223380789131;0.6850877518099798;[TSC2, ARRB2, KLF4, SIRT1, PKHD1, BANK1, AKT1, EPHA2]
GO:1904998;negative regulation of leukocyte adhesion to arterial endothelial cell;9.0;1.0;0.896240625180289;9.628524252492122;105.70174406809066;9.777073627680469;0.0035377422485653965;0.896240625180289;[KLF4]
GO:1903429;regulation of cell maturation;6.0;0.6696747006330769;0.657957662906683;8.529911963824013;30.449342762684836;6.781341354126479;0.0010191120996377043;0.6699184248047958;[EDNRB, PPP2R1A, LRRK2, BCL2, KIF14, AURKA]
GO:0002220;innate immune response activating cell surface receptor signaling pathway;10.0;0.8653626801206646;0.8479223519212526;9.523163736834295;627.0113613116039;5.572381008289503;0.020985505989509944;0.7002128357670632;[FCN1, CLEC10A, ICAM2, ICAM3, LILRA2, RELB, PAK1, NRAS, KLRK1, PLCG2, MUC13, FFAR2, FYN, MUC15, PRKACB, LYN, FCER1G, CHUK, SYK, CARD9, PRKCD, NFKB1, MUC3B, CLEC4A, CLEC4D, CLEC4E, CARD11]
GO:0002221;pattern recognition receptor signaling pathway;10.0;0.6467165523344657;0.7385992880281531;8.89455507741192;408.2729656680319;5.049685808968129;0.01366452873909497;0.6734821789659555;[FCN1, ITGAM, ITGB2, TNFAIP3, CTSS, IFIH1, FFAR2, CD36, PGLYRP1, HAVCR2, CHUK, DDX58, RIPK2, PRKCE, CD180, IRAK3, TLR1, BTK, IRF7, TLR8, TLR10, TLR7, PIK3C3, TLR6, TLR5, TLR4, S100A9, S100A8, TLR2, COLEC12, UNC93B1, LY96, NOD2, HSPD1, CLEC7A, S100A14, CD14, CD300LF, MAP2K6, NR1H4, NFKBIA, MARCO, TNIP3, MYD88]
GO:0070192;chromosome organization involved in meiotic cell cycle;5.0;0.7043150770688792;0.6423985503953599;8.567652291806858;44.78603005185074;5.682729065458369;0.0014989481210252074;0.5808560405423884;[BUB1B, SMC4, NCAPH, SMC2, PPP2R1A, BUB1, MLH1, RAD50, RAD51, RAD51C, CCNE2, CCNE1, FANCD2, NCAPD2, NCAPD3, TRIP13]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[CLEC10A, ICAM2, ICAM3, RELB, PAK1, NRAS, KLRK1, PLCG2, MUC13, FYN, MUC15, PRKACB, LYN, FCER1G, CHUK, SYK, CARD9, PRKCD, NFKB1, MUC3B, CLEC4A, CLEC4D, CLEC4E, CARD11]
GO:0042953;lipoprotein transport;8.0;1.0;0.875;9.628524252492122;68.44752614357394;7.138016298065211;0.0022908771012512216;0.7400384854347593;[MSR1, CUBN, LRP1, PRKCB, CD36, LRP2, ZDHHC17]
GO:0002455;humoral immune response mediated by circulating immunoglobulin;7.0;1.0;0.8509193652572005;9.628524252492122;48.293467131004675;8.390779266560578;0.001616338883576055;0.7800242071602487;[EXO1, BCL3, HLA-DQB1]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[CPNE8, NLGN1, CAMK2D, CPNE5, SERPINE1, PHB2, ECT2, JUNB, KCNH1, MEF2A, MEF2C, JUN, EDN1, FOS, TUBG1, FOSB]
GO:0051661;maintenance of centrosome location;6.0;1.0;0.8231203125901445;9.628524252492122;46.01609631687506;7.9853141584524145;0.0015401173319278046;0.7314896500084853;[ASPM, GPSM2]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[BRCA2, CENPA, RACGAP1, STMN1, NUSAP1, ECT2, MYH10, CEP55, CDT1, PLK1, CKAP2, KIF23, CIT, ANLN, ESPL1, KIF4A, KIF20A]
GO:0071276;cellular response to cadmium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.139487467954083;0.0026274528238337297;0.6370939872166814;[JUN, GSN, CHUK, NCF1, CYBB, FOS, MMP9, AKT1, HMOX1]
GO:0006816;calcium ion transport;8.0;0.6696747006330769;0.7098373503165385;8.690254613899192;35.67391733828006;4.3132418226548594;0.001193973908871026;0.5955793873968269;[DENND5B, PHB2, SLC8A1, CTGF, PRKCE, F2R, CACNA2D3, CALCRL, CUL5, PSEN2, ITPR3, CACNA1F, CORO1A, PLCG2, CCR1, VDR, CAV1, BSPRY, PTPRC, ATP2A3, FASLG, JPH2, CCR7, CCR5, TRPC7, TRPC3, TRPC1, TMEM37, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, ATP2C2, CCL8, PLN, CCL5, NPY, FYN, CCL19, CCL21, FKBP1B, RAMP1]
GO:2000377;regulation of reactive oxygen species metabolic process;5.0;0.660418147677249;0.6204500856995447;8.475844742553736;26.78229071161683;4.7018998124466425;8.963791676210415E-4;0.5306963869301438;[PID1, HP, TNF, CLU, ICAM1, AKT1, CYP1B1, CD177, PDGFRB, PRKCD, AGTR1, FPR2, SLC30A10, FOXO1, KLRK1, TGFB1, AGXT2, CAV1, DHFR, BST1, BCL2, NOX4, CDKN1A, ITGAM, ITGB2, BRCA1, FOXM1, RAC2, CD36, CD34, IL10, EDN1, SYK, PAX2, DNM2, IFNG, IL1B, TLR6, TLR4, BIRC2, PTGS2, THBS1, AIF1, GNAI2, SNCA, GCH1, MAPK14, KLF4, F2RL1, PTX3]
GO:2000134;negative regulation of G1/S transition of mitotic cell cycle;9.0;0.7980440201809971;0.7952626352707877;9.394909401310617;355.88113835876356;5.244474134527214;0.011911021428637128;0.6644432763129993;[CDKN1A, BTG2, CASP2, SOX4, CDC25C, TFDP1, PCNA, PRKDC, AURKA, CCNB1, GPNMB, NACC2, E2F1, CCL2, SFN, E2F7, E2F8, PLK2, RPA2, KLF4, PML, CNOT3, CDK2, CDK1, BCL2, EZH2]
GO:2001222;regulation of neuron migration;7.0;0.7866048967936545;0.7442218136540277;9.510741216835738;102.29339340919134;6.221725566191056;0.0034236678193284823;0.6690987000520388;[SEMA6A, COL3A1, FLRT2, FLNA, PLXNB2, KIF20B]
GO:2001224;positive regulation of neuron migration;8.0;0.8933024483968273;0.8216512241984136;9.59462270081644;536.247192550588;7.138016298065211;0.017947710943527356;0.7400384854347593;[SEMA6A, FLNA, KIF20B]
GO:2000378;negative regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;113.12708673636307;5.905872616772578;0.003786261785297929;0.6251469128630576;[HP, BRCA1, SLC30A10, CD34, IL10, CAV1, PAX2, BCL2]
GO:1903671;negative regulation of sprouting angiogenesis;9.0;0.8653626801206646;0.8289219652406215;9.456673995565463;200.36531453095495;6.599019797332524;0.00670604676027516;0.7337148045016781;[SEMA6A, KLF4, THBS1, E2F2]
GO:1900163;positive regulation of phospholipid scramblase activity;9.0;1.0;0.896240625180289;9.628524252492122;406.95467434623936;9.777073627680469;0.013620406714939737;0.896240625180289;[PRKCD]
GO:0035372;protein localization to microtubule;8.0;0.7980440201809971;0.7740220100904985;9.36615998802463;35.99248463016168;7.379178354882098;0.0012046360694383546;0.7523715242355574;[KIF20B]
GO:1903672;positive regulation of sprouting angiogenesis;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;183.7504864323888;6.139487467954083;0.00614996341619065;0.6889736746265369;[IL10, PPP1R16B, GHSR, NRP1, ANXA1, PLK2, PTGS2, KLF4, PIK3C2A, DLL1, AGTR1, HMOX1]
GO:0002230;positive regulation of defense response to virus by host;8.0;1.0;0.875;9.628524252492122;73.08237040089334;6.599019797332524;0.0024460011674546805;0.712474179321389;[DDX58, STAT1, LILRB1, PARP9, IL23A, IL12RB1]
GO:1903438;positive regulation of mitotic cytokinetic process;9.0;0.7436939687323844;0.7680876095464813;9.223059144383958;347.7403829701856;9.083926447120524;0.011638557671985614;0.8607930461318132;[NUP62, KIF20B]
GO:0002224;toll-like receptor signaling pathway;11.0;0.6763753087927167;0.7706166067260205;9.040737587590003;409.6592600291497;5.311165509025885;0.01371092676377766;0.7040422034557006;[ITGAM, ITGB2, CTSS, CD36, HAVCR2, CHUK, RIPK2, PRKCE, CD180, IRAK3, TLR1, BTK, IRF7, TLR8, TLR10, TLR7, PIK3C3, TLR6, TLR5, TLR4, S100A9, S100A8, TLR2, COLEC12, UNC93B1, LY96, HSPD1, S100A14, CD14, CD300LF, NR1H4, NFKBIA, TNIP3, MYD88]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, AKT1, CASP2, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, CASP8AP2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:0030913;paranodal junction assembly;6.0;1.0;0.8231203125901445;9.628524252492122;88.99224575364705;7.8311634786251565;0.00297849037755313;0.7236063770733796;[EPB41L3, CD9]
GO:0000050;urea cycle;6.0;1.0;0.8231203125901445;9.628524252492122;229.46365912673008;7.292166977892469;0.007679942167085809;0.6960420709600095;[CEBPA, ARG1, CAD]
GO:2000145;regulation of cell motility;5.0;0.46812423412493653;0.5243031289233886;6.883086519318291;34.54403569627484;3.0677692874221707;0.001156157787140571;0.44712687588555144;[SERPINE1, SPINT2, ADARB1, MYLK, C3AR1, AKT1, CYP1B1, HOXA7, MEF2C, PRKCE, CLDN7, PADI2, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, KLRK1, FLRT2, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, JUN, JAG1, ACE, HACE1, JUP, PLK2, FN1, NR2F2, COL1A1, NOX4, SNAI2, GPR18, ARHGAP4, MMP28, TIMP1, ANXA1, ANXA3, TACR3, EMP2, SIRT1, F3, TMEFF2, PLCB1, HBEGF, ENG, PTAFR, PTGS2, GPNMB, NTF3, FLNA, CCL19, JAM3, CCL21, CCL20, SULF1, COL3A1, PKN1, PF4, SEMA5B, PLXND1, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, DACH1, PHLDA2, SEMA6A, IGFBP5, IGFBP3, F2R, TPM1, ADAM9, ADAM8, CD274, CSF1R, CD151, TACSTD2, CORO1A, CXCL10, CXCL11, DAB2, CXCL12, PTPRC, CDK6, BCL2, PLXNB2, ITGB3, PIK3CD, PIK3C2A, CYR61, DUSP10, EMILIN1, ITGA4, XCL2, XCL1, CX3CR1, LRP1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, SEMA4A, SEMA4B, TIE1, KLF4, IL1RN, IFITM1, SPARC, ICAM1, LGALS3, IL1R1, ACTN4, MIF, EREG, BTC, SFRP2, IL23A, PFN1, TRIB1, KIF20B, NBL1, EPHA2, TWIST1, CCR1, TNFSF14, PPBP, IGF1, PTK2, BST1, NRP1, PTPRR, NRP2, ECM1, CD40, KIF14, PTPRK, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, GAB1, IL1A, CEACAM1, CEACAM6, IL1B, KIT, SGK1, SP100, AIF1, GNAI2, PAK1, CXCR3, CXCR2, PDPN, CTNNA1, MPP1, CD74, IL33, PODN, DLC1, F2RL1, ETS1, PLAU, ARHGDIB, IL6R, PDGFRB, PDGFRA, POSTN, VCL, C5AR1, FBLN1, STAP1, TGFB2, TGFB1, SELP, VIL1, IL6, BMP2, NR4A3, FES, DOCK5, CXCL6, CXCL9, DOCK4, MCTP1, TNFAIP6, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, MYOCD, DDX58, ARAP3, MMP9, DCN, FGR, GREM1, IFNG, LAMA2, LAMA4, LAMA3, LEF1, THBS1, SPOCK3, EGF, LAMB1, MAPK14, SOD2, RPS6KB1, TEK]
GO:0033189;response to vitamin A;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;42.3983228833862;6.781341354126479;0.0014190337108936392;0.6977174774718518;[ARG1, ABCB4, RARA, TYMS]
GO:2001235;positive regulation of apoptotic signaling pathway;8.0;0.6997970393407541;0.724898519670377;9.176539128749065;291.4603159253591;4.6590798152637145;0.009754914476767216;0.6132655584219551;[PYCARD, PPP2R1A, PRKCD, MAL, S100A9, ATF3, S100A8, NACC2, TP53BP2, SFN, TNFSF12, CAV1, INHBA, BCL2, NOX1, ITM2C, BCL2L1, SRPX, PLEKHF1, CTSH, TIMP3, CASP2, YWHAH, PLAUR, MMP9, SIRT1, TFDP1, LCK, THBS1, E2F1, CTNNA1, GSN, BIK, G0S2, GZMB, PML, PPP1CA, LTBR]
GO:1902990;mitotic telomere maintenance via semi-conservative replication;9.0;1.0;0.896240625180289;9.628524252492122;232.51800064843582;8.67846133901236;0.007782168229088393;0.8400575416471059;[PCNA, DNA2]
GO:0002281;macrophage activation involved in immune response;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;81.79914540449643;7.379178354882098;0.0027377437822370863;0.7004918368257019;[CX3CR1, IL33, SBNO2, SUCNR1, TYROBP, SYK, PRKCE, HAVCR2]
GO:0036297;interstrand cross-link repair;8.0;0.8933024483968273;0.8216512241984136;9.541512875502493;183.0506323445446;5.905872616772578;0.006126539929698291;0.6770266002729131;[DCLRE1A, RAD51AP1, FANCI, FANCL, RPA1, RPA2, FANCG, MSH6, RAD51, MSH2, FANCD2, RPA3, UBE2T]
GO:0002283;neutrophil activation involved in immune response;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;82.20461051260416;3.594988720963838;0.002751314334510546;0.5347672556313635;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PGLYRP1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, NRAS, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, NPC2, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CTSD, CAMP, CD33, CTSB, CD53, CCT2, FCER1G, MME, SYK, GAA, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, GGH, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, DOCK2, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0048679;regulation of axon regeneration;10.0;0.6799073451904818;0.7551946844561612;9.136047767394327;147.26161645906015;6.686031174322154;0.004928713776034301;0.7571649570480019;[FKBP1B, SPP1, TNR, KLF4, RGMA]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[, NUP107, PHB2, AP1S2, AKT1, HOMER3, WLS, ZFYVE16, NUP85, NUP88, SRP9, MMP12, SNX17, NCF1, CSE1L, TNF, CLU, LAMP2, AP2M1, RAB32, RAB31, SLC27A2, EVI5, BCL6, BCL3, TLK1, ARL4C, NLGN1, UNC93B1, RAB21, PML, VPS41, IFIT1, ARFIP1, SEC63, EGR2, POLA2, CD24, AKAP12, XPO1, TMED6, SYK, STRADB, RAB33B, NAPA, HSD17B4, STX11, RANBP2, RANBP1, CD74, RANBP6, NEDD4, NUPL2, RAMP1, SCARB2, ZFAND6, TSC2, ATP1B1, HGS, COPB2, LTBP2, TGFB1, NUP155, NFKBIA, TBCK, NUP62, YWHAH, NUP133, TBC1D8, TBC1D9, IFNG, EHHADH, NUP54, HSPD1, NUP35, RAN]
GO:0006887;exocytosis;6.0;0.6696747006330769;0.657957662906683;8.375761283996754;37.082880499217325;3.1596706497059923;0.0012411306378830758;0.4847060165558207;[, CDA, CYFIP1, SERPINE1, ABCA13, PSMD3, C3AR1, PRSS3, PGLYRP1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, SERPING1, CFD, FPR1, PDGFA, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, LYN, JUP, FUCA1, FN1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, TIMP3, TIMP1, ANXA3, ARG1, NFAM1, ANXA5, F5, PSMA5, PSMA2, EXOC1, SERPINB10, GRN, PTAFR, NRAS, ALOX5, FLNA, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, PF4, ATP8A1, PROS1, ITGA2B, HP, F13A1, APEH, CLU, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, LIN7A, GPR84, CORO1A, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, COPS5, PTPRC, LCN2, HPSE, LAT, ITGAM, ITGB3, ITGB2, PIK3CD, ITGAL, PIK3C2A, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, VWF, NDUFC2, TNFRSF1B, NPC2, PECAM1, BPI, ACPP, FGL2, CCL8, TTR, CCL5, PCDH7, CPPED1, FCGR2A, P2RX1, IMPDH2, VPS41, PTPN6, MNDA, FOLR3, SPARC, LGALS3, ANPEP, ACTN1, SLC11A1, ACTN4, MIF, ANK1, CHIT1, SLPI, CRISPLD2, TLN1, LLGL2, STXBP2, MGST1, CD14, A2M, CCR1, PRG2, NBEAL2, PPBP, IGF1, BST1, TF, VNN1, ORM1, ECM1, CTSZ, CTSW, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CTSD, CAMP, CD33, CTSB, CD53, CCT2, FCER1G, MME, GAA, RHOG, LAT2, HCK, CEACAM1, CEACAM6, KIT, CEACAM8, TLR2, LILRA3, STX11, CST3, PAK1, CXCR1, CXCR2, CD58, CCT8, GCA, LHFPL2, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, APLP2, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, RASGRP1, MYH10, MGAM, TGFB2, TGFB1, SYT2, HSPA6, GGH, SELP, NR4A3, SELL, MS4A3, TNFAIP6, CRISP3, PLEK, TNFAIP2, CXCL1, SIRPB1, HK3, PLAUR, MMP8, SYNGR3, MMP9, FGR, MMRN1, CHI3L1, DOCK2, LTF, CLEC12A, RETN, THBS1, EGF, MAPK14, CD9, S100P, PTX3]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[IL1RN, CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, PDGFRA, CXADR, PRKCD, CH25H, HOXB9, BIN2, AGTR1, PRKCQ, ADAM8, S100A9, S100A8, EPHA2, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, S100A12, NCKAP1L, CCR10, CCR1, TGFB2, EGR3, VCAM1, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, IL6, CXCL12, NRP1, CXCL6, CXCL9, DOCK4, ITGB2, HMGB2, PIK3CD, CXCL1, ARRB2, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR3, CCR2, IL10, ANXA1, FCER1G, SYK, PDE4D, RHOG, GAB1, VAV1, IL1B, KIT, XCL2, XCL1, HBEGF, CX3CR1, CCL13, LEF1, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR3, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, PF4]
GO:0006879;cellular iron ion homeostasis;10.0;0.8436909121759173;0.837086467948879;9.474373572664863;186.73793370626092;5.69953618377475;0.006249950587919157;0.706715557354699;[ALAS2, TFRC, ABCB6, SLC40A1, HEPH, HMOX1, SLC11A1, CYBRD1, TF, LCN2, LTF, ABCG2]
GO:0030502;negative regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;172.15796001199809;6.943860283624253;0.005761971989496609;0.7060287030842711;[CCR1, GREM1, ECM1, GATA1]
GO:0006878;cellular copper ion homeostasis;10.0;0.8653626801206646;0.8479223519212526;9.523163736834295;186.04478652569694;7.138016298065211;0.006226751575577643;0.7802794972956796;[SLC31A2, ATP7B, CCDC22]
GO:0032928;regulation of superoxide anion generation;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;29.554879433861746;6.781341354126479;9.891752169867288E-4;0.6977174774718518;[TGFB1, ITGAM, SYK, PRKCD, ITGB2, FPR2, GNAI2, F2RL1, CD177]
GO:0070365;hepatocyte differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;24.20171999872632;7.212124270218933;8.100097882234571E-4;0.659069382437994;[HHEX, ANXA1, HNF1B, E2F7, E2F8]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFITM1, PRF1, ADARB1, IFIT1, IFIT3, IFIT2, PYCARD, HERC5, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, DDX60, NLRP3, IFNA21, EIF2AK2, ISG15, AZU1, DEFA1, CXCL10, IL6, PTPRC, BCL2, SERINC5, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, DDX58, PARP9, PLSCR1, IFNG, OAS1, OAS3, IRF7, TLR8, TLR7, ZMYND11, EXOC1, UNC93B1, SAMHD1, IL33, STAT1, MX2, CARD9, LILRB1, PML, F2RL1]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[SUV39H2, SUV39H1, MPL, RORA, PHB2, SLC8A1, AQP1, ICAM1, AKT1, EDN1, KCND2, PRKCE, SIRT1, CCNA2, ADAM8, TWIST1, PTGS2, CCNB1, BRIP1, E2F1, HMOX1, FABP1, BCL2]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, LRRK2, CETN3, CALML4, SLC8A1, GRM5, EDNRB, CCRL2, CCR9, TNFSF11, CCR7, CCR6, CCR5, CCR3, CCR2, EDN1, AVPR1A, ATP1B1, LAT2, BTK, AGTR1, CX3CR1, CAMK2D, CXCR5, CXCR4, FPR2, CXCR6, PLN, CXCR1, CXCR3, CXCR2, PLCG2, DMD, PLCG1, CCR10, CCR1, VCAM1, CCL20, AZU1, SELE, SELP, FKBP1B, CALM3, LAT]
GO:2001243;negative regulation of intrinsic apoptotic signaling pathway;9.0;0.7436939687323844;0.7680876095464813;9.413412872875176;597.3701724921605;5.233778845410465;0.0199934420750612;0.663896318730187;[LRRK2, CLU, AKT1, GPX1, PLAUR, MIF, MMP9, SIRT1, SFRP2, NDUFS3, BCL2A1, TAF9, PTGS2, FIGNL1, CD74, WFS1, SOD2, VNN1, CXCL12, BCL2, SNAI2, GRINA, BCL2L1]
GO:0051603;proteolysis involved in cellular protein catabolic process;6.0;0.6519675769143192;0.6491041010473041;8.270400768338927;49.64990487012002;3.4509241545253704;0.001661737633989536;0.49960073433695684;[, PSMD3, NEDD4L, ADAMTS12, HACE1, PLK1, TGFB1I1, SIRT1, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, USP1, USP9Y, PSMC6, PSMC2, RNF43, CUL5, UBR1, WFS1, CDK1, ARRB1, ARRB2, SCPEP1, DTL, BIRC2, UHRF1, HM13, VPS4B, ZNRF1, RNF24, GZMA, PML, CCNF, CDC20, TRIM25, SKP2, CDC34, CTSZ, KIF14, CTSW, CTSS, CTSH, CTSB, RNF144B, PCNP, RANBP2, RANBP1, FAP, NEDD4, MAD2L1, BUB1B, PTTG1, PSMD14, CCNB1, UBE2C, ISG15, UBE2S, TNFAIP3, RNF6, USP18, AURKB, AURKA, TBX21, CPVL]
GO:2001244;positive regulation of intrinsic apoptotic signaling pathway;9.0;0.7671156992804218;0.7797984748205;9.413412872875176;596.4251749563025;5.75172193694532;0.019961813857978603;0.6903839525180965;[PLEKHF1, NACC2, CAV1, SIRT1, LCK, BCL2, S100A9, ATF3, S100A8, NOX1, BCL2L1]
GO:0071459;protein localization to chromosome, centromeric region;7.0;0.7980440201809971;0.7499413753476991;9.117698628726131;34.71951895434896;6.8867018697843045;0.001162031053863633;0.7031056191423581;[MIS12, CDK1, BUB1B, TTK, CENPA, AURKB]
GO:0051601;exocyst localization;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;40.77205030767364;7.57984905034425;0.001364603831334836;0.710754145523778;[, TNFAIP2, EXOC1]
GO:2001022;positive regulation of response to DNA damage stimulus;7.0;0.7043150770688792;0.7030769037916401;8.890925309361343;86.91339641844894;5.382624473008031;0.0029089131611469855;0.6261870311244675;[BLM, PCNA, FMR1, BRCA1, FOXM1, NACC2, APBB1, PRKCD, H2AFX, PARP9, SIRT1, TIMELESS]
GO:0060311;negative regulation of elastin catabolic process;8.0;1.0;0.875;9.628524252492122;870.446617572591;9.777073627680469;0.029133064939058265;0.875;[CST3]
GO:1901673;regulation of mitotic spindle assembly;10.0;1.0;0.9152410118609203;9.628524252492122;218.77880646863287;6.832634648514029;0.0073223297643623805;0.7646622655359331;[VPS4B, PLK1, SMC1A, SMC3, STAG2]
GO:0002292;T cell differentiation involved in immune response;7.0;0.7586651285174919;0.7302519295159464;9.260799472366804;150.83672260445746;6.686031174322154;0.00504836936133411;0.692843310444282;[EOMES, SEMA4A, FCER1G, LEF1, RORA, GATA3, RELB, CLEC4D, BCL3, CLEC4E, IL18R1]
GO:1902523;positive regulation of protein K63-linked ubiquitination;12.0;0.9326813400603323;0.9144609826203107;9.593432932680852;695.4271152056829;8.67846133901236;0.02327531970216374;0.8919372290569614;[PTPN22, NOD2, BIRC2]
GO:0002052;positive regulation of neuroblast proliferation;8.0;1.0;0.875;9.628524252492122;500.99868276789744;6.781341354126479;0.016767975042699966;0.7217981122146513;[CX3CR1, ASPM, SMARCD3]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[SPARC, TFRC, CLEC10A, ICAM3, KIAA1109, DPYSL2, CUBN, SLC11A1, HSPG2, RIN2, CFI, FPR2, CD14, IGHA1, ELANE, SLAMF1, MSR1, CDC7, MARCO, DENND1B, ACHE, ADM, CLINT1, ASGR1, ASGR2, STAB1, CD36, ANXA1, FCER1G, SYK, ANXA3, NME1, CEACAM1, RARA, RHOU, CD302, CD5L, TMPRSS2, IGKC, CXCR1, CXCR2, SORT1, LILRB1, SNX17, NEDD4, SIGLEC1, RAMP1, SCARB2, NCF2, NCF4, HP, LY75, CXCL16, LOXL2, PYCARD, AP2M1, TGM2, CD93, TSC2, RAB31, PRTN3, CALCRL, PLD4, ADRB2, CORO1A, IGLV1-44, CD163, SYT2, CAV2, CAV1, LRP1B, MARCH3, DAB2, SYNJ1, IGKV3-20, LRP12, BCL2L1, LRRK2, ITGB3, ITGB2, ARRB1, ARRB2, ITGAL, PIK3C2A, GHR, ITGA4, DNM2, PECAM1, IRF8, PIK3C3, DOCK2, COLEC12, NLGN1, LRP1, CEBPE, LRP2, DLL1, FCGR1A, FCGR1B, ATP9A, SNCA, NLGN4Y, CD6, CD5, CD9, FCGR2B]
GO:1904706;negative regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.8833163751231;6.8867018697843045;0.0027070918088165762;0.7031056191423581;[IL10, CNN1, MEF2C, CDKN1A, MYOCD, TPM1, HMOX1, SOD2]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[SCARB2, SPARC, TFRC, HP, CXCL16, LOXL2, AP2M1, CUBN, HSPG2, RAB31, CALCRL, CFI, FPR2, ADRB2, IGLV1-44, CD14, IGHA1, MSR1, CD163, CAV2, CAV1, LRP1B, MARCO, DAB2, SYNJ1, IGKV3-20, LRP12, ACHE, ITGB2, ADM, ARRB1, ARRB2, ASGR1, ASGR2, STAB1, CD36, FCER1G, SYK, ITGA4, DNM2, CEACAM1, COLEC12, LRP1, CD5L, TMPRSS2, LRP2, DLL1, IGKC, CXCR1, CXCR2, FCGR1A, FCGR1B, SNCA, LILRB1, CD6, SNX17, CD5, NEDD4, CD9, FCGR2B, RAMP1]
GO:0060313;negative regulation of blood vessel remodeling;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;101.63443030228625;8.67846133901236;0.0034016129171686622;0.7669372290569613;[CST3]
GO:0006895;Golgi to endosome transport;7.0;1.0;0.8509193652572005;9.628524252492122;52.5351401021073;6.8867018697843045;0.0017583038606610233;0.7031056191423581;[SORT1, KIF16B]
GO:0048208;COPII vesicle coating;6.0;1.0;0.8231203125901445;9.628524252492122;62.43707956725794;5.6339389012889365;0.0020897128633926582;0.6112402100070131;[NAPA, SERPINA1, CTSZ, TGFA, F5]
GO:0071681;cellular response to indole-3-methanol;6.0;1.0;0.8231203125901445;9.628524252492122;467.4090985487011;8.16763571524637;0.01564376188754665;0.7408135829017477;[JUP, CDH1, CTNNA1, BRCA1]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[, PROS1, ANK1, NRBP1, COPB2, TGFA, SPTA1, SERPINA1, CTSZ, SPTAN1, TMED6, SPTB, F5, RAB33B, NAPA, GOPC]
GO:0009913;epidermal cell differentiation;5.0;0.7436939687323844;0.6620879962271125;8.712233520617966;24.20171999872632;5.277263957350204;8.100097882234571E-4;0.560120536057681;[YAP1, CSTA, HDAC2, DSP, MED1, ST14, JAG1, ANXA1, KLF4, USH2A, EREG, FA2H, ADAM9, EPHA2]
GO:0071447;cellular response to hydroperoxide;5.0;0.8653626801206646;0.7229223519212526;9.485423408851448;143.11325921270426;7.697632086000634;0.004789871992277907;0.6838982747154925;[DAPK1, PRKCD, MGST1, CD36, AIF1]
GO:0071205;protein localization to juxtaparanode region of axon;5.0;0.9326813400603323;0.7565816818910864;9.510741216835738;40.92839637806193;8.16763571524637;0.0013698365936084043;0.7079342821725234;[EPB41L3]
GO:0050766;positive regulation of phagocytosis;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;175.32691305650852;5.825829909099042;0.005868033996023792;0.6729332124801218;[SIRPG, TNF, SIRPB1, C2, PYCARD, C3, STAP1, CCL2, SIRPA, NCKAP1L, CD36, CD300LF, FCER1G, SLC11A1, AZU1, DNM2, IL1B, F2RL1, PTX3, FCGR2B, DOCK2]
GO:0016202;regulation of striated muscle tissue development;6.0;0.6108066114563391;0.628523618318314;8.273978589686811;41.666489171895165;4.964889272308052;0.001394539895177614;0.5770249808669412;[ARRB2, JPH2, EPHB1, MEF2C, MYOCD, EDN1, TGFBR3, GREM1, LEF1, TWIST1, DLL1, PAK1, CCNB1, TGFB1, IGF1, MAPK14, MEIS1, BMP2, CENPF, RPS6KB1, CDK1, BCL2]
GO:0050764;regulation of phagocytosis;7.0;0.6873818243518346;0.6946102774331178;9.05316010758856;47.10255867462412;5.4730085344763;0.0015764802492890249;0.6308092762312435;[SIRPG, TNF, SIRPB1, PYCARD, SIRPA, CD36, FCER1G, SYK, SLC11A1, DNM2, FGR, HCK, IL1B, PRTN3, DOCK2, TLR2, C2, C3, STAP1, CCL2, NCKAP1L, CSK, CD300LF, TGFB1, AZU1, F2RL1, PTX3, FCGR2B]
GO:0050765;negative regulation of phagocytosis;8.0;0.8436909121759173;0.7968454560879586;9.503361109538115;175.4194889364855;7.069023426578259;0.005871132427413739;0.7365101867784198;[TGFB1, PRTN3, CSK, FCGR2B, CD300LF, TLR2]
GO:0019934;cGMP-mediated signaling;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;28.507808342730176;7.069023426578259;9.541306898693577E-4;0.7365101867784198;[EDNRB, PRKAR1B, PRKAR2B, CD36]
GO:0060100;positive regulation of phagocytosis, engulfment;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;308.80984280932773;7.57984905034425;0.010335587528013168;0.7838744581139225;[STAP1, F2RL1, NCKAP1L, CD36]
GO:0014002;astrocyte development;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.09911675737102;6.832634648514029;0.001141266750656509;0.639662265535933;[CDK6, PLP1, TSPAN2, DLL1, S100A9, S100A8]
GO:0060585;positive regulation of prostaglandin-endoperoxide synthase activity;6.0;1.0;0.8231203125901445;9.628524252492122;94.41559583685607;8.67846133901236;0.003160005024139943;0.7669372290569613;[EDN1, NOD2]
GO:0060586;multicellular organismal iron ion homeostasis;10.0;1.0;0.9152410118609203;9.628524252492122;58.33118610341119;7.57984905034425;0.0019522923042219213;0.8028748447945538;[SLC11A1, SLC40A1, RHAG]
GO:0090197;positive regulation of chemokine secretion;10.0;0.8933024483968273;0.861892236059334;9.567899630675686;759.1048076819071;7.292166977892469;0.025406554763140368;0.7881627702307852;[PYCARD, CSF1R, IL33, POSTN]
GO:0061436;establishment of skin barrier;8.0;1.0;0.875;9.628524252492122;44.874432655588755;6.781341354126479;0.0015019068766151408;0.7217981122146513;[CLDN4, STMN1, SFN, ALOX12]
GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity;11.0;0.7866048967936545;0.8257314007264895;9.474373572664863;340.6851601099881;5.181953777545879;0.011402425712143147;0.6974343094988531;[CDKN1A, CCNT2, CCNH, CCNF, TNFAIP3, CCNC, CKS1B, HERC5, HHEX, AKT1, MEN1, MYOCD, CDC25C, CDC25A, CCNA2, PSRC1, CCNE2, CCNE1, CKS2, CEBPA, BLM, PKMYT1, CCNB2, CCNB1, SFN, CDKN2C, PLK1, GTF2H1, CDC6, NR2F2, CDK6, CDKN3]
GO:0050773;regulation of dendrite development;9.0;0.7586651285174919;0.775573189439035;9.510741216835738;86.24077544028233;4.857092701852345;0.002886401142327329;0.6446325718309276;[CYFIP1, LRRK2, FMR1, CDC20, YWHAH, MEF2C, DCC, SHANK3, NLGN1, HDAC2, SDC2, NEDD4L, RAB21, PLK2, NEDD4, ID1, CAMK1, EZH2]
GO:0070383;DNA cytosine deamination;9.0;1.0;0.896240625180289;9.628524252492122;166.36310735944548;7.57984905034425;0.005568023486244473;0.7838744581139225;[APOBEC3A]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CDKN1A, FOXM1, PPP2R1A, NEK2, SKP2, TUBG1, MASTL, CDC25C, CKAP5, CDC25A, CIT, DNM2, CCNA2, MELK, PLCB1, PKMYT1, AURKA, CCNB2, CCNB1, PRKAR2B, CEP72, CEP76, PLK4, CEP152, PLK1, WEE1, CDK2, CDK1, CDK14]
GO:0050772;positive regulation of axonogenesis;10.0;0.7436939687323844;0.7870879962271125;9.36383169826504;884.0118179988558;5.395046993006588;0.02958707998943757;0.6911439659786198;[ROBO2, CYFIP1, NRP1, PLXND1, PAK1, ARHGDIA, FN1, CXCL12, MAP1B, PLXNB2]
GO:0000083;regulation of transcription involved in G1/S transition of mitotic cell cycle;10.0;0.8933024483968273;0.861892236059334;9.541512875502493;264.067998117236;6.444869117505266;0.008838118251214853;0.7448319182472036;[CDT1, PCNA, RRM2, GFI1, CDC6, TYMS, DHFR, POLA1, TFDP1, CDC45, CCNE1, E2F1, FBXO5, E2F7]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[CDKN1A, MCM7, MCM8, GMNN, MCM10, SKP2, CDC25A, DBF4, CDC34, CCNE2, CCNE1, MCM3, MCM4, RHOU, MCM5, MCM6, BCAT1, MCM2, PRIM2, CUL5, PRIM1, IQGAP3, GSPT1, CDC45, RBBP8, RANBP2, RANBP1, CDT1, CDKN2C, PLK2, RPA1, RPA2, CDC7, CDC6, INHBA, POLA1, POLA2, WEE1, CDK6, NASP, RPS6KB1, POLE2, RPA3, CDK2, CDKN3]
GO:0071479;cellular response to ionizing radiation;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;48.660440229648614;5.602686357784832;0.0016286211429333208;0.6096419534788213;[YAP1, CDKN1A, BLM, RAD51AP1, FIGNL1, ECT2, EGR1, TGFB1, H2AFX, MAPK14, SIRT1, DNM2, RAD51, SFRP2, NOX4, BCL2L1]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, CYFIP1, TFRC, CLEC10A, SLA2, MYB, TRBC1, C3AR1, UBASH3A, PGLYRP1, PRKACB, MED1, MEF2C, CXADR, PRKCH, PRKCB, PRKCE, PRKCD, SERPING1, PRKCQ, CFB, CFD, CFH, HHLA2, PRKDC, CFI, FPR1, FPR3, FPR2, GATA3, THY1, CFP, PRKCZ, SAMSN1, C2, C3, KLRK1, C7, PLCG2, HMOX1, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, ELANE, LYN, JUN, HLA-DRB4, FZD5, KIR2DS1, KIR2DS2, COL1A1, COL1A2, HLA-DRB1, DENND1B, ITK, SIGLEC9, IFIH1, CTLA4, JAK3, HLA-DPA1, HAVCR2, ANXA1, DUSP3, ARG1, IFNGR1, RIPK2, FCRL3, NFAM1, IFNGR2, PAWR, SERPINB9, PAX5, FOS, SIRT1, MMP12, FCER2, PLSCR1, RARA, TLR10, HLA-DQB1, PTAFR, UNG, NRAS, HLA-DMB, CCL19, IL12RB1, STAT1, NR1H2, CARD9, NR1H4, KIR3DL1, COL3A1, HLA-DPB1, PKN1, CLC, SIGLEC7, LGR4, PROS1, CXCL13, TNF, CLU, PYCARD, IGHG1, FCGRT, GRAP2, IL13RA2, CD177, LAG3, CD180, MSH6, CLEC4A, ADCYAP1, CLEC4D, MSH2, ADAM8, CLEC4E, S100A9, S100A8, BLK, CD274, LY96, CLEC7A, IGLV1-44, CD300LF, MAP2K6, EIF2B3, BMX, NFKB1, PTPRC, BCL6, BCL2, HLA-DRA, LAT, MYD88, ITGAM, ITGB2, PIK3CD, TREM2, PTPN22, ARRB2, ITGAL, TREM1, TNFSF13B, FCGR3A, DUSP10, ITGB7, CR2, CR1, GPX1, CHUK, ITGA4, PVRIG, LCK, XCL1, LCP2, PIK3C3, BIRC2, BIRC3, C1S, UNC93B1, C1R, NLRC3, NLRC4, NOD2, CCL5, FYN, CSK, FCGR1A, FCGR1B, FCGR2A, PTPN6, MNDA, CD247, FCGR2B, CLEC2D, IFITM1, GFI1, ICAM2, ICAM3, ICAM1, LGALS3, DHX58, ICOSLG, RSAD2, SLC11A1, HLA-B, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IL23A, BTK, TXK, STXBP2, CD1E, CD1D, CD1C, CD1B, CD1A, CD79B, CD79A, CD19, INPP5D, SLAMF7, CD14, A2M, PAG1, SH2D1A, TNFSF13, PILRA, PTK2, MARCO, CD28, CD24, CD200, IGHM, ECM1, CD40, IFNA2, CD3G, CD3E, CD3D, CTSS, RAC2, FCER1A, CTSH, MUC13, CD38, FFAR2, CTSG, CCR7, MUC15, CD36, CD34, CD33, CCR2, IL10, FCER1G, SYK, IL15, IL18, GAB2, PARP9, LIME1, VAV1, LAT2, TLR1, NCR1, HCK, CEACAM1, IL1B, KIT, IGHD, TLR8, TLR7, CD48, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA1, LILRA2, RELB, PAK1, IGKC, NPDC1, CD74, IL33, LILRB1, LILRB2, MLH1, LILRB4, CD40LG, F2RL1, C1QC, CD86, FCN1, CD80, TRAC, IL18RAP, IL6R, CD96, THEMIS, MUC3B, OSCAR, TYROBP, CD8B, CD8A, KLRF1, CD300C, CARD11, KLRB1, C5AR1, KIR2DL1, KIR2DL2, CACNA1F, DDX60, KIR2DL3, RASGRP1, KIR2DL4, STAP1, NLRP3, LPXN, KLRC1, BTNL8, TGFB2, TGFB1, VCAM1, CAV1, CRTAM, NFKBIA, IL6, NR4A3, SELL, FES, KLRD1, IL7R, NFKBID, IGKV3-20, HMGB2, TNFAIP3, PDE4B, DDX58, MMP2, PDE4D, IRAK3, FGR, ZAP70, IFNG, LTA, IRF7, LTF, COLEC12, CLEC12B, SAMHD1, USP18, HSPD1, CNR1, HLX, TBX21, TRAT1, MAPK14, CD4, TNIP3]
GO:0051865;protein autoubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;155.4032479663248;5.769740442447999;0.005201206855589802;0.7103058064080809;[UHRF1, BRCA1, UBE2T]
GO:0045190;isotype switching;12.0;0.8259837884571596;0.8611122068187244;9.517298617381897;267.39842152832483;6.943860283624253;0.00894958452559752;0.8032296504172152;[MLH1, HSPD1, MSH6, CD40LG, MSH2, EXO1, CCR6]
GO:2001268;negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;1177.790893893302;8.16763571524637;0.039419601275621635;0.8802482350792397;[PLAUR, MMP9]
GO:0014013;regulation of gliogenesis;7.0;0.622025257344104;0.6619319939292525;8.625222143628337;62.256296269576055;5.152100814396198;0.0020836622091136505;0.6143980405026119;[DUSP10, MYB, CCR2, PRKCH, ADCYAP1, SPINT1, DAAM2, IL1B, LTA, ASPA, TLR2, HDAC2, CXCR4, LRP2, ASCL2, STAP1, LYN, LIF, BMP2, LIN28A, SYNJ1, CDK1, EZH2]
GO:0060574;intestinal epithelial cell maturation;6.0;1.0;0.8231203125901445;9.628524252492122;41.35061092186203;8.390779266560578;0.0013839677344209735;0.7522251544931926;[CDKN1A, TYMS, HOXA5]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, IFI30, OASL, ICAM1, TRIM25, HLA-DPA1, IFNGR1, IFNGR2, PRKCD, HLA-B, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E, HCK, IFNG, OAS1, OAS3, IRF7, IRF8, HLA-DQB1, CAMK2D, SP100, PTAFR, NCAM1, FCGR1A, FCGR1B, HLA-DQA2, HLA-DQA1, HLA-DRB4, VCAM1, STAT1, PML, HLA-DPB1, HLA-DRA, HLA-DRB1]
GO:0034088;maintenance of mitotic sister chromatid cohesion;4.0;0.8653626801206646;0.6826813400603323;9.158520623246385;27.51648075733887;8.390779266560578;9.20951847723215E-4;0.6791048419030481;[DSCC1]
GO:0048469;cell maturation;3.0;0.6954798709641801;0.5458602480722345;8.242229891372231;25.22197897315013;4.886724499458715;8.441569379239579E-4;0.4480276307483924;[CDKN1A, IHH, BRCA2, ROPN1L, FBXO5, HOXA5, HBZ, IL15, RUNX2, EREG, TAL1, BTK, FAM20C, CFTR, CEBPA, EPB42, GATA3, TYMS, CCNB1, CCL19, FZD5, CCL21, NR4A2, FEV, GNAQ, SLC26A8, PLP1, TRIP13, SLC26A3]
GO:0006633;fatty acid biosynthetic process;8.0;0.6493065804076676;0.6996532902038338;8.912904216080118;359.8485513982277;5.076593261888053;0.01204380717262807;0.6346172154986847;[TECR, ACSM2A, ACSM5, BRCA1, EDN1, ELOVL4, ELOVL6, MIF, ELOVL7, MGST1, ALOX12, PTGS2, CYP3A4, PTGS1, ALOX5, CD74, PNPLA8, FA2H, SCD, NDUFAB1, PLP1]
GO:0006876;cellular cadmium ion homeostasis;10.0;1.0;0.9152410118609203;9.628524252492122;329.3407122754199;9.777073627680469;0.011022737252460356;0.9152410118609203;[SLC11A1]
GO:0006631;fatty acid metabolic process;7.0;0.5408746917014966;0.6213567111079488;7.849668188099975;91.0232021896581;4.037280715501235;0.0030464646617242943;0.5573860888006872;[, SCARB2, ACSM5, CYP1B1, ACSL1, ACSL5, MIF, POR, SLC27A3, SLC27A2, MGST1, ALOX12, ACAT1, C3, PRKAR2B, CYP4F2, CYP4F3, CYP4F12, FA2H, TBXAS1, TECR, ACSM2A, ETFA, BRCA1, GHR, ACADM, HIBCH, EDN1, GPX1, ELOVL4, CYP4A11, ELOVL6, ELOVL7, NDUFS6, EHHADH, ACSBG1, HSD17B4, AOAH, PTGS2, CYP3A4, PTGS1, ALOX5, SNCA, CD74, PNPLA8, MAPK14, SCD, NDUFAB1, PLP1]
GO:0034080;CENP-A containing nucleosome assembly;9.0;1.0;0.896240625180289;9.628524252492122;242.74046782674554;6.343086423195323;0.00812430500592325;0.7206263598461826;[CENPW, HJURP, CENPA, NASP, CENPH, CENPI, CENPK, RUVBL1, CENPL, CENPM, CENPN, OIP5, CENPO]
GO:0070371;ERK1 and ERK2 cascade;10.0;1.0;0.9152410118609203;9.628524252492122;233.3964595037646;6.481236761676141;0.007811569456414605;0.7466917612613706;[MED1, MAP2K2, EGF, IGF1, IQGAP3, TNFSF11, CTSH]
GO:0070372;regulation of ERK1 and ERK2 cascade;10.0;0.8653626801206646;0.8479223519212526;9.541512875502493;158.98679164778278;4.069963362931594;0.0053211448376282704;0.623379127513894;[PHB2, TNF, CTGF, ICAM1, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, ATF3, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FBLN1, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PKHD1, PDGFD, PDGFC, FAM83D, SLAMF1, LYN, CCR1, JUN, TGFB1, LIF, FN1, MARCO, BMP2, NOX4, NRP1, PTPRR, TREM2, PTPN22, ARRB1, ARRB2, CYR61, DUSP10, TIMP3, CCR7, EMILIN1, CD36, HAVCR2, DUSP3, SYK, DUSP1, RIPK2, DUSP6, CEACAM1, IL1B, KIT, XCL2, CHI3L1, XCL1, TLR4, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, KLF4, CD4, NLRP12, F2RL1, PTPN6, TEK]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CSF3, CD80, GFI1, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, ICAM1, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, IL10, GHSR, MEF2C, ARG1, PDE4D, CD180, PDCD1LG2, TNFRSF1B, IL1B, RARA, ADAM9, IRF8, TLR4, CX3CR1, CD274, CEBPB, CEBPE, SBNO2, KLRK1, STAP1, NLRP3, CCL2, CD14, ABCA1, CCL20, NR1H2, DEFA4, NR1H4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, TNIP3, PF4]
GO:0048478;replication fork protection;10.0;1.0;0.9152410118609203;9.628524252492122;1135.309178205509;7.57984905034425;0.037997776482613155;0.8028748447945538;[SMARCAL1, BLM, TIPIN, DONSON, TIMELESS, BRCA2]
GO:0071223;cellular response to lipoteichoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;155.87545856417063;7.474488534686424;0.005217011319337755;0.7053660038532718;[CCL20, RIPK2, TREM2, CD36, CD14, MAPK14, TLR2]
GO:0048477;oogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;84.68474556890583;6.481236761676141;0.002834322222868324;0.6216917612613706;[ASPM, TRIP13, MLH1]
GO:0070373;negative regulation of ERK1 and ERK2 cascade;11.0;1.0;0.9324289523296623;9.628524252492122;1180.902522994834;5.6339389012889365;0.039523744701365535;0.7205488497465309;[PTPRR, FBLN1, ARRB1, DUSP10, TIMP3, CSK, EMILIN1, EPHB2, LYN, DUSP3, DUSP1, LIF, KLF4, DUSP6, NLRP12, TLR4, ATF3]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, ICAM1, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PDGFD, PDGFC, SLAMF1, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, ARRB1, ARRB2, CCR7, CD36, HAVCR2, RIPK2, IL1B, KIT, XCL2, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, CD4, F2RL1, TEK]
GO:0071226;cellular response to molecule of fungal origin;5.0;1.0;0.7902410118609202;9.628524252492122;58.24779613319063;9.083926447120524;0.00194950131696474;0.7547934328124444;[SYK, BTK]
GO:0071466;cellular response to xenobiotic stimulus;4.0;0.7436939687323844;0.6218469843661922;8.578702127993445;40.79473292833871;5.769740442447999;0.0013653629982354628;0.5450647945471605;[MCM7, FECH, ABCB4, AIF1, SLC8A1, FOXO1, AQP1, ICAM1, E2F1, EGR1, TGFB1, ARG1, CCNA2, RPS6KB1, APOBEC3A]
GO:0071224;cellular response to peptidoglycan;6.0;1.0;0.8231203125901445;9.628524252492122;318.29655603595194;8.16763571524637;0.010653099282220678;0.7408135829017477;[RIPK2, NLRP3, TREM2, NOD2]
GO:0071225;cellular response to muramyl dipeptide;7.0;1.0;0.8509193652572005;9.628524252492122;334.57737126116905;8.16763571524637;0.011198003516026267;0.7686126355688037;[RIPK2, PTPN22, NOD2]
GO:1990918;double-strand break repair involved in meiotic recombination;9.0;1.0;0.896240625180289;9.628524252492122;208.20493307654428;8.67846133901236;0.006968431737797406;0.8400575416471059;[BRIP1]
GO:0030951;establishment or maintenance of microtubule cytoskeleton polarity;6.0;0.9326813400603323;0.7894609826203107;9.533214072687796;65.29771360028688;8.390779266560578;0.002185455710074652;0.7522251544931926;[KIF2C, CKAP5]
GO:0014005;microglia development;5.0;1.0;0.7902410118609202;9.628524252492122;67.63861772680754;8.67846133901236;0.0022638036645123614;0.7340579283277371;[TSPAN2, TLR2]
GO:0042536;negative regulation of tumor necrosis factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;858.4851481575464;7.9853141584524145;0.0287327253223603;0.7833693374183408;[IL10, GHSR, BCL3, LILRB1]
GO:0045806;negative regulation of endocytosis;7.0;0.7192862368539868;0.710562483684194;9.057979394024509;124.57926064357885;5.8650506222523235;0.004169555739685066;0.6508583268319309;[MCTP1, LGALS3, CSK, CD300LF, TGFB1, NR1H2, CAV1, LILRB1, PRTN3, FCGR2B, EPHA3, TLR2]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[CSF3, NCF1, PDGFA, CCL5, PDGFD, PDGFC, FYN, PDGFRB, PDGFRA, TGFB2, F2R, IL18, IGF1, SIRT1, PTK2, DCN, FGR, SELP, GH1, NEDD4, KIT, CD28, HCLS1, F2RL1, PTPN6, TEK]
GO:0014067;negative regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;7.292166977892469;0.00799223380789131;0.747921758369865;[TSC2, TWIST1, NLRC3, KLF4]
GO:0014066;regulation of phosphatidylinositol 3-kinase signaling;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;45.070113835906206;5.202362649177086;0.001508456149618737;0.6169684330707209;[CSF3, NCF1, CEP55, IER3, PDGFRB, PPP1R16B, PDGFRA, F2R, IL18, TSC2, SIRT1, DCN, FGR, CEACAM1, KIT, HCLS1, TWIST1, PDGFA, NLRC3, RASGRP1, CCL5, PDGFD, PDGFC, FYN, PIP5K1B, TGFB2, IGF1, C3orf58, KLF4, PTK2, SELP, GH1, NEDD4, CD28, F2RL1, PTPN6, TEK]
GO:0045807;positive regulation of endocytosis;7.0;0.6873818243518346;0.6946102774331178;8.89763674394933;124.48668476360231;4.886724499458715;0.0041664573082951335;0.6008266834154484;[LRRK2, FMR1, SIRPG, SERPINE1, ARRB1, ARRB2, TNF, CLU, SIRPB1, PYCARD, SIRPA, CD36, FCER1G, SYK, SLC11A1, ACTN4, DNM2, GREM1, SFRP4, IL1B, DOCK2, NLGN1, CD151, LRP1, NEDD4L, DLL1, C2, RAB21, C3, NTF3, PLCG2, STAP1, CCL2, NCKAP1L, CCL19, CD14, CD300LF, SNCA, CCL21, EGF, AZU1, SELE, TF, DAB2, SYNJ1, F2RL1, PTX3, FCGR2B]
GO:0014063;negative regulation of serotonin secretion;8.0;1.0;0.875;9.628524252492122;272.1012405442988;8.390779266560578;0.009106983645799836;0.8041048419030481;[LILRB1]
GO:0051490;negative regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;173.84791521056468;8.67846133901236;0.005818533269131697;0.8400575416471059;[PRKCD]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[CSF1R, CD40, HDAC2, IFNA2, GHR, CCL5, FYN, IL6R, LYN, IL15, LIF, IL18, OSM, IGF1, PARP9, GH1, IL6, IFNG, IL23A, KIT, HCLS1]
GO:0008625;extrinsic apoptotic signaling pathway via death domain receptors;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;52.44533375847466;6.311337724880743;0.0017552981231601008;0.6736814700148209;[FASLG, TNF, CASP8AP2, SORT1, DAPK1, TNFRSF10B, BCL2]
GO:0042535;positive regulation of tumor necrosis factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;857.3444905607055;7.379178354882098;0.028694548539119222;0.7523715242355574;[TLR1, CYBB, AZU1, TLR4, THBS1, CCR2]
GO:1990001;inhibition of cysteine-type endopeptidase activity involved in apoptotic process;13.0;1.0;0.9625549647676366;9.628524252492122;2010.8653136723324;7.292166977892469;0.06730185238732382;0.8354767231375014;[BIRC5, NLRC4, NAIP, BIRC2, BIRC3]
GO:0031638;zymogen activation;7.0;0.8259837884571596;0.7639112594857803;9.387362195675234;102.5832240862455;6.113511981550823;0.00343336819125881;0.663564652301091;[C1R, RIPK2, F11, CD5L, DHCR24, ASPH, PLAU, PERP, CTSH, PRSS3]
GO:0032727;positive regulation of interferon-alpha production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.7325511899570465;0.0028249751562838235;0.6952223462072524;[CHUK, DDX58, RIPK2, STAT1, HSPD1, MMP12, IFIH1, IRF7, TLR8, TLR7, TLR4]
GO:0051005;negative regulation of lipoprotein lipase activity;7.0;1.0;0.8509193652572005;9.628524252492122;65.18845533903233;8.16763571524637;0.0021817989343965133;0.7686126355688037;[SORT1]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[CYFIP1, NRP1, CPNE5, CXCL16, RPS6KA1, AKT1, CD38, EDN1, AVPR1A, SFRP2, MAP1B, S100A9, S100A8, HBEGF, TAF9, LEF1, NEDD4L, PAK1, SFN, TGFB2, SYT2, FN1, IGF1, CXCL12, BCL2]
GO:0051000;positive regulation of nitric-oxide synthase activity;7.0;1.0;0.8509193652572005;9.628524252492122;123.23454311126406;6.832634648514029;0.0041245492540456985;0.7003406189322132;[DHFR, FCER2, GCH1, AKT1]
GO:0010933;positive regulation of macrophage tolerance induction;7.0;1.0;0.8509193652572005;9.628524252492122;164.43476621900118;9.777073627680469;0.005503483643668157;0.8509193652572005;[IRAK3]
GO:0032728;positive regulation of interferon-beta production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.343086423195323;0.0028249751562838235;0.6753050999230941;[HMGB2, IFIH1, DDX58, RIPK2, IRF7, TLR8, TLR7, TLR4, TLR2]
GO:0010936;negative regulation of macrophage cytokine production;8.0;1.0;0.875;9.628524252492122;311.05347994333346;8.16763571524637;0.010410680043746014;0.7926932703116032;[TGFB2, TGFB1, IRAK3]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[PTPN22, CD3E, TNF, PYCARD, PDE4B, IL6R, CCR2, HLA-DPA1, HAVCR2, RIPK2, SLC11A1, PDE4D, IL18, IL23A, IL1B, LTA, TLR8, IRF8, TLR7, TLR4, TXK, EBI3, RASGRP1, HSPD1, KLRK1, CD14, IL12RB1, IL12RB2, FZD5, CD2, BCL3, HLA-DPB1, IL18R1, CD244]
GO:0032722;positive regulation of chemokine production;6.0;0.7140352122741334;0.6801379187272112;8.734706376470026;66.68357405504983;5.8067817141283475;0.002231839212302133;0.6200793994936333;[CSF1R, TWIST1, TNF, PYCARD, HMOX1, FFAR2, IL6R, HAVCR2, EGR1, CD74, IL33, POSTN, RIPK2, EIF2AK2, AZU1, MIF, ADCYAP1, IL1A, IL6, IL1B, TLR7, TLR4, TLR2]
GO:0032720;negative regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.92712208559752;5.926926025970411;0.002875903446815721;0.6540226378555745;[ORM1, TNFAIP3, TWIST1, PTPN22, NLRC3, ARRB2, GPNMB, CD34, HAVCR2, SLAMF1, IL10, GHSR, NR1H4, LILRB1, IRAK3, BCL3, RARA, BPI, TLR4, GPR18]
GO:0051248;negative regulation of protein metabolic process;6.0;0.4463712279514003;0.5463059265658446;6.752138736570697;129.5306506172274;2.7979283526116596;0.004335274306141412;0.46620649865967934;[PID1, SPI1, SERPINE1, SPINT2, ADARB1, AKT1, DAPK1, PRKCE, PRKCD, SPINT1, PRKAR1B, SERPING1, ATF3, PRKDC, THY1, PRKCZ, SAMSN1, C3, FLRT2, PRKAR2B, SFN, NCKAP1L, ELANE, LYN, JUN, PLK1, EIF2AK2, NR2F2, DHFR, PKIG, CDKN1A, BTG2, SERPINA1, LRRC4, TIMP2, PBK, TIMP3, TIMP1, JAK3, DUSP2, SERPINB2, DUSP3, DUSP1, BGN, SERPINB9, PAX5, SIRT1, DUSP6, PAX2, SRP9, RARA, GAS1, HBEGF, ENG, SERPINB10, LRRC19, FAM129A, PTGS2, NTF3, FLNA, DMD, CDKN2C, NR1H2, FABP1, PKN1, FMR1, PROS1, TNF, CLU, PYCARD, LAMP3, MEN1, PPP1R16B, LAG3, IGFBP5, CISH, IGFBP3, DNMT1, FOXO1, SOCS2, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, PTPRC, CDK6, CNOT3, BCL3, PTTG3P, LRRK2, ITGB3, PTPN22, ARRB1, ARRB2, FOXM1, ALAD, HHEX, DUSP10, EMILIN1, CR1, GPX1, TNFRSF1B, BIRC5, BIRC2, BIRC3, PPP1R15A, CEBPA, HDAC2, NLRC4, FYN, CSK, KLF4, PML, EIF3E, PTPN6, AQP1, EDNRB, PPP2R1A, RPS6KA1, FBXO5, EPHB2, SOX4, IL1R2, PAQR3, MIF, POR, SFRP2, SLPI, TRIB1, NAIP, TWIST1, INPP5D, A2M, TNFSF14, GADD45B, LIF, CD27, CALM3, ITM2A, ITM2C, PTPRR, ECM1, CTSZ, BRCA1, IL10, EDN1, GP1BA, CEACAM1, BANK1, IL1B, TLR4, CSTA, IFI6, CST7, TYMS, GNAI2, CST3, PURA, TM4SF20, APBB1, LILRB1, LILRB2, PODN, NLRP12, FKBP1B, F2RL1, MAD2L1, PTTG1, GHSR, APLP2, TSC2, FBLN1, CCNB1, TGFB1, CAV1, CRIM1, ISG15, INHBA, EIF2S1, VIL1, IL6, LIN28A, GNAQ, TNFAIP8, TNFAIP3, LRRTM4, NUP62, MYOCD, PDE4D, PLAUR, IRAK3, MASTL, MMP9, DCN, GREM1, COL6A3, ZMYND11, LTF, TAF9, LEF1, THBS1, SPOCK3, SNCA, PTX3]
GO:0042789;mRNA transcription by RNA polymerase II;11.0;1.0;0.9324289523296623;9.628524252492122;1288.3918881325048;6.832634648514029;0.043121317018375266;0.781850206004675;[MED1, C5AR1, LMO2, FLNA]
GO:0036089;cleavage furrow formation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;34.64508192741332;7.8311634786251565;0.001159539713561072;0.7236063770733796;[AURKB]
GO:0016239;positive regulation of macroautophagy;8.0;0.7671156992804218;0.7585578496402109;9.242861771680136;266.06548500403863;5.666199763507158;0.008904972339694651;0.6647697194109919;[ADRB2, SESN3, HMOX1, RIPK2, TSC2, SIRT1, DCN]
GO:0045814;negative regulation of gene expression, epigenetic;7.0;0.7671156992804218;0.7344772148974115;9.081980546124052;80.1036275103501;5.2552850506314295;0.0026809963241870454;0.6196748871422394;[CREBZF, SPI1, SUV39H1, BMI1, HELLS, H2AFX, SIRT1, DNMT1, EZH2]
GO:0042307;positive regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;778.7460608588023;6.063501560976162;0.02606392983099081;0.706328376990269;[LRRK2, PTGS2, CDH1, ECT2, MED1, TGFB1, JUP, PRKCD, IGF1, MAPK14, IFNG, CDK1, HCLS1]
GO:0042308;negative regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;779.1118030345037;7.138016298065211;0.026076170892464952;0.7612791106150483;[MDFIC, CD36, PKIG]
GO:0006691;leukotriene metabolic process;7.0;0.7586651285174919;0.7302519295159464;9.193206181234276;59.92630818990423;6.343086423195323;0.002005679604940167;0.6753050999230941;[SYK, CYP4F2, CYP4F3, CYP4A11, ALOX12, CYP4F12, ALOX5, TLR2]
GO:0002092;positive regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;393.55365953464764;6.599019797332524;0.013171886809326083;0.7337148045016781;[GREM1, SFRP4, SYK, EGF, FMR1, NTF3, PLCG2, ARRB1, ARRB2, SELE]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP1, COL12A1, LST1, IHH, SPINT2, ANTXR1, CLU, CDH5, C1GALT1C1, CDH3, POF1B, CDH1, MED1, MEF2C, ACTN1, COL23A1, CLDN3, ADAM8, EPHA2, SLC1A3, EPB41L5, NCKAP1L, ECT2, ST14, TGFB2, BCL11B, VDR, FN1, PARVB, BCL6, ID1, NOX4, IL7R, NRP1, COL14A1, ITGB3, KIF14, LAMC1, ITGB7, ITGA4, STRADB, GP1BA, GREM1, PALLD, COL6A2, CDH11, COL6A1, COL6A3, CDH17, YAP1, LEF1, PDPN, SLITRK6, FLNA, LAMB1, MAPK14, GRHL2, TEK]
GO:0014075;response to amine;5.0;0.7980440201809971;0.6892630219514189;9.223059144383958;29.79647000066773;6.139487467954083;9.972610358403309E-4;0.6042146864874571;[HDAC2, ARG1, CAD, NME1, ICAM1, NR4A2, CDK1, DRD4]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, PRF1, TCL1A, TNFSF11, TGM2, MIF, OLFM4, CLDN3, KCTD12, KCTD15, BLM, MGST1, ITPR3, ACAT1, CD79B, CD79A, NACC2, HMOX1, ECT2, VASP, CAV1, EHD3, DPYS, CD3G, CD3E, CD3D, ALAD, EMILIN1, TK1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, RXRA, POLQ, GCH1, SOD2, MARCKS, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;52.930841574252625;6.943860283624253;0.001771547632825523;0.7060287030842711;[GPX1, PRKCD, PML, MELK, BCL2, CYP1B1]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[CDKN1A, BCL2A1, PRKDC, BRCA1, BRCA2, TNF, PYCARD, E2F1, HMOX1, CASP2, SFN, MLH1, TNFRSF1B, SIRT1, PML, MSH6, MSH2, BCL3, BCL2, EPHA2, BCL2L1]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, ETS1, SLC8A1, AQP1, IL18RAP, MYB, CYP1B1, PDGFRB, ANXA1, GPX1, DUSP1, ARG1, PRKCD, SIRT1, PAX2, ADAM9, HDAC2, PCNA, KCNA5, FOXO1, CST3, PDGFD, HMOX1, ECT2, JUN, STAT1, KLF4, MAPK13, COL1A1, FABP1, FOSL1, IL6, NR4A3, FKBP1B, CDK1, BCL2, SDC1, EZH2]
GO:0009725;response to hormone;4.0;0.5257808277979137;0.5128904138989568;7.033269545535256;21.85620986101781;3.280298637494607;7.315076747364311E-4;0.41775462487096104;[CYFIP1, IL1RN, PID1, SPARC, AQP1, ICAM1, EDNRB, AKT1, PRKACB, JUNB, PTGDR, MED1, MEF2C, PRKCE, PRKCD, EREG, SFRP4, CLDN4, POR, ADCY9, PRKAR1B, SIK1, PRKDC, ABCB4, SLC30A10, GATA1, BRIP1, PRKAR2B, LYN, EGR1, EGR2, JUN, CDC6, NR2F2, COL1A1, FOSL1, SDC1, EZH2, ROBO2, CDKN1A, GABRB1, BTG2, ADM, BRCA2, CTSS, TIMP2, CTSH, TIMP3, CD38, CCR7, TIMP1, CTSB, IL10, EDN1, ANXA1, DUSP1, ANXA3, ARG1, TACR3, AVPR1A, FOS, SIRT1, NME1, CEACAM1, IL1B, KIT, RARA, MMP19, HCLS1, ACSBG1, ENG, TLR2, YAP1, PCNA, PTGER2, PTAFR, PTGS2, TYMS, AIF1, GNAI1, CST3, PAK1, SPP1, CCL19, CCL21, SORT1, STAT1, SORBS1, POU4F1, FOSB, RAMP1, TNC, IHH, TNF, ETS1, CTGF, SESN3, RUVBL2, MEN1, PDGFRB, GHSR, LHCGR, POSTN, IGFBP5, LMO2, CYBB, ADCYAP1, RAB31, LOX, ADAM9, FECH, FOXO1, ACAT1, SOCS2, IGFBP7, CYC1, GAS2L1, EIF2B3, TGFB2, TGFB1, CAV1, GGH, DHCR24, INHBA, NFKB1, NR4A2, NR4A1, GH1, IL6, KIF18A, CXCL12, NR4A3, NASP, BCL2, ALPL, FBN1, HMGB2, FHL2, GHR, ALAD, HHEX, CA2, UQCRFS1, GLP2R, CAD, TGFBR3, CCNA2, RETN, THBS1, P2RY6, PLN, RBBP8, FYN, CSK, TSHR, CD4, RPS6KB1, TEK]
GO:0009966;regulation of signal transduction;5.0;0.3290196849396939;0.45475085433076723;5.351858133476067;37.58855813399747;1.7469895334129066;0.0012580552132388425;0.37958213784297784;[, SLA2, AKT1, VSTM1, PRKACB, WLS, ATF3, PDGFA, GATA3, ADAMTS12, GATA1, PDGFD, PDGFC, SFN, PIP5K1B, JUN, JAG1, JUP, FN1, EIF2AK2, ARHGAP9, ARHGAP6, ARHGAP4, JAK3, DUSP2, DUSP3, DUSP1, BGN, GMIP, DUSP6, MMP12, PLSCR1, PXDN, FRZB, SPP1, BIK, COL3A1, PKN1, LGR4, SLA, EFEMP1, MAP3K8, IFNA14, CISH, IFNA16, PKP3, IFNA10, BLK, LY96, ZNF423, IFNA21, LY86, OGN, HPSE, ITGB3, TNFSF13B, HHEX, TAGAP, ADAMTS20, ACPP, E2F1, FYN, GZMB, ICAM1, LGALS3, LGALS1, TNFSF11, TRIM25, ACTN4, BTC, CDC34, TRIB1, NAIP, TGFA, PKHD1, RACGAP1, EGR1, TNFSF14, TNFSF12, TNFSF13, PPBP, IGF1, PTK2, BST1, PEX5L, NRP1, ECM1, AKAP12, RAC2, IL10, SYK, IL15, GAB1, IL18, IL1A, IL1B, KIT, YAP1, GNAI1, GNAI2, IL32, IL33, OSM, KITLG, IL18R1, GRINA, ZFAND6, PLAU, FAM3D, IL6R, TGM2, CARD11, HTRA1, CACNA1F, LPXN, ECT2, CAV2, CAV1, GH1, GNAQ, IL7R, FBN1, PLEK, TNFAIP3, GHR, MYOCD, IRAK3, GREM1, ELF3, CHI3L1, ZMYND11, FBP1, SHANK3, RNF6, RETN, CD4, TNIP3, TEK, PHB2, EPS8, PROK2, HOMER3, PRKCH, PRKCB, PRKCE, PRKCD, DEPDC1B, DAAM2, PRKCQ, SEH1L, PRKCZ, SAMSN1, FLRT2, PRDM16, HMOX1, ICOS, NDFIP2, PLK2, SNAI2, TIMP2, PBK, TIMP3, TIMP1, CEP55, ZEB1, GAS1, GRN, SGMS1, FGD3, FGD4, GPNMB, GSN, NR1H2, NR1H4, G0S2, PF4, CSF3, TNF, CLU, FGF5, TLE4, MAP2K2, UBR1, CD300LF, DRD4, MAP2K6, DAB2, COPS5, BCL6, BCL3, BCL2, CSPG4, CCDC22, LAT, BCL2L1, PLEKHF1, CYR61, LBH, EMILIN1, PLEKHG1, TFDP1, LCK, XCL2, XCL1, HDAC2, NLRC3, TTK, NLRC4, NOD2, PLN, TTR, CSK, PML, P2RX5, IL1RN, GFI1, PPP2R1A, IL1R1, IL1R2, FLT3LG, TIAM2, POR, IL23A, SIK1, NBL1, SH2D2A, TXK, TWIST1, APCDD1, TP53BP2, SH2D1A, LIF, TPX2, VNN1, CD320, IFNA5, IFNA4, IFNA7, IFNA2, PRL, IFNA8, RALGPS2, EDN1, STRADB, GP1BA, PARP9, ZDHHC17, VAV1, TLR1, TLR7, TLR6, TLR5, TLR4, TLR2, TYMP, SORBS1, CD40LG, F2RL1, SIPA1, F2RL3, ARHGDIA, ARHGDIB, POSTN, HGS, FANCD2, FBLN1, HRH4, NLRP3, FAM83D, SELP, KDM5D, LRRTM4, BLNK, CASP2, PLAUR, AXIN2, DCN, DNM2, ZAP70, LTA, LTB, PFDN5, LTF, CLEC12B, LEF1, THBS1, SNCA, C3orf58, RPS6KB1, PID1, UBASH3A, MEF2C, PADI2, FPR1, FPR2, THY1, SLC30A10, IQGAP3, C3, FIGNL1, LYN, ABCA1, COL1A1, NOX4, GPR18, NOX1, EZH2, SRPX, LRRC4, JPH2, GPR37, ARG1, GPR35, RIPK2, MYOF, EMP2, SIRT1, F3, LRRC19, PTGS2, NTF3, FLNA, DMD, STAT1, TMEM64, LRG1, NCF1, RORA, CXCL13, CTGF, CXCL16, SESN3, RUVBL2, RUVBL1, PPP1R16B, ADCYAP1, MAL, S100A9, S100A8, TNFRSF11A, FOXO1, SOCS2, TNFRSF10B, NFKB1, PTPRE, CXCL10, CXCL11, CXCL12, PTPRC, MYD88, ARHGAP11A, LRRK2, PIK3CD, FASLG, ARRB1, ARRB2, FOXM1, TNFSF12-TNFSF13, PVRIG, BIRC5, BIRC2, BIRC3, PPP1R15A, LRP1, LRP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, SH2B1, CTHRC1, PRRX1, TIE1, PTPN6, FCGR2B, DHX58, EPHB2, EPHB1, RSAD2, PAQR3, HNF1B, MIF, EREG, SFRP4, SFRP2, EPHA3, EPHA2, PIK3R5, CD19, TSPAN5, CD14, A2M, PAG1, SLAMF1, CCR1, ID1, CD28, CD27, CALM3, CD24, PTPRR, CD40, KIF14, SECTM1, BRCA1, CD3E, PCSK6, CTSH, CCR7, CD36, BANK1, PAK1, CD74, PPP1CA, NLRP12, KIF26A, NEDD4, FKBP1B, RAMP1, IL17A, SCARB2, CD86, CD80, IHH, RGS1, PDGFRB, PDGFRA, CALCA, DDX60, RASGRP1, RASGRP4, INHBA, IL6, BMP2, HMGB2, ARHGEF10L, NUP62, YWHAH, ARHGEF12, MMP9, NDUFS3, IRF7, BCL2A1, TAF9, AURKB, AURKA, EPS8L1, EPS8L3, EGF, MAPK14, SOD2, TAF5, CYFIP1, SERPINE1, STMN1, CYP1B1, IER3, MED1, DAPK1, MAML3, S100A12, ELANE, FZD1, FZD5, FZD8, PNOC, CDK14, TGFB1I1, ADM, HAVCR2, FCRL2, IFNGR1, FCRL3, NFAM1, IFNGR2, PAWR, PAX5, AES, HCLS1, PLCB1, HBEGF, ENG, CCL13, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, SULF1, POU4F1, SULF2, GUCA1C, PYCARD, CDH3, GRAP2, PHLDA2, CD177, MEN1, RNF43, IGFBP5, IGFBP3, CD180, F2R, ADAM9, ADAM8, CSF1R, RASAL2, NACC2, PSAP, WFS1, CDK2, CDK1, TREM2, PTPN22, DUSP10, PSD3, GPX1, CHUK, TRAF1, ASPM, CX3CR1, NLGN1, KLF4, CHEK1, SKP2, SOX7, SOX4, RUNX2, RRAGD, LLGL2, EBI3, INPP5D, GADD45B, MARCO, ITM2C, ESM1, MAP4K1, RHOG, RHOH, CEACAM1, MDFIC, FAM20C, RHOU, SP100, IFI6, CXCR4, LILRA2, NPY, CTNNA1, PODN, LILRB4, DLC1, GOLT1B, GHSR, TSC2, C5AR1, ARHGAP19, ADRB2, ARHGAP15, STAP1, TGFB2, TGFB1, ARHGAP25, NR4A2, NFKBIA, TBCK, LIN28A, ARHGAP30, JMY, NFKBID, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, TMEM100, PTGIR, PDE4D, ARAP3, ARAP1, TGFBR3, FGR, IFNG, PDE5A, CAMK2D, DLL1, USP18, CMTM8, TRAT1, CMTM2, LTBR]
GO:0046900;tetrahydrofolylpolyglutamate metabolic process;7.0;0.9326813400603323;0.8172600352873667;9.582004236857228;233.86979834373935;9.083926447120524;0.007827411681411262;0.8154717862087246;[GGH]
GO:0032715;negative regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.96654663153603;6.166155715036245;0.002174371849661483;0.6384578026126634;[ORM1, TNFAIP3, PTPN22, NLRC3, ARRB1, ARRB2, TNF, INPP5D, NCKAP1L, CSK, HAVCR2, SLAMF1, IL10, GHSR, NR1H4, IRAK3, NLRP12, BANK1, BPI, TLR4]
GO:0051497;negative regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;338.83785420150645;6.781341354126479;0.01134059804585365;0.7792270645443136;[TMEFF2, DLC1, STMN1, TACSTD2, ARAP1, PFN1, ARHGAP6]
GO:0006206;pyrimidine nucleobase metabolic process;7.0;0.7307253602413294;0.7162820453778652;9.242861771680136;227.00687585227206;6.8867018697843045;0.007597715841851099;0.7031056191423581;[CDA, ALDH6A1, RRM1, DPYS, DPYD, CAD, TYMS, TYMP]
GO:0051256;mitotic spindle midzone assembly;5.0;1.0;0.7902410118609202;9.628524252492122;55.94550109770304;7.474488534686424;0.001872445574057981;0.6724867031240476;[RACGAP1, KIF4A, KIF23, AURKB]
GO:0010705;meiotic DNA double-strand break processing involved in reciprocal meiotic recombination;9.0;1.0;0.896240625180289;9.628524252492122;174.6664316074383;8.67846133901236;0.005845928276318126;0.8400575416471059;[BLM, BRIP1]
GO:0032959;inositol trisphosphate biosynthetic process;8.0;1.0;0.875;9.628524252492122;361.00324016623335;9.083926447120524;0.012082453566540795;0.839552420951524;[PTAFR, PLCG2]
GO:0016242;negative regulation of macroautophagy;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;266.4734130419696;6.343086423195323;0.0089186253240128;0.6993857346658935;[LRRK2, AKT1, HMOX1, TSC2]
GO:0019752;carboxylic acid metabolic process;5.0;0.32428578997777324;0.4523839068498069;5.309370859636751;42.504421911339485;2.9735683700721314;0.0014225847498763097;0.4423094365914798;[, ENO2, AKT1, CYP1B1, UPB1, CH25H, MTHFD1, PADI4, ACMSD, C3, PRKAR2B, CYP4F2, CYP4F3, DHFR, SLC6A6, FA2H, BHMT, NOX4, DPYS, PFAS, ATIC, ELOVL4, ARG1, BGN, ELOVL6, ELOVL7, SLC7A5, SLC7A7, SLC7A8, DPYD, ACSBG1, GART, AOAH, PTGS2, PTGS1, ALOX5, NR1H4, AGMAT, PLP1, HNMT, SLC16A3, UGT2B15, UGT2B17, PGD, SLC27A3, SLC27A2, GMPS, HMMR, ACAT1, OSBPL7, AGXT2, CYP4F12, P4HA2, TBXAS1, CSPG4, SERINC5, ETFA, SCPEP1, DSE, UGT2A3, GPX1, BPGM, TST, BCAT1, ASPA, UGT2B28, CYP3A4, SLC25A21, IL1RN, ACSM5, MCCC2, ACSL1, ACSL5, MIF, ASRGL1, POR, SUCLG1, MGST1, PKHD1, IGF1, HAL, ALDH6A1, VNN1, VNN2, VNN3, ALDH18A1, HIBADH, TECR, BRCA1, HNF4A, ACADM, EDN1, SYK, IL15, BHMT2, IL1B, TLR2, HSD17B4, NPL, TYMS, CD74, GCH1, PNPLA8, NDUFAB1, SCARB2, CPOX, KMO, SLC1A3, ALOX12, GLYAT, TGFB1, GGH, NR4A3, ACSM2A, GHR, HK3, KYNU, HIBCH, CYP4A11, CAD, PRODH2, DCN, VCAN, NDUFS6, EHHADH, SLC3A1, SNCA, MAPK14, SCD]
GO:0010942;positive regulation of cell death;5.0;0.5391707831400974;0.559826403430969;7.325939159498076;41.77857356132841;3.304727333179569;0.0013982912588225433;0.45924492136526085;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, PRKDC, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, FOSL1, NOX4, NOX1, SRPX, CDKN1A, ADM, CTLA4, TIMP3, ANXA1, DUSP1, RIPK2, PAWR, FOS, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, POU4F1, HP, TNF, CLU, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A9, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, BCL2, BCL2L1, ITGAM, PLEKHF1, LRRK2, ITGB2, PIK3CD, FASLG, ARRB1, ARRB2, CYR61, ITGA4, TFDP1, LCK, LRP1, NLRC4, CCL5, E2F1, CCL2, FYN, GZMA, GZMB, PML, P2RX1, MNDA, FCGR2B, IFIT2, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, EGR1, GADD45B, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, CD36, IL10, VAV1, IL1B, TLR6, TLR4, CXCR2, CTNNA1, APBB1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, TGM2, PDGFRB, KMO, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, NFKBID, UBE2M, TNFAIP8, CASP2, MYBL2, YWHAH, ARHGEF12, PLAUR, AXIN2, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
GO:0048096;chromatin-mediated maintenance of transcription;11.0;1.0;0.9324289523296623;9.628524252492122;1311.6223032101445;7.57984905034425;0.043898818105007634;0.8200627852632958;[CHEK1, PADI2]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[ACHE, CALCRL, LRP1, TFRC, ITGB2, ADM, ARRB1, ARRB2, CXCR1, CXCR2, CD36, AP2M1, SNCA, FCER1G, SYK, CAV1, LILRB1, DNM2, CEACAM1, RAB31, SYNJ1, NEDD4, CD9, RAMP1]
GO:0051017;actin filament bundle assembly;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;39.792633402144126;5.734022359845919;0.001331823628924752;0.6163584827319739;[ITGB5, ARRB1, AIF1, EPS8, PLS1, ACTN1, PAWR, ACTN4, SORBS1, MARCKS, ZYX, LCP1]
GO:0051259;protein complex oligomerization;5.0;0.7763722522362496;0.6784271379790451;9.089527751759436;40.42272244673708;3.6012063575747084;0.0013529121422039536;0.47440687246051283;[CDA, PRF1, IKZF1, TCL1A, TNFSF11, MCCC2, MIF, CLDN3, KCTD12, KCTD15, MGST1, PRKCZ, ACMSD, CD79B, CD79A, HMOX1, VASP, JUP, COL1A1, EHD3, COL1A2, ACHE, DPYS, CD3G, CD3E, CD3D, TK1, HBZ, FCER1G, KCND2, ARG1, KCNA5, RXRA, CTNNA1, CD74, GCH1, GOPC, KCNG2, TGM2, CHRNB4, OLFM4, BLM, ITPR3, RASGRP1, ACAT1, NACC2, NLRP3, ECT2, CAV2, CAV1, TNFAIP3, ALAD, NUP62, EMILIN1, ADSL, VWF, COL6A2, COL6A1, NUP54, ACPP, FBP1, BIRC2, BIRC3, COLEC12, NLGN1, CAMK2D, HM13, NLRC4, NOD2, SAMHD1, PLN, CCL5, POLQ, RRM1, SOD2, MARCKS, RAD51, P2RX1, IMPDH2, TEK, CD247, RBMX]
GO:0043406;positive regulation of MAP kinase activity;12.0;0.7043150770688792;0.8002778511245842;9.369013057007038;2605.6877929993507;4.201124524534153;0.08721002546492271;0.6629660161470909;[, IL1RN, TNF, PROK2, TNFSF11, MAP3K8, PDGFRB, MAP2K2, F2R, MIF, ADAM9, ADAM8, C5AR1, FPR1, TGFA, PDGFA, TNFRSF11A, IQGAP3, RASGRP1, PIK3R5, PDGFD, PDGFC, S100A12, ELANE, DRD4, MAP2K6, TGFB1, FZD5, GADD45B, FZD8, EIF2AK2, IGF1, GH1, BMP2, CDK1, NOX4, CSPG4, CD24, EZH2, CD40, LRRK2, ARRB1, GHR, MAP4K1, EDN1, SYK, RIPK2, DUSP6, MDFIC, IL1B, KIT, PDE5A, TLR6, TLR4, CXCR4, NOD2, THBS1, PAK1, NTF3, CSK, CCL19, CD74, EGF, MAPK14, CD40LG, PKN1]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[PTPN22, DUSP10, PPP2R1A, NUP62, DUSP2, DUSP3, DUSP1, PAQR3, PRKCD, IRAK3, DUSP6, SFRP2, IL1B, LYN, CAV1, PTPN6]
GO:1904355;positive regulation of telomere capping;9.0;0.9326813400603323;0.8625812952104552;9.59462270081644;613.4505056642549;6.943860283624253;0.02053163635497091;0.7513499630073597;[NEK7, PRKCQ, NEK2, AURKB]
GO:0002062;chondrocyte differentiation;4.0;0.8933024483968273;0.6966512241984136;9.446202695698167;21.066225782797595;6.039404009397101;7.050676185779127E-4;0.5588554019015759;[MEF2C, TGFB1, IHH, AXIN2, MAPK14, RUNX2, BMP2, TGFBI]
GO:0051272;positive regulation of cellular component movement;5.0;0.5452700253111464;0.5628760245164934;7.377232453885626;52.22589589123734;3.603287523778533;0.0017479537352249267;0.4745133033969606;[SPARC, SERPINE1, MYLK, ICAM1, LGALS3, STMN1, C3AR1, AKT1, IL1R1, PRKCE, ACTN4, IL23A, CLDN7, PFN1, KIF20B, TWIST1, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, IGF1, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, ANXA1, ANXA3, GAB1, TACR3, SIRT1, F3, IL1A, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, AIF1, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CD74, CCL21, CCL20, F2RL1, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, ETS1, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, POSTN, SEMA6A, IGFBP5, F2R, ADAM9, ADAM8, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, VIL1, CXCL10, CXCL11, IL6, BMP2, DAB2, CXCL12, PTPRC, NR4A3, BCL6, BCL2, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, PIK3CD, LAMC2, CXCL1, CXCL3, PIK3C2A, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL2, XCL1, LEF1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, SEMA4A, EGF, SEMA4B, LAMB1, MAPK14, SOD2, RPS6KB1, TEK]
GO:1904117;cellular response to vasopressin;8.0;1.0;0.875;9.628524252492122;462.69925393661634;8.67846133901236;0.015486127626965131;0.8188169164668168;[CDC6]
GO:1905448;positive regulation of mitochondrial ATP synthesis coupled electron transport;12.0;0.9326813400603323;0.9144609826203107;9.600353375525426;1375.5648477489242;8.390779266560578;0.04603891752616661;0.8772251544931927;[CCNB1, CDK1]
GO:0022900;electron transport chain;4.0;0.7140352122741334;0.6070176061370667;8.475844742553736;29.758801740447502;4.623782033182691;9.96000313069993E-4;0.48646042820481683;[DMGDH, NCF1, NCF2, COX6A1, LOXL2, CYBB, COX6B1, POR, COX7A2L, UQCRC1, NDUFB10, UQCRB, UQCRH, CYC1, UQCRQ, P4HA2, NOX4, COX7B, ETFA, COX7C, ALDH2, UQCRFS1, COX8A, GPX2, NDUFC2, NDUFS8, NDUFS7, ASPH, NDUFS6, NDUFS4, NDUFS3, NDUFB7, NDUFB6, NDUFB4, NDUFB3, NDUFB2, NDUFB1, UQCR10, COX5B, COX5A, SNCA, NDUFA8, NDUFA7, NDUFA6, NDUFA4, NDUFA3, NDUFA2, COX6C, NDUFAB1]
GO:0043401;steroid hormone mediated signaling pathway;6.0;0.7508913569872202;0.6985659910837546;8.801845679307654;25.735219620490994;4.909539177224887;8.613346405038622E-4;0.5741943744303455;[TGFB1I1, FHL2, HNF4G, RORA, BRCA1, NR3C2, HNF4A, YWHAH, MED1, CCNE1, RARA, PADI2, YAP1, NR1I2, LEF1, RXRA, VDR, NR1H2, NR1H4, DEFA1, NR2F2, NR4A2, NR4A1, NR4A3, NEDD4, RAN]
GO:0045824;negative regulation of innate immune response;7.0;0.6240278086381567;0.6629332695762788;8.460919092337061;174.18841360624353;5.970411137910149;0.005829929444006407;0.6562464685024372;[CLEC12B, TNFAIP3, NLRC3, ARRB2, DUSP10, DHX58, A2M, HAVCR2, CD96, CR1, ARG1, NR1H2, LILRB1, SERPINB9, IRAK3, HLA-E, MMP12, CEACAM1, SERPING1]
GO:0051026;chiasma assembly;4.0;1.0;0.75;9.628524252492122;42.501794097528276;7.697632086000634;0.0014224967993129276;0.6436572628545723;[BRIP1]
GO:0006417;regulation of translation;7.0;0.5221699919663294;0.6120043612403652;8.01908634005802;212.8215771898108;3.9901762463137618;0.007122946661558481;0.554977164055858;[CYFIP1, MAGOH, RPS6KA1, AKT1, SOX4, DAPK1, UPF3B, EIF2AK2, DHFR, CD28, BTG2, SRP9, BANK1, RARA, PTAFR, FAM129A, TYMS, PURA, RXRA, PPP1CA, FMR1, TNF, IGFBP5, S100A9, EIF2S1, IL6, LIN28A, CNOT3, BCL3, GRM5, NCBP2, PPP1R15A, THBS1, CCL5, EIF4H, EIF3K, RPS6KB1, EIF3H, EIF3E, EIF3D]
GO:0032707;negative regulation of interleukin-23 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.96654663153603;9.083926447120524;0.002174371849661483;0.7876727335416686;[TLR4]
GO:0030521;androgen receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;54.01143535742291;5.948432231191374;0.0018077141342769656;0.6792031009335148;[TGFB1I1, FHL2, BRCA1, MED1, CCNE1, RAN]
GO:0032700;negative regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.25422870398782;7.292166977892469;0.002184000309729388;0.6960420709600095;[TGFB1, IFNG, NCKAP1L, TLR4]
GO:0019985;translesion synthesis;9.0;0.8933024483968273;0.8428918493787028;9.572954401337311;760.2225735865501;6.063501560976162;0.025443965382044766;0.706328376990269;[PCNA, POLD3, POLD1, TRIM25, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA2, ISG15, POLE2, RPA3, DTL]
GO:0014038;regulation of Schwann cell differentiation;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;65.83981520803086;8.67846133901236;0.0022035993630260702;0.8400575416471059;[CDK1]
GO:0045839;negative regulation of mitotic nuclear division;8.0;0.6997970393407541;0.724898519670377;9.076455670192082;276.53900459362586;6.166155715036245;0.009255511614802463;0.6903374900225189;[PLK1, BUB1B, TTK, CENPF, PTTG1, RAD21, CHEK1, TRIP13, AURKAIP1, BUB1, MAD1L1, PTTG3P, MAD2L1]
GO:0014050;negative regulation of glutamate secretion;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;415.4544886335298;7.8311634786251565;0.013904887849799128;0.7967266896635242;[IL1RN, IL1B]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[, IL1RN, PHB2, ICAM1, PROK2, TNFSF11, EPHB2, EPHB1, PRKCE, MIF, EPHA3, EPHA2, FPR1, TGFA, PDGFA, FPR2, SLC30A10, IQGAP3, PRKCZ, PIK3R5, PDGFD, PDGFC, S100A12, ELANE, SLAMF1, CCR1, JUN, FZD5, GADD45B, LIF, FZD8, EIF2AK2, IGF1, MARCO, NOX4, CD27, CD24, NOX1, EZH2, NRP1, CD40, TIMP2, CCR7, CD36, HAVCR2, MAP4K1, EDN1, GPR37, SYK, RIPK2, FCRL3, DUSP6, MDFIC, BANK1, IL1B, KIT, TLR6, PLCB1, TLR4, CCL13, CXCR4, GNAI2, PAK1, GPNMB, NTF3, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, CARD9, OSM, CD40LG, F2RL1, PKN1, NCF1, TNF, CTGF, PYCARD, MAP3K8, PDGFRB, PDGFRA, MAP2K2, IGFBP3, F2R, ADCYAP1, ADAM9, ADAM8, CSF1R, C5AR1, TNFRSF11A, ADRB2, RASGRP1, PSAP, DRD4, MAP2K6, TGFB2, TGFB1, CAV2, GH1, IL6, BMP2, CDK1, CSPG4, LRRK2, TREM2, PTPN22, ARRB1, ARRB2, GHR, XCL2, CHI3L1, XCL1, PDE5A, NOD2, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, EGF, TIE1, MAPK14, CD4, LTBR, TEK, FCGR2B]
GO:0045835;negative regulation of meiotic nuclear division;8.0;0.7248374789738407;0.7374187394869203;9.271849308553389;325.6023743920082;7.212124270218933;0.010897618447788233;0.7438283705770736;[MSH2, LIF, TTK, FBXO5, TRIP13, BRCA2]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[ACHE, TAGLN, LAMA2, TWIST1, AEBP1, SGCE, BASP1, DMD, MEF2A, MEF2C, EGR3, ETV1, IGF1, SIRT1, CXCL10, CENPF, ITGA7, COL6A3, HBEGF]
GO:0019730;antimicrobial humoral response;5.0;0.8259837884571596;0.7032329060895001;9.292052015870908;43.185159168215264;5.132682728539097;0.0014453684132401858;0.5527266452925662;[IGHM, CXCL6, CCL13, CXCL9, HIST1H2BK, CXCL1, CXCL13, CXCL3, CXCL2, CLU, CXCL5, GNLY, S100A12, CTSG, IGHA1, PRSS3, PGLYRP1, ELANE, CAMP, DEFA4, SLC11A1, RNASE6, RNASE3, AZU1, DEFA1, PPBP, LYZ, HLA-E, CXCL10, CXCL11, SLPI, BCL3, LCN2, PRTN3, BPI, S100A9, IGKV3-20, S100A8, LTF, PF4]
GO:0085020;protein K6-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;7.697632086000634;0.00527474598481953;0.8260862151842345;[BARD1, UBE2S, UBE2T, RNF6, BRCA1]
GO:0032930;positive regulation of superoxide anion generation;8.0;1.0;0.875;9.628524252492122;144.57516735605006;7.004484905440688;0.00483880074220378;0.7332096838060964;[TGFB1, ITGAM, PRKCD, ITGB2, F2RL1, FPR2, GNAI2, CD177]
GO:0019319;hexose biosynthetic process;6.0;0.7508913569872202;0.6985659910837546;9.148951172230236;135.7739215098454;5.8650506222523235;0.004544230964338322;0.6230592741648748;[ENO2, CHST15, BPGM, FBP1, ATF3]
GO:0021879;forebrain neuron differentiation;6.0;0.7980440201809971;0.722142322680643;9.0094850440859;26.729186262933762;7.069023426578259;8.946018095145202E-4;0.6846304993685643;[CSF1R, BCL11B, LEF1, INHBA, SHANK3]
GO:1904778;positive regulation of protein localization to cell cortex;8.0;0.8653626801206646;0.8076813400603323;9.474373572664863;109.22370981396446;8.16763571524637;0.003655619272516407;0.7926932703116032;[GPSM2, GNAI1]
GO:0042730;fibrinolysis;9.0;1.0;0.896240625180289;9.628524252492122;252.8988266382142;6.7325511899570465;0.008464296133413719;0.740543606130341;[SERPINB2, PLAU, PROS1, SERPINE1, PLAUR, SERPING1, GP1BA]
GO:0009756;carbohydrate mediated signaling;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;23.17027026302992;8.390779266560578;7.75488093814194E-4;0.7193458537639684;[COLEC12, CLEC7A]
GO:0071295;cellular response to vitamin;7.0;0.7436939687323844;0.7227663496233927;9.033817144745429;139.32535531563298;6.781341354126479;0.004663094257735114;0.6977174774718518;[COL1A1, POSTN, BRIP1, IL15, TNC]
GO:0098532;histone H3-K27 trimethylation;12.0;1.0;0.9481203125901445;9.628524252492122;767.5947827162904;7.9853141584524145;0.02569070658705971;0.8564896500084854;[EZH2]
GO:0051445;regulation of meiotic cell cycle;5.0;0.5498737448241444;0.5651778842729924;7.5284634236095505;25.888472835594534;5.8650506222523235;8.664638876944386E-4;0.5901799734356507;[TTK, BRCA2, CDC20, PPP2R1A, FBXO5, PRKACB, DUSP1, LIF, CDC25C, CDC25A, ASPM, MSH2, CDK1, TRIP13, PLCB1]
GO:0032526;response to retinoic acid;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;43.78950961223322;5.123113277522946;0.0014655954787213788;0.5522372631225753;[YAP1, HDAC2, TNC, PHB2, AQP1, RXRA, MYB, CTSH, HOXA2, CD38, IGFBP7, LYN, ABCA1, PDGFRB, DUSP1, TIE1, KLF4, PAX2, COL1A1, SYNJ1, RARA, EPHA3]
GO:0009749;response to glucose;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;32.95598622603122;4.917261223318797;0.001103007200523252;0.6023883328937558;[SLC8A1, CTGF, ICAM1, LGALS1, HNF4A, SOX4, MEN1, RMI1, HNF1B, PAX2, NME1, IL1B, COL6A2, THBS1, EGR1, EIF2B3, TGFB1, LIN28A, RPS6KB1, FKBP1B, NOX4]
GO:0072383;plus-end-directed vesicle transport along microtubule;9.0;0.9326813400603323;0.8625812952104552;9.584072489921288;265.6185688795062;7.8311634786251565;0.00889001445920495;0.7967266896635242;[KIF23]
GO:0098535;de novo centriole assembly involved in multi-ciliated epithelial cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;68.46281579932104;8.16763571524637;0.00229138883226928;0.7686126355688037;[PLK4, CEP152]
GO:0033619;membrane protein proteolysis;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;49.64990487012002;6.166155715036245;0.001661737633989536;0.6384578026126634;[HM13, PSEN2, CTSH, TGFB1, NFKB1, ADAM9, PRTN3, PRKCQ, RBMX]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ORM1, LRRK2, CLU, PYCARD, IFIH1, CD36, CCR2, HAVCR2, FCER1G, DDX58, RIPK2, CYBB, MIF, HLA-E, TLR1, IL23A, TLR4, TLR2, HDAC2, PTAFR, LY96, TWIST1, NOD2, THBS1, RASGRP1, CCL19, CD14, FZD5, CARD9, AZU1, CD2, PF4]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, ADCYAP1, MAP1B, S100A9, EPHA3, NEDD4L, LYN, FZD1, SYT2, FN1, CXCL12, FES, PLXNB2, EZH2, ROBO2, NRP1, NME1, SHANK3, NLGN1, RAB21, PAK1, CNR1, FYN, APBB1, FKBP1B, CAMK1]
GO:0017148;negative regulation of translation;8.0;0.6493065804076676;0.6996532902038338;9.081980546124052;1114.6737408694362;4.99795013456894;0.03730712696566269;0.6305954023103058;[BTG2, FMR1, IGFBP5, DAPK1, SRP9, BANK1, RARA, TYMS, PURA, EIF2AK2, EIF2S1, DHFR, LIN28A, CNOT3, EIF3E]
GO:0032764;negative regulation of mast cell cytokine production;8.0;1.0;0.875;9.628524252492122;311.05347994333346;9.083926447120524;0.010410680043746014;0.839552420951524;[BCL6, HMOX1]
GO:0010972;negative regulation of G2/M transition of mitotic cell cycle;9.0;0.811012628672052;0.801746939516315;9.394909401310617;357.14964968422294;5.926926025970411;0.011953477361114177;0.699343897778663;[BLM, BRCA1, AURKB, AURKA, RAD21, TOPBP1, NAE1, CLSPN, FANCI, DONSON, CDC6, MSH6, CDK1]
GO:0010971;positive regulation of G2/M transition of mitotic cell cycle;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;355.9636244052406;6.481236761676141;0.011913782162380092;0.7276913745807394;[SMARCD3, VPS4B, CDC7, CDC25C, CDC25A, CCNB1, RAD51C, CDK1, DTL]
GO:0032765;positive regulation of mast cell cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;311.82526325162985;8.67846133901236;0.010436510936514811;0.8400575416471059;[FCER1G, NR4A3]
GO:1900182;positive regulation of protein localization to nucleus;7.0;0.8436909121759173;0.7727648213451592;9.36615998802463;74.62336946219564;5.446340287394138;0.0024975770192273523;0.6294454608352614;[LRRK2, CDH1, AKT1, CCT3, CCT2, MED1, PRKCD, PARP9, IFNG, HCLS1, PTGS2, FYN, CCT8, CCT7, ECT2, CCT5, CCT4, TGFB1, JUP, PLK1, LIF, IGF1, MAPK14, CCT6A, CDK1]
GO:0042747;circadian sleep/wake cycle, REM sleep;5.0;1.0;0.7902410118609202;9.628524252492122;21.52050227545479;8.67846133901236;7.202718439648486E-4;0.7340579283277371;[CST3]
GO:0000707;meiotic DNA recombinase assembly;8.0;0.8259837884571596;0.7879918942285797;9.405380701177911;133.9647452985807;7.697632086000634;0.004483679464700174;0.7686572628545723;[RAD51, RAD51C]
GO:1905875;negative regulation of postsynaptic density organization;8.0;1.0;0.875;9.628524252492122;179.1445802505115;9.777073627680469;0.005995807881329661;0.875;[LILRB2]
GO:0000706;meiotic DNA double-strand break processing;8.0;0.8933024483968273;0.8216512241984136;9.533214072687796;173.9732844268755;7.9853141584524145;0.005822729263976651;0.7833693374183408;[BLM, BRIP1, EXO1]
GO:0031670;cellular response to nutrient;6.0;0.6162540371078848;0.6312473311440869;8.506381466413817;111.40291525692865;5.845247994956144;0.003728555317534849;0.6220465668840318;[ABCB4, TNC, PTGS2, BRIP1, HMOX1, FYN, POSTN, IL15, NR1H4, CYBB, COL1A1, FOXA2]
GO:1904300;positive regulation of transcytosis;7.0;1.0;0.8509193652572005;9.628524252492122;59.34352194186286;9.777073627680469;0.001986174273691794;0.8509193652572005;[PTAFR]
GO:1904306;positive regulation of gastro-intestinal system smooth muscle contraction;9.0;0.8436909121759173;0.8180860812682478;9.360260265897443;88.99922634012424;7.9853141584524145;0.0029787240115004016;0.8046099625986299;[GHSR, PTAFR, KIT]
GO:0007344;pronuclear fusion;6.0;1.0;0.8231203125901445;9.628524252492122;29.37726267204044;9.777073627680469;9.832305438132773E-4;0.8231203125901445;[CDK1]
GO:0007100;mitotic centrosome separation;4.0;1.0;0.75;9.628524252492122;26.82333357677892;7.9853141584524145;8.977528353818361E-4;0.6583693374183408;[NUP62, KIF11, AURKA]
GO:0038063;collagen-activated tyrosine kinase receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;57.50475921673876;7.474488534686424;0.0019246325400609058;0.7572456912631272;[COL1A1, SYK, COL4A2, COL4A1]
GO:1904303;positive regulation of maternal process involved in parturition;5.0;1.0;0.7902410118609202;9.628524252492122;118.0711512965144;9.777073627680469;0.003951735176756968;0.7902410118609202;[PTAFR]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, SERPINE1, HP, CXCL13, TNF, MPO, PYCARD, IGHG1, TRBC1, PGLYRP1, IL6R, SLC11A1, PRKCD, RNASE6, RNASE3, HLA-E, CLEC4D, SLPI, IL23A, CLEC4E, S100A9, S100A8, SEH1L, C5AR1, CFP, KLRK1, NLRP3, S100A12, S100A14, IGHA1, ELANE, DEFA4, PRG2, ISG15, AZU1, DEFA1, PPBP, LYZ, SELP, IL6, BCL3, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, GNLY, STAB1, CTSG, CD36, CAMP, HAVCR2, IL10, FCER1G, SYK, ANXA3, RIPK2, TLR1, FGR, IGHD, LTA, IRF8, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPB, CEBPE, HIST1H2BK, NLRC4, NOD2, IGKC, CCL20, CARD9, NR1H4, CD4]
GO:0048298;positive regulation of isotype switching to IgA isotypes;11.0;1.0;0.9324289523296623;9.628524252492122;1407.9016349495496;8.16763571524637;0.04712120069255247;0.8501222226412654;[TGFB1, MSH2, TNFSF13, MLH1]
GO:0010508;positive regulation of autophagy;7.0;0.7192862368539868;0.710562483684194;9.040737587590003;216.89043707272492;5.132682728539097;0.007259127740103463;0.6134049986888465;[PLEKHF1, LRRK2, SESN3, DAPK1, RIPK2, TSC2, SIRT1, DCN, IFNG, ADRB2, FOXO1, HMOX1, PLK2]
GO:0071285;cellular response to lithium ion;6.0;1.0;0.8231203125901445;9.628524252492122;77.8106912628645;7.212124270218933;0.002604253811492351;0.6919486831672181;[CEBPA, CDH1]
GO:0031668;cellular response to extracellular stimulus;4.0;0.5452700253111464;0.5226350126555732;7.377232453885626;45.163559484697416;4.334655917158676;0.0015115836913881548;0.47167450518560927;[EHMT2, TNC, ICAM1, SESN3, LAMP2, SKP2, POSTN, CYBB, SFRP2, RRAGD, SIK1, ATF3, SEH1L, ABCB4, FOXO1, BRIP1, HMOX1, GAS2L1, LYN, JUN, EIF2AK2, EIF2S1, NR4A2, COL1A1, FOSL1, BCL2, PLEKHF2, CDKN1A, PLEKHF1, LRRK2, KRT20, ASGR1, UPP1, IL15, AVPR1A, FOS, SIRT1, AES, PIK3C3, PTGS2, AIF1, FYN, NR1H4, SIPA1, FOXA3, FOXA2]
GO:0032757;positive regulation of interleukin-8 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.948432231191374;0.002183412136085803;0.6273234135236593;[FCN1, SERPINE1, NOD2, TNF, PYCARD, FFAR2, CD58, CD14, ELANE, DDX58, F2R, TLR1, CD2, IL1B, TLR8, F2RL1, TLR7, TLR5, TLR4, CD244, TLR2]
GO:0070194;synaptonemal complex disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;39.82835148474282;9.083926447120524;0.0013330190810051427;0.7876727335416686;[PLK1]
GO:0031427;response to methotrexate;5.0;0.9326813400603323;0.7565816818910864;9.548481544818586;103.34292003900198;8.390779266560578;0.0034587945311156006;0.7193458537639684;[DHFR]
GO:0071283;cellular response to iron(III) ion;7.0;1.0;0.8509193652572005;9.628524252492122;96.28817659807011;9.083926447120524;0.003222678617004505;0.8154717862087246;[CCNB1]
GO:0016042;lipid catabolic process;4.0;0.5127202928476964;0.5063601464238482;6.883086519318291;43.14795622097559;4.114113147544524;0.0014441232640765526;0.4603959376912539;[GBA3, ABHD12, CYP1B1, PLBD1, SLC27A2, PLD4, PLA2G7, PLD3, ACAT1, PLCG2, PLCG1, RARRES3, CYP4F2, FUCA1, CYP4F3, SRD5A3, CYP4F12, ETFA, GM2A, ACADM, HIBCH, YWHAH, CYP4A11, EHHADH, PLCB1, HSD17B4, AOAH, CYP3A4, SPP1, PNPLA8, FABP1, SNX17, FABP7, PNPLA6]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, PTPN22, TNF, CCL5, AKT1, CCL2, CD14, LYN, TGFB1, RIPK2, PRKCE, IL18, MAPK14, NFKBIA, HCK, CD6, IL1B, TLR4, TLR2]
GO:0016045;detection of bacterium;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;95.72483819449377;7.697632086000634;0.0032038241876084527;0.7167775754447168;[NLRC4, CD1D, NOD2, PGLYRP1]
GO:0010744;positive regulation of macrophage derived foam cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;113.85781812010546;7.004484905440688;0.0038107187070962377;0.6813299963962409;[MSR1, PRKCH, AGTR1, IL18, CD36, NFKB1, PF4]
GO:0016046;detection of fungus;6.0;0.8653626801206646;0.7558016526504768;9.474373572664863;96.01252026694556;9.777073627680469;0.0032134526476763577;0.8231203125901445;[TLR4]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[IL1RN, TNF, PYCARD, IFIH1, CD36, IL6R, FCER1G, DDX58, RIPK2, F2R, EREG, TLR1, ADCYAP1, IL1A, IL1B, TLR8, TLR7, TLR6, TLR4, TLR2, PTAFR, TWIST1, NOD2, HSPD1, IL33, SIGLEC16, CARD9, LILRB2, MAPK13, IL6, F2RL1, MYD88, IL17A]
GO:0030334;regulation of cell migration;6.0;0.4770562410916853;0.5616484331359872;7.1128459440373675;36.74126027361157;3.1319826581748256;0.0012296969163702938;0.48329005138129355;[SERPINE1, ADARB1, MYLK, C3AR1, AKT1, CYP1B1, HOXA7, MEF2C, PRKCE, PADI2, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, KLRK1, FLRT2, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, JUN, JAG1, ACE, HACE1, JUP, PLK2, FN1, NR2F2, COL1A1, NOX4, SNAI2, GPR18, ARHGAP4, MMP28, TIMP1, ANXA1, ANXA3, EMP2, SIRT1, F3, TMEFF2, PLCB1, HBEGF, ENG, PTAFR, PTGS2, GPNMB, NTF3, FLNA, CCL19, JAM3, CCL21, CCL20, SULF1, COL3A1, PF4, SEMA5B, PLXND1, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, DACH1, PHLDA2, SEMA6A, IGFBP5, IGFBP3, F2R, TPM1, ADAM9, ADAM8, CD274, CSF1R, CD151, TACSTD2, CORO1A, CXCL10, CXCL11, DAB2, CXCL12, PTPRC, BCL2, PLXNB2, ITGB3, PIK3CD, PIK3C2A, CYR61, DUSP10, EMILIN1, ITGA4, XCL2, XCL1, CX3CR1, LRP1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, SEMA4A, SEMA4B, TIE1, KLF4, IL1RN, IFITM1, SPARC, ICAM1, LGALS3, IL1R1, ACTN4, MIF, SFRP2, IL23A, PFN1, TRIB1, KIF20B, NBL1, EPHA2, CCR1, TNFSF14, PPBP, IGF1, PTK2, BST1, NRP1, PTPRR, NRP2, ECM1, CD40, KIF14, PTPRK, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, GAB1, IL1A, CEACAM1, CEACAM6, IL1B, KIT, SGK1, SP100, AIF1, GNAI2, PAK1, CXCR3, CXCR2, PDPN, MPP1, CD74, IL33, PODN, DLC1, F2RL1, ETS1, PLAU, ARHGDIB, IL6R, PDGFRB, PDGFRA, POSTN, VCL, C5AR1, STAP1, TGFB2, TGFB1, SELP, VIL1, IL6, BMP2, NR4A3, DOCK5, CXCL6, CXCL9, DOCK4, MCTP1, TNFAIP6, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, MYOCD, DDX58, ARAP3, MMP9, DCN, FGR, GREM1, IFNG, LAMA2, LAMA4, LAMA3, LEF1, THBS1, EGF, LAMB1, MAPK14, SOD2, RPS6KB1, TEK]
GO:0031666;positive regulation of lipopolysaccharide-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;344.2408759115043;7.697632086000634;0.011521432320083432;0.7445766281117727;[CD180, LY86, LY96, MIF]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[IL1RN, IFITM1, SERPINE1, ADARB1, CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, IGFBP5, IGFBP3, TPM1, MIF, SFRP2, PADI2, TRIB1, NBL1, VCL, TACSTD2, THY1, KLRK1, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, CXCL12, BCL2, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, GREM1, TMEFF2, PLCB1, ENG, CX3CR1, SP100, LRP1, THBS1, AIF1, CCL2, IL33, CCL21, TIE1, PODN, KLF4, SULF1, COL3A1, DLC1]
GO:0031665;negative regulation of lipopolysaccharide-mediated signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.582004236857228;344.71221365858594;7.212124270218933;0.011537207570301822;0.7197477358342742;[TNFAIP3, TRIB1, LILRA2, LTF]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[SPARC, SERPINE1, MYLK, ICAM1, LGALS3, C3AR1, AKT1, IL1R1, PRKCE, ACTN4, IL23A, PFN1, KIF20B, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, IGF1, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, ANXA1, ANXA3, GAB1, SIRT1, F3, IL1A, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, AIF1, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CD74, CCL21, CCL20, F2RL1, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, ETS1, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, POSTN, SEMA6A, IGFBP5, F2R, ADAM9, ADAM8, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, VIL1, CXCL10, CXCL11, IL6, BMP2, DAB2, CXCL12, PTPRC, NR4A3, BCL2, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, PIK3CD, LAMC2, CXCL1, CXCL3, PIK3C2A, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL2, XCL1, LEF1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, SEMA4A, EGF, SEMA4B, LAMB1, MAPK14, SOD2, RPS6KB1, TEK]
GO:1900195;positive regulation of oocyte maturation;9.0;0.9326813400603323;0.8625812952104552;9.589303539338841;598.4140132004883;9.083926447120524;0.020028378484173288;0.8607930461318132;[AURKA]
GO:0042759;long-chain fatty acid biosynthetic process;9.0;0.7980440201809971;0.7952626352707877;9.372590878354922;458.549617088559;6.375876246018314;0.015347243016091356;0.722303232910233;[ELOVL6, ALOX12, PTGS2, CYP3A4, ALOX5, PLP1]
GO:0000915;actomyosin contractile ring assembly;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;135.1741411845403;7.9853141584524145;0.004524156856617609;0.7833693374183408;[ANLN, RACGAP1, KIF23]
GO:1903223;positive regulation of oxidative stress-induced neuron death;9.0;0.9326813400603323;0.8625812952104552;9.582004236857228;363.38011971363295;8.390779266560578;0.012162005585939545;0.8253454670833372;[TLR6, TLR4]
GO:1904317;cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine;6.0;1.0;0.8231203125901445;9.628524252492122;456.1864936163678;9.777073627680469;0.015268151400150165;0.8231203125901445;[PTAFR]
GO:0009972;cytidine deamination;11.0;1.0;0.9324289523296623;9.628524252492122;2918.4586051188953;7.474488534686424;0.09767818307110789;0.8146746435927894;[CDA, APOBEC3A]
GO:1904798;positive regulation of core promoter binding;7.0;1.0;0.8509193652572005;9.628524252492122;62.59990527316089;7.9853141584524145;0.002095162493235609;0.7592887026755414;[IFNG, KLF4]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[, SLA2, MYLK, AKT1, PRKACB, MEF2A, MED1, MEF2C, PRKCH, DAPK1, PRKCB, PRKCE, PRKCD, PRKAR1B, PRKCQ, PRKDC, PDGFA, THY1, IQGAP3, PRKCZ, LYN, PLK4, PLK2, PLK1, EIF2AK2, CDC7, CDK14, ITK, PBK, JAK3, RIPK2, DUSP6, CIT, RARA, HBEGF, NRAS, IL12RB2, GTF2H1, PKN1, CCNT2, IL5RA, SLA, TNF, FGF5, EFEMP1, GRAP2, MAP3K8, NEK2, STK32B, KCNH1, MEN1, KCNH2, MAP2K2, IGFBP3, VRK1, NRBP1, MELK, BLK, CSF1R, RASAL2, PKMYT1, MAP2K6, NEK7, BMX, NFKB1, CDK6, CDK2, CDK1, BCL2, LAT, LRRK2, PIK3CD, TLK1, CHUK, SPTB, LCK, IL3RA, BIRC5, PIK3C3, TTK, NOD2, IL2RG, CCL8, CCL5, CCL2, FYN, CSK, TIE1, PML, IL2RB, PTPN6, CCNH, CCNC, CHEK1, RPS6KA1, TNFSF11, EPHB2, EPHB1, PAQR3, EREG, BTC, BTK, SIK1, ALPK2, TRIB1, EPHA3, EPHA2, TXK, LIF, IGF1, PTK2, CTSH, CTSG, CCR5, SPTAN1, MAP4K1, SYK, IL15, STRADB, IL18, GFRA3, HCK, IL1B, KIT, FAM20C, TLR7, SGK1, TLR4, TLR2, GUCY2C, PAK1, PRKY, KITLG, CAMK4, CAMK1, BUB1B, PDGFRB, PDGFRA, MATK, CCNE1, CSF2RB, CSF2RA, RASGRP1, RASGRP4, SPTA1, CCNB1, CLSPN, TGFB2, TGFB1, EIF2S1, CLK4, CLK1, BMP2, FES, GHR, CAD, IRAK3, MASTL, TGFBR3, FGR, CCNA2, ZAP70, SHANK3, CAMK2D, AURKB, AURKA, NCAM1, BUB1, EGF, MAPK14, MAPK13, WEE1, RPS6KB1, TEK]
GO:0042754;negative regulation of circadian rhythm;4.0;0.8259837884571596;0.6629918942285797;9.040737587590003;21.64841646219066;7.069023426578259;7.245530166796041E-4;0.6115101867784198;[SUV39H2, SUV39H1]
GO:0010718;positive regulation of epithelial to mesenchymal transition;6.0;0.811012628672052;0.7286266269261705;9.377209824211215;170.70262580884207;5.9928839937622085;0.005713263263432726;0.6295966787287501;[HDAC2, TGFB1I1, LEF1, TWIST1, LOXL2, EPB41L5, PDPN, TGFB2, TGFB1, AXIN2, COL1A1, BMP2, DAB2, IL1B, EZH2, ENG]
GO:0051225;spindle assembly;7.0;0.7508913569872202;0.7263650437508107;9.168991923113682;86.84099814437;5.266214121163619;0.00290649005606778;0.6202338003175094;[KIF11, AURKA, CDC20, FLNA, NEK2, MYBL2, FBXO5, CENPW, NEK7, TUBG1, ASPM, TPX2, KIFC1, BIRC5, BIRC2, BIRC3]
GO:0097421;liver regeneration;6.0;1.0;0.8231203125901445;9.628524252492122;47.21654787453615;6.250713103064308;0.0015802953652264606;0.6427820713687392;[IL10, CEBPB, PCNA, TGFB1, IHH, TYMS, SULF2, AURKA, NFKBIA, HMOX1, EZH2]
GO:0009968;negative regulation of signal transduction;6.0;0.43649654099988644;0.5413685830900877;6.680044863788677;140.65047919891595;2.686163805600486;0.0047074449615745265;0.460490854527945;[, PID1, SERPINE1, SLA2, PHB2, STMN1, AKT1, HOMER3, UBASH3A, PRKACB, DAPK1, PRKCB, PRKCD, PADI2, PRKCQ, ATF3, GATA3, THY1, ADAMTS12, GATA1, PRKCZ, FLRT2, FIGNL1, PRDM16, HMOX1, LYN, FZD1, SNAI2, EZH2, TGFB1I1, LRRC4, TIMP2, PBK, TIMP3, DUSP2, DUSP3, DUSP1, ARG1, FCRL3, BGN, PAWR, SIRT1, DUSP6, AES, MMP12, PXDN, LRRC19, PTGS2, FRZB, STAT1, NR1H2, NR1H4, TMEM64, SULF1, SULF2, LGR4, PF4, RORA, TNF, CLU, PYCARD, SESN3, RUVBL2, MEN1, TLE4, RNF43, IGFBP5, CISH, IGFBP3, CSF1R, LY96, UBR1, RASAL2, FOXO1, SOCS2, CD300LF, WFS1, TNFRSF10B, PTPRE, DAB2, CXCL12, PTPRC, BCL6, BCL3, BCL2, CCDC22, BCL2L1, LRRK2, FASLG, PTPN22, ARRB1, ARRB2, FOXM1, HHEX, LBH, DUSP10, EMILIN1, GPX1, PVRIG, CX3CR1, PPP1R15A, LRP1, NLRC3, LRP2, CCL5, FYN, CSK, CTHRC1, TIE1, KLF4, PTPN6, IL1RN, ICAM1, LGALS3, PPP2R1A, DHX58, EPHB2, EPHB1, IL1R2, PAQR3, MIF, RUNX2, SFRP4, SFRP2, CDC34, SIK1, TRIB1, NBL1, EPHA3, EPHA2, TWIST1, APCDD1, PKHD1, INPP5D, CD14, SLAMF1, EGR1, LIF, IGF1, VNN1, CALM3, NRP1, PTPRR, ECM1, BRCA1, CD3E, STRADB, RHOH, GP1BA, IL1A, CEACAM1, BANK1, IL1B, KIT, TLR6, TLR4, YAP1, IFI6, LILRA2, GNAI2, CTNNA1, CD74, PODN, LILRB4, NLRP12, KIF26A, DLC1, NEDD4, FKBP1B, F2RL1, GRINA, RGS1, PDGFRB, PDGFRA, TSC2, HGS, HTRA1, FBLN1, ADRB2, STAP1, NLRP3, LPXN, TGFB2, TGFB1, CAV2, CAV1, ARHGAP25, NR4A2, NFKBIA, IL6, BMP2, NFKBID, FBN1, PLEK, HMGB2, TNFAIP3, LRRTM4, NUP62, PTGIR, MYOCD, PLAUR, ARAP3, IRAK3, AXIN2, MMP9, DCN, DNM2, TGFBR3, GREM1, NDUFS3, ZMYND11, FBP1, PFDN5, LTF, BCL2A1, CLEC12B, TAF9, LEF1, THBS1, SNCA, EGF, MAPK14, SOD2, RPS6KB1, TNIP3, TEK]
GO:0032508;DNA duplex unwinding;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;23.726073882073138;5.734022359845919;7.940903407527885E-4;0.64415753539903;[BLM, MCM7, RAD54B, PURA, BRIP1, CDC45, RUVBL2, RUVBL1, GINS1, GINS2, ANXA1, GINS4, HMGA1, RPA1, RAD50, RAD51, MCM4, MCM6, DNA2, MCM2]
GO:0010716;negative regulation of extracellular matrix disassembly;7.0;1.0;0.8509193652572005;9.628524252492122;86.13995449886744;8.390779266560578;0.002883026756151129;0.7800242071602487;[DPP4, CST3, TGFB1, FAP]
GO:0032509;endosome transport via multivesicular body sorting pathway;6.0;0.8436909121759173;0.7449657686781032;9.446202695698167;62.963525230995856;6.599019797332524;0.002107332525987629;0.6605944919115335;[SORT1, VPS4B]
GO:0099606;microtubule plus-end directed mitotic chromosome migration;6.0;1.0;0.8231203125901445;9.628524252492122;45.439948165668724;9.777073627680469;0.0015208341718066008;0.8231203125901445;[CENPE]
GO:0032740;positive regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.23665507211369;7.212124270218933;0.002183412136085803;0.6919486831672181;[TGFB1, IL23A, IL15, IL18, PRKCQ, NOD2, LY9, MYD88]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[PROS1, SERPINE1, SPINT2, AQP1, PTTG1, LAMP3, RPS6KA1, AKT1, APLP2, POR, SFRP2, SPINT1, SLPI, SERPING1, NAIP, C3, SFN, A2M, TNFSF14, TNFRSF10C, CRIM1, TNFRSF10B, DHCR24, VIL1, CD27, TNFAIP8, SERPINA1, ARRB1, ARRB2, TIMP2, TIMP3, TIMP1, CR1, SERPINB2, GPX1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, COL6A3, BIRC5, BIRC2, LTF, BIRC3, SERPINB10, CSTA, LEF1, IFI6, NLRC4, PTGS2, CST7, THBS1, CST3, SPOCK3, SNCA, KLF4, FABP1]
GO:0032741;positive regulation of interleukin-18 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;8.390779266560578;0.0021737836760178982;0.7522251544931926;[TLR2]
GO:0099607;lateral attachment of mitotic spindle microtubules to kinetochore;5.0;1.0;0.7902410118609202;9.628524252492122;28.61509304600606;9.777073627680469;9.577214123380371E-4;0.7902410118609202;[CENPE]
GO:0010711;negative regulation of collagen catabolic process;6.0;1.0;0.8231203125901445;9.628524252492122;104.12861204372116;9.777073627680469;0.0034850909354366545;0.8231203125901445;[CST3]
GO:0019546;arginine deiminase pathway;11.0;1.0;0.9324289523296623;9.628524252492122;560.9534287236577;9.777073627680469;0.018774606434071004;0.9324289523296623;[PADI4]
GO:0042769;DNA damage response, detection of DNA damage;5.0;0.7866048967936545;0.6835434602577475;9.143016436710422;39.83823472227698;6.139487467954083;0.0013333498640710748;0.6042146864874571;[PCNA, POLD3, POLD1, USP1, SOX4, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA2, RPA3, DTL]
GO:0043619;regulation of transcription from RNA polymerase II promoter in response to oxidative stress;12.0;0.811012628672052;0.8536266269261705;9.523163736834295;532.6985892857467;7.379178354882098;0.017828942385788714;0.825491836825702;[HMOX1]
GO:0006470;protein dephosphorylation;7.0;0.7586651285174919;0.7302519295159464;9.223059144383958;177.1697810635027;4.458953633836253;0.005929713129744359;0.5789504614541361;[PPP2R1A, CDC25C, CDC25A, PTPRE, PTPRC, BCL2, PTPRR, PTPN22, PTPRK, DUSP10, DLGAP5, DUSP2, PPP1R12A, DUSP3, DUSP1, DUSP6, LCK, PPP1R15A, TPTE, CPPED1, PPP1CA, PTPN6, PTPN7, PTPN4, CDKN3]
GO:1903238;positive regulation of leukocyte tethering or rolling;10.0;1.0;0.9152410118609203;9.628524252492122;440.9461040801303;8.390779266560578;0.014758069277832396;0.8443458537639685;[ITGA4, PTAFR, ELANE, CCR2]
GO:0009743;response to carbohydrate;4.0;0.6347111282356054;0.5673555641178027;8.102467948997072;27.321196622860832;4.720827822332161;9.144158634865458E-4;0.49142335437501145;[SPARC, SLC8A1, CTGF, ICAM1, LGALS1, HNF4A, SOX4, MEN1, RMI1, HNF1B, PAX2, NME1, IL1B, COL6A2, CALCRL, PTGS2, THBS1, CST3, MAP2K6, LYN, EGR1, CDT1, EIF2B3, TGFB1, MAPK13, LIN28A, RPS6KB1, FKBP1B, NOX4]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[IL1RN, ADM, PRL, ETS1, THBD, CD38, TGFB1, IGFBP5, CAD, FOS, FOSL1, ADCYAP1, CLDN4, PNOC, RARA, BCL2, FOSB]
GO:0000921;septin ring assembly;7.0;1.0;0.8509193652572005;9.628524252492122;107.16030555582066;7.069023426578259;0.003586558988939603;0.7124295520356204;[ANLN]
GO:0006231;dTMP biosynthetic process;12.0;0.9326813400603323;0.9144609826203107;9.610505746989444;6271.9915988638395;8.390779266560578;0.2099179143880009;0.8772251544931927;[TYMS]
GO:0007569;cell aging;3.0;0.7980440201809971;0.597142322680643;8.935377071932177;24.751975343904395;5.618190544320798;8.284263394289076E-4;0.485434838299289;[CDKN1A, SERPINE1, BRCA2, ICAM1, NUP62, CHEK1, MME, PRKCD, H2AFX, HMGA1, MIF, MAPK14, SIRT1, PML, DNAJA3, CDK1, BCL2, NOX4, ENG]
GO:0006235;dTTP biosynthetic process;12.0;1.0;0.9481203125901445;9.628524252492122;6270.758393425197;8.390779266560578;0.20987664011178236;0.8772251544931927;[DTYMK, TYMS]
GO:0097681;double-strand break repair via alternative nonhomologous end joining;10.0;1.0;0.9152410118609203;9.628524252492122;369.5024620707547;9.083926447120524;0.012366914874882012;0.8797934328124444;[POLQ, PRKDC]
GO:0007567;parturition;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;7.57984905034425;0.0010979889214459554;0.585754145523778;[MAFF, PTAFR]
GO:0030316;osteoclast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.375876246018314;0.0015755275618510598;0.6491829203200885;[CSF1R, TGFB1, FCER1G, TFRC, TREM2, TNFRSF11A, GAB2, MAPK14, TNF, OSCAR, SBNO2, TYROBP, TNFSF11, JUNB, EPHA2]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[CD40, HSPD1, CCR7, CD36, CCL19, RIPK2, MAPK14, HLA-G, CD40LG, IFNG, IL23A, IRF8, LTB, PLCB1, TLR4, TLR2]
GO:0031641;regulation of myelination;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.055147161688105;6.250713103064308;0.001407547928326502;0.6427820713687392;[KIF14, TYMP, RARA, AKT1, WASF3]
GO:0032733;positive regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.375876246018314;0.002183412136085803;0.6491829203200885;[CD274, CD83, FCER1G, NOD2, PRKCZ, HSPD1, PYCARD, CD40LG, IL23A, BCL3, CD28, XCL1, TIGIT, TLR4, CD34, TLR2]
GO:0007252;I-kappaB phosphorylation;8.0;1.0;0.875;9.628524252492122;180.75330000196035;7.292166977892469;0.006049650283656873;0.747921758369865;[CHUK, TLR7, TLR4, TLR2]
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[HMGB2, LRP2, GATA3, MEA1, GATA1, HOXA11, HOXA10, CTNNA1, PDGFRB, LHCGR, TGFB2, RRM1, BIK, INHBA, EIF2S2, ASPM, KITLG, SFRP2, NASP, MSH2, KIT, BCL2, BCL2L1]
GO:0090331;negative regulation of platelet aggregation;10.0;0.9326813400603323;0.8815816818910864;9.601125278304007;548.6740902153413;7.379178354882098;0.01836362802488484;0.7926125360964777;[CEACAM1, PRKCD, CD9, ALOX12]
GO:1904058;positive regulation of sensory perception of pain;8.0;1.0;0.875;9.628524252492122;66.22319046309637;8.16763571524637;0.0022164305877977837;0.7926932703116032;[PTAFR]
GO:0042495;detection of triacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;192.9668546023468;9.083926447120524;0.006458426964646296;0.839552420951524;[TLR1, TLR2]
GO:0009435;NAD biosynthetic process;11.0;0.7980440201809971;0.8314509624201607;9.500690880982237;2002.0309936558642;5.825829909099042;0.06700617564674446;0.730362164809784;[PTGS2, ENO2, HK3, KYNU, BPGM, KMO, PARP9]
GO:0007257;activation of JUN kinase activity;14.0;1.0;0.9759193652572005;9.628524252492122;8640.54909511404;6.088194173566533;0.2891914022241413;0.7872698984233759;[TNFSF11, CCL19, MAP4K1, SYK, RIPK2, CD40LG, MDFIC, PKN1]
GO:0090330;regulation of platelet aggregation;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;97.23557350837086;6.943860283624253;0.0032543871389904074;0.7513499630073597;[LYN, CEACAM1, SYK, PDPN, PRKCD, CD9, PRKCQ, ALOX12]
GO:0042496;detection of diacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;192.9668546023468;9.083926447120524;0.006458426964646296;0.839552420951524;[TLR6, TLR2]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD86, CD80, PIK3CD, SLA2, PIK3C2A, FGF5, IMPA1, IMPA2, PDGFRB, PDGFRA, CISH, GAB1, TTC7B, VAV1, EREG, BTC, LCK, KIT, PIK3C3, HBEGF, PDGFA, PIK3R3, PIK3R5, SOCS2, CD19, FYN, PIP5K1B, ICOS, TRAT1, EGF, KITLG, PIKFYVE, CD28]
GO:0045762;positive regulation of adenylate cyclase activity;12.0;0.8933024483968273;0.8947715367885583;9.589303539338841;6276.064729494611;7.697632086000634;0.21005423840463325;0.8417775754447168;[LHCGR, TIMP2, TSHR]
GO:0007254;JNK cascade;11.0;1.0;0.9324289523296623;9.628524252492122;290.6144555783003;5.926926025970411;0.009726604292176047;0.735532224928036;[NOD2, TNF, RIPK2, TRIB1]
GO:0007019;microtubule depolymerization;7.0;0.811012628672052;0.7564256795932265;9.34084218004034;92.92880478075006;7.004484905440688;0.003110243465517153;0.7091290490632969;[KIF18A, KIF18B, STMN1, KIF2C, CKAP5]
GO:0045769;negative regulation of asymmetric cell division;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;59.684029898698746;9.777073627680469;0.0019975707685698256;0.8231203125901445;[ASPM]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, ADM, BRCA1, PIK3C2A, ETS1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, CCR3, IL10, PPP1R16B, GHSR, ANXA1, ANXA3, PRKCB, GAB1, CYBB, SIRT1, F3, GREM1, IL1A, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, C3, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0007016;cytoskeletal anchoring at plasma membrane;6.0;1.0;0.8231203125901445;9.628524252492122;66.89368938276097;7.474488534686424;0.002238871583229107;0.7053660038532718;[JUP, EPB41L3, TLN1]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[IHH, EDNRA, PDGFRA, TPM1, MSH2, TWIST1, GATA3, GATA1, EPB41L5, CCNB2, CCNB1, PLCG1, MYH10, STIL, EIF2S2, FOSL1, BMP2, MAFF, BCL2L1, PTPRR, TMEM100, HHEX, EDN1, DUSP3, RXRA, TIE1]
GO:0032201;telomere maintenance via semi-conservative replication;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;216.32599304453976;6.7325511899570465;0.0072402363064467505;0.719302980950052;[RFC5, PRIM2, RFC3, FEN1, PCNA, RFC4, RFC1, RFC2, PRIM1, RPA1, RPA2, POLD3, POLA1, POLA2, POLD1, RPA3, DNA2]
GO:0030263;apoptotic chromosome condensation;8.0;1.0;0.875;9.628524252492122;25.04782972205294;8.16763571524637;8.383283192138855E-4;0.7926932703116032;[TOP2A, ACIN1]
GO:0001947;heart looping;7.0;1.0;0.8509193652572005;9.628524252492122;47.98143023837329;5.71663061713405;0.001605895289594654;0.6432681208679463;[IHH, DLL1, MEF2C, STIL, ENG]
GO:0031110;regulation of microtubule polymerization or depolymerization;8.0;0.7248374789738407;0.7374187394869203;9.117698628726131;35.502556834779206;5.4730085344763;0.001188238627033293;0.6548899109740429;[SKA3, SKA1, PAK1, STMN1, SNCA, CKAP2, PSRC1, FES, MAP1B]
GO:0034620;cellular response to unfolded protein;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;123.17901887317109;6.8867018697843045;0.004122690907765296;0.6753065664753021;[HSPA6]
GO:0010656;negative regulation of muscle cell apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.485423408851448;104.61422944852276;6.250713103064308;0.003501344112948074;0.6946617587785947;[MYOCD, EDN1, DNMT1, ALOX12, ARRB2, IGF1, ADCYAP1, SFRP2, HMOX1]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[IL10, CD274, CD96, IL33, NR1H4, LILRB1, INHBA, PDCD1LG2, GATA3, RARA, XCL1, PGLYRP1, TLR4, HAVCR2]
GO:0031116;positive regulation of microtubule polymerization;10.0;0.8933024483968273;0.861892236059334;9.589303539338841;431.61701704611926;6.518977089658987;0.014445833130437288;0.7486218033895181;[PAK1, PSRC1, FES]
GO:0031115;negative regulation of microtubule polymerization;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;405.4514152206468;7.292166977892469;0.013570093984851534;0.7881627702307852;[STMN1, SNCA]
GO:0007263;nitric oxide mediated signal transduction;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;27.814661162170232;6.832634648514029;9.309316775279788E-4;0.7003406189322132;[FPR1, CD36]
GO:0090344;negative regulation of cell aging;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;80.6841056931466;6.686031174322154;0.002700424406568797;0.6321649570480018;[PRKDC, PLK2, TWIST1, MIF, SLC30A10, FOXM1, SIRT1, CDK6, BCL6]
GO:0007264;small GTPase mediated signal transduction;6.0;0.7369933605727446;0.6916169928765168;8.741221057491218;26.42836680105094;4.015022244900292;8.845336528452411E-4;0.5284487369119741;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK2, DOK3, RAB31, AGTR1, RIN2, DNMT1, IQGAP3, RASGRP1, RASGRP4, G3BP2, HMOX1, JUN, HACE1, PLK2, DHCR24, IGF1, ARHGAP30, COL1A2, BCL6, CDK2, RGL4, RGL1, LAT, DOCK5, GPSM2, CDKN1A, DOCK4, ARHGAP6, ARHGAP4, RAC2, RALGPS2, ARHGEF12, CHUK, RHOG, RHOH, VAV1, RAB33B, CCNA2, RHOU, DOCK2, AIF1, RAB21, PAK1, NRAS, PDPN, EPS8L1, EPS8L3, DNAJA3]
GO:0030261;chromosome condensation;7.0;0.8259837884571596;0.7639112594857803;9.223059144383958;23.949217433387346;6.343086423195323;8.01558754599117E-4;0.6753050999230941;[TOP2A, CDCA5, NCAPG2, NCAPG, SMC4, NCAPH, SMC2, CDK1, NUSAP1, ACIN1, NCAPD2, NCAPD3]
GO:0043111;replication fork arrest;10.0;0.8436909121759173;0.837086467948879;9.546846221477855;1135.309178205509;7.9853141584524145;0.037997776482613155;0.8236103492792612;[MSH6, TIPIN, MSH2, TIMELESS]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK2, DOK3, RAB31, AGTR1, DNMT1, IQGAP3, RASGRP1, G3BP2, JUN, HACE1, PLK2, DHCR24, IGF1, COL1A2, BCL6, CDK2, LAT, GPSM2, CDKN1A, ARHGAP6, ARHGAP4, RAC2, ARHGEF12, CHUK, RHOG, RHOH, RAB33B, CCNA2, RHOU, AIF1, RAB21, PAK1, NRAS, PDPN, EPS8L1, EPS8L3]
GO:0046627;negative regulation of insulin receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;294.34753946768484;6.311337724880743;0.009851547250396369;0.6736814700148209;[PID1, CISH, PRKCB, PRKCD, TSC2, SLA2, PRKCZ, SOCS2, PTPRE, RPS6KB1, IL1B, PRKCQ]
GO:0001954;positive regulation of cell-matrix adhesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;50.25702962731741;5.926926025970411;0.0016820575532361247;0.6262235851885184;[NRP1, THY1, PRKCZ, EPB41L5, CCR7, CD36, JUP, CCL21, EMP2, CDK6, CEACAM6, NINJ1, TEK]
GO:0045780;positive regulation of bone resorption;7.0;1.0;0.8509193652572005;9.628524252492122;82.90338698468558;6.943860283624253;0.002774701754173115;0.7060287030842711;[TFRC, SYK, CA2, SPP1, TNFSF11, ADAM8, TNFRSF11A, TMEM64]
GO:0033762;response to glucagon;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;6.166155715036245;0.0024778305216419678;0.6662568552797195;[ARG1, ABCB4, GLP2R, CCNA2, ADCY9, PRKAR1B, RPS6KB1, PRKAR2B, CYC1, PRKACB]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[CDKN1A, CEBPB, PCNA, C5AR1, IHH, ADM, TYMS, AURKA, ATIC, HMOX1, IL10, MED1, TGFB1, ANXA3, CAD, SULF2, TGFBR3, NFKBIA, CCNA2, CXCL12, NR4A3, CDK1, LCP1, EZH2]
GO:0032436;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;11.0;0.8259837884571596;0.845420846558242;9.498471124243924;3778.5456327194074;5.334422371190153;0.12646452185682636;0.705231560468336;[LRRK2, CLU, AKT1, CBFA2T3, RNF144A, RNF144B, TRIB1, CEBPA, AURKA, IL33, PLK2, CAV1, PLK1, DAB2]
GO:0018149;peptide cross-linking;7.0;0.6007507099811141;0.6512947202477576;8.117066748418225;151.15475272427284;5.69953618377475;0.005059013543235805;0.6423939107509793;[DSP, CSTA, ANXA1, EPB42, FN1, BGN, F13A1, THBS1, DCN, COL3A1, SPOCK3, TGM2]
GO:0034614;cellular response to reactive oxygen species;5.0;0.7671156992804218;0.6737988615011312;9.197741336399668;144.094088465717;5.076593261888053;0.004822699464687224;0.5498582273596049;[NCF1, TNFAIP3, PTPRK, ETS1, AQP1, IL18RAP, MYB, AKT1, CYP1B1, PDGFRA, ANXA1, CHUK, ARG1, TPM1, PRKCD, FOS, MMP9, SIRT1, PAX2, DNM2, CCNA2, BTK, HDAC2, PCNA, FOXO1, CST3, PDGFD, ECT2, JUN, KLF4, MAPK13, FABP1, IL6, CDK2, CDK1, EZH2]
GO:0031103;axon regeneration;7.0;0.8436909121759173;0.7727648213451592;9.427853557029971;96.50678923292918;6.832634648514029;0.00322999538515464;0.7003406189322132;[DHFR, JUN, CHL1, TNC, CTNNA1, BCL2, JAM3]
GO:0071800;podosome assembly;5.0;1.0;0.7902410118609202;9.628524252492122;81.13164658075348;7.697632086000634;0.00271540319731635;0.6838982747154925;[BIN2, NCF1, NCF1C]
GO:0032435;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;11.0;0.8436909121759173;0.8542744084176208;9.523163736834295;3784.4609618058316;6.343086423195323;0.1266625025978984;0.7568146869955557;[TAF9, PBK]
GO:0071801;regulation of podosome assembly;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;64.45443428147517;7.069023426578259;0.002157231910176139;0.7124295520356204;[HCK, GSN, LCP1, TNF]
GO:0070508;cholesterol import;8.0;1.0;0.875;9.628524252492122;77.49126092049113;7.9853141584524145;0.0025935627654017587;0.7833693374183408;[CD36]
GO:0090316;positive regulation of intracellular protein transport;8.0;0.7090535922965819;0.729526796148291;9.107227328858835;289.7860898249656;4.74012102526684;0.009698879635892712;0.6174100096703167;[, CHRM1, CDH1, MED1, PRKCD, PDZK1, KIF20B, SFN, ECT2, TGFB1, JUP, FZD5, IGF1, CDK1, ITGAM, LRRK2, ITGB2, RAC2, IFNG, IL1B, HCLS1, RHOU, PTGS2, PAK1, ABLIM3, FYN, MAPK14, CAMK1]
GO:0070507;regulation of microtubule cytoskeleton organization;7.0;0.6073376606709605;0.6545881955926808;8.242229891372231;33.71079736555127;4.584116776790259;0.0011282700500770656;0.5853513104054853;[CEP120, CCNF, SMC3, STMN1, CHEK1, NEK2, MAP1B, EPHA3, SKA3, SKA1, PKHD1, CEP76, PLK4, STIL, PLK2, PLK1, TPX2, KIF18A, STAG2, FES, GPSM2, BRCA1, KIF11, XPO1, NUP62, CKAP2, SMC1A, PSRC1, VPS4B, GNAI1, AURKA, PAK1, POC1A, SNCA, RANBP2, RANBP1, SPAG5, TACC3]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, TRIM25, WLS, TGM2, PRKCB, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, SECTM1, FASLG, NUP62, CCR7, CD36, CHUK, RIPK2, ZDHHC17, IL1B, TLR6, BIRC2, LTF, BIRC3, NOD2, FLNA, FYN, CCL19, CD74, CCL21, CARD9, CD4, F2RL1, LTBR]
GO:0048812;neuron projection morphogenesis;7.0;0.6547035408479693;0.6782711356811852;8.502512989635898;62.99970935475633;4.360973225476049;0.002108543576046295;0.5739397388140403;[ADARB1, STMN1, EPHB2, EPHB1, MNX1, MEF2A, MAP1B, KIF20B, NBL1, SDC2, EPB41L3, NCKAP1L, GP5, PTK2, NR4A2, LRFN4, OGN, BCL2, NRP1, LRRK2, RAC2, DCC, STRADB, PAX2, DNM2, CDH11, SGK1, DSCAML1, SHANK3, NLGN1, LRP2, PAK1, NTF3, SLITRK6, FYN, APBB1, LINGO1, SEMA4A, POU4F1, WEE1]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[EHMT2, CCNF, SMC3, UXT, CHEK1, FBXO5, PRKACB, SOX4, TIPIN, MIF, RRAGD, DNA2, AURKAIP1, KIF20B, PRKDC, GATA3, BRIP1, RAD21, TP53BP2, SFN, BARD1, CDT1, PLK2, PLK1, LIF, CDC7, CDC6, NR2F2, ZWINT, STAG2, EZH2, TOP2A, CDKN1A, BTG2, PTPRK, BRCA1, BRCA2, BMI1, TIMP2, IL10, DUSP1, STRADB, GAS1, PCNA, PTGS2, GPNMB, APBB1, CDKN2C, RPA2, LILRB1, CENPF, FAP, TRIP13, SIPA1, MAD2L1, CDKN3, ZWILCH, GMNN, BUB1B, TNF, PTTG1, KNTC1, NEK2, MEN1, CDC25C, MSH6, ADCYAP1, MSH2, TIMELESS, MAD1L1, BLM, CUL5, CCNB1, NACC2, NAE1, CLSPN, GAS2L1, MAP2K6, FANCI, TGFB2, TGFB1, DHCR24, INHBA, NR4A1, BMP2, CDK6, BCL6, CNOT3, JMY, CDK2, CDK1, BCL2, PTTG3P, BCL2L1, TNFAIP3, HHEX, CASP2, TOPBP1, MYOCD, H2AFX, SMC1A, TFDP1, IFNG, ESPL1, DTL, PPP1R15A, CEBPA, TTK, THBS1, AURKB, AURKA, CDC45, RBBP8, E2F1, CCL2, BUB1, E2F7, E2F8, RRM2, DONSON, MAPK14, KLF4, PML, WEE1, RAD51, EVI2B]
GO:0045787;positive regulation of cell cycle;5.0;0.5265193887476639;0.5535007062347522;7.230628979693751;42.184038669436575;3.8238302933926853;0.0014118618110960173;0.4857918708913159;[, CCNH, CCNF, CCNC, PHB2, CHEK1, AKT1, SOX4, MED1, PRKCE, TAS2R13, FLT3LG, MIF, EREG, BTC, KIF20B, CDCA5, TGFA, RACGAP1, RAD21, SFN, PLK4, CDT1, PLK2, CDC7, CDC6, IGF1, FOSL1, CD28, CDKN1A, FEN1, BTG2, KIF14, BRCA1, BRCA2, DLGAP5, IL10, EDN1, ANXA1, DUSP3, KIF23, CIT, IL1A, RAD51C, TAL1, IL1B, CKS2, RARA, PLCB1, PCNA, CXCR5, KCNA5, AIF1, RANBP2, RANBP1, SVIL, POU4F1, FAP, MAD2L1, CCNT2, CEP120, CTGF, NUSAP1, PDGFRB, CDC25C, CDC25A, CCNE2, CCNE1, CCNB2, CCNB1, ECT2, FAM83D, TGFB2, TGFB1, UBE2C, NDC80, NR4A3, CNOT3, CDK2, CDK1, GPSM2, CKS1B, NUP62, CASP2, CCNA2, PSRC1, TFDP1, ESPL1, DTL, SMARCD3, VPS4B, AURKB, AURKA, CDC45, E2F1, POC1A, E2F7, SH2B1, E2F8, SPAG5, EGF, MEIS2, PML, RPS6KB1, EVI2B]
GO:0097190;apoptotic signaling pathway;5.0;0.6954798709641801;0.6379809473430103;8.529911963824013;23.17027026302992;4.145861845859104;7.75488093814194E-4;0.5022605794604473;[TNF, PYCARD, CYP1B1, IL6R, DAPK1, PRKCD, MSH6, MELK, MSH2, IFI27, LGALS12, BTK, EPHA2, CUL5, PRKDC, LY96, TNFRSF11A, TP53BP2, HMOX1, SFN, CD14, TGFB2, TGFB1, TNFSF12, CAV1, TNFRSF10C, TNFRSF10B, INHBA, JMY, BCL3, CD28, BCL2, CD27, CD24, BCL2L1, CDKN1A, CD40, FASLG, BRCA1, BRCA2, CD3E, CD38, CASP2, GPX1, DCC, PAWR, TNFRSF1B, SIRT1, IL1A, IFNG, IL1B, TLR4, PPP1R15A, CEBPB, BCL2A1, IFI6, PERP, E2F1, E2F2, CASP8AP2, IL33, SORT1, G0S2, GZMB, MLH1, POU4F1, PML, GZMH, CD5]
GO:0042276;error-prone translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.7325511899570465;0.025467164394386097;0.7595439928109722;[RFC5, RFC3, PCNA, RFC4, RFC1, RFC2, RPA1, RPA2, POLE2, RPA3]
GO:0043124;negative regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;6.063501560976162;0.008015432820232688;0.6850877518099798;[TNFAIP3, RORA, NLRC3, PYCARD, STAT1, NR1H4, RHOH, SIRT1, NLRP12, TNIP3, CCDC22, ZMYND11, NFKBID]
GO:0046638;positive regulation of alpha-beta T cell differentiation;10.0;0.7671156992804218;0.7987988615011312;9.488762310116963;1285.3660192826185;5.970411137910149;0.04302004391107474;0.7205681151061569;[CD86, CD83, CD80, IHH, PRKCZ, HLX, MYB, NLRP3, NCKAP1L, CCL19, IL12RB1, ANXA1, SYK, RIPK2, IL18, ZAP70, IFNG, IL23A, RARA, NFKBID]
GO:0043129;surfactant homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;28.07196958697662;7.474488534686424;9.395435589437007E-4;0.7331650565203278;[CTSH]
GO:2000816;negative regulation of mitotic sister chromatid separation;10.0;0.811012628672052;0.8207473261969463;9.507163395487854;941.8965548825082;6.599019797332524;0.03152443004005238;0.7527151911823093;[PLK1, BUB1B, TTK, CENPF, PTTG1, RAD21, TRIP13, BUB1, MAD1L1, PTTG3P, MAD2L1]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, ITGB2, PLEK, ITGAL, CTGF, ADAMTS1, ITGAX, ITGB8, ITGB7, ITGB6, FCER1G, SYK, ITGA4, VAV1, FGR, HCK, CEACAM1, TYROBP, ADAM9, ITGA7, TLN1, CDH17, TXK, THY1, PTK2, COL3A1, ZYX, PLP1, LAT]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, HDAC2, PTGS2, THBS1, HMOX1, LYN, HSPA6, MYOF, EIF2S1, CXCL10, IL1A, TFEC]
GO:0046641;positive regulation of alpha-beta T cell proliferation;10.0;0.8653626801206646;0.8479223519212526;9.54628615425515;937.8544877713971;6.8867018697843045;0.03138914569146771;0.7674272657460779;[BLM, SYK, RIPK2, EBI3, IL18, CD3E, HLA-E, ZAP70, IL23A, CD28, XCL1, CCR2]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, JUNB, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, JAK3, HLA-DPA1, ANXA1, SERPINB2, IFNGR1, GPR35, RIPK2, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, ZEB1, PLCB1, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, STAT1, IL10RA, HLA-DPB1, PF4, CSF3, CSF3R, F13A1, IL5RA, RORA, CXCL13, TNF, PYCARD, IGHG1, MAP3K8, IL13RA2, IL13RA1, IFNA14, CISH, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, CD300LF, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, BCL2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, PIK3CD, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL2, XCL1, BIRC5, LCP1, BIRC2, BIRC3, CX3CR1, CEBPA, CEBPD, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, IL21R, CCL2, CCL1, FYN, FCGR1A, FCGR1B, PML, KLF6, IL2RB, PTPN6, IL1RN, IFITM1, IFI30, IFIT1, IFIT3, IFIT2, ICAM1, TNFSF11, TRIM25, RSAD2, ACSL1, IL1R1, IL1R2, HLA-B, FLT3LG, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IFI27, IL23A, EBI3, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, CD27, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, IL10, SYK, IL15, IL18, GP1BA, GAB2, IL17RB, VAV1, HCK, IL1A, CEACAM1, IL1B, KIT, RHOU, SP100, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR3, CXCR2, IL32, CD74, IL33, OSM, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, ISG15, NFKBIA, IL6, IL7R, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, LMNB1, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, IRF8, LTB, CAMK2D, SAMHD1, NCAM1, MX2, SOD2, CD4, LTBR]
GO:0060707;trophoblast giant cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;42.294635617598914;7.292166977892469;0.0014155633914202197;0.6631627702307852;[PLK4, LIF, NR2F2, E2F7, E2F8]
GO:1990426;mitotic recombination-dependent replication fork processing;10.0;1.0;0.9152410118609203;9.628524252492122;328.81961107458824;9.083926447120524;0.011005296464229153;0.8797934328124444;[RAD51, BRCA2]
GO:0031573;intra-S DNA damage checkpoint;10.0;1.0;0.9152410118609203;9.628524252492122;277.3883443919017;7.069023426578259;0.009283938253494562;0.7767511986393403;[TIPIN, MSH2]
GO:0010634;positive regulation of epithelial cell migration;8.0;0.7866048967936545;0.7683024483968273;9.383401794459138;242.52723865374625;4.901876304479318;0.00811716841739676;0.6256821821716325;[DOCK5, NRP1, NRP2, CD40, SPARC, ITGB3, PIK3C2A, ETS1, EPB41L4B, AKT1, CTSH, CCR6, EDN1, ANXA1, ANXA3, PRKCE, MMP9, SIRT1, IFNG, ADAM9, PFN1, HBEGF, GATA3, PTGS2, THBS1, EPB41L5, HMOX1, PLCG1, JUN, TGFB2, TGFB1, PLK2, VIL1, TEK]
GO:0070987;error-free translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.781341354126479;0.025467164394386097;0.7620391240755716;[RFC5, RFC3, PCNA, RFC4, RFC1, RFC2, RPA1, RPA2, RPA3]
GO:0031577;spindle checkpoint;7.0;0.7866048967936545;0.7442218136540277;9.292052015870908;53.07061143901962;6.686031174322154;0.0017762256044145627;0.692843310444282;[PLK1, BUB1B, TTK, AURKB, CENPF, TRIP13, BUB1, MAD1L1, MAD2L1]
GO:0070979;protein K11-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;6.375876246018314;0.00527474598481953;0.7584915600596062;[UBE2C, UBE2S, UBE2T]
GO:0022617;extracellular matrix disassembly;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;37.09213040667776;5.69953618377475;0.0012414402239614005;0.581715557354699;[MMP1, MMP2, HTRA1, LAMC1, MMP8, MMP9, CTSS, MMP12, TIMP2, MMP19, CTSG, ADAM8, TIMP1, LCP1, A2M, ELANE]
GO:0046645;positive regulation of gamma-delta T cell activation;9.0;0.8653626801206646;0.8289219652406215;9.50592193039979;251.56717180496403;8.16763571524637;0.008419726844556379;0.8139338954918922;[SYK, LILRB1, NCKAP1L, NOD2]
GO:0006396;RNA processing;7.0;0.49247393176386933;0.5971563311391352;7.484544189674715;115.0816327851482;3.0330144413691222;0.0038516786825735262;0.5060278648384131;[POP5, ADARB1, WDHD1, MBNL2, SLBP, UPF3B, SIRT1, GTF2H1, ELP4, FMR1, SNRPG, SNRPE, SNRPF, SNRPA, LSM5, LSM3, ESRP1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, NOP56, CCNH, LGALS3, SNRPD2, PPP2R1A, SNRPD1, MAGOH, SNRPD3, AURKAIP1, TRMT11, SUV39H1, FBL, PUS7, LIN28A, NCBP2, RBM38, ACIN1, RBMX]
GO:0008333;endosome to lysosome transport;6.0;0.8436909121759173;0.7449657686781032;9.36615998802463;62.67584315854233;5.769740442447999;0.0020977040659196657;0.618185107137305;[VPS4B, DENND3, ADRB2, CDX2, SORT1, VPS41]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[TNF, AKT1, CHUK, RIPK2, BTK, TLR8, TLR7, TLR4, CARD11, BIRC2, BIRC3, LY96, NLRC3, RELB, CD14, CARD9, NFKB1, NFKB2, NFKBIA, BCL3]
GO:0043137;DNA replication, removal of RNA primer;8.0;0.9326813400603323;0.8413406700301662;9.593432932680852;683.7334329296626;8.390779266560578;0.022883942680016138;0.8041048419030481;[FEN1, RNASEH2A, DNA2]
GO:0046651;lymphocyte proliferation;5.0;0.6873818243518346;0.6339319240368375;8.734706376470026;28.263571572696247;5.500407508664414;9.459563049751445E-4;0.571532107649126;[IFNA5, IFNA4, IFNA7, CD40, IFNA2, IFNA8, IL10, HELLS, MEF2C, CR2, IFNA14, IFNA16, RIPK2, IL15, SLC11A1, CD180, PRKCD, IL23A, DOCK2, MS4A1, CARD11, IFNA10, CD151, LEF1, EBI3, HSPD1, CD79A, FYN, IFNA21, TNFSF14, LILRB1, CD40LG, PTPRC, IMPDH2, FKBP1B, BCL2, IL7R]
GO:0001932;regulation of protein phosphorylation;8.0;0.49565848909023646;0.6228292445451182;7.636094087801916;109.02632868365667;2.531418560085934;0.00364901310371649;0.5044568628857964;[, PID1, ADARB1, PHB2, AKT1, PROK2, ROPN1L, PRKACB, PRKCE, PRKCD, PRKAR1B, ATF3, PRKDC, FPR1, PDGFA, FPR2, THY1, SLC30A10, IQGAP3, GATA1, PRKCZ, SAMSN1, C3, FLRT2, PRKAR2B, PDGFD, PDGFC, S100A12, SFN, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, PLK1, FN1, FZD8, EIF2AK2, CDC6, AZU1, NR2F2, NOX4, PKIG, NOX1, EZH2, CDKN1A, LRRC4, TIMP2, PBK, TIMP3, HAVCR2, DUSP2, GPR37, DUSP3, DUSP1, RIPK2, FCRL3, BGN, EMP2, SIRT1, DUSP6, CKS2, HCLS1, PLCB1, HBEGF, ENG, CCL13, LRRC19, FAM129A, PTGS2, GPNMB, NTF3, DMD, CCL19, CCL18, CCL23, CDKN2C, CCL21, CCL20, CARD9, GTF2H1, ELP4, CENPE, PKN1, CDKN3, CSF3, CCNT2, NCF1, FMR1, TNF, CLU, CTGF, PYCARD, MAP3K8, MEN1, IFNA14, MAP2K2, CISH, IFNA16, IGFBP3, F2R, CDC25C, CDC25A, ADCYAP1, ADAM9, ADAM8, IFNA10, CSF1R, BLM, TNFRSF11A, PKMYT1, FOXO1, SOCS2, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, CXCL10, DAB2, COPS5, PTPRC, CDK6, CDK1, BCL2, PLXNB2, CSPG4, LAT, LRRK2, ITGB3, ITGB2, TREM2, PTPN22, ARRB1, ARRB2, FOXM1, CYR61, HHEX, DUSP10, EMILIN1, XCL2, XCL1, LCP2, CEBPA, HDAC2, TTK, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, KLF4, PML, RAD50, PTPN6, FCGR2B, PPIL4, IL1RN, CCNH, CCNF, CCNC, ICAM1, HERC5, TCL1A, EDNRB, PPP2R1A, TNFSF11, EPHB2, EPHB1, ACSL1, SLC11A1, PAQR3, FLT3LG, MIF, EREG, SFRP2, IL23A, TRIB1, EPHA3, EPHA2, TGFA, TWIST1, PIK3R5, PKHD1, SLAMF1, CCR1, EGR1, GADD45B, LIF, IGF1, PTK2, BST1, MARCO, TPX2, ID1, CD27, CALM3, CD24, IFNA5, IFNA4, NRP1, IFNA7, PTPRR, CD40, IFNA2, KIF14, CD3E, IFNA8, RAC2, CCR7, CD36, MAP4K1, EDN1, SYK, IL15, STRADB, IL18, GP1BA, PARP9, CEACAM1, MDFIC, BANK1, IL1B, KIT, TLR8, TLR7, TLR6, TLR4, CXCR4, AIF1, GNAI2, PAK1, CD74, OSM, PODN, NLRP12, CD40LG, F2RL1, CAMK1, CD80, IL6R, PDGFRB, PDGFRA, TSC2, CCNE2, HGS, CCNE1, CALCA, C5AR1, FBLN1, ADRB2, RASGRP1, CCNB2, CCNB1, HRH4, STAP1, CLSPN, ECT2, FAM83D, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, GNAQ, TNFAIP3, CKS1B, GHR, GRM5, LRRTM4, NUP62, MYOCD, PDE4D, PLAUR, IRAK3, AXIN2, MMP9, DCN, FGR, CCNA2, GREM1, PSRC1, IFNG, NDUFS4, CHI3L1, PDE5A, ZMYND11, LTF, THBS1, SNCA, EGF, MAPK14, CD4, LTBR, TEK]
GO:0001933;negative regulation of protein phosphorylation;9.0;0.6056485694559711;0.6990649099082746;8.75603614327636;664.693789818838;3.7392027077583316;0.02224670295966317;0.5874636255457587;[PID1, ADARB1, PPP2R1A, AKT1, EPHB2, PAQR3, PRKCD, SFRP2, PRKAR1B, TRIB1, ATF3, PRKDC, TWIST1, THY1, PRKCZ, SAMSN1, FLRT2, PRKAR2B, SFN, LYN, JUN, GADD45B, PLK1, LIF, NR2F2, CALM3, PKIG, CDKN1A, PTPRR, LRRC4, PBK, TIMP3, DUSP2, DUSP3, DUSP1, BGN, GP1BA, SIRT1, DUSP6, CEACAM1, IL1B, TLR4, ENG, LRRC19, FAM129A, NTF3, DMD, CDKN2C, PODN, NLRP12, F2RL1, PKN1, PYCARD, MEN1, CISH, IGFBP3, TSC2, FBLN1, FOXO1, SOCS2, CCNB1, TGFB1, CAV1, PTPRC, CDK6, GNAQ, LRRK2, TNFAIP3, PTPN22, ARRB1, ARRB2, FOXM1, HHEX, DUSP10, LRRTM4, NUP62, EMILIN1, MYOCD, PDE4D, IRAK3, DCN, GREM1, ZMYND11, CEBPA, CSK, SNCA, KLF4, PTPN6]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[, PHB2, AKT1, PROK2, PRKACB, PRKCE, PRKCD, PRKAR1B, FPR1, PDGFA, FPR2, SLC30A10, IQGAP3, GATA1, PRKCZ, C3, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, PLK1, FZD8, EIF2AK2, CDC6, AZU1, NOX4, NOX1, EZH2, CDKN1A, TIMP2, HAVCR2, GPR37, RIPK2, FCRL3, EMP2, SIRT1, DUSP6, CKS2, HCLS1, PLCB1, HBEGF, ENG, CCL13, FAM129A, PTGS2, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, CENPE, PKN1, CSF3, CCNT2, NCF1, FMR1, TNF, CLU, CTGF, PYCARD, MAP3K8, IFNA14, MAP2K2, IFNA16, IGFBP3, F2R, ADCYAP1, ADAM9, ADAM8, IFNA10, CSF1R, TNFRSF11A, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, DAB2, PTPRC, CDK1, BCL2, CSPG4, LAT, LRRK2, ITGB3, TREM2, PTPN22, ARRB1, ARRB2, CYR61, XCL2, XCL1, LCP2, HDAC2, TTK, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, RAD50, FCGR2B, IL1RN, CCNH, CCNC, ICAM1, TCL1A, EDNRB, TNFSF11, EPHB2, EPHB1, ACSL1, SLC11A1, FLT3LG, MIF, EREG, SFRP2, IL23A, EPHA3, EPHA2, TGFA, PIK3R5, SLAMF1, CCR1, EGR1, GADD45B, LIF, IGF1, PTK2, MARCO, TPX2, CD27, CALM3, CD24, IFNA5, IFNA4, NRP1, IFNA7, CD40, IFNA2, KIF14, CD3E, IFNA8, CCR7, CD36, MAP4K1, EDN1, SYK, IL15, STRADB, IL18, PARP9, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CXCR4, AIF1, GNAI2, PAK1, CD74, OSM, CD40LG, F2RL1, CAMK1, CD80, IL6R, PDGFRB, PDGFRA, CALCA, C5AR1, ADRB2, RASGRP1, CCNB1, STAP1, CLSPN, ECT2, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, CKS1B, GHR, GRM5, PLAUR, AXIN2, MMP9, GREM1, PSRC1, IFNG, CHI3L1, PDE5A, LTF, THBS1, SNCA, EGF, MAPK14, CD4, LTBR, TEK]
GO:0010886;positive regulation of cholesterol storage;7.0;1.0;0.8509193652572005;9.628524252492122;69.4460343959197;7.8311634786251565;0.002324296273858149;0.7514054297404357;[MSR1, CD36]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, ICAM1, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, SIRPA, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, DOK2, PRTN3, ADAM8, S100A9, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, FUT7, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, ESAM, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, PIK3CD, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, PDE4D, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, SLC7A9, IL1B, CEACAM5, KIT, PECAM1, XCL2, XCL1, CD48, CEACAM8, CX3CR1, CCL13, SELPLG, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR3, TBX21, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, F2RL1, PTPN6, TEK, CD244, PF4]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1A, DUSP1, STRADB, MSH2, IFNG, RRAGD, GAS1, KIF20B, PPP1R15A, CUL5, THBS1, APBB1, GAS2L1, MAP2K6, BARD1, TGFB2, TGFB1, CDKN2C, DHCR24, INHBA, PML, CDK6, FAP, JMY, CDKN3]
GO:1905342;positive regulation of protein localization to kinetochore;7.0;1.0;0.8509193652572005;9.628524252492122;73.70707873031733;8.390779266560578;0.002466909593039506;0.7800242071602487;[CDT1, NDC80]
GO:0043306;positive regulation of mast cell degranulation;11.0;0.8933024483968273;0.8790801765280758;9.584072489921288;1034.300036297698;7.212124270218933;0.03461709140528456;0.8012573229067359;[FGR, FCER1G, SYK, GAB2]
GO:0007051;spindle organization;6.0;0.6873818243518346;0.6668112247660618;8.690254613899192;44.522636097919765;4.786641040901733;0.0014901325624263064;0.5679093580234316;[GPSM2, CEP120, KIF11, CDC20, STMN1, NUF2, NEK2, MYBL2, FBXO5, TUBG1, CKAP5, ASPM, ESPL1, KIFC1, BIRC5, BIRC2, BIRC3, TTK, AURKB, AURKA, CCNB1, POC1A, FLNA, CEP72, RANBP2, RANBP1, STIL, CENPW, SPAG5, PLK2, NEK7, NDC80, CENPE, TPX2, KIF4A, RAN, SPC25]
GO:1905341;negative regulation of protein localization to kinetochore;7.0;1.0;0.8509193652572005;9.628524252492122;73.78875676133134;9.777073627680469;0.0024696432832320894;0.8509193652572005;[CDT1]
GO:0030071;regulation of mitotic metaphase/anaphase transition;10.0;0.7586651285174919;0.7945735761196663;9.405380701177911;262.3324330841205;5.885253329569843;0.0087800304514636;0.7162131408273906;[BUB1B, TTK, CCNB1, RAD21, BUB1, DLGAP5, CDT1, DUSP1, UBE2C, PLK1, CDC6, NDC80, CENPE, CENPF, ESPL1, TRIP13, MAD1L1, MAD2L1]
GO:0045727;positive regulation of translation;8.0;0.6634067003016617;0.7067033501508309;9.123968241739727;1032.6861465930526;5.104244793218563;0.03456307596927652;0.6360313160968547;[FMR1, TNF, SOX4, PPP1R15A, PTAFR, FAM129A, THBS1, RXRA, CCL5, UPF3B, IL6, LIN28A, RPS6KB1, BCL3, CD28, EIF3E, EIF3D]
GO:0030073;insulin secretion;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;236.67564318465372;6.166155715036245;0.007921320783140251;0.711578115202808;[IL1RN, ANXA1, HNF1B, ADCYAP1, FKBP1B]
GO:0032494;response to peptidoglycan;5.0;0.8653626801206646;0.7229223519212526;9.461470167828956;77.33766349313319;7.379178354882098;0.002588421997736798;0.6676125360964777;[IL6, RIPK2, C5AR1, CARD9, NLRP3, TREM2, IRAK3, NOD2]
GO:0007052;mitotic spindle organization;7.0;0.8259837884571596;0.7639112594857803;9.280217558223907;96.21539173928952;5.486614186532078;0.0032202425732832385;0.6315050699101035;[GPSM2, TTK, KIF11, AURKB, AURKA, CDC20, CCNB1, STMN1, NUF2, POC1A, FLNA, NEK2, MYBL2, STIL, PLK2, TUBG1, NDC80, CENPE, TPX2, KIFC1, KIF4A, BIRC5, RAN, BIRC2, SPC25, BIRC3]
GO:1904498;protein localization to mitotic actomyosin contractile ring;9.0;1.0;0.896240625180289;9.628524252492122;102.47693557236114;8.67846133901236;0.003429810810352553;0.8400575416471059;[ANLN]
GO:0043542;endothelial cell migration;7.0;0.7980440201809971;0.7499413753476991;9.143016436710422;24.971868181253015;5.71663061713405;8.357859548042604E-4;0.6432681208679463;[NRP1, PLXND1, ITGB2, CXCL13, LOXL2, DPP4, CYP1B1, PRSS3, EGR3, GPX1, TNFSF12, EMP2, PTK2, GREM1, NR4A1, FAP, ID1, S100P]
GO:0007057;spindle assembly involved in female meiosis I;10.0;1.0;0.9152410118609203;9.628524252492122;179.89568969163926;9.083926447120524;0.006020946838369597;0.8797934328124444;[FBXO5, AURKA]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[F11R, ICAM1, TIAM2, DEPDC1B, RIN2, LLGL2, EPHA2, THY1, RACGAP1, NCKAP1L, A2M, JUN, EZH2, ARHGAP9, DENND1B, NRP1, CD40, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, DEPDC1, PLCB1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL21, CCL20, DLC1, F2RL1, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ADCYAP1, ACAP1, PRTN3, ARHGAP19, RASAL2, ARHGAP15, RASGRP1, ADAP2, ECT2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, GNAQ, ARHGAP11A, DOCK4, LRRK2, ARRB1, TAGAP, ARHGEF12, TBC1D8, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL2, XCL1, DOCK2, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0043305;negative regulation of mast cell degranulation;11.0;0.9326813400603323;0.8987696223598284;9.607470843294289;1077.1478631716955;7.9853141584524145;0.03605116961021663;0.8407982897480031;[HMOX1, IL13RA2]
GO:0044878;mitotic cytokinesis checkpoint;10.0;1.0;0.9152410118609203;9.628524252492122;492.819650181817;8.390779266560578;0.016494230182695288;0.8443458537639685;[AURKB]
GO:0043304;regulation of mast cell degranulation;10.0;0.7980440201809971;0.8142630219514189;9.523163736834295;224.79395709788088;6.409777797693995;0.007523651442639206;0.7430373465201421;[LYN, FCER1G, SYK, STXBP2, GAB2, FGR, FES, RAC2, HMOX1, IL13RA2]
GO:0002830;positive regulation of type 2 immune response;6.0;0.8933024483968273;0.7697715367885581;9.461470167828956;108.5833891387084;7.069023426578259;0.0036341883157667808;0.6846304993685643;[CD86, CD74, IL33, IL6, RSAD2, RARA, IL18, NLRP3, XCL1, GATA3, NOD2, PRKCZ]
GO:0035519;protein K29-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;8.16763571524637;0.00527474598481953;0.8501222226412654;[UBE2S, UBE2T]
GO:0032487;regulation of Rap protein signal transduction;9.0;1.0;0.896240625180289;9.628524252492122;48.758993290020136;8.67846133901236;0.0016319196251719597;0.8400575416471059;[TIMP2, KIF14]
GO:0031398;positive regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;528.4459358446122;5.113634533568402;0.01768660990225356;0.6767525197159333;[LRRK2, PTPN22, ARRB1, BRCA1, ARRB2, BMI1, CDC20, SKP2, RIPK2, MASTL, BIRC2, BIRC3, ADRB2, NOD2, FANCI, NDFIP2, WFS1, UBE2C, CAV1, PLK1, UBE2S]
GO:0035999;tetrahydrofolate interconversion;8.0;1.0;0.875;9.628524252492122;262.53585291497376;7.292166977892469;0.008786838730136297;0.747921758369865;[MTHFD1, TYMS]
GO:0010216;maintenance of DNA methylation;7.0;1.0;0.8509193652572005;9.628524252492122;149.0421272461911;8.16763571524637;0.0049883058697239;0.7686126355688037;[HELLS, DNMT1, UHRF1]
GO:0019048;modulation by virus of host morphology or physiology;6.0;0.5173302570349838;0.5817854411076364;7.2718719382278;41.653513925674126;6.193554689224359;0.0013941056253635594;0.6398589874268261;[TYMS, RXRA, TGFB1, EIF2AK2, CD4, BCL2L1]
GO:0034421;post-translational protein acetylation;9.0;1.0;0.896240625180289;9.628524252492122;308.12661660850654;8.67846133901236;0.010312720561935343;0.8400575416471059;[DSCC1, ESCO2]
GO:0010458;exit from mitosis;5.0;1.0;0.7902410118609202;9.628524252492122;29.819065850336454;7.379178354882098;9.980172985937987E-4;0.6676125360964777;[EPS8, UBE2C, UBE2S]
GO:0032006;regulation of TOR signaling;7.0;0.7866048967936545;0.7442218136540277;9.260799472366804;45.070113835906206;5.244474134527214;0.001508456149618737;0.6191220163899107;[SESN3, TSC2, SIRT1, RRAGD, SIK1, SEH1L, UBR1, PKHD1, FAM83D, TBCK, LIN28A]
GO:0045739;positive regulation of DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.360260265897443;499.6181899148078;5.8650506222523235;0.01672177118926996;0.6749389615747303;[BLM, PCNA, BRCA1, FOXM1, APBB1, H2AFX, PARP9, SIRT1, TIMELESS]
GO:0090305;nucleic acid phosphodiester bond hydrolysis;6.0;0.6073376606709605;0.6267891429256247;8.355558576679234;112.24841944109592;4.100319825412187;0.0037568535816745637;0.5328108591460956;[DCLRE1A, POP5, RNASE6, RNASE3, RNASE2, DNA2, RNASEH2A, ERI2, FEN1, HMGB2, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, NCBP2, PCNA, SAMHD1, POLD3, POLD1, RBBP8, POLR2I, RPA1, RPA2, GTF2H1, RAD50, RPA3]
GO:0007062;sister chromatid cohesion;5.0;0.7508913569872202;0.6656866903545304;8.801845679307654;32.565640385727406;6.113511981550823;0.001089942676536732;0.6028862989048107;[CDCA5, PLK1, BUB1B, ESCO2, SMC1A, SMC3, PHB2, CDC20, RAD51C, STAG2, PPP2R1A, RAD21, BUB1]
GO:0045737;positive regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2922.0785093664276;6.193554689224359;0.09779933800857048;0.7648589874268262;[CCNT2, CCNH, CCNC, CKS1B, CCNB1, AKT1, CDC6, PSRC1, CKS2]
GO:0032481;positive regulation of type I interferon production;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;65.23665507211369;5.618190544320798;0.002183412136085803;0.610434838299289;[HMGB2, PTPN22, IFIH1, DHX58, CHUK, SYK, DDX58, RIPK2, MMP12, IRF7, TLR8, TLR7, TLR4, TLR2, PRKDC, HSPD1, PLCG2, CD14, STAT1, NFKB1, NFKB2, MYD88]
GO:0007063;regulation of sister chromatid cohesion;8.0;0.6260725219892441;0.688036260994622;8.694215015115288;54.93577305356617;6.686031174322154;0.0018386508851169624;0.7169239451870815;[FEN1, CDCA5, AXIN2, ESPL1, RAD21, BUB1]
GO:0007064;mitotic sister chromatid cohesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;49.163113097731234;7.212124270218933;0.0016454451514518356;0.6919486831672181;[CDC20, CDCA5, SMC1A]
GO:0032482;Rab protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;5.500407508664414;9.9090025448413E-4;0.6562910957882058;[RAB21, RAB33B, RAB32, RAB31]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[LYN, PDGFRB, PDGFRA, TGFB1, CCL21, FPR2, NOD2, PTK2, FGR, KIT, CCR7, TEK, CCL19]
GO:0045732;positive regulation of protein catabolic process;7.0;0.7043150770688792;0.7030769037916401;9.033817144745429;231.0521549826792;4.39257856489138;0.0077331076938309705;0.5755560373415389;[FMR1, TNF, CLU, AKT1, ADAM9, ADAM8, TRIB1, NEDD4L, FOXO1, BARD1, OSBPL7, PLK2, TNFSF12, CAV1, PLK1, PTK2, DAB2, CCDC22, LRRK2, TNFAIP3, TNFRSF1B, CBFA2T3, RNF144A, RNF144B, IFNG, IL1B, DTL, CEBPA, LRP1, LRP2, AURKA, IL33, EGF, PSMC6, NEDD4, PSMC2]
GO:0043551;regulation of phosphatidylinositol 3-kinase activity;10.0;0.8259837884571596;0.8282329060895002;9.517298617381897;113.71851024663684;5.9928839937622085;0.0038060561979401893;0.7217173779995258;[LYN, PDGFRB, PDGFRA, TGFB1, CCL21, PIK3R3, FPR2, NOD2, KLF4, PTK2, PIK3R5, FGR, KIT, CCR7, TEK, CCL19]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PGLYRP1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, NRAS, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, NPC2, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CTSD, CAMP, CD33, CTSB, CD53, CCT2, FCER1G, MME, GAA, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, GGH, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, DOCK2, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0008156;negative regulation of DNA replication;8.0;0.7090535922965819;0.729526796148291;9.223059144383958;828.3435142391211;6.113511981550823;0.02772391196081998;0.6876452870438905;[SMARCAL1, BLM, GMNN, BRCA2, SMC3, S100A11, TIPIN, DONSON, CDC6, SMC1A, MSH6, STAG2, MSH2, BCL6, TIMELESS]
GO:0045736;negative regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2927.1185870500644;6.375876246018314;0.09796802487286638;0.7741829203200885;[CEBPA, CDKN1A, MYOCD, CDKN2C, PLK1, TNFAIP3, NR2F2, HHEX, CDK6, MEN1]
GO:0043313;regulation of neutrophil degranulation;10.0;0.8933024483968273;0.861892236059334;9.537552474286395;150.84516981286367;7.8311634786251565;0.005048652081797471;0.8157270763441555;[ITGAM, SYK, PTAFR, ITGB2, CD177]
GO:0097186;amelogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;26.73958370240551;7.474488534686424;8.949498024565515E-4;0.7053660038532718;[SLC24A4, CSF3R, ITGB4, PERP]
GO:0043315;positive regulation of neutrophil degranulation;11.0;1.0;0.9324289523296623;9.628524252492122;798.7725987099202;8.390779266560578;0.0267342000301538;0.8615337942327104;[ITGAM, PTAFR, ITGB2, CD177]
GO:0097178;ruffle assembly;6.0;1.0;0.8231203125901445;9.628524252492122;77.5241744012752;7.379178354882098;0.0025946643499833917;0.7004918368257019;[AIF1]
GO:0001755;neural crest cell migration;6.0;0.7980440201809971;0.722142322680643;9.089527751759436;22.57397290845719;5.825829909099042;7.555305579894227E-4;0.6210535250702663;[NRP1, SEMA5B, SEMA4A, SEMA6A, SEMA4B, LEF1, TWIST1, EDNRB]
GO:0031145;anaphase-promoting complex-dependent catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;350.55619955642163;6.221725566191056;0.011732800519056534;0.7334203466557586;[BUB1B, AURKB, AURKA, CDC20, CCNB1, PTTG1, UBE2C, PLK1, UBE2S, CDK1, MAD2L1]
GO:0002606;positive regulation of dendritic cell antigen processing and presentation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.28681003950749;7.8311634786251565;0.0018503997771236419;0.7236063770733796;[CD74, CCL21, SLC11A1, CCR7, CCL19, NOD2]
GO:0031146;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;350.55619955642163;6.063501560976162;0.011732800519056534;0.7253287636709003;[, CCNF, KIF14, SKP2]
GO:0030299;intestinal cholesterol absorption;8.0;1.0;0.875;9.628524252492122;82.41160815185232;7.57984905034425;0.002758242359210401;0.7626338329336335;[CD36]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, CSF3, NCF1, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, FAM3D, EPHB2, PHLDA2, MED1, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IL23A, NBL1, IFNA10, CALCA, EBI3, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, IGF1, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, FBN1, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, SECTM1, CXCL1, FASLG, ADM, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, TNFSF12-TNFSF13, IL10, EDN1, IL15, PDE4D, IL18, GREM1, IL1A, IFNG, IL1B, LTA, XCL2, XCL1, LTB, SHANK3, HBEGF, CCL13, NLGN1, GRN, CLEC12B, RETN, TYMP, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, SPP1, CCL2, CCL1, CCL19, CCL18, IL32, CMTM8, IL33, CCL23, CCL21, EGF, CCL20, OSM, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0090308;regulation of methylation-dependent chromatin silencing;11.0;0.8933024483968273;0.8790801765280758;9.5544162803384;378.0478930493778;7.57984905034425;0.01265292275934795;0.8200627852632958;[DNMT1, UHRF1]
GO:0035984;cellular response to trichostatin A;6.0;1.0;0.8231203125901445;9.628524252492122;367.2586666355552;8.390779266560578;0.012291817060950673;0.7522251544931926;[MEF2C, EZH2]
GO:0010466;negative regulation of peptidase activity;9.0;0.7090535922965819;0.75076742132858;9.3498108500231;435.8964092118286;4.224114042758852;0.014589060535020671;0.6122620137683685;[PROS1, SERPINE1, SPINT2, AQP1, PTTG1, LAMP3, RPS6KA1, AKT1, APLP2, POR, SFRP2, SPINT1, SLPI, SERPING1, NAIP, C3, SFN, A2M, TNFSF14, TNFRSF10C, CRIM1, TNFRSF10B, DHCR24, VIL1, CD27, PTTG3P, ECM1, TNFAIP8, SERPINA1, ARRB1, ARRB2, TIMP2, TIMP3, TIMP1, CR1, SERPINB2, GPX1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, COL6A3, BIRC5, BIRC2, LTF, BIRC3, SERPINB10, CSTA, LEF1, IFI6, NLRC4, PTGS2, CST7, THBS1, CST3, SPOCK3, SNCA, KLF4, FABP1]
GO:0090306;spindle assembly involved in meiosis;8.0;0.7866048967936545;0.7683024483968273;9.310070521373587;158.5973765159689;7.9853141584524145;0.005308111463617325;0.7833693374183408;[ASPM, FBXO5, AURKA]
GO:0090307;mitotic spindle assembly;8.0;1.0;0.875;9.628524252492122;186.05212215721153;6.193554689224359;0.006226997092562797;0.6917386748366816;[KIF11, CDC20, TPX2, KIFC1, FLNA, BIRC5, NEK2, MYBL2, BIRC2, BIRC3]
GO:0033567;DNA replication, Okazaki fragment processing;7.0;0.9326813400603323;0.8172600352873667;9.567899630675686;149.0421272461911;8.67846133901236;0.0049883058697239;0.7947362817240173;[LIG1, DNA2]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, LST1, ICAM1, EPS8, TPM1, VRK1, CSF1R, EPB42, ARHGAP15, CORO1A, SPTA1, EPB41L3, MYH14, MYH10, FN1, CDC7, PARVB, PTK2, VIL1, FES, PLXNB2, ITGB2, ANXA1, RHOG, ARAP3, RHOH, ARAP1, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD3, FGD4, CCL7, PDPN, CCL2, FYN, WASF3, SEMA4A, DLC1]
GO:1904037;positive regulation of epithelial cell apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.148951172230236;105.42595785554589;6.375876246018314;0.0035285119322230004;0.701062607729944;[CD40, GSN, ITGA4, SORT1, FASLG, ARRB2, EIF2S1, THBS1, SFRP4, IL6, CD40LG, CCL2, PLCG1]
GO:1904036;negative regulation of epithelial cell apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.148951172230236;105.53052018039445;6.139487467954083;0.003532011539135699;0.6889736746265369;[WFS1, SERPINE1, TNFAIP3, GATA3, ICAM1, HMOX1, TEK]
GO:0006189;'de novo' IMP biosynthetic process;12.0;1.0;0.9481203125901445;9.628524252492122;6149.890129209738;7.9853141584524145;0.20583128808286652;0.8564896500084854;[ADSL, ATIC, PAICS, PFAS, GART]
GO:0045742;positive regulation of epidermal growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;233.1839134473908;6.280566066213989;0.0078044557311868065;0.6961884407023742;[NCF1, EGF, PLAUR, TGFA, FASLG, ARAP1, MMP9, EREG, NUP62, AKT1]
GO:0045740;positive regulation of DNA replication;8.0;0.7671156992804218;0.7585578496402109;9.427853557029971;747.3070825002359;6.166155715036245;0.025011695518573164;0.6903374900225189;[CDT1, JUN, PCNA, CDC7, EREG, CST3, DBF4, CDK2, CDK1, DNA2, E2F7, E2F8]
GO:0007035;vacuolar acidification;12.0;0.9326813400603323;0.9144609826203107;9.57973408832269;182.53781204849716;6.686031174322154;0.006109376295897887;0.7900442577772261;[SLC11A1, DMXL2]
GO:0045741;positive regulation of epidermal growth factor-activated receptor activity;12.0;0.9326813400603323;0.9144609826203107;9.611429819132821;2972.107935112762;7.292166977892469;0.09947377786474029;0.8210420709600095;[NCF1, EGF, TGFA, EREG]
GO:0045747;positive regulation of Notch signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;187.6437959822434;5.926926025970411;0.006280268983073171;0.6540226378555745;[NOD2, DLL1, TSPAN5, TGFB2, JAG1, ELF3, KIT, MAML3]
GO:2000617;positive regulation of histone H3-K9 acetylation;12.0;1.0;0.9481203125901445;9.628524252492122;1488.212472397538;7.8311634786251565;0.049809132146875434;0.8486063770733797;[GATA3, BRCA1]
GO:0060907;positive regulation of macrophage cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;311.82526325162985;7.9853141584524145;0.010436510936514811;0.8046099625986299;[CD74, CD36]
GO:0001960;negative regulation of cytokine-mediated signaling pathway;7.0;0.7140352122741334;0.7079369713942671;8.965230035081857;244.80256319284138;5.8067817141283475;0.008193321482061134;0.6478784521606894;[ECM1, IL1RN, CCL5, STAP1, ARG1, NR1H2, IL1R2, CAV1, NR1H4, IRAK3, MMP12, IL6, PTPRC, PXDN, PADI2, F2RL1]
GO:0019262;N-acetylneuraminate catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;426.13404097731706;7.9853141584524145;0.014262322855772573;0.7592887026755414;[NPL]
GO:2000615;regulation of histone H3-K9 acetylation;11.0;0.8933024483968273;0.8790801765280758;9.533214072687796;182.99191619144386;7.379178354882098;0.006124574752895117;0.8098004765652196;[CHEK1, GATA3, BRCA1]
GO:0043330;response to exogenous dsRNA;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;30.956451235720028;5.970411137910149;0.0010360845638621964;0.6284474158353811;[IFNA5, COLEC12, IFNA4, IFNA7, IFNA14, IFNA16, DDX58, RIPK2, CAV1, IFNA2, CARD9, IRAK3, IFIT1, IFNA8, NFKBIA, IFIH1, IFNA21, IFNA10]
GO:0032465;regulation of cytokinesis;6.0;0.5930994877375815;0.6196700564589352;8.140447197062288;31.798591743249187;5.358233019883872;0.0010642702487719462;0.5971405984103235;[AHCTF1, KIF14, BRCA2, NUP62, PRKCE, TAS2R13, KIF23, CIT, PIK3C3, KIF20A, KIF20B, CXCR5, AURKB, AURKA, RACGAP1, ECT2, E2F7, E2F8, SVIL, PLK1, CDC6, PRC1, CALM3, BCL2L1]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[CDKN1A, FMR1, PTPRK, AQP1, RUVBL2, CHEK1, PBK, MME, SIRT1, CDC25A, PCNA, PTGS2, AURKB, POLD1, EIF2S1, MAPK13, MFAP4, NEDD4]
GO:0032466;negative regulation of cytokinesis;7.0;0.7140352122741334;0.7079369713942671;9.015419779605713;142.53412634803104;7.8311634786251565;0.004770488936483034;0.7514054297404357;[E2F7, AURKB, E2F8]
GO:0035973;aggrephagy;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;41.777574812335935;7.9853141584524145;0.001398257831592581;0.7592887026755414;[WDFY3]
GO:0033316;meiotic spindle assembly checkpoint;12.0;0.9326813400603323;0.9144609826203107;9.607470843294289;1388.1064304510658;9.777073627680469;0.04645867301251565;0.9481203125901445;[TTK]
GO:0032467;positive regulation of cytokinesis;7.0;0.7043150770688792;0.7030769037916401;9.015419779605713;142.0565341908292;6.193554689224359;0.004754504356786525;0.6676580400938822;[SVIL, PRKCE, CXCR5, TAS2R13, KIF14, KIF23, CDC6, AURKB, CIT, RACGAP1, NUP62, ECT2, KIF20B]
GO:0033314;mitotic DNA replication checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;738.0966094602528;7.379178354882098;0.02470342927481251;0.8098004765652196;[CDC6, TOPBP1, NAE1, CLSPN]
GO:1904044;response to aldosterone;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;94.91012926799756;8.16763571524637;0.0031765566130290556;0.7926932703116032;[CYBB]
GO:0070936;protein K48-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;5.8650506222523235;0.00527474598481953;0.7323679139043926;[TNFAIP3, NEDD4L, RNF6, ZNRF1, UBE2Q2, HACE1, UBE2C, CDC34, UBE2T]
GO:0007286;spermatid development;5.0;1.0;0.7902410118609202;9.628524252492122;72.7828096339012;5.370354380416217;0.0024359751381706407;0.5648811846224242;[BRIP1, JAM3, FNDC3A, FANCG, KIT, TRIP13]
GO:0090521;glomerular visceral epithelial cell migration;7.0;1.0;0.8509193652572005;9.628524252492122;24.971868181253015;8.390779266560578;8.357859548042604E-4;0.7800242071602487;[ANLN]
GO:0007284;spermatogonial cell division;3.0;1.0;0.6981203125901445;9.628524252492122;30.19503809316806;9.083926447120524;0.0010106007512083216;0.6626727335416686;[BRIP1]
GO:0030041;actin filament polymerization;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;66.55674193746657;6.409777797693995;0.0022275942554681166;0.6787156999164222;[GSN, ARHGAP6, AIF1, VIL1, HCLS1, WASF3]
GO:0045995;regulation of embryonic development;5.0;0.5017827139744404;0.5411323688481404;6.887684228566921;27.37613670804801;4.981283082083729;9.162546586948941E-4;0.5449840603320351;[IL1RN, CELSR1, HNF4A, PHLDA2, PRKACB, IL10, HNF1B, DUSP6, SFRP2, PLCB1, LAMA2, LAMA4, LAMA3, GATA3, DLL1, GATA1, RACGAP1, FZD1, FZD2, CDX2, CDX1, IGF1, KLF4, SULF1, COL5A1, COL5A2, CDK1, FOXA2]
GO:0046600;negative regulation of centriole replication;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;466.4695881312043;7.697632086000634;0.015612317319377515;0.8260862151842345;[BRCA1]
GO:0046601;positive regulation of centriole replication;11.0;0.9326813400603323;0.8987696223598284;9.592156608321247;492.4861511887348;8.67846133901236;0.016483068271526433;0.8762458687964789;[PLK4, VPS4B, NUP62]
GO:0045751;negative regulation of Toll signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;187.41437209568753;9.777073627680469;0.006272590372058239;0.8509193652572005;[NLRP12]
GO:0045994;positive regulation of translational initiation by iron;10.0;1.0;0.9152410118609203;9.628524252492122;1474.0558344206913;9.083926447120524;0.049335322213937396;0.8797934328124444;[RXRA, TNF]
GO:0042246;tissue regeneration;4.0;0.7586651285174919;0.629332564258746;8.935377071932177;42.88961059103013;6.039404009397101;0.0014354766683382502;0.5588554019015759;[POSTN, GSN, GPX1, TXK, CCNB1, NINJ1]
GO:0046605;regulation of centrosome cycle;8.0;0.7192862368539868;0.7346431184269935;9.193206181234276;52.95861036100919;5.69953618377475;0.0017724770291279795;0.6664745454937787;[VPS4B, CEP120, CCNF, BRCA1, KIF11, AURKA, PKHD1, XPO1, NUP62, CHEK1, POC1A, NEK2, CEP76, RANBP2, PLK4, RANBP1, STIL, PLK2]
GO:0046602;regulation of mitotic centrosome separation;9.0;0.8933024483968273;0.8428918493787028;9.503361109538115;111.3333211242262;7.212124270218933;0.003726226064543951;0.7650689957573628;[RANBP2, RANBP1, CHEK1, NEK2, KIF11]
GO:1990000;amyloid fibril formation;5.0;1.0;0.7902410118609202;9.628524252492122;65.1103285866179;7.697632086000634;0.0021791841023027143;0.6838982747154925;[GSN, CD36]
GO:0014806;smooth muscle hyperplasia;6.0;1.0;0.8231203125901445;9.628524252492122;38.937902165230305;9.083926447120524;0.0013032165436334183;0.7876727335416686;[HMOX1]
GO:2000620;positive regulation of histone H4-K16 acetylation;13.0;1.0;0.9625549647676366;9.628524252492122;1673.9769773112196;9.083926447120524;0.056026502949136;0.9271073857191605;[BRCA1]
GO:0032212;positive regulation of telomere maintenance via telomerase;10.0;1.0;0.9152410118609203;9.628524252492122;1624.1830741800397;6.250713103064308;0.054359945822938814;0.734902770639515;[AURKB, NEK2, CCT8, CCT7, CCT5, CCT4, CCT3, CCT2, NEK7, CCT6A, PRKCQ]
GO:0002827;positive regulation of T-helper 1 type immune response;8.0;0.8933024483968273;0.8216512241984136;9.503361109538115;171.8650643746189;6.943860283624253;0.005752169036102488;0.7301093378270707;[ANXA1, RIPK2, SLC11A1, CD80, IL18, IL23A, HLX, XCL1, CCL19, IL12RB1, IL6R, CCR2]
GO:0030277;maintenance of gastrointestinal epithelium;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;27.01847773359639;7.004484905440688;9.042841346921778E-4;0.7091290490632969;[MUC13, NOD2, TLR4]
GO:0032695;negative regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;7.004484905440688;0.002184000309729388;0.6813299963962409;[IL10, LILRB1, IRAK3, ARRB2, THBS1, NFKB1, TLR8, TIGIT, JAK3, SLAMF1]
GO:0030036;actin cytoskeleton organization;5.0;0.6347111282356054;0.607596575978723;8.048073876931273;29.6146440060229;3.9779809732199434;9.911754834323397E-4;0.49367514382642164;[F11R, TNF, ANTXR1, AQP1, POF1B, MYOZ2, PLS1, PDGFRB, MEF2A, TMOD1, PDGFRA, GAS2L3, CXADR, TPM1, DAAM2, TLN1, PFN1, S100A9, LLGL2, PDGFA, CORO1A, PRKCZ, EPB41L5, CNN1, RACGAP1, EPB41L3, MYH14, MYH11, NCKAP1L, PLEK2, MYH10, PARVB, CORO2A, CORO2B, VIL1, TBCK, ANLN, DIAPH3, BCL6, NRP1, ITGB5, PLEK, LMOD1, ARHGEF10L, CXCL1, ARRB1, EPB41L4B, ANXA1, RHOG, GAB1, RHOH, KIF23, PALLD, KIT, RHOU, DOCK2, FGD3, FGD4, PAK1, ABLIM3, FLNA, SORBS1, KRT19, DLC1, ZYX]
GO:0035722;interleukin-12-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.948432231191374;0.00101047745553359;0.6551224661907153;[LMNB1, STAT4, IL12RB1, IL12RB2, IL10, SERPINB2, MIF, SOD2, IFNG, LCP1, PLCB1]
GO:0007094;mitotic spindle assembly checkpoint;13.0;1.0;0.9625549647676366;9.628524252492122;1801.8011146821202;6.781341354126479;0.060304661792685066;0.8093530769822879;[PLK1, BUB1B, TTK, CENPF, TRIP13, BUB1, MAD1L1, MAD2L1]
GO:0007095;mitotic G2 DNA damage checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;857.7571147403349;6.7325511899570465;0.028708358699073767;0.7767319332797141;[MSH6, FANCI, BLM, DONSON, CDK1, TOPBP1, CLSPN]
GO:0035563;positive regulation of chromatin binding;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;31.32148238131123;7.292166977892469;0.0010483018277984315;0.6631627702307852;[CDT1, GMNN, PARP9]
GO:0060761;negative regulation of response to cytokine stimulus;5.0;0.6954798709641801;0.6379809473430103;8.438940185618286;40.831621184480156;5.734022359845919;0.001366597614971242;0.5834791820027497;[ECM1, IL1RN, CCL5, STAP1, ARG1, NR1H2, IL1R2, CAV1, NR1H4, IRAK3, KLF4, AES, MMP12, IL6, PTPRC, PXDN, PADI2, F2RL1]
GO:0007093;mitotic cell cycle checkpoint;7.0;0.7140352122741334;0.7079369713942671;9.0094850440859;132.2042645947957;5.142344639450834;0.0044247577598742595;0.6138991092621975;[TOP2A, ZWILCH, BUB1B, BRCA1, KNTC1, TOPBP1, TIPIN, MSH6, MSH2, MAD1L1, BLM, TTK, AURKB, NAE1, CLSPN, BUB1, FANCI, TGFB1, PLK2, PLK1, DONSON, RPA2, CDC6, ZWINT, WEE1, CENPF, CDK2, CDK1, TRIP13, MAD2L1, BCL2L1]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[PPP1R12A, PLK1, CETN3, CEP120, HEPACAM2, TUBE1, BRCA1, CKAP5, UXT, FES, NUP62, CDK1]
GO:0007099;centriole replication;6.0;1.0;0.8231203125901445;9.628524252492122;79.09414177220606;6.781341354126479;0.0026472097450095456;0.6699184248047958;[PLK4, CEP152, CDK2, CEP72]
GO:0007096;regulation of exit from mitosis;8.0;0.7763722522362496;0.7631861261181248;9.249034630787218;94.90422389775904;6.8867018697843045;0.0031763589656016605;0.7271862538851576;[ANLN, TGFB1, UBE2C, CDCA5, KNTC1, PHB2]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[ORM1, FZD5, RIPK2, NOD2, PYCARD, NLRP12, TLR8, NLRP3, CCL19, TLR4]
GO:0061614;pri-miRNA transcription by RNA polymerase II;11.0;1.0;0.9324289523296623;9.628524252492122;587.6398479969114;7.57984905034425;0.019667776870928726;0.8200627852632958;[FOSL1, SPI1, KLF4, ETS1]
GO:0045124;regulation of bone resorption;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;23.47587490287836;6.139487467954083;7.857164060836016E-4;0.6370939872166814;[CSF1R, CALCA, TFRC, SYK, ITGB3, TNFAIP3, TNFRSF11A, TMEM64, IL6, CA2, INPP5D, SPP1, TNFSF11, CD38, CSK, ADAM8]
GO:0060528;secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development;7.0;1.0;0.8509193652572005;9.628524252492122;72.45322871866053;8.390779266560578;0.002424944361541102;0.7800242071602487;[RXRA]
GO:0000212;meiotic spindle organization;7.0;0.7671156992804218;0.7344772148974115;9.168991923113682;69.6769368299192;7.292166977892469;0.002332024370525413;0.7238411236270654;[ASPM, ESPL1, FBXO5, TUBG1, AURKA]
GO:0045132;meiotic chromosome segregation;4.0;0.7980440201809971;0.6490220100904985;9.089527751759436;42.955130674290615;6.8867018697843045;0.001437669566560732;0.6021862538851576;[ESPL1, PTTG1, NUF2, PLK1, TTK, MLH1, SMC4, NCAPH, PTTG3P, SMC2]
GO:0015707;nitrite transport;7.0;1.0;0.8509193652572005;9.628524252492122;31.194310375271012;9.777073627680469;0.0010440454952036402;0.8509193652572005;[SLC11A1]
GO:0015949;nucleobase-containing small molecule interconversion;6.0;0.7671156992804218;0.7066781622303554;9.271849308553389;109.52544358977337;6.409777797693995;0.003665718030449963;0.6509166472493662;[DTYMK, TYMS, NME1]
GO:0019088;immortalization of host cell by virus;8.0;1.0;0.875;9.628524252492122;54.80099909185045;9.777073627680469;0.0018341401219070278;0.875;[TYMS]
GO:0071897;DNA biosynthetic process;7.0;0.7090535922965819;0.7054461614054914;9.249034630787218;573.3007402310989;5.058574756385375;0.01918785983836615;0.609615113546532;[BRCA2, CTGF, TRIM25, TK1, RFC5, RFC3, RFC4, RFC1, LIG1, RFC2, SIRT1, DTL, PRIM2, BLM, PCNA, TYMS, POLD3, POLD1, POLQ, RPA1, RPA2, ISG15, POLA1, POLA2, RAD50, CENPF, POLE2, RPA3]
GO:0050715;positive regulation of cytokine secretion;9.0;0.6913464685778243;0.7419138594692012;9.0689084645567;549.4808578036607;5.03214149931722;0.0183906298100222;0.6535845754738829;[FCN1, ORM1, LRRK2, PTPN22, TNF, PYCARD, IFIH1, CLEC5A, FFAR2, CD34, HAVCR2, IL10, POSTN, CHUK, SYK, DDX58, RIPK2, F2R, MIF, IL17RB, MMP12, TLR1, FGR, IL1A, IL1B, IGHD, TLR8, CLEC4E, TLR4, TLR2, CD274, CSF1R, TWIST1, GATA3, NOD2, PRKCZ, RASGRP1, NLRP3, CD58, CCL19, CD14, IL33, FZD5, CRTAM, MAPK14, CD2, NLRP12, F2RL1, CD244, IL17A]
GO:0032289;central nervous system myelin formation;6.0;1.0;0.8231203125901445;9.628524252492122;33.54444455821997;8.67846133901236;0.0011227023713234936;0.7669372290569613;[TLR2]
GO:0050711;negative regulation of interleukin-1 secretion;10.0;0.8933024483968273;0.861892236059334;9.567899630675686;756.1696569975245;7.138016298065211;0.0253083179111982;0.7802794972956796;[NLRP12, IL1R2, NLRP3, PML]
GO:0007091;metaphase/anaphase transition of mitotic cell cycle;10.0;1.0;0.9152410118609203;9.628524252492122;246.8513480975109;8.16763571524637;0.008261892469033718;0.8329342821725234;[TACC3, BUB1B]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, COL1A2, ARHGAP6, ARHGAP4, JAK3, DUSP1, RIPK2, GMIP, SIRT1, DUSP6, PTAFR, NRAS, STAT4, DMD, STAT1, PKN1, LGR4, CTGF, SESN3, MAP3K8, KCNH1, KCNH2, CISH, CDC25C, MSH6, ADCYAP1, MSH2, BLK, LY96, SOCS2, G3BP2, TNFRSF10B, BMX, CORO2A, NFKB1, NFKB2, LRRK2, PIK3CD, FOXM1, TNFRSF1B, SPTB, LCP2, PIK3C3, LCP1, DTL, BIRC2, BIRC3, PPP1R15A, IL2RG, CCL5, E2F1, CCL2, E2F2, FYN, E2F7, SH2B1, E2F8, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, EREG, BTC, BTK, TRIB1, RIN2, EPHA2, PIK3R5, RACGAP1, CD14, PAG1, CCR1, IGF1, PTK2, CALM3, RGL4, CD24, RGL1, CD40, CETN3, BRCA1, BRCA2, CCR9, RAC2, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR3, CCR2, IL18, GAB2, LAT2, MC3R, IL1B, KIT, DEPDC1, YAP1, PCNA, GNAI2, RELB, PAK1, PERP, KITLG, FKBP1B, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, PDGFRA, DOK2, DOK3, TYROBP, CARD11, CALCA, PSEN2, RASGRP1, RASGRP4, SPTA1, CCNB1, ECT2, VCAM1, GH1, GNAQ, PLEK, TNFAIP3, GHR, GRM5, ARHGEF12, DDX58, IRAK3, MASTL, CCNA2, NDUFS4, IRF7, SHANK3, BCL2A1, AURKA, EPS8L1, EPS8L3, EGF, MAPK14, MAPK13, TEK, CYFIP1, EPS8, STMN1, CYP1B1, MED1, PRKCH, DAPK1, PRKCB, PRKCE, PRKCD, DEPDC1B, ADCY9, LGALS12, PRKCQ, PRKDC, PRKCZ, PLCG2, HMOX1, PLEK2, PLCG1, PLK2, PLK1, ITK, CDKN1A, BTG2, ADM, IFIH1, NFAM1, PAX2, CIT, HCLS1, PLCB1, HBEGF, EXOC1, GSN, CCL20, CARD9, POU4F1, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, IGFBP5, DGKZ, NRBP1, RAB32, MELK, RAB31, CSF1R, DNMT1, CALCRL, CUL5, ITPR3, RASAL2, MAP2K6, DHCR24, BCL6, CNOT3, BCL3, CDK2, CDK1, BCL2, CSPG4, LAT, BCL2L1, PIK3C2A, TREM1, TLK1, GPX1, CHUK, TFDP1, IL3RA, CX3CR1, CEBPB, NLRC3, NOD2, RAB21, PLN, PML, DNAJA3, CALML4, EDNRB, PPP2R1A, CHEK1, RPS6KA1, SOX4, PTGDR, TIAM2, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, EDN1, STRADB, RHOG, RHOH, AVPR1A, GFRA3, VAV1, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, GUCY2C, SP100, PTGER2, CXCR5, CXCR4, CXCR6, AIF1, CXCR1, CXCR3, CXCR2, PDPN, MLH1, CAMK4, CAMK1, SIPA1, SIRPG, ARHGDIA, ARHGDIB, TSC2, ATP1B1, CSF2RB, ADRB2, CSF2RA, TGFB1, SELE, NFKBIA, SELP, ARHGAP30, JMY, DOCK5, GPSM2, DOCK4, MCTP1, CXCL1, TMEM100, BLNK, CASP2, PTGIR, PDE4D, TGFBR3, ZAP70, DOCK2, CAMK2D, NCAM1, TSHR, PIKFYVE, RPS6KB1]
GO:0010032;meiotic chromosome condensation;8.0;1.0;0.875;9.628524252492122;72.23175504670313;8.16763571524637;0.002417531837054052;0.7926932703116032;[NCAPD2, NCAPD3, SMC4, NCAPH, SMC2]
GO:0071409;cellular response to cycloheximide;6.0;1.0;0.8231203125901445;9.628524252492122;692.5175601227966;8.67846133901236;0.023177939511969108;0.7669372290569613;[KLF4]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[TNFAIP6, TNFAIP3, RORA, ETS1, CDH5, DUSP10, PBK, PGLYRP1, IL10, GHSR, GPX1, IL1R2, PRKCD, TNFRSF1B, ADCYAP1, CALCRL, NLRC3, GATA3, NT5E, NLRP3, ELANE, NR1H4, KLF4, NFKB1, NLRP12, TEK, FCGR2B]
GO:0034220;ion transmembrane transport;5.0;0.44800904580126355;0.514245534761552;6.183841758890227;26.332710660334534;2.96803432163749;8.813321279004005E-4;0.4420264250971726;[SLC35B3, AQP9, SLC4A1, SLC4A3, PHB2, AQP1, SCN1A, SLC6A16, SLC11A1, SLC6A15, PRKCE, CACNA2D3, SLC6A13, SLC6A12, CLDN4, COX7A2L, KCNQ1, CFTR, SLC22A4, TTYH3, TTYH2, SLC22A2, ATP5J, NEDD4L, ATP5I, ATP5H, SLC30A10, ATP5O, ATP5L, GJC1, ANKH, KCNMB3, PLCG2, KCNN3, SCN3A, ABCA1, SLC6A6, FXYD2, SFXN3, FXYD6, NOX1, GABRB1, COX7B, CLIC3, GRIK3, SLC7A11, COX7C, JPH2, CCR7, CCR5, COX8A, KCND2, ZDHHC17, TMEM37, SLC7A5, SLC7A7, SLC7A8, SLC7A9, CLDN17, SGK1, CAPS2, SLC43A2, KCNA5, COX5B, COX5A, ANO10, SLC17A6, CCL19, GABRE, SLC17A1, SLC17A3, CCL21, SLC31A2, GABRA5, COX6C, FKBP1B, RHAG, KCNG2, STEAP3, STEAP4, ATP8A1, DENND5B, COX6A1, SLC8A1, BEST1, SLC26A11, SLC16A3, KCNH1, KCNH2, CHRNB4, SLC38A1, F2R, ATP11C, CYBB, ATP1B2, ATP1B1, ATP5J2, COX6B1, RHCE, KCNE3, CUL5, KCNE4, HVCN1, SLC41A2, SLC1A3, SLC38A11, ITPR3, CACNA1F, SLC1A6, SLC38A6, CYC1, SLC15A3, CLCA4, GRIA4, ATP8B2, PTPRC, SLC26A8, SLC26A7, SLC26A3, KCNK5, ATP2A3, SLC40A1, FASLG, SLC2A6, ATP7B, SLC36A1, TRPC7, SLC13A1, TRPC3, TRPC1, NDUFS7, ASPH, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, SLC3A1, LRP2, ATP2C2, SLC5A10, SLC12A2, SLC35A3, NDUFA4, SLC12A1, KCNIP4, KCNJ15, KCNJ16, SLC4A7, P2RX5, P2RX1]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[SERPINE1, TNF, ETS1, TNFSF11, FFAR2, CCR7, CCR2, TGM2, FCER1G, IL15, IL18, IL17RB, IL23A, IL1B, BTK, AGTR1, LTA, TLR10, TLR7, ADAM8, TLR6, TLR4, S100A9, S100A8, TLR2, SUCNR1, TNFRSF11A, NOD2, PTGS2, PLA2G7, C3, CNR1, CCL4, S100A12, CCL18, SNCA, IL33, CCL23, OSM, MAPK13, NFKBIA, NLRP12, IL6, CD6, CD28, MYD88, IL17A]
GO:0046466;membrane lipid catabolic process;6.0;0.7307253602413294;0.6884829927108091;9.176539128749065;159.2067488982067;6.409777797693995;0.005328506608851286;0.6509166472493662;[FUCA1, GBA3, GM2A, CYP1B1]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[CALML4, UXT, CDC20, STMN1, FBXO5, MAP1B, KIF20A, LLGL2, PRKCZ, FIGNL1, CEP72, PLK2, PLK1, PTK2, TPX2, CETN3, KIF11, NUF2, TUBG1, KIFC1, KIF2C, CENPA, FLNA, RANBP2, RANBP1, CENPW, TUBE1, CENPE, TACC3, SPC25, CEP120, NUSAP1, NEK2, GAS2L3, MAP7D1, MAP7D2, CCNB1, STIL, NEK7, NDC80, KIF18A, KIF18B, FES, KIF4A, CDK1, GPSM2, MYBL2, NAV1, CKAP5, ASPM, PSRC1, ESPL1, BIRC5, BIRC2, BIRC3, VPS4B, TTK, AURKB, AURKA, POC1A, SPAG5, WEE1, PRC1, RAN]
GO:0061844;antimicrobial humoral immune response mediated by antimicrobial peptide;6.0;1.0;0.8231203125901445;9.628524252492122;44.28377145688295;5.682729065458369;0.0014821379778550245;0.6137353412716126;[CXCL6, CCL13, CXCL9, HIST1H2BK, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, GNLY, S100A12, PGLYRP1, CAMP, DEFA4, RNASE6, RNASE3, DEFA1, PPBP, CXCL10, CXCL11, S100A9, LTF, PF4]
GO:2000406;positive regulation of T cell migration;10.0;0.7980440201809971;0.8142630219514189;9.461470167828956;351.7821234142529;6.518977089658987;0.011773831087318304;0.7486218033895181;[TNFSF14, CCL21, ITGA4, CCL20, CXCL13, AIF1, PYCARD, CXCL10, CXCL12, CCL5, XCL2, XCL1, ADAM8, CCR2]
GO:0001556;oocyte maturation;4.0;1.0;0.75;9.628524252492122;79.08984218955116;6.8867018697843045;0.0026470658418474595;0.6021862538851576;[CCNB1, FBXO5, TRIP13, BRCA2, EREG]
GO:0001798;positive regulation of type IIa hypersensitivity;12.0;0.9326813400603323;0.9144609826203107;9.606051396640064;1378.0251110012991;9.083926447120524;0.04612126032313042;0.9126727335416687;[C3, FCER1G]
GO:0045381;regulation of interleukin-18 biosynthetic process;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;154.99429437694414;9.777073627680469;0.005187519546987567;0.8509193652572005;[NLRP12]
GO:0001558;regulation of cell growth;5.0;0.5833093054345528;0.5818956645781967;7.6590836060266145;26.25041167864861;3.793137346993279;8.785776550476476E-4;0.4842222321850823;[CDA, CYFIP1, CPNE5, KIAA1109, PPP2R1A, DPYSL2, RPS6KA1, AKT1, SFRP2, MAP1B, AGTR1, PRKCQ, NEDD4L, EPB41L3, SFN, FN1, IGF1, FXYD2, NRP1, CDKN1A, KIF14, ARHGAP4, ESM1, HNF4A, CD38, EDN1, AVPR1A, SIRT1, IL17RB, CEACAM1, SGK1, HBEGF, PAK1, FRZB, SPP1, APBB1, CDKN2C, KIF26A, SIPA1, SEMA5B, CTGF, CXCL16, TNR, SEMA6A, IGFBP5, CISH, IGFBP3, S100A9, S100A8, HTRA1, SOCS2, IGFBP7, TGFB2, TGFB1, SYT2, CRIM1, INHBA, CXCL12, BCL6, BCL2, CYR61, TCHP, MYOCD, DCC, DNM2, GREM1, PSRC1, NDUFS3, FBP1, CAMK2D, TAF9, LEF1, RNF6, RAB21, SEMA4A, SEMA4B, PML]
GO:0002407;dendritic cell chemotaxis;7.0;0.8653626801206646;0.7836007053175329;9.485423408851448;93.27947089202779;6.8867018697843045;0.0031219799446826077;0.7031056191423581;[CCR1, CXCR1, CCL21, CCL5, CXCR2, CXCR4, CCR7, CCR6, CCL19, CCR5, CCR2]
GO:0045143;homologous chromosome segregation;5.0;1.0;0.7902410118609202;9.628524252492122;44.56456858672447;7.697632086000634;0.00149153600508981;0.6838982747154925;[ESPL1, PTTG1, PLK1, PTTG3P]
GO:2000649;regulation of sodium ion transmembrane transporter activity;9.0;0.7140352122741334;0.7532582313173557;9.105276108727574;122.59439798633444;5.8650506222523235;0.004103124172807513;0.6961795867550195;[CAMK2D, NEDD4L, DMD, DRD4, YWHAH, PRKCE, ACTN4, ATP1B1, DNM2, FXYD2, NEDD4, FXYD6]
GO:0030098;lymphocyte differentiation;5.0;0.6144040707577935;0.597443047239817;8.242229891372231;42.30537076970773;4.498958968449952;0.001415922687300292;0.5203179827304387;[SPI1, RORA, IKZF1, LGALS1, SOX4, TPD52, EOMES, IFNA14, RSAD2, IFNA16, FLT3LG, ATP11C, RUNX2, CLEC4D, MSH2, CD8A, CLEC4E, CARD11, IFNA10, BLM, PRKDC, TXK, TCF7, GATA3, CD79B, CD79A, FUT7, PLCG2, NKX2-3, IFNA21, EGR1, TGFB1, VCAM1, BCL11B, FZD5, FZD8, BMX, PTPRC, MAFB, BCL6, BCL3, CD28, BCL2, IL7R, ITM2A, GPR18, IFNA5, IFNA4, ITK, IFNA7, IFNA2, PIK3CD, CD3G, PTPN22, CD3E, IFNA8, CD3D, LYL1, HHEX, BLNK, CCR9, CCR6, JAK3, IL10, CR2, ANXA1, FCER1G, ITGA4, IL15, NFAM1, RHOH, VAV1, ZAP70, LCK, KIT, CDH17, LEF1, DLL1, RELB, TBX21, SEMA4A, CD4, KLF6, CD40LG, DNAJA3, FCGR2B, IL18R1]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[SERPINE1, EDNRB, C3AR1, TNFSF11, PGLYRP1, IL1R1, IL1R2, PRKCD, IL23A, BTK, AGTR1, SERPING1, CFB, CFH, CFI, GATA3, ADAMTS12, CFP, PLA2G7, C2, C3, C7, CD19, S100A12, A2M, ELANE, LYN, BST1, CD28, PBK, FFAR2, CCR7, CCR2, IL10, ANXA1, FCER1G, IL15, IL18, IL17RB, PSMA6, HCK, IL1B, TLR10, TLR7, TLR6, TLR4, TLR2, C1QB, C1QA, PTGS2, NT5E, IGKC, CCL18, IL33, CCL23, NR1H4, OSM, NLRP12, ZYX, IL17A, C1QC, PROS1, RORA, TNF, CLU, ETS1, CDH5, IGHG1, TGM2, GHSR, ADCYAP1, FANCD2, ADAM8, S100A9, S100A8, SUCNR1, CALCRL, C5AR1, TNFRSF11A, SBNO2, IGLV1-44, NLRP3, SELE, NFKB1, NFKBIA, IL6, BCL6, IGKV3-20, MYD88, TNFAIP6, TNFAIP3, DUSP10, CR2, CR1, GPX1, TNFRSF1B, LTA, XCL1, BIRC2, BIRC3, C1S, C1R, NLRC3, NOD2, USP18, CNR1, CCL5, CCL4, SNCA, MAPK14, KLF4, MAPK13, CD6, TEK, FCGR2B]
GO:0035548;negative regulation of interferon-beta secretion;10.0;1.0;0.9152410118609203;9.628524252492122;774.9330078742448;9.777073627680469;0.025936310379122567;0.9152410118609203;[LILRB1]
GO:0035307;positive regulation of protein dephosphorylation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;660.9024749708963;6.063501560976162;0.022119811063664396;0.706328376990269;[PPP1R15A, CDCA2, PDGFRB, PPP1R16B, TGFB1, PPP1R12A, FCRL3, PRKCD, LILRB2, DLC1, CALM3]
GO:0070317;negative regulation of G0 to G1 transition;7.0;1.0;0.8509193652572005;9.628524252492122;83.03241800612349;6.139487467954083;0.002779020306340262;0.6648930398837374;[EHMT2, BRCA1, BMI1, UXT, CHEK1, RBBP8, E2F1, RRM2, CDC7, RAD51, TFDP1, EZH2]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[IL1RN, AQP9, IFIT1, AQP1, ICAM1, LGALS1, AKT1, CYP1B1, MED1, MEF2C, KCNQ1, CFTR, ABCB4, ABCA1, EGR1, JUP, COL1A1, ID1, NOX4, EZH2, GABRB1, BRCA1, IFIH1, IL10, EDN1, ANXA1, ARG1, IL15, IL18, IL1B, PTAFR, PTGS2, AIF1, GNAI1, CTNNA1, SPP1, P2RY13, STAT1, POU4F1, TNC, RORA, TNF, SLC8A1, CDH1, RUVBL2, IGFBP5, ADCYAP1, BLM, FECH, FOXO1, CCNB1, OSBPL7, TGFB1, CAV1, INHBA, NFKB1, NFKBIA, BMP2, KIF18A, NR4A3, ALPL, SLC26A3, LRRK2, PDE4B, DDX58, PDE4D, DNM2, CCNA2, COLEC12, CEBPA, CEBPB, HDAC2, NOD2, P2RY6, CCL5, CCL2, SNCA, KLF4, RAD51, KLF5, RPS6KB1]
GO:0033129;positive regulation of histone phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1473.5624568792941;7.697632086000634;0.04931880931163779;0.8088982747154926;[CCNB1, IL1B, FMR1]
GO:0071404;cellular response to low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;7.004484905440688;0.0018993574991869968;0.6813299963962409;[ABCA1, FCER1G, SYK, ITGB2, CD9, CD36]
GO:0032270;positive regulation of cellular protein metabolic process;7.0;0.47017759384120705;0.586008162177804;7.412950536487706;288.49227156764;2.455885070940991;0.00965557670318086;0.47651344199545814;[, AKT1, PRKACB, PRKAR1B, AGTR1, CDCA2, FPR1, PDGFA, FPR2, GATA3, SLC30A10, IQGAP3, GATA1, C3, PRKAR2B, PDGFD, PDGFC, LYN, JUN, FN1, EIF2AK2, AZU1, NOX4, NOX1, EZH2, GPR37, RIPK2, EMP2, SIRT1, F3, DUSP6, CKS2, PTAFR, PTGS2, NTF3, CASP8AP2, CENPE, PSMC6, PSMC2, PKN1, CCNT2, NCF1, CTGF, RUVBL2, MAP3K8, PPP1R16B, IFNA14, IFNA16, ADCYAP1, S100A9, S100A8, IFNA10, TNFRSF11A, IFNA21, TNFRSF10B, PTPRC, LRRK2, ITGB3, FASLG, ARRB1, ARRB2, PPP1R12A, TNFRSF1B, LCP2, BIRC2, BIRC3, PPP1R15A, LRP1, UHRF1, LRP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, TIE1, EIF3E, FCGR2B, EIF3D, CCNH, CCNC, ICAM1, CDC20, TCL1A, TNFSF11, EPHB2, EPHB1, MIF, EREG, SFRP2, IFI27, TRIB1, EPHA3, EPHA2, TGFA, PIK3R5, SLAMF1, CCR1, EGR1, IGF1, PTK2, CD28, CD27, CALM3, CD24, NRP1, CD40, KIF14, BRCA1, CD3E, BMI1, CTSH, CCR7, CD36, SYK, IL15, IL18, RNF144A, RNF144B, BANK1, IL1B, KIT, GNAI2, PAK1, RXRA, PERP, CD74, IL33, OSM, NLRP12, RAMP1, CD80, IL6R, PDGFRB, PDGFRA, PCOLCE, CALCA, PSMD14, RASGRP1, CCNB1, ECT2, CAV2, UBE2C, CAV1, INHBA, GH1, IL6, BMP2, UBE2S, TNFAIP3, GHR, GRM5, MASTL, MMP9, GREM1, PSRC1, CHI3L1, AURKA, EGF, MAPK14, CD4, TEK, PHB2, MYB, PROK2, DAPK1, PRKCE, PRKCD, PRKCZ, S100A12, NCKAP1L, ELANE, FZD1, NDFIP2, ACE, FZD5, PLK2, PLK1, FZD8, UPF3B, CDC6, CDKN1A, TIMP2, HAVCR2, FCRL3, HCLS1, PLCB1, HBEGF, ENG, CCL13, FAM129A, GPNMB, CCL19, CCL18, CCL23, GSN, CCL21, CCL20, NR1H2, CARD9, CSF3, FMR1, TNF, CLU, PYCARD, MAP2K2, IGFBP3, F2R, ADAM9, ADAM8, CSF1R, DNMT1, PSAP, DRD4, MAP2K6, FANCI, OSBPL7, WFS1, DAB2, BCL6, BCL3, CDK1, BCL2, CSPG4, CCDC22, LAT, TREM2, PTPN22, CYR61, CR1, ASPH, LCK, XCL2, XCL1, CEBPA, HDAC2, TTK, NLRC4, NOD2, CSK, KLF4, PML, RAD50, P2RX1, IL1RN, ANTXR1, EDNRB, SKP2, SOX7, SOX4, ACSL1, SLC11A1, FLT3LG, IL23A, AURKAIP1, GADD45B, LIF, MARCO, TPX2, IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, MAP4K1, EDN1, STRADB, PARP9, CBFA2T3, MDFIC, TLR6, TLR4, CXCR4, AIF1, LILRB2, CD40LG, DLC1, F2RL1, CAMK1, C5AR1, FBLN1, ADRB2, STAP1, NLRP3, CLSPN, TGFB2, TGFB1, NFKBIA, LIN28A, CKS1B, PLAUR, AXIN2, IFNG, PDE5A, LTF, THBS1, HSPD1, SNCA, HSPE1, RPS6KB1, LTBR]
GO:0007076;mitotic chromosome condensation;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;40.5466901453896;7.004484905440688;0.0013570612295141678;0.7332096838060964;[CDCA5, NCAPG, SMC4, NCAPH, SMC2, NUSAP1, NCAPD2, NCAPD3]
GO:0090399;replicative senescence;4.0;1.0;0.75;9.628524252492122;26.138269705024182;7.212124270218933;8.748243641116619E-4;0.6188283705770736;[CDKN1A, MME, CHEK1, SERPINE1]
GO:0007077;mitotic nuclear envelope disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;74.08347249058063;7.292166977892469;0.002479507153463127;0.6960420709600095;[CCNB2, CCNB1, PRKCB, PLK1, CDK1, VRK1]
GO:0009253;peptidoglycan catabolic process;7.0;0.9326813400603323;0.8172600352873667;9.571365838652174;290.8497463603801;7.8311634786251565;0.009734479262904302;0.7514054297404357;[PGLYRP1]
GO:0090398;cellular senescence;4.0;0.8653626801206646;0.6826813400603323;9.446202695698167;55.136139509281044;6.343086423195323;0.0018453569700716361;0.5743857346658935;[CDKN1A, PRKCD, H2AFX, HMGA1, MAPK14, SIRT1, PML]
GO:0080111;DNA demethylation;9.0;0.8653626801206646;0.8289219652406215;9.537552474286395;342.028404744498;6.781341354126479;0.011447382901218509;0.7430387373949403;[APOBEC3A, APOBEC3B]
GO:1902975;mitotic DNA replication initiation;10.0;1.0;0.9152410118609203;9.628524252492122;177.94490236465032;9.083926447120524;0.005955655742129888;0.8797934328124444;[POLA1, GINS2]
GO:0060548;negative regulation of cell death;5.0;0.5408746917014966;0.5606783577116685;7.270369308343265;41.94029430001592;2.875336421023895;0.0014037039064071987;0.4372858501489002;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, PRKDC, ABCB4, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, PLCG2, HMOX1, SFN, NCKAP1L, BARD1, FZD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, GPR37, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, HCLS1, PTGS2, UNG, GPNMB, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, CSF3, TNF, CLU, CTGF, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, DNMT1, CORO1A, FOXO1, SOCS2, PSAP, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, GPX1, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, VPS4B, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, DNAJA3, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, SOX4, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, IGF1, PTK2, VNN1, ID1, CD28, CD27, NRP1, KIF14, BRCA1, CTSH, CD38, CCR7, CCR5, CD34, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CST3, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, CASP2, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, AURKA, SNCA, SOD2, RPS6KB1, TEK, NAA15]
GO:0007079;mitotic chromosome movement towards spindle pole;7.0;1.0;0.8509193652572005;9.628524252492122;93.22236288778774;8.67846133901236;0.0031200685911745604;0.7947362817240173;[CENPE, DLGAP5]
GO:1902977;mitotic DNA replication preinitiation complex assembly;8.0;1.0;0.875;9.628524252492122;93.82476133550486;9.777073627680469;0.003140230325096247;0.875;[CDC45]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, TGM2, PDGFRB, IL10, EDN1, IGFBP5, MMP2, IL18, MMP9, EREG, HBEGF, DNMT1, CALCRL, PTAFR, PTGS2, THBS1, AIF1, GNAI2, PAK1, CCL5, PDGFD, HMOX1, ELANE, JUN, STAT1, IGF1, IL6, NR4A3, RPS6KB1, NOX1]
GO:0071673;positive regulation of smooth muscle cell chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;372.1937940336002;8.67846133901236;0.012456991333636938;0.8400575416471059;[PDGFD, AIF1]
GO:0072520;seminiferous tubule development;4.0;1.0;0.75;9.628524252492122;49.55861996907746;7.379178354882098;0.0016586824105027187;0.6273715242355574;[KIF18A, BRIP1]
GO:1990822;basic amino acid transmembrane transport;10.0;0.7508913569872202;0.7906866903545304;9.277126365654233;267.5048622669104;7.697632086000634;0.008953147001327533;0.8088982747154926;[SLC7A7, SLC3A1]
GO:0048662;negative regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.58586787906956;5.970411137910149;0.0021281617743466354;0.6284474158353811;[CDKN1A, TNFAIP3, AIF1, CNN1, HMOX1, IL10, MEF2C, PTGIR, MYOCD, IGFBP5, IL15, IGFBP3, TPM1, KLF4, SOD2, IFNG, OGN, TRIB1]
GO:0071672;negative regulation of smooth muscle cell chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;373.36881743152423;8.390779266560578;0.012496318309313052;0.8253454670833372;[AIF1]
GO:0034446;substrate adhesion-dependent cell spreading;6.0;1.0;0.8231203125901445;9.628524252492122;56.23121614310476;6.088194173566533;0.0018820081995007299;0.63447084575632;[NRP1, ITGA4, ITGB3, FN1, KIF14, LAMB1, LAMC1, PARVB, ANTXR1, ITGB7, TEK]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CSF3, NCF1, CD80, ITGB3, IFNA2, TREM2, ARRB2, CD3E, ICAM1, GHR, GRM5, CD36, IL6R, SYK, RIPK2, IL15, IL18, MIF, PARP9, EREG, GREM1, IFNG, BANK1, IL23A, KIT, HCLS1, HBEGF, CSF1R, HDAC2, TGFA, GATA1, CCL5, NTF3, STAP1, FYN, LYN, CD74, TGFB1, ACE, EGF, LIF, OSM, IGF1, GH1, CD4, IL6, CSPG4, CD24]
GO:0050732;negative regulation of peptidyl-tyrosine phosphorylation;10.0;0.7980440201809971;0.8142630219514189;9.446202695698167;781.0212663083519;5.926926025970411;0.02614007890983527;0.7183442844592942;[THY1, PRKCZ, SAMSN1, PPP2R1A, NTF3, CAV1, PRKCD, SFRP2, PTPN6]
GO:0035772;interleukin-13-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;9.777073627680469;0.00101047745553359;0.8509193652572005;[CD300LF]
GO:1902981;synthesis of RNA primer involved in mitotic DNA replication;11.0;1.0;0.9324289523296623;9.628524252492122;652.7939449187966;9.777073627680469;0.021848425860023894;0.9324289523296623;[POLA1]
GO:0007088;regulation of mitotic nuclear division;7.0;0.5860072649471136;0.6439229977307573;8.169909229792605;54.97351338155213;4.573066940603674;0.0018399140199305624;0.5847862212690335;[CCNF, BUB1B, SMC3, MKI67, PHB2, PTTG1, CHEK1, NUSAP1, KNTC1, NEK2, FBXO5, PDGFRB, CDC25C, EREG, BTC, CCNE2, CCNE1, AURKAIP1, KIF20B, MAD1L1, CDCA5, TGFA, PKMYT1, CCNB2, CCNB1, RAD21, CDT1, TGFB1, CAV2, UBE2C, PLK1, CDC6, IGF1, NDC80, ANLN, STAG2, CD28, PTTG3P, KIF11, NUP62, DLGAP5, EDN1, DUSP1, SMC1A, CCNA2, IL1A, ESPL1, IL1B, VPS4B, TTK, AURKA, BUB1, SH2B1, RANBP2, RANBP1, EGF, CENPE, CENPF, TACC3, TRIP13, MAD2L1]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[CCNF, HERC5, SKP2, FBXW2, CDC34, NEDD4L, BARD1, HACE1, UBE2C, MARCH1, UBE2S, UBE2T, BCL2, TNFAIP3, BRCA1, UBE2Q2, RNF144A, RNF144B, DTL, BIRC2, RNF6, ZNRF1, RNF24, NEDD4]
GO:0090166;Golgi disassembly;5.0;1.0;0.7902410118609202;9.628524252492122;58.9131161342151;7.9853141584524145;0.001971768978649902;0.6986103492792611;[CDK1, VRK1]
GO:0009263;deoxyribonucleotide biosynthetic process;9.0;0.6913464685778243;0.7419138594692012;9.253830803050711;956.1008338098185;6.943860283624253;0.03199983447272836;0.7513499630073597;[DTYMK, RRM1, RRM2, TYMS]
GO:1901653;cellular response to peptide;6.0;0.6913464685778243;0.6687935468790567;8.798175950418692;225.6348642598113;4.473768719621393;0.007551795848581705;0.5519090529631041;[CYFIP1, AKT1, PRKACB, MEN1, GHSR, LHCGR, PRKCD, POR, ADCY9, RAB31, PRKAR1B, TIMELESS, PRKDC, FPR2, ADRB2, SLC30A10, FOXO1, BRIP1, PRKAR2B, TGFB1, CAV1, CDC6, IGF1, NFKB1, NR4A2, NR4A1, NR4A3, ID1, FBN1, PTPN22, GRM5, CD36, EDN1, ARG1, RIPK2, GLP2R, CCNA2, CEACAM1, TLR6, TLR4, LRP1, NOD2, PAK1, FYN, CSK, STAT1, SORBS1, KLF4, TSHR, KLF1, KLF5, RPS6KB1, FCGR2B]
GO:0007089;traversing start control point of mitotic cell cycle;10.0;1.0;0.9152410118609203;9.628524252492122;354.407431007331;8.390779266560578;0.01186169776983519;0.8443458537639685;[CDC6]
GO:1902983;DNA strand elongation involved in mitotic DNA replication;11.0;0.8933024483968273;0.8790801765280758;9.541512875502493;179.04351465331663;9.777073627680469;0.005992425306744681;0.9324289523296623;[GINS1]
GO:0046488;phosphatidylinositol metabolic process;7.0;0.6835726970475526;0.6927057137809769;8.801845679307654;147.2037350013595;4.383446081328108;0.004926776535734991;0.5750890017074093;[CD86, CD80, SLA2, FGF5, PDGFRB, PDGFRA, CISH, TTC7B, EREG, BTC, PLBD1, CSF1R, PDGFA, PIK3R3, PIK3R5, SOCS2, CD19, INPP5D, PLCG2, PIP5K1B, ICOS, BMX, SYNJ1, CD28, PLEK, PIK3CD, PIK3C2A, IMPA1, IMPA2, GAB1, VAV1, LCK, KIT, PIK3C3, PLCB1, HBEGF, FYN, TRAT1, EGF, MBOAT7, KITLG, PIKFYVE]
GO:0001774;microglial cell activation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;31.19674186509269;6.8867018697843045;0.001044126874979773;0.6753065664753021;[CX3CR1, IL33, JUN, ITGAM, ITGB2, FPR2, AZU1, CLU, AIF1, TLR8, TLR7, TLR6, TLR2, SNCA]
GO:1903827;regulation of cellular protein localization;5.0;0.4816167172285496;0.5310493704751951;6.85593553025234;25.722958397114;3.605373030269554;8.609242683918189E-4;0.47461995629589737;[, PID1, AKT1, EPHB2, MED1, PRKCH, PRKCE, PRKCD, PDZK1, IFI27, KIF20B, EPHA3, EPHA2, CDCA5, NEDD4L, TP53BP2, CEP72, SFN, BARD1, CDT1, JUP, FZD5, PLK1, LIF, IGF1, CCT6A, PKIG, CDKN1A, XPO1, RAC2, CD36, CCT3, CCT2, FCER1G, RHOG, PARP9, SIRT1, MDFIC, IL1B, HCLS1, RHOU, SP100, PTGS2, GNAI1, PAK1, CCT8, CCT7, CCT5, CCT4, GSN, SORBS1, LILRB4, NUCB1, GOPC, CAMK1, CHRM1, TNF, CDH1, AP2M1, PLS1, CCNE2, CCNE1, ECT2, TGFB1, NDC80, VIL1, DAB2, CDK1, BCL2, BCL2L1, GPSM2, ITGAM, LRRK2, ITGB2, TREM2, NUP62, YWHAH, TFDP1, IFNG, NUP54, LCP1, LRP1, ABLIM3, E2F1, FYN, CSK, EGF, GZMB, MAPK14, CD247]
GO:2000427;positive regulation of apoptotic cell clearance;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;227.08343208129315;7.8311634786251565;0.007600278109940302;0.7967266896635242;[C3, CCL2, CD300LF, C2]
GO:2000426;negative regulation of apoptotic cell clearance;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;226.6651823375042;9.083926447120524;0.007586279667416017;0.8607930461318132;[CD300LF]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TFRC, ICAM1, TNFSF11, TRIM25, MYBL2, TLE4, PCOLCE, SIRT1, PADI2, SBNO2, LAPTM5, KLF4, PML, BSPRY, KLF5]
GO:0070574;cadmium ion transmembrane transport;9.0;1.0;0.896240625180289;9.628524252492122;134.4975615453565;8.390779266560578;0.00450151234497627;0.8253454670833372;[SLC11A1]
GO:0071421;manganese ion transmembrane transport;9.0;0.8933024483968273;0.8428918493787028;9.4949928598676;98.82364420707664;8.390779266560578;0.003307538436105251;0.8253454670833372;[SLC11A1, SLC30A10]
GO:2000669;negative regulation of dendritic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;128.74299079791163;7.8311634786251565;0.004308912040836728;0.7967266896635242;[CXCL12, CCL21, LILRB1, CCR7, CCL19]
GO:0032498;detection of muramyl dipeptide;7.0;1.0;0.8509193652572005;9.628524252492122;223.28847168028474;9.777073627680469;0.007473264200561175;0.8509193652572005;[NOD2]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, IL1RN, CSF3, SPARC, CD80, GFI1, SERPINE1, CXCL13, MPO, LOXL1, ICAM1, PYCARD, EDNRB, JUNB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, TRIB1, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, SBNO2, KLRK1, PLCG2, STAP1, NLRP3, S100A14, CD14, ELANE, ABCA1, JUN, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, NFKB2, SELP, CXCL10, CXCL11, IL6, ALPL, CD27, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, ADM, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, IL10, PTGIR, EDN1, CHUK, ARG1, PDE4D, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, RARA, IRF8, TLR4, CX3CR1, CEBPB, HDAC2, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, SNCA, GCH1, CCL20, NR1H2, IL10RA, NR1H4, LILRB1, LILRB2, MAPK14, CD6, RPS6KB1, TNIP3, LTBR, PF4]
GO:0032497;detection of lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;150.00497270670016;8.390779266560578;0.005020531440782482;0.7522251544931926;[LY96, TREM2, TLR4]
GO:2000660;negative regulation of interleukin-1-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;306.2706419112467;8.16763571524637;0.010250602759086841;0.7926932703116032;[IL6, IL1RN, IL1R2]
GO:0007080;mitotic metaphase plate congression;7.0;1.0;0.8509193652572005;9.628524252492122;61.63195576956532;6.193554689224359;0.002062766094448262;0.6676580400938822;[SEH1L, CDCA5, VPS4B, KIF14, CDCA8, CCNB1, NUP62, CENPE, KIF18A, PSRC1, KIFC1, KIF2C]
GO:0072757;cellular response to camptothecin;7.0;1.0;0.8509193652572005;9.628524252492122;502.88914831670934;8.390779266560578;0.016831247223310163;0.7800242071602487;[BLM, RAD51]
GO:0016601;Rac protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;6.7325511899570465;9.9090025448413E-4;0.719302980950052;[CYFIP1, HACE1, RHOG, AIF1, EPS8, RAC2, RHOU]
GO:0072708;response to sorbitol;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;29.400638164542393;8.16763571524637;9.840129005107402E-4;0.7079342821725234;[CDT1, MAP2K6, MAPK13]
GO:0046655;folic acid metabolic process;7.0;0.8933024483968273;0.7975705894556142;9.551563211355994;318.75190525379287;6.7325511899570465;0.010668339410754122;0.6952223462072524;[DHFR, MTHFD1]
GO:0046654;tetrahydrofolate biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.603206444507832;1227.4757260734505;7.697632086000634;0.04108250789524529;0.7686572628545723;[DHFR, ATIC, GCH1, MTHFD1, GART]
GO:0043388;positive regulation of DNA binding;5.0;0.7090535922965819;0.6447678080092112;8.578702127993445;32.525455185636034;5.825829909099042;0.0010885977140540058;0.5881742243410422;[HMGB2, TWIST1, GATA3, MYOCD, TGFB1, EGF, PLAUR, IGF1, KLF4, MMP9, POU4F1, NME1, IFNG]
GO:0032091;negative regulation of protein binding;5.0;0.6997970393407541;0.6401395315312973;8.48339194818912;32.716075545242866;5.171903441692378;0.0010949776059428606;0.5547323943871747;[LRRK2, CTSZ, ARRB2, IFIT1, IFIT2, RUVBL2, STMN1, AKT1, IL10, ITGA4, PRKCD, AES, SLPI, LEF1, ADRB2, AURKB, AURKA, EPB41L5, CCL23, CAV1, EIF2S1, PPP1CA, DAB2, ID1, CAMK1]
GO:0000022;mitotic spindle elongation;4.0;1.0;0.75;9.628524252492122;36.9885698197415;9.083926447120524;0.001237974144315121;0.714552420951524;[PRC1, KIF23]
GO:0043392;negative regulation of DNA binding;5.0;0.7586651285174919;0.6695735761196662;8.866384200445225;32.533753988449135;5.788089581116195;0.0010888754675157227;0.5862441822128946;[SP100, HDAC2, LEF1, GATA1, E2F1, HMOX1, NEK2, JUN, GZMA, NFKBIA, ID1]
GO:0002439;chronic inflammatory response to antigenic stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;42.97336350789415;8.390779266560578;0.0014382798030929574;0.7522251544931926;[IL1RN, IL1B, TNF]
GO:0060729;intestinal epithelial structure maintenance;8.0;1.0;0.875;9.628524252492122;27.01847773359651;8.390779266560578;9.042841346921817E-4;0.8041048419030481;[TLR4]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[TNFAIP8, ARRB1, ARRB2, AQP1, LAMP3, RPS6KA1, AKT1, GPX1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, BIRC2, BIRC3, LEF1, IFI6, NLRC4, PTGS2, THBS1, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4, FABP1, VIL1, CD27]
GO:0014898;cardiac muscle hypertrophy in response to stress;7.0;1.0;0.8509193652572005;9.628524252492122;75.67165931027915;7.138016298065211;0.002532662337043095;0.7159578506919597;[MEF2C, EZH2]
GO:0035357;peroxisome proliferator activated receptor signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;25.568165535828406;7.697632086000634;8.557434906291208E-4;0.7167775754447168;[MED1, RXRA, ACTN4]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[GFI1, TNFAIP3, ARRB1, ARRB2, PYCARD, CYP1B1, HAVCR2, IL10, CHUK, IRAK3, SIRT1, NLRC3, PKHD1, G3BP2, NLRP3, NR1H4, KLF4, NFKBIA, NLRP12, CCDC22, NFKBID]
GO:0048843;negative regulation of axon extension involved in axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;2931.023726508963;6.558197802812269;0.09809872637615838;0.7835068532133509;[NRP1, SEMA5B, SEMA4A, SEMA6A, SEMA4B]
GO:0045579;positive regulation of B cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.503361109538115;803.2041625246294;7.212124270218933;0.026882520482883615;0.7650689957573628;[SYK, INPP5D, BTK, ATP11C, CD27, NCKAP1L]
GO:0046427;positive regulation of JAK-STAT cascade;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;286.6013214379199;5.459585514144159;0.009592288304083759;0.675444082270312;[CSF1R, CD40, HDAC2, IFNA2, PRL, GHR, CCL5, CYP1B1, FYN, IL6R, LYN, IL15, F2R, LIF, IL18, OSM, IGF1, PARP9, GH1, IL6, IFNG, IL23A, KIT, HCLS1]
GO:1900745;positive regulation of p38MAPK cascade;12.0;1.0;0.9481203125901445;9.628524252492122;1761.632567075866;6.7325511899570465;0.05896025665364957;0.7924232935401965;[NCF1, GADD45B, BMP2, IL1B]
GO:0002686;negative regulation of leukocyte migration;8.0;0.6664901433067099;0.7082450716533549;8.992535485772125;239.840353788688;6.193554689224359;0.008027240799002647;0.6917386748366816;[IL33, CCL21, MIF, GREM1, KLRK1, CXCL12, MMP28, STAP1, PADI2, CCL2, HMOX1, EMILIN1, HOXA7, PLCB1, NBL1, GPR18]
GO:0045342;MHC class II biosynthetic process;5.0;1.0;0.7902410118609202;9.628524252492122;39.16312370347755;9.777073627680469;0.0013107545058323288;0.7902410118609202;[SLC11A1]
GO:0060718;chorionic trophoblast cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;8.16763571524637;7.050676185779127E-4;0.6676932703116032;[FZD5, HTRA1, E2F7, E2F8]
GO:0070512;positive regulation of histone H4-K20 methylation;11.0;1.0;0.9324289523296623;9.628524252492122;803.63682017253;9.777073627680469;0.02689700114499224;0.9324289523296623;[BRCA1]
GO:0006809;nitric oxide biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;241.09966064176743;7.212124270218933;0.008069388666072628;0.6919486831672181;[GCH1, AKT1, CYP1B1, RORA]
GO:0032079;positive regulation of endodeoxyribonuclease activity;9.0;1.0;0.896240625180289;9.628524252492122;975.1149925155983;8.390779266560578;0.03263622125297896;0.8253454670833372;[PRKCD, AKT1]
GO:0035589;G-protein coupled purinergic nucleotide receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;82.06132384088221;7.069023426578259;0.0027465186585576445;0.7365101867784198;[P2RY13, P2RY6, P2RY14, P2RY2, GPR87, PTAFR, GPR171]
GO:0033160;positive regulation of protein import into nucleus, translocation;10.0;1.0;0.9152410118609203;9.628524252492122;970.0189350156829;7.292166977892469;0.03246566079461078;0.7881627702307852;[MED1, IFNG, LRRK2, CDK1, IGF1]
GO:0032077;positive regulation of deoxyribonuclease activity;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;813.6405734422207;8.16763571524637;0.027231817764135358;0.7926932703116032;[PCNA, PRKCD, AKT1]
GO:0045588;positive regulation of gamma-delta T cell differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;1283.265958453736;8.67846133901236;0.04294975676506408;0.8590579283277371;[SYK, NCKAP1L]
GO:0045347;negative regulation of MHC class II biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.30203964950672;8.16763571524637;0.0049300667038400395;0.7686126355688037;[IL10, HDAC2, SPI1, PF4]
GO:0045589;regulation of regulatory T cell differentiation;9.0;0.7866048967936545;0.7895430735771163;9.517298617381897;133.46855707074621;6.518977089658987;0.004467072491254967;0.7296214167088868;[TGFB1, CR1, LILRB2, HLA-G, LILRB4, DUSP10, BCL6, IFNG, FANCD2, CD28, CTLA4]
GO:0045345;positive regulation of MHC class I biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.9853141584524145;0.0049295844405465;0.7592887026755414;[CIITA, NLRP12, PML]
GO:0045591;positive regulation of regulatory T cell differentiation;10.0;0.8933024483968273;0.861892236059334;9.60254876608886;997.8066164740876;7.292166977892469;0.03339568948573388;0.7881627702307852;[TGFB1, DUSP10, BCL6, IFNG, LILRB2, HLA-G, LILRB4]
GO:0046680;response to DDT;5.0;1.0;0.7902410118609202;9.628524252492122;46.407574972267774;9.777073627680469;0.0015532197702158826;0.7902410118609202;[CCNB1]
GO:0070542;response to fatty acid;5.0;0.6696747006330769;0.6250783621774587;8.578702127993445;43.78950961223322;5.382624473008031;0.0014655954787213788;0.5655086777281872;[PID1, TNC, CTGF, ALAD, AKT1, FFAR2, CCR7, CD36, PTGDR, EDN1, DGAT2, ACSL1, PRKCE, NME1, TGFBR3, IL1B, TLR2, PTGER2, PTAFR, PTGS2, P2RY6, CCNB1, E2F1, CCL19, CCL21, NR1H4]
GO:0071874;cellular response to norepinephrine stimulus;8.0;1.0;0.875;9.628524252492122;410.2922764159275;8.67846133901236;0.01373211325256535;0.8188169164668168;[IL1RN]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[HDAC2, PCNA, TNFAIP3, ETS1, FOXO1, AQP1, CST3, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:0070543;response to linoleic acid;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;46.1874048850311;9.083926447120524;0.0015458508755362855;0.7876727335416686;[CD36]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[PTPRR, PTPN22, PTPRK, DUSP10, DUSP2, DUSP3, DUSP1, CDC25C, DUSP6, CDC25A, TPTE, PTPRE, PTPRC, PTPN6, PTPN7, PTPN4, CDKN3]
GO:0015721;bile acid and bile salt transport;9.0;0.9326813400603323;0.8625812952104552;9.5544162803384;89.96332036720499;6.375876246018314;0.003010991370958501;0.722303232910233;[ABCC3, SLC10A2, AQP9, NR1H4, CEACAM1, RXRA, SLCO2B1]
GO:0090129;positive regulation of synapse maturation;7.0;0.9326813400603323;0.8172600352873667;9.571365838652174;185.50285720788708;7.57984905034425;0.006208613689015268;0.738553198190834;[CDC20]
GO:0072719;cellular response to cisplatin;6.0;1.0;0.8231203125901445;9.628524252492122;120.46332589257861;8.16763571524637;0.004031799107669873;0.7408135829017477;[TIMELESS, HMOX1]
GO:0034244;negative regulation of transcription elongation from RNA polymerase II promoter;12.0;1.0;0.9481203125901445;9.628524252492122;4178.882431846446;7.379178354882098;0.13986343424388045;0.825491836825702;[EZH2]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[TGFB1I1, RORA, GATA3, TNF, FOXO1, E2F1, TGFB1, JAG1, SORT1, SIRT1, IL6]
GO:0044267;cellular protein metabolic process;5.0;0.3358520568840654;0.45816704030295297;5.574370570853267;80.86766357206795;1.6585685600933726;0.0027065679235849286;0.3750602851554211;[, POP5, SPI1, SLA2, AKT1, PRKACB, CDCA3, PDGFA, GATA3, FN1, EIF2AK2, JAK3, DLGAP5, DUSP2, DUSP3, DUSP1, BGN, DUSP6, NRAS, SPP1, IL12RB2, COL3A1, PKN1, CDKN3, SLA, EFEMP1, MAP3K8, NEK2, KCNH1, KCNH2, CISH, CDC25C, FBXW2, CDC25A, BLK, PKMYT1, NAE1, NEK7, BMX, SPTB, UHRF1, HM13, IL2RG, ZNRF1, EIF4H, FYN, IL2RB, EIF3F, CDC20, HERC5, C1GALT1C1, LGALS1, TNFSF11, TRIM25, SNRPD3, ALG8, BTC, CDC34, BTK, TRIB1, NAIP, EPB42, SDC2, GSPT1, EGR2, IGF1, PTK2, MUC13, MUC15, SPTAN1, SYK, IL15, IL18, RNF144A, RNF144B, IL1B, KIT, PCNA, PCNP, IL33, KITLG, NDUFAB1, BUB1B, LOXL1, LOXL2, TGM2, MUC3B, UBE2C, NAT8, UBE2S, UBE2T, UBA3, UBE2M, FBN1, TNFAIP3, GHR, CAD, IRAK3, SHANK3, RNF6, SPOCK3, TNIP3, TEK, PRKCH, PRKCB, PRKCE, PRKCD, HMBS, PRKCQ, PRKDC, PRKCZ, PRDM16, ST3GAL6, IGHA1, BARD1, PLK4, PLK2, PLK1, BTG2, ASGR1, ASGR2, IFIH1, PBK, TIMP1, CIT, RARA, USP1, GSN, NR1H4, ELP4, NUCB1, TNC, IL5RA, TNF, FGF5, LAMP2, MAP2K2, VRK1, NRBP1, FKBP3, UBR1, MAP2K6, FANCL, COPS5, P4HA2, BCL2, CCDC22, LAT, GAL3ST1, CYR61, TLK1, LCK, HDAC2, TPTE, DENND3, TTK, NLRC4, NOD2, TTR, CSK, PML, CPPED1, PPIL4, PPP2R1A, RPS6KA1, ESCO2, POR, SIK1, CFTR, TXK, LIF, PRL, STRADB, GFRA3, PARP9, ZDHHC17, HCK, TLR7, TLR4, TLR2, GUCY2C, CSTA, CST3, APBB1, QPCT, LOX, NLRP3, CLSPN, CBX4, EIF2S1, KDM5D, DCN, ZAP70, LTF, HIST1H2BK, LEF1, THBS1, BUB1, SNCA, WEE1, RPS6KB1, EHMT2, MYLK, KRTCAP2, PSMD3, MEF2A, MEF2C, HSPG2, PRKAR1B, PADI2, SPARCL1, PADI4, UQCRC2, THY1, IQGAP3, C3, LYN, ABCA1, HACE1, LYZ, BHMT, EZH2, RIPK2, ACTL6A, SIRT1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FSTL1, USP9Y, PSMC6, PSMC2, CCNT2, F13A1, RUVBL2, RUVBL1, AP2M1, S100A9, S100A8, FOXO1, SOCS2, NFKB1, PTPRE, PTPRC, ST6GALNAC2, LRRK2, PIK3CD, ARRB1, ARRB2, UTY, DSP, PPP1R12A, BIRC5, PIK3C3, DTL, BIRC2, BIRC3, PPP1R15A, CCL8, CCL5, CCL2, NDUFA7, TIE1, PTPN6, PTPN7, PTPN4, CCNH, CCNF, CCNC, EPHB2, EPHB1, PAQR3, EREG, MXRA8, ALPK2, EPHA3, EPHA2, TF, SUV39H2, PTPRR, FKBP14, SUV39H1, PTPRK, BRCA1, BRCA2, BMI1, PCSK5, CTSH, CTSG, CCR5, PDZRN3, PAK1, PRKY, PPP1CA, NEDD4, FKBP1B, GXYLT2, PDGFRB, PDGFRA, CCNE1, CALCA, KLHL14, PSMD14, PSEN2, RASGRP1, RASGRP4, FUT4, FUT3, SPTA1, CCNB1, FUT7, ISG15, CLK4, CLK1, IL6, BMP2, LAMC1, UBE2Q2, MMP1, DDX58, MMP2, MASTL, CCNA2, VCAN, TAF9, AURKB, AURKA, GALNT7, GALNT6, EGF, LAMB1, MAPK14, MAPK13, TAF5, NAA15, MED1, DAPK1, NEDD4L, CDC7, CDK14, ITK, SERPINA1, ANXA1, HBEGF, FAM105A, RNF130, GTF2H1, CHRM1, ABHD12, GRAP2, MACROD2, STK32B, MEN1, RNF43, IGFBP5, IGFBP3, MELK, CSF1R, CUL5, RASAL2, NACC2, IGFBP7, WFS1, MARCH3, MARCH1, CDK6, CDK2, CDK1, PTPN22, DUSP10, GPX1, CHUK, ASPH, IL3RA, RNF24, CHEK1, SKP2, BCL11A, MAP4K1, B3GNT5, FAM20C, SGK1, RANBP2, CAMK4, CAMK1, GALNT14, DSCC1, ARID4A, ARID4B, FBL, APLP2, MATK, CSF2RB, ADRB2, DTX3, CSF2RA, TGFB2, TGFB1, NFKBIA, FES, TGFBI, TGFBR3, FGR, EHHADH, CAMK2D, USP18, NCAM1]
GO:0044027;hypermethylation of CpG island;9.0;1.0;0.896240625180289;9.628524252492122;74.95921705947427;9.083926447120524;0.002508817536065054;0.8607930461318132;[SPI1]
GO:0045113;regulation of integrin biosynthetic process;6.0;0.8259837884571596;0.7361122068187242;9.446202695698167;47.68886481839192;8.16763571524637;0.001596103388279661;0.7408135829017477;[TMEFF2, TGFB2, S100A9, NOX1]
GO:0045356;positive regulation of interferon-alpha biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;8.390779266560578;0.0286306378699575;0.8041048419030481;[TLR8, TLR7]
GO:0002430;complement receptor mediated signaling pathway;9.0;0.9326813400603323;0.8625812952104552;9.57973408832269;218.73839564357212;7.212124270218933;0.007320977250414979;0.7650689957573628;[CR2, CR1, C5AR1, FPR1, C3AR1, FPR3, FPR2]
GO:0046209;nitric oxide metabolic process;5.0;0.8933024483968273;0.736892236059334;9.474373572664863;82.70267162507076;6.943860283624253;0.002767983991718903;0.6453503496879909;[POR, GCH1, AKT1, CYP1B1, RORA, TLR6, TLR2]
GO:0002431;Fc receptor mediated stimulatory signaling pathway;9.0;0.8933024483968273;0.8428918493787028;9.533214072687796;218.73839564357212;4.87179884924204;0.007320977250414979;0.6453846448923425;[CYFIP1, CD3G, IGHG1, FCGR3A, FCER1G, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, PLCG2, NCKAP1L, FYN, PLCG1, FCGR1A, LYN, PTK2, FCGR2A, NR4A3, CD247, FCGR2B, IGKV3-20]
GO:0045359;positive regulation of interferon-beta biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;7.8311634786251565;0.0286306378699575;0.7754860644832351;[TLR8, TLR7]
GO:0060732;positive regulation of inositol phosphate biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.59462270081644;800.1222801547256;7.212124270218933;0.026779372653476994;0.7438283705770736;[LHCGR, PTAFR, CD244, SNCA]
GO:1902943;positive regulation of voltage-gated chloride channel activity;10.0;1.0;0.9152410118609203;9.628524252492122;1152.1971065561047;9.083926447120524;0.03856300024635883;0.8797934328124444;[PTAFR, CFTR]
GO:0044030;regulation of DNA methylation;7.0;0.7980440201809971;0.7499413753476991;9.253830803050711;73.34977914704017;6.7325511899570465;0.0024549510975359675;0.6952223462072524;[SPI1, BRCA1, GRHL2]
GO:0002666;positive regulation of T cell tolerance induction;7.0;0.8653626801206646;0.7836007053175329;9.4949928598676;165.82106058012107;7.8311634786251565;0.005549881668350914;0.7514054297404357;[LILRB2, CD3E, HLA-G]
GO:0001578;microtubule bundle formation;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;33.1981629444775;5.8067817141283475;0.0011111126373447525;0.6200793994936333;[PLK1, NAV1, PSRC1, FES, PRC1, MAP1B, KIF20A]
GO:0046452;dihydrofolate metabolic process;7.0;0.9326813400603323;0.8172600352873667;9.584072489921288;283.0980526959044;8.390779266560578;0.009475037052025674;0.7800242071602487;[DHFR, ATIC]
GO:0033147;negative regulation of intracellular estrogen receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;234.23542340630428;7.138016298065211;0.007839648823214116;0.7400384854347593;[LBH, BRCA1, PHB2]
GO:0072711;cellular response to hydroxyurea;6.0;1.0;0.8231203125901445;9.628524252492122;186.99437101104425;7.8311634786251565;0.006258533313731664;0.7236063770733796;[BLM, FMR1, TIMELESS]
GO:0070534;protein K63-linked ubiquitination;11.0;0.9326813400603323;0.8987696223598284;9.577230958104572;157.60047254366168;6.166155715036245;0.00527474598481953;0.747766442352181;[UBE2S, NEDD4, UBE2T]
GO:0050702;interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;137.76275822249997;7.697632086000634;0.004610795539274035;0.8260862151842345;[ABCA1, F2RL1, NLRC4, CD36, TLR6, TLR4]
GO:0036413;histone H3-R26 citrullination;11.0;1.0;0.9324289523296623;9.628524252492122;343.59953251902647;9.083926447120524;0.011499967133908778;0.8969813732811862;[PADI2, PADI4]
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[SPARC, SERPINE1, FASLG, PRL, HHEX, STAB1, EMILIN1, HOXA5, CCR2, SEMA6A, HSPG2, DCN, COL4A2, HGS, CX3CR1, THBS2, THBS1, E2F2, SEMA4A, TGFB2, STAT1, PLK2, TIE1, KLF4, SULF1, PML, CXCL10, TEK, PF4]
GO:0060009;Sertoli cell development;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;53.96940310801817;7.138016298065211;0.0018063073527159576;0.6552794972956795;[CST3, ARID4A, FLNA, SDC1, ARID4B, FNDC3A, ICAM1]
GO:1900017;positive regulation of cytokine production involved in inflammatory response;8.0;1.0;0.875;9.628524252492122;226.66426644256094;7.004484905440688;0.0075862490132365176;0.7332096838060964;[CD6, TLR6, NOD2, TLR4, MYD88, IL17A]
GO:0006957;complement activation, alternative pathway;8.0;1.0;0.875;9.628524252492122;200.06168254027287;7.212124270218933;0.006695884470798082;0.7438283705770736;[CFD, C3, CFH, C7, CFP, CFB]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, ARRB1, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, RIPK2, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, CD74, EGF, IGF1, MAPK14, BMP2, CD40LG, CDK1, CSPG4, PKN1]
GO:0071373;cellular response to luteinizing hormone stimulus;8.0;1.0;0.875;9.628524252492122;601.1788189541068;8.67846133901236;0.020120914044583264;0.8188169164668168;[CCNA2, LHCGR]
GO:0050672;negative regulation of lymphocyte proliferation;8.0;0.7436939687323844;0.7468469843661922;9.271849308553389;262.9542115637972;5.514393750639154;0.008800840817614076;0.6570063528532206;[CD86, CD274, CEBPB, TNFRSF13B, CD80, LST1, IHH, LRRC32, GPNMB, INPP5D, CTLA4, HAVCR2, LYN, IL10, TGFB1, ARG1, PAWR, LILRB1, PDCD1LG2, LILRB2, HLA-G, BTK, XCL1, PTPN6, MNDA, PDE5A, PKN1, FCGR2B, MAD1L1]
GO:0031915;positive regulation of synaptic plasticity;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;41.65758488823441;7.57984905034425;0.0013942418768168238;0.7626338329336335;[CDC20, PTGS2, EPHB2]
GO:0050679;positive regulation of epithelial cell proliferation;6.0;0.7192862368539868;0.682763431017138;8.647694999480395;65.06748660449396;4.584116776790259;0.002177750219716307;0.5575522577384293;[NRP1, NRP2, ECM1, ITGB3, HMGB2, IHH, TNFAIP3, LAMC1, CDH3, AKT1, CCR3, IL10, PPP1R16B, GHSR, MED1, ITGA4, ARG1, SIRT1, F3, PAX2, NME1, MMP12, AGTR1, C5AR1, HTRA1, TGFA, TWIST1, NOD2, IQGAP3, NRAS, CCL5, HMOX1, PLCG1, JUN, TGFB1, EGR3, CAV2, TNFSF12, LAMB1, IGF1, NR4A1, BMP2, LRG1, CXCL12, NR4A3, ID1, TEK]
GO:0036123;histone H3-K9 dimethylation;12.0;1.0;0.9481203125901445;9.628524252492122;1326.2992443831567;8.67846133901236;0.04439004211767886;0.8919372290569614;[SUV39H2, SUV39H1]
GO:0036124;histone H3-K9 trimethylation;12.0;1.0;0.9481203125901445;9.628524252492122;1326.076100831845;8.16763571524637;0.044382573703832605;0.8658135829017477;[SUV39H2, SUV39H1, ARID4A, ARID4B]
GO:2000010;positive regulation of protein localization to cell surface;7.0;1.0;0.8509193652572005;9.628524252492122;73.70707873031733;7.004484905440688;0.002466909593039506;0.7091290490632969;[FCER1G, TNF, AKT1, CD247]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[NRP1, HCK, CSF3, FES, NTF3, STAP1, HCLS1, TEK]
GO:0036120;cellular response to platelet-derived growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.781341354126479;0.003262744749111514;0.6699184248047958;[PDGFRB, CCNA2, PDGFD, FYN]
GO:1900264;positive regulation of DNA-directed DNA polymerase activity;10.0;1.0;0.9152410118609203;9.628524252492122;1106.254199480119;7.9853141584524145;0.03702533249245755;0.8236103492792612;[RFC5, RFC3, RFC4, RFC2, DSCC1]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[SMC3, AKT1, WDHD1, WDR76, PRKDC, CDCA5, RAD21, HMOX1, SFN, BARD1, LYN, MCTS1, PLK2, PLK1, CDC7, CDKN1A, BTG2, CHAF1B, CHAF1A, CTLA4, ACTL6A, SIRT1, UNG, USP1, PMS1, GTF2H1, FMR1, TNF, PYCARD, RUVBL2, RUVBL1, MACROD2, MEN1, CDC25C, MSH6, MSH2, BLM, RNASEH2A, CUL5, FOXO1, RAD51AP1, MAP2K6, FANCI, FANCL, FANCG, COPS5, BCL6, CNOT3, BCL3, CDK2, CDK1, BCL2, BCL2L1, MCM7, MCM8, MCM10, FOXM1, EXO1, TLK1, RFC5, RFC3, RFC4, RFC1, RFC2, SMC1A, TNFRSF1B, TFDP1, DTL, PPP1R15A, UHRF1, CDC45, RBBP8, POLR2E, E2F1, POLR2I, POLR2J, E2F7, POLR2K, POLR2L, E2F8, DONSON, MND1, PML, RAD50, RAD51, MNDA, SMARCAL1, CCNH, CHEK1, TRIM25, SOX4, TIPIN, ESCO2, MIF, NEIL3, DNA2, EPHA2, BRIP1, POLA1, TOP2A, FEN1, SUV39H1, BRCA1, BRCA2, PARP9, RAD51C, SGK1, YAP1, SP100, PCNA, RAD54B, RAD54L, APBB1, GINS2, GINS4, RPA1, RPA2, MLH1, RPA3, NEDD4, TRIP13, DCLRE1A, PTTG1, LIG1, FANCD2, TIMELESS, PSMD14, CCNB1, CLSPN, HMGA1, ISG15, UBE2T, JMY, CASP2, TOPBP1, H2AFX, MASTL, IRF7, BCL2A1, TAF9, AURKA, POLD3, POLD1, POLQ, MAPK14, POLE2]
GO:0002374;cytokine secretion involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;8.67846133901236;0.004587596526932657;0.8590579283277371;[NLRP3, NOD2, TLR2]
GO:0006975;DNA damage induced protein phosphorylation;8.0;1.0;0.875;9.628524252492122;212.05375489921127;7.697632086000634;0.007097248340487313;0.7686572628545723;[CHEK1, MAP2K6]
GO:0060236;regulation of mitotic spindle organization;9.0;0.7980440201809971;0.7952626352707877;9.360260265897443;71.51327617590798;6.193554689224359;0.0023934849958375417;0.7129793000169707;[GPSM2, VPS4B, SMC3, GNAI1, NUP62, PLK1, SMC1A, TPX2, PSRC1, STAG2, TACC3]
GO:0006730;one-carbon metabolic process;3.0;0.8933024483968273;0.6447715367885581;9.292052015870908;26.874295102004712;6.518977089658987;8.994584717687482E-4;0.5315011041187423;[TYMS, DHFR, MTHFD1]
GO:0071361;cellular response to ethanol;6.0;1.0;0.8231203125901445;9.628524252492122;330.81194821622347;7.138016298065211;0.011071978195372667;0.6881587980249038;[SPI1, CCL7, PRKCE, CYBB]
GO:0002369;T cell cytokine production;6.0;0.8653626801206646;0.7558016526504768;9.4949928598676;52.63383953837513;7.379178354882098;0.0017616072419691818;0.7004918368257019;[DENND1B, IL18RAP, SLC11A1, IL18]
GO:0006729;tetrahydrobiopterin biosynthetic process;8.0;1.0;0.875;9.628524252492122;752.8847007962319;7.8311634786251565;0.02519837338340958;0.7754860644832351;[DHFR, GCH1]
GO:0051770;positive regulation of nitric-oxide synthase biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.069023426578259;0.0049295844405465;0.7124295520356204;[CCL20, STAT1, LRRK2, NOD2, FCER2, CCL2, TLR4, TLR2, MAP2K6]
GO:0071363;cellular response to growth factor stimulus;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;60.394260804020476;4.247644540169047;0.0020213415578046274;0.5074657511808371;[SPARC, SPINT2, AKT1, PDGFRB, MED1, MEF2C, POSTN, RUNX2, SPINT1, COL4A2, CALCA, TWIST1, GATA3, ADAMTS12, EPB41L5, PDGFD, PLCG1, TGFB1, EGR3, VCAM1, CAV1, COL1A1, VIL1, NR4A1, BMP2, ID1, NOX4, SNAI2, FBN1, NRP1, MCM7, TMEM100, IL10, EDN1, ANXA1, ARG1, CAD, TNFRSF1B, PAX2, CCNA2, XCL1, GAS1, CX3CR1, DTYMK, HDAC2, THBS1, CCL5, E2F1, CCL2, FYN, SNCA, MAPK14, KLF4, RPS6KB1]
GO:2000001;regulation of DNA damage checkpoint;7.0;0.7866048967936545;0.7442218136540277;9.446202695698167;47.13716505022567;7.004484905440688;0.0015776384935366925;0.7091290490632969;[RPA2, WDR76]
GO:2000484;positive regulation of interleukin-8 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;7.069023426578259;0.02521906460756386;0.7767511986393403;[FCN1, F2R, TLR1, CD2, PYCARD, F2RL1, FFAR2, CD58, CD14, CD244, TLR2]
GO:2000249;regulation of actin cytoskeleton reorganization;8.0;0.8933024483968273;0.8216512241984136;9.427853557029971;36.19570401534177;6.221725566191056;0.0012114376393747596;0.6931793347948383;[NRP1, PDGFRA, CSF1R, CSF3, TGFB1, F11R, HCK, FES, ARHGDIA, NTF3, ARHGDIB, STAP1, HCLS1, TEK]
GO:0035264;multicellular organism growth;3.0;1.0;0.6981203125901445;9.628524252492122;22.582921643529833;5.382624473008031;7.558300640989654E-4;0.47338797845741154;[IHH, ADARB1, BRCA2, HHEX, SLITRK6, HOXA5, STIL, RMI1, PDE4D, GRHL2, NDUFS6, RARA]
GO:0035023;regulation of Rho protein signal transduction;9.0;0.8436909121759173;0.8180860812682478;9.318369324188282;48.758993290020136;4.879233827729558;0.0016319196251719597;0.645764870037956;[NRP1, ARHGEF10L, ARRB1, EPS8, ARHGDIA, STMN1, ARHGDIB, PDGFRB, PLEKHG1, ARHGEF12, GPR35, F2R, ARAP3, VAV1, TIAM2, FGD3, FGD4, EPS8L1, EPS8L3, ECT2, ABCA1, COL3A1, BCL6, DLC1, F2RL1, GPR18, F2RL3]
GO:0035024;negative regulation of Rho protein signal transduction;10.0;1.0;0.9152410118609203;9.628524252492122;340.00127024396755;6.832634648514029;0.011379536533788362;0.7646622655359331;[BCL6, DLC1, STMN1, ARAP3]
GO:1900271;regulation of long-term synaptic potentiation;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;41.65758488823441;6.193554689224359;0.0013942418768168238;0.6917386748366816;[CX3CR1, LILRB2, NRGN, EPHB2, SHANK3]
GO:1902216;positive regulation of interleukin-4-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;305.68887294206377;9.083926447120524;0.01023113147524637;0.839552420951524;[CD300LF]
GO:0003431;growth plate cartilage chondrocyte development;6.0;1.0;0.8231203125901445;9.628524252492122;32.15320660831846;9.083926447120524;0.001076138889173156;0.7876727335416686;[POC1A]
GO:0042832;defense response to protozoan;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;69.6526388451159;6.832634648514029;0.0023312111388408135;0.6725415662651573;[IL10, CD40, ARG1, SLC11A1, DEFA1, CLEC7A, BCL3, IRF8, PF4]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, ECM1, SERPINA1, SPARC, PROS1, ITGB3, ITGA2B, SERPINE1, PLEK, F13A1, CTSW, CLU, LAMP2, TIMP3, CD36, TIMP1, VWF, ACTN1, APLP2, ANXA5, ACTN4, F5, MMRN1, PECAM1, SERPING1, TLN1, VCL, CFD, STXBP2, PDGFA, THBS1, PSAP, FLNA, A2M, LYN, TGFB2, TGFB1, EGF, PCDH7, FN1, LHFPL2, PPBP, IGF1, SELP, TF, CD9, PF4]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, TNF, FGF5, TNFSF11, MAP3K8, MEN1, PDGFRB, MEF2A, PDGFRA, MED1, MEF2C, MAP2K2, PAQR3, EREG, BTC, TRIB1, PDGFA, CSF2RB, RASAL2, IQGAP3, CSF2RA, RASGRP1, RASGRP4, SPTA1, MAP2K6, TGFB1, IGF1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, JAK3, MAP4K1, CHUK, RIPK2, STRADB, IL18, GFRA3, SPTB, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, CAMK2D, NOD2, IL2RG, NRAS, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, MAPK13, KITLG, IL2RB, TEK]
GO:0048384;retinoic acid receptor signaling pathway;6.0;0.7866048967936545;0.7164227609869718;8.935377071932177;25.568165535828406;7.004484905440688;8.557434906291208E-4;0.6813299963962409;[RXRA, NR1H2, RARA, ACTN4, PML]
GO:0002578;negative regulation of antigen processing and presentation;5.0;0.6913464685778243;0.6359142461498324;8.48339194818912;38.82783361315856;7.8311634786251565;0.0012995326482508427;0.6907270763441554;[LILRB2, FCGR2B, HLA-DOA, HLA-DOB, THBS1]
GO:0071392;cellular response to estradiol stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;338.1710882258028;6.221725566191056;0.011318281988697268;0.6412996473849828;[IL10, ABCB4, POU4F1, CCNA2, KIF18A, RUVBL2]
GO:0071398;cellular response to fatty acid;6.0;0.7369933605727446;0.6916169928765168;9.004369943419128;203.00017448222317;5.8067817141283475;0.006794233151624104;0.6200793994936333;[PID1, PTGER2, PTAFR, TNC, P2RY6, CCNB1, E2F1, AKT1, FFAR2, PTGDR, EDN1, DGAT2, PRKCE, NR1H4, NME1, IL1B]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, PRKDC, PDGFA, BMI1, AQP1, CCNB1, PDGFD, MYB, PDGFC, E2F1, PDGFRB, PDGFRA, CD74, JUN, TGFB1, FN1, CDC6, MIF, IGF1, PML, EREG, FOSL2, BTC, CCNA2, CDK6, NDUFS4]
GO:0048387;negative regulation of retinoic acid receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;187.41437209568753;7.57984905034425;0.006272590372058239;0.738553198190834;[EZH2]
GO:0071158;positive regulation of cell cycle arrest;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;83.12201169572153;5.395046993006588;0.002782018926502022;0.6268223193749;[CDKN1A, BTG2, BRCA1, CASP2, SOX4, CDC25C, TFDP1, PCNA, AURKA, CCNB1, E2F1, SFN, E2F7, E2F8, TGFB1, PLK2, POU4F1, PML, FAP, CNOT3, CDK2, CDK1]
GO:0051307;meiotic chromosome separation;4.0;0.8653626801206646;0.6826813400603323;9.223059144383958;35.562483153567804;8.67846133901236;0.0011902443069929621;0.6938169164668168;[BLM, ESPL1]
GO:0034162;toll-like receptor 9 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;7.004484905440688;0.013811191226989502;0.8063299963962409;[UNC93B1, NR1H4, TLR8, TLR7, PIK3C3, MYD88, HAVCR2]
GO:0033077;T cell differentiation in thymus;7.0;0.8653626801206646;0.7836007053175329;9.420884887713877;66.99450330244977;6.481236761676141;0.002242245734394454;0.6823701146576509;[BCL11B, FZD5, PRKDC, FZD8, MAFB, DNAJA3, BCL2, CCR6]
GO:1904646;cellular response to amyloid-beta;7.0;1.0;0.8509193652572005;9.628524252492122;273.93391051768003;6.518977089658987;0.009168321460513012;0.6843001567857983;[LRP1, FPR2, ADRB2, IGF1, GRM5, CD36, TLR6, FCGR2B, TLR4]
GO:0051310;metaphase plate congression;6.0;0.8436909121759173;0.7449657686781032;9.34084218004034;45.439948165668724;5.948432231191374;0.0015208341718066008;0.6273234135236593;[SEH1L, CDCA5, VPS4B, KIF14, CDCA8, CCNB1, NUP62, FAM83D, MLH1, GEM, NDC80, CENPE, CENPF, KIF18A, PSRC1, KIFC1, KIF2C]
GO:0097755;positive regulation of blood vessel diameter;7.0;0.7508913569872202;0.7263650437508107;9.0689084645567;39.67967046252893;5.845247994956144;0.0013280428609958766;0.6498456195510879;[DOCK5, CALCA, DOCK4, GPX1, GCH1, PTAFR, ADM, ADRB2, SOD2, ADCYAP1, SCPEP1, EDNRB, HMOX1, F2RL1, PTGDR]
GO:0034158;toll-like receptor 8 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;9.777073627680469;0.013811191226989502;0.9481203125901445;[TLR8]
GO:0036336;dendritic cell migration;6.0;0.8436909121759173;0.7449657686781032;9.405380701177911;29.137022145890857;6.7325511899570465;9.751899096054872E-4;0.6674232935401965;[CCR1, CCL21, CXCR4, EPS8, NLRP12, CXCR1, CCL5, CXCR2, CCR7, CCR6, CCL19, CCR5, CCR2]
GO:0051798;positive regulation of hair follicle development;6.0;0.8259837884571596;0.7361122068187242;9.377209824211215;137.70877785042182;7.292166977892469;0.004608988864799761;0.6960420709600095;[TGFB2, HPSE, TNF]
GO:0051315;attachment of mitotic spindle microtubules to kinetochore;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;27.921945865447032;7.379178354882098;9.345223999966889E-4;0.6273715242355574;[CENPE, CDT1, SEH1L, MIS12, NUF2, KIF2C, NDC80, MAD1L1]
GO:0021915;neural tube development;5.0;1.0;0.7902410118609202;9.628524252492122;33.009488292418915;6.409777797693995;0.0011047978665365144;0.618037346520142;[STIL, TGFB1, NUP133, TCF7, GRHL2]
GO:0055096;low-density lipoprotein particle mediated signaling;6.0;1.0;0.8231203125901445;9.628524252492122;23.86341744358871;8.67846133901236;7.986871061555342E-4;0.7669372290569613;[CD36]
GO:0038110;interleukin-2-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.379178354882098;0.00101047745553359;0.728290889492758;[SYK, IL2RB, IL2RG, JAK3]
GO:2000042;negative regulation of double-strand break repair via homologous recombination;10.0;0.9326813400603323;0.8815816818910864;9.597752593825367;1180.5845594884313;7.292166977892469;0.039513102748954816;0.7881627702307852;[POLQ]
GO:1900454;positive regulation of long term synaptic depression;9.0;1.0;0.896240625180289;9.628524252492122;54.16329535062315;8.16763571524637;0.0018127967515842568;0.8139338954918922;[LILRB2]
GO:0006520;cellular amino acid metabolic process;6.0;0.406884124246779;0.526562374713534;6.526182243879872;77.81072980309767;4.002522082136061;0.0026042551013992716;0.5278094780068945;[CPOX, HNMT, MCCC2, KMO, UPB1, ASRGL1, MTHFD1, PADI4, GMPS, SLC1A3, GLYAT, ACMSD, ACAT1, AGXT2, SLC6A6, HAL, ALDH6A1, BHMT, P4HA2, NOX4, ALDH18A1, SERINC5, HIBADH, DPYS, PFAS, GHR, HNF4A, KYNU, HIBCH, ARG1, BHMT2, CAD, PRODH2, SLC7A5, SLC7A7, SLC7A8, TST, DPYD, BCAT1, GART, ASPA, SLC3A1, SLC25A21, AGMAT]
GO:0060687;regulation of branching involved in prostate gland morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;105.64673904754125;7.8311634786251565;0.003535901280028912;0.7236063770733796;[RXRA]
GO:0030866;cortical actin cytoskeleton organization;6.0;0.7671156992804218;0.7066781622303554;9.117698628726131;53.946853691669205;6.088194173566533;0.0018055526440439148;0.63447084575632;[PLEK, TNF, RACGAP1, EPB41L3, NCKAP1L, PLS1, KIF23, VIL1, ANLN, TLN1, LLGL2]
GO:0050872;white fat cell differentiation;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.75937296335754;7.292166977892469;7.282666309192915E-4;0.6631627702307852;[CEBPA, PRDM16, SIRT1]
GO:0050873;brown fat cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;6.444869117505266;7.282666309192915E-4;0.6198319182472036;[CEBPA, CEBPB, LAMB3, ADRB2, PTGS2, ALDH6A1, LRG1, PRDM16]
GO:0050870;positive regulation of T cell activation;8.0;0.6260725219892441;0.688036260994622;8.781226392104918;216.0655637178415;4.493869898942481;0.007231519971253338;0.6048167156182404;[CD86, CD83, TFRC, CD80, SIRPG, IHH, PYCARD, LGALS1, GRAP2, MYB, AKT1, TNFSF11, SIRPA, MAP3K8, IL6R, ICOSLG, HLA-G, HLA-E, IL23A, PRKCQ, ADAM8, CARD11, CD274, BLM, HHLA2, EBI3, GATA3, CD1D, THY1, CORO1A, PRKCZ, RASGRP1, DPP4, KLRK1, BTLA, NLRP3, NCKAP1L, ICOS, LYN, TGFB1, EGR3, VCAM1, TNFSF14, CAV1, IGF1, IL6, VNN1, PTPRC, BCL6, CD28, CD27, CD24, IL7R, NFKBID, CD3E, SIRPB1, TNFSF13B, DUSP10, CTLA4, CCR7, JAK3, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, RIPK2, IL15, IL18, PDCD1LG2, VAV1, ZAP70, IFNG, LCK, IL1B, RARA, XCL1, NOD2, AIF1, HSPD1, PAK1, HLA-DMB, HLX, CCL5, CCL2, FYN, CSK, CCL19, IL12RB1, CD74, CCL21, LILRB1, LILRB2, LILRB4, CD4, CD40LG, CD6, CD5, DNAJA3, HLA-DPB1, PTPN6]
GO:0050871;positive regulation of B cell activation;8.0;0.7436939687323844;0.7468469843661922;9.117698628726131;160.32529438548238;4.695669262696007;0.00536594331968482;0.6151367444652258;[, IGHM, CDKN1A, CD40, TFRC, TNFSF13B, IGHG1, TRBC1, CD38, MEF2C, SYK, FCRL3, ATP11C, MIF, MSH6, MSH2, BTK, IGHD, CARD11, NOD2, UNG, IGKC, INPP5D, TBX21, NCKAP1L, IGHA1, CD74, TGFB1, TNFSF13, MLH1, BST1, IL6, PTPRC, BCL6, CD28, BCL2, CD27, CD320]
GO:0051969;regulation of transmission of nerve impulse;6.0;0.811012628672052;0.7286266269261705;9.34084218004034;42.49049401117059;7.004484905440688;0.0014221185955919531;0.6813299963962409;[GHSR, CHRNB4, GPR35, FMR1, TNR, AVPR1A, TYMP]
GO:0072425;signal transduction involved in G2 DNA damage checkpoint;9.0;0.9326813400603323;0.8625812952104552;9.590783924509275;196.6208089386036;7.292166977892469;0.006580721527935406;0.769162383550154;[CHEK1, PLK1, BRCA1, DTL]
GO:0016572;histone phosphorylation;8.0;0.7090535922965819;0.729526796148291;9.195660170195843;367.80445225036385;6.444869117505266;0.012310084014303157;0.7045909063862833;[PRKCB, PRKCD, VRK1, AURKB, AURKA, CCNA2, CCNB1, CHEK1, CDK2, CDK1, PKN1]
GO:0031953;negative regulation of protein autophosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;780.3281191277907;7.379178354882098;0.026116879897493853;0.7926125360964777;[NLRP12, JUN, CAV1, ENG]
GO:0051964;negative regulation of synapse assembly;7.0;0.8259837884571596;0.7639112594857803;9.437469015729413;219.30269939314178;7.9853141584524145;0.007339863989072673;0.7592887026755414;[ROBO2, PTK2, TLR2]
GO:1901796;regulation of signal transduction by p53 class mediator;7.0;0.7192862368539868;0.710562483684194;9.117698628726131;45.070113835906206;4.948759890378168;0.001508456149618737;0.6039991761920099;[CHEK1, AKT1, MIF, SIRT1, TAF9, TWIST1, AURKB, AURKA, TP53BP2, CD74, MAPK14, POU4F1, PML, TPX2, JMY, CDK2, SNAI2, TAF5]
GO:0002175;protein localization to paranode region of axon;5.0;1.0;0.7902410118609202;9.628524252492122;40.92839637806193;8.390779266560578;0.0013698365936084043;0.7193458537639684;[EPB41L3]
GO:1903974;positive regulation of cellular response to macrophage colony-stimulating factor stimulus;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;111.61630484940933;8.67846133901236;0.0037356972751570123;0.7947362817240173;[TLR4, TLR2]
GO:1900227;positive regulation of NLRP3 inflammasome complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;140.3817219977405;7.9853141584524145;0.004698449899916962;0.7592887026755414;[CD36, TLR6, TLR4]
GO:0030855;epithelial cell differentiation;4.0;0.5489353771682173;0.5244676885841086;6.961296045910167;21.066225782797595;4.034070439870987;7.050676185779127E-4;0.45630254989846264;[EHF, LGALS3, BASP1, AKT1, HOXA5, SOX4, MEN1, MED1, MEF2C, HNF1B, EREG, COL4A1, ADAM9, HOXB5, EPHA2, GATA3, PSAP, FZD1, ST14, JUN, TGFB1, JAG1, FZD2, VIL1, FA2H, BMP2, DAB2, CDK1, CD24, TGFB1I1, SLC7A11, TMEM100, HHEX, LBH, CD34, CTSB, DSP, ANXA1, PAX2, GREM1, ELF3, TST, RARA, FAM20C, YAP1, TAGLN, CEBPB, CSTA, HDAC2, PCNA, LEF1, RXRA, E2F7, E2F8, CDX2, KLF4, USH2A, GRHL2]
GO:0045063;T-helper 1 cell differentiation;11.0;1.0;0.9324289523296623;9.628524252492122;473.70362526189734;8.16763571524637;0.01585443403193107;0.8501222226412654;[SEMA4A, LEF1, IL18R1, RELB]
GO:0051973;positive regulation of telomerase activity;9.0;0.9326813400603323;0.8625812952104552;9.600353375525426;952.4250073221435;6.193554689224359;0.031876807868214944;0.7129793000169707;[AURKB, NEK2, CCT4, CCT2, NEK7, KLF4, GRHL2, GREM1, PRKCQ]
GO:0071320;cellular response to cAMP;7.0;1.0;0.8509193652572005;9.628524252492122;327.37290077043656;5.825829909099042;0.01095687637230394;0.6488525777373224;[IGFBP5, PTAFR, AQP9, SLC8A1, AQP1, KCNQ1, NOX4, SLC26A3, CFTR]
GO:2000045;regulation of G1/S transition of mitotic cell cycle;8.0;0.7436939687323844;0.7468469843661922;9.040737587590003;58.63952701093024;4.821246570079209;0.0019626121969077833;0.6215587738047448;[AKT1, SOX4, CDC25C, PRKDC, CCNB1, NACC2, SFN, PLK2, CDC6, CDK6, CNOT3, CDK2, CDK1, BCL2, EZH2, CDKN1A, BTG2, KIF14, CASP2, ANXA1, TFDP1, PLCB1, PCNA, KCNA5, AIF1, AURKA, CDC45, GPNMB, E2F1, CCL2, E2F7, E2F8, CDKN2C, RPA2, KLF4, PML, PTPN6]
GO:0016321;female meiosis chromosome segregation;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;64.47658740127405;8.390779266560578;0.0021579733551592936;0.7193458537639684;[PLK1, TTK, MLH1]
GO:0030851;granulocyte differentiation;6.0;0.8653626801206646;0.7558016526504768;9.310070521373587;47.07409398820286;7.069023426578259;0.0015755275618510598;0.6846304993685643;[CEBPA, CSF3, SPI1, CEBPE, TAL1, LEF1, CBFA2T3, GATA1]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[PLEKHF1, F11R, TNF, CDH1, FCER1G, GOLPH3L, TTC7B, EMP2, ATP1B1, ANK1, RAB31, PKP3, TSPAN33, PRKCZ, EPB41L3, FLNA, TSPAN5, JUP, KCNIP4, TSPAN15, EHD3, RAMP1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, MED1, CDCA3, PRKDC, NEDD4L, BARD1, HACE1, PLK1, SIRT1, RNF130, RNF43, CISH, FBXW2, CUL5, UBR1, SOCS2, FANCL, MARCH3, MARCH1, BCL2, ARRB1, ARRB2, BIRC5, DTL, BIRC2, BIRC3, UHRF1, NLRC4, ZNRF1, RNF24, CCNF, CDC20, HERC5, TRIM25, SKP2, CDC34, NAIP, BRCA1, BMI1, RNF144A, RNF144B, PDZRN3, PCNA, PCNP, NEDD4, KLHL14, DTX3, UBE2C, UBE2S, UBE2T, UBE2M, TNFAIP3, UBE2Q2, HIST1H2BK, RNF6]
GO:0035067;negative regulation of histone acetylation;11.0;0.811012628672052;0.8379352666656883;9.498471124243924;1304.334881216342;6.943860283624253;0.04365491464912905;0.7875382901567328;[SPI1, TWIST1, BRCA1, SIRT1, SNCA]
GO:0036151;phosphatidylcholine acyl-chain remodeling;8.0;1.0;0.875;9.628524252492122;185.56639978848355;6.481236761676141;0.0062107404020032226;0.7064507494004503;[PNPLA8, LPCAT2, MBOAT2, PLBD1]
GO:0036152;phosphatidylethanolamine acyl-chain remodeling;8.0;1.0;0.875;9.628524252492122;185.56639978848355;6.518977089658987;0.0062107404020032226;0.7083807915285978;[RARRES3, PNPLA8, MBOAT2, PLBD1]
GO:1902895;positive regulation of pri-miRNA transcription by RNA polymerase II;12.0;1.0;0.9481203125901445;9.628524252492122;1721.2385553242598;6.599019797332524;0.0576083054325737;0.7855944919115336;[JUN, TGFB2, BMP2, TGFB1, KLF5, SPI1, PRL, FOS]
GO:1903507;negative regulation of nucleic acid-templated transcription;9.0;0.5547065974044363;0.6735939238825073;8.375761283996754;898.5514994986271;2.646975117554892;0.030073710044371104;0.5316070557889775;[SPI1, EHMT2, SLA2, PHB2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, FZD1, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, HELLS, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, ZEB1, TAL1, RARA, HCLS1, PLCB1, NR1I2, ASCL2, BTAF1, FLNA, CASP8AP2, STAT1, NR1H2, NR1H4, POU4F1, CENPF, FOSB, LGR4, GMNN, TNF, DACH1, RUVBL2, MEN1, TLE4, DNMT1, AEBP1, FOXO1, SBNO2, NACC2, ZNF423, WFS1, NFKB1, NFKB2, DAB2, BCL6, BCL3, CDK2, CIITA, FHL2, FASLG, FOXM1, HHEX, EMILIN1, RFC1, PEG3, XCL1, BIRC5, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, E2F8, PRRX1, KLF4, PML, KLF8, KLF5, DNAJA3, GFI1, IKZF1, UXT, ZNF608, EDNRB, DPF3, SOX7, SOX4, HNF1B, RUNX2, EREG, NIF3L1, SFRP2, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H2, SUV39H1, IFNA2, PTPRK, BRCA1, BMI1, XPO1, CD38, CD36, HBZ, EDN1, PARP9, CBFA2T3, MDFIC, IL1B, TFEC, DEPDC1, YAP1, SP100, SATB2, RELB, PURA, RXRA, APBB1, CDX2, LILRB4, NEDD4, ARID4A, LOXL2, CHCHD3, BASP1, EOMES, CCNE1, TIMELESS, CALCA, TCF7, TGFB1, CBX4, VDR, CAV1, HMGA1, NR4A2, BMP2, NR4A3, FEV, UBA3, MXD1, CREBZF, HMGB2, MYOCD, KLF12, H2AFX, GREM1, IFNG, ELF3, IRF7, IRF8, ZMYND11, FBP1, PFDN5, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0006978;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;8.0;1.0;0.875;9.628524252492122;145.46952913610525;7.004484905440688;0.004868734226108882;0.7332096838060964;[CDKN1A, SP100, BRCA1, BRCA2, FOXM1]
GO:0051984;positive regulation of chromosome segregation;5.0;0.6634067003016617;0.6219443620117511;8.39638057119949;42.06625563378019;6.444869117505266;0.0014079197188904481;0.6198319182472036;[CDT1, FEN1, CDC6, CCNB1, ESPL1, RAD21, DLGAP5]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[CDKN1A, BTG2, PCNA, AURKA, CCNB1, E2F1, CASP2, SFN, E2F7, SOX4, E2F8, PLK2, CDC25C, PML, TFDP1, CNOT3, CDK2, CDK1]
GO:0045078;positive regulation of interferon-gamma biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.212124270218933;0.027942676825076673;0.7438283705770736;[EBI3, TLR8, TLR7]
GO:0031938;regulation of chromatin silencing at telomere;11.0;0.8933024483968273;0.8790801765280758;9.551563211355994;304.6981139023377;9.083926447120524;0.010197971661811984;0.8969813732811862;[CDC45]
GO:0031936;negative regulation of chromatin silencing;11.0;0.811012628672052;0.8379352666656883;9.513011365370277;1837.452882547463;7.57984905034425;0.06149789437863012;0.8200627852632958;[ATAD2, HMGA1]
GO:0045077;negative regulation of interferon-gamma biosynthetic process;8.0;1.0;0.875;9.628524252492122;836.0204953067102;8.390779266560578;0.027980853608317785;0.8041048419030481;[LILRB1, INHBA]
GO:0071353;cellular response to interleukin-4;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;6.599019797332524;0.0027327542132076126;0.6605944919115335;[ARG1, LEF1, TCF7, GATA3, CORO1A, PML, ALAD, IMPDH2, XCL1, MCM2]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, ZFAND6, RORA, BRCA1, ICAM1, PYCARD, TCL1A, AKT1, EDN1, POSTN, CHUK, SIRT1, XCL2, CHI3L1, XCL1, CCL13, CEBPA, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, VCAM1, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0016310;phosphorylation;5.0;0.5310727365277519;0.5557773801247963;6.876988939450173;24.405590426795786;2.7321685105510984;8.168331479794688E-4;0.42996423654933263;[, SLA2, ENO2, MYLK, AKT1, PRKACB, MEF2A, MED1, MEF2C, PRKCH, DAPK1, PRKCB, PRKCE, PRKCD, PRKAR1B, UQCRC1, PRKCQ, UQCRC2, PRKDC, PDGFA, THY1, IQGAP3, PRKCZ, PIP5K1B, ICOS, LYN, PLK4, PLK2, PLK1, EIF2AK2, CDC7, CDK14, ITK, IMPA1, IMPA2, PBK, TK1, JAK3, RIPK2, DUSP6, CIT, RARA, HBEGF, SGMS1, NRAS, IL12RB2, GTF2H1, PKN1, CCNT2, IL5RA, SLA, TNF, FGF5, EFEMP1, GRAP2, MAP3K8, NEK2, STK32B, KCNH1, MEN1, KCNH2, MAP2K2, CISH, IGFBP3, VRK1, DGKZ, NRBP1, MELK, MSH2, BLK, CSF1R, PFKFB4, UQCRB, RASAL2, PKMYT1, UQCRH, SOCS2, MAP2K6, NEK7, BMX, NFKB1, CDK6, CDK2, CDK1, BCL2, LAT, CIITA, LRRK2, PIK3CD, PIK3C2A, TLK1, CHUK, BPGM, SPTB, LCK, IL3RA, BIRC5, PIK3C3, TTK, NOD2, IL2RG, CCL8, CCL5, CCL2, FYN, CSK, TIE1, PML, RAD50, IL2RB, PTPN6, PANK3, CCNH, CCNC, CHEK1, RPS6KA1, TNFSF11, EPHB2, EPHB1, PAQR3, EREG, BTC, BTK, SIK1, ALPK2, TRIB1, EPHA3, EPHA2, TXK, ATP5J, PIK3R3, ATP5I, ATP5H, ATP5O, ATP5L, PIK3R5, CD19, LIF, IGF1, PTK2, CD28, ALDH18A1, CTSH, CTSG, CCR5, SPTAN1, MAP4K1, SYK, IL15, STRADB, GAB1, IL18, GFRA3, VAV1, NME1, HCK, IL1B, KIT, FAM20C, TLR7, SGK1, TLR4, TLR2, GUCY2C, DTYMK, COX5B, PAK1, PRKY, KITLG, CAMK4, CAMK1, CD86, CD80, BUB1B, PDGFRB, PDGFRA, TTC7B, MATK, ATP5J2, CCNE1, CSF2RB, CSF2RA, RASGRP1, RASGRP4, SPTA1, CCNB1, CYC1, CLSPN, TGFB2, TGFB1, EIF2S1, CLK4, CLK1, BMP2, FES, GHR, HK3, CAD, IRAK3, MASTL, DCK, TGFBR3, FGR, CCNA2, ZAP70, SHANK3, CAMK2D, AURKB, AURKA, NCAM1, BUB1, TRAT1, EGF, MAPK14, MAPK13, WEE1, PIKFYVE, RPS6KB1, TEK]
GO:0051987;positive regulation of attachment of spindle microtubules to kinetochore;7.0;0.8653626801206646;0.7836007053175329;9.485423408851448;141.20478198009135;8.16763571524637;0.004725996976820352;0.7686126355688037;[CCNB1]
GO:0036149;phosphatidylinositol acyl-chain remodeling;8.0;1.0;0.875;9.628524252492122;149.40095957869912;6.943860283624253;0.005000315664964811;0.7301093378270707;[MBOAT7, PLBD1]
GO:0051988;regulation of attachment of spindle microtubules to kinetochore;6.0;0.7763722522362496;0.7113064387082693;9.271849308553389;31.575448191934637;7.212124270218933;0.0010568018349256063;0.6919486831672181;[CCNB1, RACGAP1, SPAG5, NEK2, ECT2]
GO:0045071;negative regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.23964546052278;5.8067817141283475;0.0028528942228632634;0.6719590869034888;[IFITM1, IFIT1, TNF, OASL, CCL5, RSAD2, EIF2AK2, ISG15, PLSCR1, SLPI, OAS1, OAS3, APOBEC3A, LTF]
GO:0016554;cytidine to uridine editing;9.0;1.0;0.896240625180289;9.628524252492122;133.9430579393504;7.292166977892469;0.0044829536083040925;0.769162383550154;[RBM47, APOBEC3A, APOBEC3B]
GO:0140052;cellular response to oxidised low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;8.16763571524637;0.0018993574991869968;0.7408135829017477;[CD36, TLR6, TLR4, MYD88]
GO:0019805;quinolinate biosynthetic process;8.0;1.0;0.875;9.628524252492122;691.6482702327052;8.67846133901236;0.023148845161657855;0.8188169164668168;[KYNU, KMO]
GO:0006750;glutathione biosynthetic process;8.0;1.0;0.875;9.628524252492122;528.5812657394678;7.069023426578259;0.017691139272045377;0.7365101867784198;[CHAC2]
GO:1904845;cellular response to L-glutamine;7.0;1.0;0.8509193652572005;9.628524252492122;543.0623632319648;8.67846133901236;0.01817580857297763;0.7947362817240173;[CYBB]
GO:0006751;glutathione catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;452.007296405459;7.379178354882098;0.015128277430534352;0.728290889492758;[CHAC2]
GO:1900006;positive regulation of dendrite development;10.0;0.8653626801206646;0.8479223519212526;9.59462270081644;582.4293208864839;5.557565922504363;0.01949338521771267;0.6994551915910392;[CYFIP1, NLGN1, FMR1, RAB21, CAMK1, SHANK3, EZH2]
GO:0006513;protein monoubiquitination;10.0;0.8653626801206646;0.8479223519212526;9.574457031221845;155.4032479663248;5.649939242635378;0.005201206855589802;0.704179167478338;[UHRF1, NEDD4L, BMI1, TRIM25, FANCL, UBE2T, DTL]
GO:0061304;retinal blood vessel morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;25.965694757875163;8.16763571524637;8.690484359379531E-4;0.7079342821725234;[COL4A1, CYP1B1]
GO:1902426;deactivation of mitotic spindle assembly checkpoint;13.0;1.0;0.9625549647676366;9.628524252492122;1950.7008717452545;9.777073627680469;0.0652882026605069;0.9625549647676366;[CDT1]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[, CCNF, CDC20, PSMD3, TRIM25, SKP2, CDC34, NEDD4L, HACE1, PLK1, TGFB1I1, KIF14, SIRT1, PSMA5, PSMA6, RNF144B, PSMA3, PSMA4, PSMA2, PCNP, USP1, RANBP2, RANBP1, USP9Y, PSMC6, NEDD4, PSMC2, MAD2L1, BUB1B, PTTG1, RNF43, PSMD14, CUL5, UBR1, CCNB1, WFS1, UBE2C, UBE2S, CDK1, ARRB1, ARRB2, DTL, BIRC2, UHRF1, VPS4B, RNF6, USP18, AURKB, AURKA, ZNRF1, TBX21, RNF24, PML]
GO:0050663;cytokine secretion;9.0;0.6056485694559711;0.6990649099082746;8.227631091951078;133.331941423656;5.9928839937622085;0.004462500088492957;0.7027169913188946;[NLRC4, GATA3, NOD2, NLRP3, S100A12, CCR7, ITGB6, CD36, CCL19, LYN, ABCA1, NR1H4, LILRB1, CHI3L1, F2RL1, LCP2, TLR6, TLR4, CARD11, TLR2]
GO:0045086;positive regulation of interleukin-2 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.292166977892469;0.027942676825076673;0.747921758369865;[CD86, IL1A, CD4, CD80, IL1B, CD28, PRKCQ, CD3E, CARD11]
GO:0045084;positive regulation of interleukin-12 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;8.16763571524637;0.027942676825076673;0.7926932703116032;[LTB, TLR4]
GO:0030837;negative regulation of actin filament polymerization;11.0;0.8436909121759173;0.8542744084176208;9.536150932361107;433.7598075732239;5.8067817141283475;0.014517550400993206;0.7293880392331511;[LMOD1, CAPG, EPS8, SPTA1, SPTAN1, TMOD1, GSN, PRKCD, SPTB, VIL1, PFN1]
GO:0045089;positive regulation of innate immune response;7.0;0.5408746917014966;0.6213567111079488;7.77894521237524;173.7808589209889;4.201124524534153;0.005816288955466338;0.5657650688141469;[FCN1, CLEC10A, ICAM2, ICAM3, PYCARD, IL18RAP, DHX58, PGLYRP1, PRKACB, MED1, LAG3, RSAD2, PRKCE, CD180, PRKCD, MUC3B, EREG, HLA-E, CLEC4A, CLEC4D, BTK, ADAM8, CLEC4E, S100A9, S100A8, CARD11, PRKDC, TXK, LY96, CD1D, DDX60, RASGRP1, KLRK1, CLEC7A, PLCG2, S100A14, CD14, CD300LF, MAP2K6, LYN, CAV1, SH2D1A, CRTAM, NFKB1, NFKBIA, MARCO, MYD88, ITGAM, ITGB2, HMGB2, TNFAIP3, PTPN22, CTSS, IFIH1, MUC13, FFAR2, MUC15, CD36, HAVCR2, FCER1G, CHUK, SYK, DDX58, RIPK2, MMP2, IRAK3, PARP9, VAV1, MMP12, TLR1, HCK, PLSCR1, IRF7, TLR8, TLR10, TLR7, PIK3C3, TLR6, TLR5, TLR4, LTF, TLR2, COLEC12, UNC93B1, NLRC4, NOD2, LILRA2, HSPD1, RELB, PAK1, NRAS, CCL5, FYN, CARD9, NR1H4, TNIP3, F2RL1]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, PGLYRP1, RNASE6, RNASE3, MIF, HLA-E, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, PRKDC, TXK, CFI, GATA3, CD1D, CFP, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, SIGLEC16, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, EIF2AK2, PTK2, MARCO, VNN1, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, RIPK2, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, LILRA5, RELB, IGKC, CARD9, NR1H4, KIR3DL1, F2RL1, LGR4, C1QC, FCN1, NCF1, NCF2, SLA, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, MATK, CYBB, CLEC4A, CLEC4D, TYROBP, CLEC4E, S100A9, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, PIK3CD, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[PPP2R1A, NEK2, TUBG1, CKAP5, PRKAR2B, CEP72, CEP76, PLK4, CEP152, PLK1, CDK1]
GO:0070495;negative regulation of thrombin-activated receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;238.42697029648212;8.67846133901236;0.007979936125481077;0.8188169164668168;[STMN1, SNCA]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[, PSMD3, PRSS3, UQCRC1, PRKCQ, UQCRC2, CFB, CFD, ENPEP, CFI, NEDD4L, GATA3, ADAMTS12, CFP, C2, C3, ELANE, BARD1, ST14, ACE, HACE1, PLK1, AZU1, TGFB1I1, IFIH1, MMP28, OLR1, RIPK2, ACTL6A, SIRT1, F3, MMP12, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, MMP19, FAM105A, ADAM28, USP1, USP9Y, F11, PSMC6, PSMC2, APEH, IGHG1, RUVBL1, RNF43, FBXW2, CDC25A, ADAM2, ADAM9, ADAM8, ADAM7, CUL5, AEBP1, UBR1, TMEM27, IGLV1-44, CLCA4, WFS1, DHCR24, NFKB1, COPS5, CDK1, ARRB1, ARRB2, SCPEP1, ADAMTS1, ADAMTS20, ASPH, ESPL1, MEP1A, PIK3C3, DTL, BIRC2, BIRC3, C1S, C1R, UHRF1, HM13, VPS4B, FGL2, ZNRF1, RNF24, GZMA, GZMB, PML, GZMH, GZMK, GZMM, EIF3F, CCNF, CDC20, ANPEP, TRIM25, SKP2, ASRGL1, CDC34, CFTR, CTSZ, KIF14, CTSW, BRCA1, PCSK6, PCSK5, CTSS, CTSH, CTSG, CTSD, CTSB, MME, RNF144B, C1QB, C1QA, CD5L, TMPRSS2, PCNP, IGKC, PERP, RANBP2, RANBP1, IL33, GCA, FAP, NEDD4, MAD2L1, C1QC, FCN1, IHH, BUB1B, PTTG1, PLAU, PCOLCE, ADAM12, PRTN3, PSMD14, PSEN2, HTRA1, ADRB2, TRHDE, DPP4, CCNB1, NLRP3, CLSPN, TGFB1, UBE2C, GGH, ISG15, NFKBIA, UBE2S, UBA3, IGKV3-20, TNFAIP3, CASP2, MMP1, DDX58, MMP2, MMP8, MMP9, CCNA2, LTF, RNF6, USP18, AURKB, AURKA, TBX21, NRIP3, TNIP3, CPVL, RBMX]
GO:0030838;positive regulation of actin filament polymerization;11.0;0.7866048967936545;0.8257314007264895;9.456673995565463;459.92540939869633;5.2552850506314295;0.01539328954657896;0.7011844742147011;[CYFIP1, CSF3, LMOD1, ICAM1, PYCARD, CCR7, PRKCE, HCK, PFN1, NCKAP1L, VASP, GSN, CCL21, VIL1, JMY]
GO:0045088;regulation of innate immune response;6.0;0.4673148936341128;0.556777759407201;6.780712109014753;42.469229973879315;3.8881956693475885;0.0014214069074002054;0.52196281994017;[CLEC10A, GFI1, ICAM2, ICAM3, DHX58, PGLYRP1, PRKACB, MED1, RSAD2, PRKCE, PRKCD, EREG, HLA-E, BTK, SERPING1, PRKDC, TXK, CD1D, KLRK1, PLCG2, S100A14, CD14, A2M, LYN, SH2D1A, MARCO, CTSS, IFIH1, MUC13, FFAR2, MUC15, CD36, HAVCR2, FCER1G, SYK, ARG1, IFNGR1, RIPK2, FCRL3, IFNGR2, SERPINB9, PARP9, VAV1, MMP12, TLR1, NCR1, HCK, CEACAM1, PLSCR1, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, LILRA2, RELB, PAK1, NRAS, STAT1, NR1H2, CARD9, NR1H4, LILRB1, F2RL1, LGR4, FCN1, PYCARD, IL18RAP, CD96, LAG3, CD180, MUC3B, CLEC4A, CLEC4D, ADAM8, CLEC4E, S100A9, S100A8, CARD11, LY96, DDX60, RASGRP1, CLEC7A, CD300LF, MAP2K6, CAV1, CRTAM, NFKB1, NFKBIA, MYD88, ITGAM, ITGB2, HMGB2, TNFAIP3, PTPN22, ARRB2, DUSP10, CR1, CHUK, DDX58, MMP2, IRAK3, FGR, IFNG, IRF7, PIK3C3, BIRC2, LTF, BIRC3, COLEC12, UNC93B1, CLEC12B, NLRC3, NLRC4, NOD2, SAMHD1, USP18, HSPD1, CCL5, FYN, TNIP3, PTPN6, FCGR2B]
GO:0070498;interleukin-1-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.845247994956144;0.00101047745553359;0.6498456195510879;[IL1RN, NOD2, MAP3K8, EGR1, CHUK, IL1R1, RIPK2, IL1R2, IRAK3, NFKB1, NFKBIA, IL1A, IL1B, PLCB1, MYD88]
GO:0071345;cellular response to cytokine stimulus;5.0;0.6729672293956388;0.6267246265587396;8.214830917184116;61.59823360834823;3.805811787890007;0.0020616374440603005;0.48487040368196277;[PID1, TFRC, IFIT1, IFIT3, IFIT2, ICAM1, TCL1A, AKT1, TNFSF11, TRIM25, DAPK1, CDC34, BTK, PADI2, STXBP2, GATA3, ADAMTS12, ST3GAL6, EGR1, COL1A1, CD40, BRCA1, CCR7, HLA-DPA1, EDN1, MME, ARG1, SIRT1, HCLS1, TLR4, TLR2, CCL13, SELPLG, CXCR4, AIF1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, STAT1, LAPTM5, POU4F1, NLRP12, ZYX, IL18R1, IL17A, CSF3, ZFAND6, RORA, PYCARD, TLE4, POSTN, PCOLCE, KMO, KIF16B, CSF1R, CALCA, TCF7, CSF2RB, CORO1A, SBNO2, VCAM1, NFKB1, BSPRY, ALAD, MYBL2, CHUK, ITGA4, IL3RA, XCL2, CHI3L1, XCL1, IRF8, MCM2, CEBPA, CEBPB, LEF1, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, MAPK14, KLF4, PML, MAPK13, CD4, KLF5, RPS6KB1, IMPDH2, PTPN6, PTPN7, PTPN4, RBMX]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[HLA-DPA1, EDN1, DAPK1, KIF16B, XCL2, XCL1, IRF8, TLR4, TLR2, CCL13, STXBP2, AIF1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, STAT1, RPS6KB1, ZYX]
GO:0051754;meiotic sister chromatid cohesion, centromeric;7.0;1.0;0.8509193652572005;9.628524252492122;116.99733732322595;8.16763571524637;0.003915795589440837;0.7686126355688037;[PPP2R1A, BUB1B, BUB1]
GO:0050665;hydrogen peroxide biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;211.45566258744057;7.697632086000634;0.0070772307290604825;0.7167775754447168;[CYBB]
GO:0045080;positive regulation of chemokine biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.597752593825367;840.1940438043877;7.697632086000634;0.02812053852058526;0.7686572628545723;[EGR1, IL1B, HMOX1, AZU1, TNF]
GO:0043504;mitochondrial DNA repair;8.0;1.0;0.875;9.628524252492122;333.4790539518545;8.67846133901236;0.011161243824104912;0.8188169164668168;[DNA2]
GO:0043988;histone H3-S28 phosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;711.4828594708514;8.67846133901236;0.023812691013487215;0.8762458687964789;[AURKB]
GO:0043507;positive regulation of JUN kinase activity;13.0;0.8653626801206646;0.8952363048279688;9.582714716460828;4931.413721535565;5.459585514144159;0.16504997927558432;0.7417584218576596;[IL1RN, TNF, TNFSF11, MAP4K1, EDN1, SYK, RIPK2, MDFIC, IL1B, TLR6, TNFRSF11A, PAK1, CCL19, FZD5, FZD8, CD40LG, PKN1]
GO:1902036;regulation of hematopoietic stem cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;97.61516402498306;6.558197802812269;0.003267091691972132;0.6863059058804069;[YAP1, LMO2, EIF2AK2, GATA3, GATA1, TAL1, MYB]
GO:1902275;regulation of chromatin organization;7.0;0.5120792324551303;0.6069589814847657;7.270369308343265;21.750886949199476;4.641275190630208;7.279826116623381E-4;0.5882743943473984;[SPI1, FMR1, GFI1, MKI67, RUVBL2, CHEK1, MYB, PADI2, DNMT1, TWIST1, GATA3, CCNB1, TGFB1, HMGA1, LIF, BCL6, LRRK2, ARRB1, BRCA1, TLK1, MYOCD, PAX5, SIRT1, TAL1, IL1B, CAMK2D, UHRF1, CDC45, SNCA, ATAD2]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, WLS, ZFYVE16, GATA3, LYN, ABCA1, COL1A1, SRP9, MMP12, CENPF, SNX17, GOPC, NCF1, CSE1L, AP2M1, ADCYAP1, ACAP1, SLC27A2, LIN7A, EVI5, ARRB1, ARRB2, TNFSF13B, ITGB6, ARL4C, LCP2, LRP1, LRP2, SEC63, GOLPH3L, HNF1B, ACTN4, KIF20A, MSR1, EGR2, POLA2, TF, CD24, CD3G, PCSK5, AKAP12, CCR7, CD36, SYK, NAPA, HSD17B4, STX11, CD74, NEDD4, FKBP1B, RAMP1, SCARB2, ZFAND6, CARD11, ECT2, NUP155, NASP, PLEK, NUP62, YWHAH, NUP133, TBC1D8, TBC1D9, CHI3L1, NUP54, MX2, NUP35, RAN, PHB2, AP1S2, HOMER3, CUBN, PRKCB, NUP85, S100A12, NUP88, EHD3, DENND1B, ANXA1, EXOC1, CCL19, NR1H4, TNF, CLU, LAMP2, TAP1, RAB32, RAB31, CALCRL, SLC15A3, DAB2, BCL6, BCL3, CCDC22, PLEKHF2, TLK1, NLGN1, UNC93B1, VPS4B, NLRC4, NOD2, RAB21, PML, VPS41, IL1RN, IFIT1, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, STRADB, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, RANBP6, CD40LG, F2RL1, NUPL2, STEAP3, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, LTBP2, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, KIF18A, DNM2, IFNG, EHHADH, HSPD1]
GO:1903126;negative regulation of centriole-centriole cohesion;10.0;1.0;0.9152410118609203;9.628524252492122;269.77484522762467;9.777073627680469;0.009029121288170608;0.9152410118609203;[NEK2]
GO:0010813;neuropeptide catabolic process;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;142.40199253781023;9.083926447120524;0.004766066536767652;0.8154717862087246;[CTSH]
GO:0007409;axonogenesis;8.0;0.6873818243518346;0.7186909121759173;8.667113085337498;64.60914726719044;4.956792062075433;0.0021624100145753813;0.6284905765689417;[NRP1, ADARB1, STMN1, EPHB2, EPHB1, DCC, PAX2, MAP1B, CDH11, DSCAML1, SLITRK6, APBB1, LINGO1, SEMA4A, GP5, POU4F1, PTK2, NR4A2, LRFN4, OGN, BCL2]
GO:0010815;bradykinin catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;198.73492378151718;8.16763571524637;0.00665147904914789;0.7686126355688037;[CTSH]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[KIF11, IFI30, CTSS, KIF15, AP1S2, HLA-DOA, HLA-DOB, CTSD, AP2M1, HLA-DPA1, LAG3, FCER1G, KIF23, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, CD74, HLA-DRB4, CENPE, KIF18A, KIF26A, KIF4A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[SERPINE1, HMGB2, TNFAIP3, FASLG, BRCA1, ICAM1, HMOX1, GPX1, DAPK1, TNFRSF10B, SFRP2, BCL2L1]
GO:0090502;RNA phosphodiester bond hydrolysis, endonucleolytic;8.0;0.6799073451904818;0.7149536725952409;8.878218658092228;231.13671471601307;5.395046993006588;0.007735937832006836;0.6509029541176994;[POP5, FEN1, RNASEH2A, EXO1, RNASE2]
GO:2001186;negative regulation of CD8-positive, alpha-beta T cell activation;10.0;0.8933024483968273;0.861892236059334;9.551563211355994;305.21353058757757;8.16763571524637;0.010215222194422061;0.8329342821725234;[CD274, LILRB1]
GO:2001180;negative regulation of interleukin-10 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.9724324201893;8.67846133901236;0.02523477878196853;0.8590579283277371;[LILRB1]
GO:0040001;establishment of mitotic spindle localization;7.0;0.8933024483968273;0.7975705894556142;9.577230958104572;138.61878563688504;6.481236761676141;0.0046394460064588475;0.6823701146576509;[GPSM2, CENPA, NDC80, ESPL1, NUSAP1]
GO:0038145;macrophage colony-stimulating factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;8.67846133901236;0.00101047745553359;0.7947362817240173;[CSF1R]
GO:2001183;negative regulation of interleukin-12 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.9724324201893;8.67846133901236;0.02523477878196853;0.8590579283277371;[TLR8, LILRB1]
GO:1902287;semaphorin-plexin signaling pathway involved in axon guidance;8.0;1.0;0.875;9.628524252492122;28.581916314885376;7.292166977892469;9.566110170045473E-4;0.747921758369865;[NRP1, PLXND1, PLXNB2]
GO:0045930;negative regulation of mitotic cell cycle;6.0;0.5833093054345528;0.6147749653074209;7.836764783264067;61.236897459641845;4.271742091748107;0.0020495438483445192;0.5415774018184651;[ZWILCH, BUB1B, TNF, PTTG1, CHEK1, KNTC1, SOX4, TIPIN, CDC25C, MSH6, MSH2, AURKAIP1, MAD1L1, BLM, PRKDC, CCNB1, NACC2, RAD21, SFN, NAE1, CLSPN, FANCI, CDT1, TGFB1, PLK2, PLK1, CDC6, ZWINT, BCL6, CNOT3, CDK2, CDK1, BCL2, PTTG3P, EZH2, BCL2L1, TOP2A, CDKN1A, BTG2, BRCA1, TIMP2, CASP2, TOPBP1, IL10, DUSP1, TFDP1, GAS1, PCNA, TTK, AURKB, AURKA, GPNMB, E2F1, CCL2, BUB1, E2F7, E2F8, DONSON, RPA2, KLF4, PML, WEE1, CENPF, FAP, TRIP13, MAD2L1]
GO:0051382;kinetochore assembly;6.0;1.0;0.8231203125901445;9.628524252492122;123.98170582545;7.212124270218933;0.004149556117686715;0.6919486831672181;[CENPE, CENPF, CENPW, CENPH, CENPK, MIS12, CENPN, CENPA]
GO:0006336;DNA replication-independent nucleosome assembly;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;163.41517932017535;6.088194173566533;0.005469358987733092;0.6863505331661754;[HJURP, CENPA, RUVBL1, OIP5, CENPW, NASP, CENPH, CENPI, CENPK, CENPL, CENPM, CENPN, CENPO, ASF1B]
GO:0006334;nucleosome assembly;7.0;0.8653626801206646;0.7836007053175329;9.474373572664863;104.51542930890014;4.99795013456894;0.0034980373611892576;0.6065147675675062;[HMGB2, HJURP, CHAF1B, CHAF1A, RUVBL1, OIP5, BRD2, H2AFX, PADI4, MCM2, ASF1B, HIST1H2BK, CENPA, H1FX, CENPW, NASP, CENPH, CENPI, CENPK, CENPL, CENPM, CENPN, CENPO]
GO:0006335;DNA replication-dependent nucleosome assembly;8.0;1.0;0.875;9.628524252492122;163.41517932017535;7.474488534686424;0.005469358987733092;0.7572456912631272;[CHAF1B, CHAF1A, NASP, ASF1B]
GO:1990138;neuron projection extension;4.0;0.811012628672052;0.655506314336026;9.223059144383958;50.60479478960687;5.69953618377475;0.0016936969402496266;0.5414745454937787;[CYFIP1, NRP1, SEMA5B, NRP2, PRKCZ, AURKA, ALCAM, POSTN, MAP1B, VCL]
GO:0010826;negative regulation of centrosome duplication;10.0;0.8933024483968273;0.861892236059334;9.582004236857228;270.18031033573334;7.292166977892469;0.0090426918404441;0.7881627702307852;[CCNF, BRCA1]
GO:0031508;pericentric heterochromatin assembly;7.0;1.0;0.8509193652572005;9.628524252492122;98.72405253680223;8.67846133901236;0.0033042051925278506;0.7947362817240173;[HELLS]
GO:0010825;positive regulation of centrosome duplication;10.0;0.8933024483968273;0.861892236059334;9.582004236857228;269.74818055260414;7.9853141584524145;0.009028228845494321;0.8236103492792612;[PLK4, VPS4B, NUP62, CEP120, POC1A]
GO:0016125;sterol metabolic process;5.0;0.7090535922965819;0.6447678080092112;8.712233520617966;52.055674199354506;4.901876304479318;0.001742256568387185;0.5409231940325527;[CYP1B1, CUBN, CH25H, NPC2, CFTR, CEBPA, RXRA, ABCA1, DHCR24, SNX17]
GO:2001178;positive regulation of mediator complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;140.3817219977405;9.083926447120524;0.004698449899916962;0.8154717862087246;[CDT1]
GO:2001198;regulation of dendritic cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.77525917473399;7.474488534686424;0.0023018460308635697;0.7331650565203278;[TMEM176B, TMEM176A, LILRB1, LILRB2, FCGR2B, HLA-G]
GO:2001193;positive regulation of gamma-delta T cell activation involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;449.64974642203094;9.777073627680469;0.01504937235424625;0.9152410118609203;[LILRB1]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, PRKDC, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, FOSL2, FOSL1, HOXC10, DLGAP5, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, ZEB1, TAL1, RARA, HCLS1, ENG, NR1I2, EPCAM, STAT4, STAT1, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, SBNO2, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, FOXM1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, UHRF1, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, CCNC, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, IGF1, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RELB, RXRA, APBB1, IL33, CDX1, OSM, LILRB1, GRHL2, F2RL1, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL2, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, IRF8, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, TNIP3, RBMX]
GO:0006303;double-strand break repair via nonhomologous end joining;9.0;0.8933024483968273;0.8428918493787028;9.548481544818586;368.8093148901945;5.8067817141283475;0.012343715862540626;0.693199712083778;[DCLRE1A, BLM, PSMD14, PRKDC, BRCA1, BARD1, POLQ, H2AFX, MLH1, POLA1, RAD50]
GO:0006788;heme oxidation;7.0;1.0;0.8509193652572005;9.628524252492122;126.9332679816834;9.083926447120524;0.004248342246822363;0.8154717862087246;[HMOX1]
GO:0045945;positive regulation of transcription by RNA polymerase III;11.0;1.0;0.9324289523296623;9.628524252492122;1460.8767565828284;7.379178354882098;0.04889423033910414;0.8098004765652196;[CEBPA]
GO:0006301;postreplication repair;8.0;0.8259837884571596;0.7879918942285797;9.500690880982237;183.0506323445446;5.8067817141283475;0.006126539929698291;0.6719590869034888;[PCNA, BRCA1, POLD3, POLD1, TRIM25, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA2, ISG15, MSH2, POLE2, RPA3, DTL]
GO:0043525;positive regulation of neuron apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.392135474427892;179.36331192335928;5.885253329569843;0.0060031286335741505;0.6759721289664703;[CTSZ, FASLG, MYB, CASP2, MYBL2, JUN, TGFB2, CDC34, IL1B, UBE2M]
GO:0006302;double-strand break repair;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;183.0506323445446;4.689477292448085;0.006126539929698291;0.6148200868187911;[DCLRE1A, FEN1, MCM8, BRCA1, BRCA2, H2AFX, ESCO2, PARP9, RAD51C, MSH2, BLM, PSMD14, PRKDC, CDCA5, RAD54B, RAD51AP1, BRIP1, CDC45, RAD21, RBBP8, RAD54L, APBB1, BARD1, GINS2, POLQ, GINS4, RPA1, RPA2, CDC7, MND1, MLH1, POLA1, RAD50, RAD51, RPA3, TRIP13]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, BTG2, KIF14, ARRB1, ARRB2, CHL1, MEF2C, F2R, MSH2, ADAM8, NAIP, CEBPB, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, HMOX1, FYN, SNCA, JUN, WFS1, GABRA5, SOD2, POU4F1, NR4A2, NR4A3, BCL2, BCL2L1]
GO:0030889;negative regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.3396801226706;7.004484905440688;0.016946733417578675;0.7544503089863854;[LYN, IL10, TNFRSF13B, PAWR, INPP5D, BTK, CTLA4, MNDA, PKN1, FCGR2B]
GO:0051383;kinetochore organization;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;38.75571468247735;6.8867018697843045;0.0012971188925437662;0.6424272657460779;[CDT1, CENPW, MIS12, SMC4, CENPA, NDC80, SMC2, CENPE, CENPF, CENPH, CENPK, NUF2, CENPN]
GO:0032827;negative regulation of natural killer cell differentiation involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;1099.348003954265;8.390779266560578;0.03679418834337967;0.8443458537639685;[PGLYRP1]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, ADM, TNF, AQP1, ICAM1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, FECH, ABCB4, PTAFR, PTGS2, TYMS, AIF1, FOXO1, IGFBP7, TGFB1, FOSL1, IL6, RPS6KB1, BCL2, ALPL, SDC1, FOSB]
GO:0019860;uracil metabolic process;8.0;0.8653626801206646;0.8076813400603323;9.52844079393514;250.73952180582577;8.67846133901236;0.008392026143921861;0.8188169164668168;[DPYS, DPYD, TYMS]
GO:2001189;negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;9.0;1.0;0.896240625180289;9.628524252492122;430.8793777811617;8.67846133901236;0.014421145008071396;0.8400575416471059;[LGALS3, LILRB1, HAVCR2]
GO:0016358;dendrite development;6.0;0.8259837884571596;0.7361122068187242;9.260799472366804;32.63417926892749;6.343086423195323;0.0010922366112764486;0.647506047256038;[NRP1, HDAC2, LST1, CD3E, MAP1B]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[CDC20, RUVBL1, PSMD3, SKP2, CDC25A, CFTR, PSMD14, ADRB2, GATA3, NLRP3, CLSPN, BARD1, NFKBIA, COPS5, CDK1, TNFAIP3, BRCA1, ARRB2, IFIH1, DDX58, ACTL6A, PSMA5, CCNA2, PSMA6, PSMA3, PSMA4, PSMA2, BIRC2, BIRC3, USP18, FAM105A, USP1, IL33, USP9Y, PSMC6, TNIP3, PSMC2, EIF3F]
GO:0045717;negative regulation of fatty acid biosynthetic process;8.0;0.8436909121759173;0.7968454560879586;9.480104247373848;670.1384648150137;7.138016298065211;0.022428931331895798;0.7400384854347593;[CEACAM1, BRCA1, SIRT1]
GO:0038124;toll-like receptor TLR6:TLR2 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.390779266560578;0.013811191226989502;0.8772251544931927;[CD36, TLR6, CD14, TLR2]
GO:1902065;response to L-glutamate;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;96.09026658308662;7.474488534686424;0.0032160547469104574;0.7053660038532718;[PCNA, ABCB4, FYN]
GO:0038123;toll-like receptor TLR1:TLR2 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.67846133901236;0.013811191226989502;0.8919372290569614;[TLR1, CD14, TLR2]
GO:0040020;regulation of meiotic nuclear division;7.0;0.609056648853049;0.655447689683725;8.529911963824013;66.11398289201945;6.280566066213989;0.002212775508674272;0.6721078059595746;[LIF, TTK, BRCA2, CDC20, MSH2, FBXO5, TRIP13, PLCB1]
GO:0035094;response to nicotine;4.0;0.9326813400603323;0.7163406700301662;9.446202695698167;26.17342148764107;5.926926025970411;8.760008626412986E-4;0.5531032725983739;[CHRNB4, EDN1, HDAC2, VCAM1, SLC7A11, TNF, NFKB1, CNR1, BCL2, HMOX1]
GO:0045953;negative regulation of natural killer cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.526741558182179;431.6560499367194;7.379178354882098;0.014447139526158352;0.7736121494158466;[CEACAM1, CLEC12B, LILRB1, SERPINB9, ARRB2, HAVCR2, HLA-E]
GO:0006306;DNA methylation;9.0;0.7436939687323844;0.7680876095464813;9.253830803050711;389.4685312710283;5.948432231191374;0.01303516124271949;0.7004437261138039;[DNMT1, EHMT2, FOS, EZH2]
GO:0006548;histidine catabolic process;9.0;0.7980440201809971;0.7952626352707877;9.441312710403976;962.5341159731809;7.697632086000634;0.03221515063715804;0.7898978880348613;[HAL, HNMT]
GO:0051154;negative regulation of striated muscle cell differentiation;7.0;0.7586651285174919;0.7302519295159464;9.148951172230236;145.64858387880895;6.311337724880743;0.004874727027208368;0.6736814700148209;[MYOCD, DLL1, CXCL10, PAK1, BMP2, CEACAM5, EZH2]
GO:0006309;apoptotic DNA fragmentation;9.0;1.0;0.896240625180289;9.628524252492122;682.1166149099336;7.004484905440688;0.022829829235937554;0.7544503089863854;[FEN1, HMGB2]
GO:0010803;regulation of tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;58.00234281560482;5.734022359845919;0.001941286215318787;0.64415753539903;[TNFAIP3, TNF, PYCARD, CHUK, SYK, NR1H4, TRAF1, F2RL1, BIRC2, BIRC3]
GO:0010800;positive regulation of peptidyl-threonine phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;778.6672313762616;6.375876246018314;0.026061291479152104;0.7413036195908642;[TGFB1, EGF, RIPK2, PLK1, AZU1, CHI3L1, CALM3]
GO:2001199;negative regulation of dendritic cell differentiation;8.0;1.0;0.875;9.628524252492122;349.4674446787805;7.9853141584524145;0.01169636087311766;0.7833693374183408;[TMEM176B, TMEM176A, LILRB1, FCGR2B, HLA-G]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[IL5RA, SLA, SLA2, FGF5, EFEMP1, GRAP2, EPHB2, EPHB1, PDGFRB, PDGFRA, MAP2K2, PRKCD, MATK, EREG, BTC, MELK, BTK, EPHA3, EPHA2, BLK, CSF1R, TXK, CSF2RB, CSF2RA, MAP2K6, LYN, LIF, EIF2AK2, BMX, CLK4, PTK2, CLK1, FES, ITK, GHR, JAK3, SYK, RIPK2, IL15, FGR, ZAP70, HCK, LCK, KIT, IL3RA, HBEGF, TTK, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:0000819;sister chromatid segregation;5.0;0.8933024483968273;0.736892236059334;9.427853557029971;40.65143508701015;6.221725566191056;0.0013605669484458803;0.6084203466557585;[TOP2A, SPAG5, MIS12, PLK1, CDCA8, SMC1A, TUBG1, SMC4, ZWINT, NDC80, KIF18A, KIF18B, ESPL1, KIFC1, NUSAP1, NEK2, RAN, MAD2L1]
GO:0060045;positive regulation of cardiac muscle cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;720.414482973016;6.641579411751319;0.024111624414165377;0.7548916918429109;[TGFBR3, MEF2C, CCNB1, CDK1, MAPK14]
GO:1902475;L-alpha-amino acid transmembrane transport;10.0;0.6181399273706679;0.7243109755462542;8.529911963824013;268.42115299878213;6.063501560976162;0.00898381442751516;0.7253287636709003;[SLC38A1, SLC43A2, SLC1A3, SLC7A11, SLC1A6, SLC7A5, SLC7A7, SLC7A8, SLC17A6]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, JUNB, HOXA5, SOX4, MEF2A, MED1, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, TXK, GATA3, GATA1, NHLH2, RAD21, EGR1, EGR2, JUN, BCL11B, FOSL2, FOSL1, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, PLSCR1, TFEC, SATB2, FLNA, CDX2, CDX1, GTF2H1, GRHL2, POU4F1, FOSB, TRIP13, CCNT2, ARID4A, ETS1, HOXA10, PTTG1, LMO2, C5AR1, HMGA1, NFKB1, NFKB2, COPS5, MAFB, FEV, MAFF, ARRB1, ARRB2, MYBL2, MYBL1, MYOCD, KLF13, NCBP2, ETV1, TFDP1, ELF3, IRF7, CREB5, CEBPA, CEBPB, CEBPD, CEBPE, TAF9, LEF1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF6, KLF5, POU2AF1, TAF5, RBMX]
GO:0008543;fibroblast growth factor receptor signaling pathway;8.0;0.7090535922965819;0.729526796148291;8.567652291806858;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[CTGF, FGF5, FLRT2, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, NCBP2, SHCBP1, KIF16B, ESRP1]
GO:0038195;urokinase plasminogen activator signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;9.083926447120524;8.87013979980389E-4;0.7876727335416686;[PLAUR]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CCNH, RORA, CCNC, NR3C2, CTGF, MED1, NRBP1, RUNX2, MAML3, MAZ, VDR, NR4A2, NR4A1, NR4A3, TCF4, CDKN1A, HNF4G, HNF4A, MED23, RARA, YAP1, TAF9, NR1I2, RXRA, POLR2E, E2F2, POLR2I, POLR2J, POLR2K, POLR2L, NR1H2, NR1H4, GTF2H1, TAF5]
GO:0019441;tryptophan catabolic process to kynurenine;10.0;1.0;0.9152410118609203;9.628524252492122;2139.3361475978627;8.16763571524637;0.07160165558256723;0.8329342821725234;[KYNU]
GO:0019442;tryptophan catabolic process to acetyl-CoA;10.0;1.0;0.9152410118609203;9.628524252492122;2054.5202981753127;9.083926447120524;0.06876294543170325;0.8797934328124444;[KYNU]
GO:0030224;monocyte differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;69.52661413212034;7.004484905440688;0.0023269932051117304;0.6813299963962409;[CSF1R, MED1, MEF2C, JUN]
GO:0030225;macrophage differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.8867018697843045;0.0015755275618510598;0.6753065664753021;[CSF1R, CEBPA, CSF3, SPI1, CEBPE, MMP9, SIRT1, NKX2-3]
GO:1902480;protein localization to mitotic spindle;8.0;0.9326813400603323;0.8413406700301662;9.533214072687796;35.99248463016168;9.777073627680469;0.0012046360694383546;0.875;[FAM83D]
GO:0044806;G-quadruplex DNA unwinding;7.0;1.0;0.8509193652572005;9.628524252492122;23.726073882073138;7.8311634786251565;7.940903407527885E-4;0.7514054297404357;[BLM, DNA2]
GO:1904668;positive regulation of ubiquitin protein ligase activity;12.0;1.0;0.9481203125901445;9.628524252492122;754.3373369627636;7.212124270218933;0.025246991808615726;0.8169486831672182;[CDC20, UBE2C, UBE2S, PLK1, MASTL]
GO:0007224;smoothened signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;5.528578385631111;8.87013979980389E-4;0.6058520683365068;[IHH, STIL]
GO:1905515;non-motile cilium assembly;7.0;1.0;0.8509193652572005;9.628524252492122;138.7811185870196;6.039404009397101;0.004644879144209681;0.6597747671587765;[POC1A]
GO:1904667;negative regulation of ubiquitin protein ligase activity;12.0;1.0;0.9481203125901445;9.628524252492122;755.449957599424;7.57984905034425;0.025284230220031186;0.835754145523778;[FBXO5, MAD2L1]
GO:0007221;positive regulation of transcription of Notch receptor target;12.0;1.0;0.9481203125901445;9.628524252492122;1467.8987330058965;6.8867018697843045;0.04912924957061573;0.8003065664753022;[PLXND1, STAT1, MAML3, DLGAP5]
GO:0000821;regulation of arginine metabolic process;8.0;0.7763722522362496;0.7631861261181248;9.303101852057495;103.95066091928724;9.083926447120524;0.003479135071447466;0.839552420951524;[SLC7A7]
GO:0009404;toxin metabolic process;3.0;0.5720181185523628;0.484129371866326;7.2867184463447945;27.61873557695172;6.686031174322154;9.243742245122942E-4;0.5400442577772261;[CYP1B1]
GO:0038180;nerve growth factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;27.195621953761602;7.292166977892469;9.102129923216596E-4;0.7238411236270654;[SORT1, NTF3, CORO1A]
GO:0071163;DNA replication preinitiation complex assembly;7.0;0.8653626801206646;0.7836007053175329;9.387362195675234;77.2272886234996;8.67846133901236;0.002584727850181096;0.7947362817240173;[CDT1, CDC45, GMNN]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[SPI1, EHMT2, SLA2, AKT1, MEF2A, MEF2C, ATF3, GATA3, IQGAP3, GATA1, HESX1, JUN, EIF2AK2, NR2F2, DHFR, PKIG, EZH2, SIRT1, SRP9, MMP12, BTAF1, FLNA, STAT1, CENPF, LGR4, GMNN, CTGF, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CIITA, LRRK2, FHL2, PIK3CD, FASLG, FOXM1, HHEX, ITGB8, PEG3, BIRC5, BIRC2, BIRC3, UHRF1, E2F1, FYN, E2F7, E2F8, PRRX1, EIF3E, IKZF1, UXT, HNF1B, MIF, EREG, SFRP2, IFI27, KCNQ1, NAIP, GSPT1, BRIP1, PCBP3, A2M, CCR1, EGR1, MSR1, ID1, CD28, SUV39H2, SUV39H1, CTSZ, PTPRK, BRCA1, CD3E, BMI1, CD38, CD36, CD34, BANK1, IL1B, DEPDC1, SATB2, RELB, RXRA, NEDD4, LOXL2, EOMES, CCNE1, CALCA, TCF7, CCNB1, VDR, CAV1, HMGA1, BMP2, UBA3, MXD1, HMGB2, MYOCD, NCBP2, GREM1, ELF3, IRF7, IRF8, FBP1, AURKB, TBX21, SERPINE1, PHB2, MYB, HOXA2, HOXA7, JUNB, MED1, DAPK1, HOXB4, HOXB3, SERPING1, NEDD4L, PRDM16, ELANE, BARD1, FZD1, NDFIP2, PLK1, FZD8, UPF3B, SNAI2, CDKN1A, BTG2, HAVCR2, HELLS, PAWR, PAX5, PAX2, AES, ZEB1, TAL1, RARA, GAS1, HCLS1, PLCB1, ENG, NR1I2, ASCL2, NR1H2, NR1H4, POU4F1, FOSB, FMR1, TNF, DACH1, MEN1, TLE4, MAP2K2, IGFBP5, DNMT1, AEBP1, NACC2, WFS1, LSM5, LSM3, DAB2, BCL6, CNOT3, BCL3, CDK2, PTPN22, EMILIN1, CR1, RFC1, PTBP2, XCL1, CEBPA, CEBPB, HDAC2, NLRC4, RBBP8, ZNF503, KLF4, PML, KLF8, KLF5, DNAJA3, GFI1, ZNF608, EDNRB, PPP2R1A, MAGOH, DPF3, SOX7, SOX4, IL1R2, RUNX2, TWIST1, BCL11A, IFNA2, XPO1, HBZ, EDN1, PARP9, CBFA2T3, NME1, MDFIC, SP100, TYMS, AIF1, PURA, APBB1, CDX2, MLH1, LILRB4, ARID4A, CHCHD3, BASP1, TIMELESS, TGFB2, TGFB1, CBX4, EIF2S1, NR4A2, LIN28A, NR4A3, CREBZF, KLF12, H2AFX, IFNG, PFDN5, LEF1, THBS1, SNCA, MEIS2, RBMX]
GO:0030216;keratinocyte differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;25.58801435984686;5.486614186532078;8.564078129062366E-4;0.6037060172430475;[DSP, YAP1, MED1, ST14, CSTA, JAG1, ANXA1, EREG, ADAM9, EPHA2]
GO:0051574;positive regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;804.3299673530898;7.474488534686424;0.02692020015733362;0.8146746435927894;[MYB, BRCA1, SIRT1]
GO:0007218;neuropeptide signaling pathway;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.976932752798508;5.123113277522946;9.028936615729279E-4;0.5851165638517994;[CALCA, SORT1, NPY1R, GPR84, SORCS3, LTB4R, ADCYAP1, NPY, PNOC, PROK2, GPR19]
GO:0070072;vacuolar proton-transporting V-type ATPase complex assembly;8.0;1.0;0.875;9.628524252492122;45.210214189519135;7.474488534686424;0.0015131451823720294;0.7572456912631272;[DMXL2]
GO:0030218;erythrocyte differentiation;5.0;0.8436909121759173;0.712086467948879;9.117698628726131;22.675663695230284;5.885253329569843;7.589340571069517E-4;0.5912131408273906;[ALAS2, SPI1, GATA3, IKZF1, GATA1, AHSP, JAK3, LYN, INHBA, KLF1, TGFBR3, TAL1, KIT, ACIN1, HCLS1, TRIM10]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[TMEM100, HHEX, HNF1B, FCER2, MAML3, CEBPA, PSEN2, KCNA5, DTX3, DLL1, PLN, GMDS, PERP, S1PR3, ZNF423, TGFB1, JAG1, NR1H4, KRT19, BMP2, SNAI2]
GO:0051572;negative regulation of histone H3-K4 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.8473500351352;8.390779266560578;0.026937516490087493;0.8615337942327104;[BRCA1]
GO:0071168;protein localization to chromatin;7.0;0.7369933605727446;0.7194160455435727;8.935377071932177;34.71951895434896;6.832634648514029;0.001162031053863633;0.7003406189322132;[RUVBL2, RAD21, PLK1, ESCO2, EZH2]
GO:0051573;negative regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;805.1350321075869;7.57984905034425;0.026947144950155395;0.8200627852632958;[DNMT1, PAX5, BRCA1, SIRT1]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, GATA1, C3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, DLGAP5, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, PTAFR, STAT4, SPP1, STAT1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CXCL10, MYD88, CIITA, FHL2, PIK3CD, ARRB1, ARRB2, FOXM1, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, UHRF1, CCL5, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, CCNC, IKZF1, TNFSF11, EPHB2, HNF1B, SFRP4, SFRP2, EGR1, EGR2, EGR3, IGF1, ID1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3E, CD3D, HNF4A, CTSH, CD38, CD36, CD34, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RELB, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, ACTG2, EOMES, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, NAT8, TCF4, IL7R, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL2, MYBL1, YWHAH, MYOCD, DDX58, NCBP2, ETV1, ACTA2, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, RNF6, TBX21, RBM38, EGF, MAPK14, CD4, TNIP3, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, PRKDC, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD2, FZD5, FZD8, UPF3B, FOSL2, FOSL1, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, ZEB1, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, FAM129A, EPCAM, GSN, NR1H2, NR1H4, GTF2H1, POU4F1, PLP1, FOSB, PF4, CSF3, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, LAMP3, MEN1, MAP2K2, F2R, ADAM2, ADAM8, DNMT1, DAB2, COPS5, MAFB, MAFF, BCL3, CDK2, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EPB41L4B, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR6, TLR4, TLR2, SP100, APBB1, CDX2, CDX1, LILRB1, GRHL2, CAMK4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, SLC40A1, CKS1B, KLF13, CKAP2, AXIN2, DCN, DNM2, IFNG, LEF1, DLL1, THBS1, LUM, MEIS2, MEIS1, RPS6KB1, RBMX]
GO:0051571;positive regulation of histone H3-K4 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.0422852806381;7.004484905440688;0.026910571697265715;0.7906386361357586;[DNMT1, MYB, BRCA1]
GO:0001913;T cell mediated cytotoxicity;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;37.17052405245288;7.292166977892469;0.001244063988735793;0.6960420709600095;[CTSH, EMP2]
GO:0032873;negative regulation of stress-activated MAPK cascade;11.0;0.8436909121759173;0.8542744084176208;9.56534535087059;1526.0559120613332;6.039404009397101;0.051075718015538125;0.7412843542312382;[PTPN22, FOXM1, FOXO1, DUSP10, PBK, AKT1, MEN1, DUSP3, SFRP2, F2RL1, ZMYND11]
GO:0010863;positive regulation of phospholipase C activity;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;83.73920694943958;6.139487467954083;0.0028026758962042993;0.6889736746265369;[PDGFRB, ITK, PDGFRA, TXK, C5AR1, PTAFR, AVPR1A, SELE, RASGRP4, EDNRA, GNA15, GNAQ, KIT, PLCG1]
GO:0032870;cellular response to hormone stimulus;5.0;0.6039883530135606;0.5922351883677006;7.932074963068391;80.94247679971589;3.9540277321974506;0.0027090718549867714;0.49245017396659174;[CYFIP1, PID1, TNC, AQP1, ICAM1, RUVBL2, AKT1, PRKACB, JUNB, PTGDR, MEN1, GHSR, MED1, LHCGR, MEF2C, PRKCE, PRKCD, LMO2, ADCYAP1, POR, ADCY9, RAB31, PRKAR1B, SIK1, FECH, PRKDC, ABCB4, SLC30A10, GATA1, FOXO1, SOCS2, BRIP1, PRKAR2B, IGFBP7, GAS2L1, JUN, TGFB1, CAV1, CDC6, INHBA, NFKB1, NR4A2, NR4A1, KIF18A, NR4A3, FBN1, ROBO2, CTSS, GHR, CTSH, CTSB, IL10, EDN1, ANXA1, DUSP1, ARG1, GLP2R, AVPR1A, FOS, CCNA2, CEACAM1, KIT, PTGER2, AIF1, P2RY6, PAK1, SPP1, FYN, CSK, STAT1, SORBS1, POU4F1, TSHR, RPS6KB1, FOSB, RAMP1]
GO:0001915;negative regulation of T cell mediated cytotoxicity;9.0;0.8933024483968273;0.8428918493787028;9.557065288509976;365.562885098783;7.9853141584524145;0.012235060779019208;0.8046099625986299;[CEACAM1, PTPRC, LILRB1, FCGR2B, IL7R]
GO:0001916;positive regulation of T cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.523163736834295;365.14378084230765;6.518977089658987;0.012221033736724321;0.7296214167088868;[HLA-B, HLA-C, CD1E, CD1D, HLA-A, CD1C, HLA-F, CD1B, HLA-G, CD1A, HLA-E, IL23A, XCL1, IL12RB1]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, PRKCH, PRKCB, PRKCE, PRKCD, VRK1, PRKCQ, PRKDC, PRKCZ, CCNB1, CLSPN, PLK2, PLK1, CDC7, CLK1, CDK2, CDK1, BCL2, LRRK2, MAP4K1, CHUK, SYK, MASTL, SGK1, CAMK2D, TTK, AURKB, AURKA, MAPK14, MAPK13, RPS6KB1, CAMK4, PKN1, CAMK1]
GO:0032877;positive regulation of DNA endoreduplication;10.0;1.0;0.9152410118609203;9.628524252492122;1140.1023815324472;9.083926447120524;0.03815820068436285;0.8797934328124444;[E2F7, E2F8]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[LRRK2, CHEK1, AKT1, PRKCB, PRKCD, CAD, VRK1, CAMK2D, TTK, CLK1, CDK1, BCL2, PKN1, CAMK1]
GO:0010862;positive regulation of pathway-restricted SMAD protein phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1012.5567145242198;5.905872616772578;0.033889361993245395;0.7172676121338334;[TGFB2, TGFB1, TTK, INHBA, BMP2, DAB2, ENG]
GO:0030214;hyaluronan catabolic process;8.0;1.0;0.875;9.628524252492122;501.2795327383162;6.8867018697843045;0.01677737483846132;0.7271862538851576;[PKHD1, TGFB1, HMMR]
GO:0043966;histone H3 acetylation;12.0;0.7671156992804218;0.8316781622303555;9.3498108500231;659.4528027923784;5.926926025970411;0.022071291840469662;0.7512235851885185;[SPI1, TAF9, LEF1, ELP4, BRCA2]
GO:0044818;mitotic G2/M transition checkpoint;10.0;0.8933024483968273;0.861892236059334;9.551563211355994;492.819650181817;6.343086423195323;0.016494230182695288;0.7396267465268138;[FANCI, BLM, DONSON, CDC6, BRCA1, MSH6, CDK1, TOPBP1, NAE1, CLSPN]
GO:0038178;complement component C5a signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;245.7153283963706;9.083926447120524;0.008223870911987907;0.8797934328124444;[C5AR1]
GO:0045907;positive regulation of vasoconstriction;8.0;0.8933024483968273;0.8216512241984136;9.57973408832269;103.52331479149503;6.280566066213989;0.003464832181136806;0.6961884407023742;[CAV1, PTAFR, F2R, AVPR1A, PTGS2, ICAM1, AKT1, CD38]
GO:1903589;positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis;9.0;1.0;0.896240625180289;9.628524252492122;341.3007332013115;7.57984905034425;0.01142302838952993;0.7838744581139225;[PPP1R16B, AGTR1, HMOX1]
GO:0006342;chromatin silencing;11.0;0.7763722522362496;0.820615078447787;9.454170865347344;1752.5176526080036;5.433268205826786;0.058655188669300654;0.7102865410484548;[SUV39H1, BMI1, HELLS, H2AFX, SIRT1]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[CHRM2, IFITM1, FMR1, PRF1, ADARB1, IFIT1, TNF, CLU, IFIT3, IFIT2, PYCARD, HERC5, STMN1, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, GATA3, DDX60, NLRP3, IFNA21, HMGA1, EIF2AK2, ISG15, AZU1, DEFA1, FOSL1, CXCL10, IL6, CXCL12, PTPRC, CDK6, BCL3, BCL2, SERINC5, APOBEC3A, BCL2L1, APOBEC3B, IFNA5, CREBZF, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, CHUK, IFNGR1, DDX58, IFNGR2, IRAK3, PARP9, MMP12, ACTA2, EEF1G, FGR, PLSCR1, IFNG, OAS1, PSMA2, NPC2, OAS3, IRF7, TLR8, XCL1, TLR7, ZMYND11, EXOC1, UNC93B1, CXCR4, SAMHD1, CCL8, CCL5, TBX21, CCL4, CCL19, CCT5, IL33, STAT1, MX2, CARD9, LILRB1, MAPK14, PML, F2RL1]
GO:0006346;methylation-dependent chromatin silencing;12.0;1.0;0.9481203125901445;9.628524252492122;1936.9706715625437;7.212124270218933;0.06482866521676948;0.8169486831672182;[HELLS, SIRT1]
GO:0030206;chondroitin sulfate biosynthetic process;8.0;1.0;0.875;9.628524252492122;416.1007025877491;6.558197802812269;0.013926516049292044;0.7103865406232063;[BGN, DCN, VCAN, DSE, CHST15, CSPG4]
GO:0032869;cellular response to insulin stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;5.334422371190153;0.015486127626965131;0.6478026081386739;[CYFIP1, AKT1, GHSR, CEACAM1, RAB31, PRKDC, FOXO1, PAK1, STAT1, SORBS1, RPS6KB1]
GO:0031536;positive regulation of exit from mitosis;9.0;1.0;0.896240625180289;9.628524252492122;562.0425168150831;8.16763571524637;0.018811057232375368;0.8139338954918922;[TGFB1, UBE2C, CDCA5, PHB2]
GO:0030208;dermatan sulfate biosynthetic process;8.0;1.0;0.875;9.628524252492122;665.197598747091;7.292166977892469;0.022263564991093197;0.747921758369865;[VCAN, DSE, BGN, CSPG4, DCN]
GO:0030449;regulation of complement activation;8.0;0.6873818243518346;0.7186909121759173;9.298282565621545;245.7676390307622;5.076593261888053;0.008225621701844479;0.6346172154986847;[C1QB, C1QA, CFH, C1S, C1R, PROS1, C5AR1, CFI, CFP, CLU, C2, C3, IGHG1, IGKC, C7, CD19, IGLV1-44, C3AR1, A2M, CR2, CR1, SERPING1, IGKV3-20, CFB, C1QC]
GO:0032868;response to insulin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;4.800339885259895;0.0024778305216419678;0.5964089702280253;[CYFIP1, ADM, ICAM1, SESN3, AKT1, IL10, GHSR, CAD, SIRT1, CEACAM1, RAB31, TLR2, PRKDC, RETN, FOXO1, PAK1, PLN, LYN, EGR1, EGR2, SORT1, STAT1, GGH, SORBS1, RPS6KB1]
GO:0030207;chondroitin sulfate catabolic process;8.0;1.0;0.875;9.628524252492122;411.79540990145875;7.138016298065211;0.01378242177759377;0.7400384854347593;[VCAN, BGN, CSPG4, DCN]
GO:0009609;response to symbiotic bacterium;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;57.42597956597373;9.083926447120524;0.0019219958560468828;0.7876727335416686;[GPX1, PTAFR]
GO:0060070;canonical Wnt signaling pathway;8.0;0.6729672293956388;0.7114836146978194;8.391761625343195;31.415129658942366;5.233778845410465;0.0010514361179036673;0.6426556935498979;[LRRK2, LEF1, TCF7, GATA3, CDH3, FRZB, SOX4, FZD1, FZD2, FZD5, EGF, FZD8, TMEM64, KLF4, NR4A2, SFRP4, HOXB9, SFRP2, SDC1, SNAI2, LGR4]
GO:0030200;heparan sulfate proteoglycan catabolic process;8.0;1.0;0.875;9.628524252492122;576.1643235394821;8.67846133901236;0.019283701394640074;0.8188169164668168;[HPSE]
GO:0010833;telomere maintenance via telomere lengthening;8.0;0.9326813400603323;0.8413406700301662;9.590783924509275;185.09737597092234;6.409777797693995;0.00619504259692348;0.7027963346592216;[RFC1, RPA1, RAD50, RAD51]
GO:0031532;actin cytoskeleton reorganization;6.0;1.0;0.8231203125901445;9.628524252492122;32.01253927882412;5.788089581116195;0.001071430880247358;0.6191234829421188;[NRP1, PLEK, ANTXR1, PRKCZ, PAK1, FLNA, CXADR, ANXA1, GAB1, PARVB, KIT, S100A9]
GO:0051106;positive regulation of DNA ligation;8.0;0.9326813400603323;0.8413406700301662;9.57973408832269;378.6008333431687;8.16763571524637;0.012671429173367173;0.7926932703116032;[RAD51]
GO:1900087;positive regulation of G1/S transition of mitotic cell cycle;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;354.40743100732976;6.409777797693995;0.011861697769835146;0.7240369598395108;[ANXA1, KCNA5, CDC6, AIF1, CDC45, PLCB1]
GO:0045919;positive regulation of cytolysis;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.08542638077049;7.379178354882098;0.0013750922464812324;0.6676125360964777;[LILRB1, PGLYRP1]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MNX1, MEF2A, MEF2C, PADI4, ATF3, CDCA7, GATA3, GATA1, HESX1, MCTS1, JUN, HACE1, EIF2AK2, NR2F2, EZH2, HOXC10, CHAF1B, ACTL6A, FOS, SIRT1, PLSCR1, STAT4, FLNA, ZNF467, CASP8AP2, STAT1, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CIITA, FHL2, FASLG, ARRB1, ARRB2, FOXM1, HHEX, BIRC5, BIRC2, UHRF1, ZBTB41, E2F1, E2F5, E2F7, E2F8, PRRX1, POU2AF1, CCNH, IKZF1, UXT, HNF1B, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H2, SUV39H1, BRCA1, BMI1, DEPDC1, SATB2, RELB, IL33, FOXA3, FOXA2, ETS1, LOXL2, EOMES, TCF7, LPXN, HMGA1, MXD1, PHTF2, HMGB2, AFF3, LYL1, NUP62, MYBL2, MYBL1, MYOCD, NCBP2, ETV1, ELF3, IRF7, IRF8, ZMYND11, CREB5, TAF9, TBX21, MAPK14, MAPK13, TAF5, NAA15, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, PRKCB, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, ASF1B, RAD21, PRDM16, NKX2-3, NFE2, FOSL2, FOSL1, SNAI2, BTG2, TGFB1I1, ZNF367, TCF19, BRD2, HELLS, PAWR, PAX5, PAX2, AES, ZEB1, TAL1, ASCL2, GTF2H1, POU4F1, FOSB, MEN1, TLE4, DNMT1, AEBP1, NACC2, MAP2K6, HOPX, COPS5, MAFB, BCL6, CNOT3, MAFF, BCL3, LBH, RFC1, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, MNDA, GFI1, ZNF608, DPF3, SOX7, SOX4, EBF1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, TFEC, SP100, PURA, APBB1, CDX2, CDX1, GRHL2, TRIP13, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, PTTG1, LMO2, COL4A2, TIMELESS, C5AR1, NLRP3, CBX4, NR4A2, FEV, CREBZF, KDM5D, KLF12, KLF13, LTF, LEF1, HLX, MEIS2, MEIS1, RBMX]
GO:1900086;positive regulation of peptidyl-tyrosine autophosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;1786.9389585583017;8.16763571524637;0.05980723880229299;0.8501222226412654;[GREM1, ACE, SYK]
GO:1905775;negative regulation of DNA helicase activity;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;205.113589991404;9.777073627680469;0.006864967266765914;0.896240625180289;[MCM2]
GO:1902023;L-arginine transport;11.0;0.8259837884571596;0.845420846558242;9.417215158824915;169.89972840006223;8.16763571524637;0.00568639100972162;0.8501222226412654;[SLC11A1]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[NUP107, SPI1, SLA2, SPIB, AKT1, MNX1, ATF3, CDCA7, GATA3, GATA1, JUN, JAG1, JUP, EIF2AK2, NR2F2, DHFR, PKIG, HOXC10, CHAF1B, DLGAP5, FOS, MMP12, MED23, PLSCR1, PTAFR, SPP1, ZNF467, CASP8AP2, ATAD2, NOC3L, CENPF, PKN1, LGR4, GMNN, EFEMP1, BLM, G3BP2, ZNF423, CIITA, ITGB2, HHEX, UHRF1, CDC45, E2F1, E2F2, E2F5, E2F7, E2F8, POU2AF1, SMARCAL1, IKZF1, ICAM1, TNFSF11, TRIM25, FBXO5, BTK, TRIB1, TGFA, PKHD1, BRIP1, EGR1, EGR2, EGR3, IGF1, POLA1, ECM1, IL10, SYK, IL18, IL1A, IL1B, KIT, DEPDC1, YAP1, PCNA, RELB, IL33, OSM, ETS1, NR3C2, LOXL2, CARD11, TCF7, HTRA1, LPXN, CAV1, UBA3, TCF4, MXD1, FBN1, PHTF2, PLEK, TNFAIP3, LYL1, MYBL2, MYBL1, MYOCD, NUP133, IRAK3, ETV1, GREM1, ELF3, ZMYND11, FBP1, RNF6, TBX21, RRM2, CD4, TNIP3, PHB2, PRKCH, PRKCB, PRKCQ, PRKDC, PRKCZ, NUP85, PRDM16, HMOX1, NFE2, PLK1, FOSL2, FOSL1, SNAI2, CDKN1A, BTG2, ZNF367, HELLS, ZEB1, RARA, NR1I2, ASCL2, EPCAM, NR1H2, NR1H4, ELP4, FOSB, PF4, CSF3, PLXND1, TNF, CLU, TLE4, MAP2K2, AEBP1, MAP2K6, DAB2, COPS5, BCL6, BCL3, CCDC22, SLC26A3, PTTG3P, CYR61, LBH, EMILIN1, RFC1, TFDP1, XCL1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, NLRC3, NLRC4, NOD2, ABLIM3, POLR2K, POLR2L, PML, DNAJA3, PPIL4, GFI1, PPP2R1A, RPS6KA1, FLT3LG, NIF3L1, IL23A, SIK1, NBL1, TXK, TWIST1, LIF, TOP2A, AHCTF1, IFNA2, PRL, XPO1, HBZ, EDN1, PARP9, CBFA2T3, VAV1, MLF2, HCK, TLR6, TLR4, TLR2, TYMS, PURA, APBB1, GRHL2, CD40LG, F2RL1, HOXA11, HOXA10, LMO2, FANCD2, TIMELESS, NLRP3, CBX4, KDM5D, SLC40A1, H2AFX, DCN, DNM2, PFDN5, LTF, LEF1, HLX, SNCA, LUM, RBMX, PID1, EHMT2, MEF2A, WDHD1, MEF2C, ZFYVE16, PADI2, PADI4, HESX1, MCTS1, HACE1, COL1A1, EZH2, RIPK2, ACTL6A, SIRT1, PSMA6, CKS2, FSTL1, BTAF1, STAT4, FLNA, STAT1, USP9Y, PSMC6, PSMC2, CCNT2, NCF1, RORA, RUVBL2, RUVBL1, ADCYAP1, S100A9, S100A8, MAZ, TNFRSF11A, FOXO1, SBNO2, NFKB1, NFKB2, CXCL10, MYD88, FHL2, FASLG, ARRB1, ARRB2, FOXM1, PPP1R12A, PEG3, BIRC5, BDP1, BIRC2, LRP2, ZBTB41, PRRX1, CCNH, CCNC, UXT, TMPO, HNF1B, EREG, SFRP4, SFRP2, IFI27, PCBP3, ZNF700, OR7D2, ID1, CD28, SUV39H2, CD40, SUV39H1, HNF4G, PTPRK, BRCA1, BRCA2, PCSK6, BMI1, CD3D, HNF4A, CD38, CD36, RGMA, SATB2, RXRA, CD74, NLRP12, NEDD4, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, EOMES, CCNE1, CALCA, VDR, HMGA1, INHBA, IL6, BMP2, HMGB2, ARHGEF10L, AFF3, NUP62, YWHAH, DDX58, CCNA2, PSRC1, IRF7, IRF8, CREB5, TAF9, AURKB, EGF, MAPK14, SOD2, MAPK13, NUP35, TAF5, NAA15, RAN, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, CYP1B1, HOXA7, JUNB, HOXA5, HOXA4, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB6, HOXB5, ASF1B, NEDD4L, RAD21, S100A12, ELANE, NKX2-3, FZD1, FZD2, FZD5, FZD8, CDC6, TGFB1I1, HAVCR2, TCF19, BRD2, ANXA3, NFAM1, PAWR, PAX5, PAX2, AES, TAL1, HCLS1, PLCB1, ENG, GTF2H1, SULF1, POU4F1, PYCARD, DACH1, CDH1, MEN1, F2R, ADAM8, DNMT1, NACC2, WFS1, HOPX, MAFB, CNOT3, MAFF, CDK2, CHUK, TRAF1, SMARCD3, RBBP8, ZNF503, IRX3, KLF4, KLF1, KLF8, KLF6, KLF5, MNDA, ZNF608, EDNRB, CHEK1, DPF3, SOX7, SOX4, SLC11A1, EBF1, RUNX2, PFN1, BEX1, SP140, NHLH2, CDT1, BCL11B, BCL11A, RHOG, RHOH, MDFIC, TFEC, SGK1, SP100, CDX2, CDX1, LILRB1, LILRB4, CAMK4, CAMK1, ARID4A, ARID4B, CHCHD3, PTTG1, BASP1, ADRB2, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, JMY, NFKBID, CREBZF, CKS1B, TMEM100, KLF12, KLF13, CKAP2, TGFBR3, IFNG, CAMK2D, DLL1, HSPD1, MEIS2, MEIS1]
GO:0007202;activation of phospholipase C activity;9.0;1.0;0.896240625180289;9.628524252492122;83.73920694944017;6.444869117505266;0.0028026758962043192;0.7258315315665724;[ITK, TXK, C5AR1, AVPR1A, SELE, RASGRP4, EDNRA, GNA15, GNAQ, PLCG1]
GO:0007200;phospholipase C-activating G-protein coupled receptor signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.976932752798508;5.288437257948329;9.028936615729279E-4;0.5935712398991049;[CHRM2, LHCGR, CHRM1, C5AR1, F2R, FPR1, FPR3, FPR2, GPR84, NMBR, LTB4R, MC3R, GRM5, P2RY6, GNA15, EDNRB, P2RY2, GNAQ, CXCR2, C3AR1, AGTR1, F2RL3]
GO:0006359;regulation of transcription by RNA polymerase III;10.0;0.8436909121759173;0.837086467948879;9.52844079393514;248.56913769389934;6.481236761676141;0.008319385340914571;0.7466917612613706;[CEBPA, BRCA1, BDP1]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[PID1, SPI1, EHMT2, SLA2, SPIB, AKT1, MNX1, MEF2A, WDHD1, MEF2C, ZFYVE16, ATF3, GATA3, GATA1, HESX1, JUN, JAG1, JUP, NR2F2, PKIG, EZH2, HOXC10, DLGAP5, RIPK2, ACTL6A, FOS, SIRT1, MMP12, MED23, PLSCR1, CKS2, PTAFR, FSTL1, STAT4, ZNF467, STAT1, USP9Y, ATAD2, NOC3L, PSMC6, PSMC2, PKN1, CCNT2, RORA, RUVBL2, RUVBL1, ADCYAP1, MAZ, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, FASLG, ARRB1, FOXM1, HHEX, PPP1R12A, PEG3, UHRF1, LRP2, ZBTB41, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, POU2AF1, SMARCAL1, CCNH, CCNC, IKZF1, UXT, TNFSF11, HNF1B, SFRP4, SFRP2, IFI27, TGFA, BRIP1, PCBP3, ZNF700, EGR1, EGR2, EGR3, IGF1, ID1, CD28, SUV39H2, ECM1, CD40, SUV39H1, HNF4G, BRCA1, PCSK6, BMI1, CD3D, HNF4A, CD36, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RELB, RXRA, IL33, OSM, NEDD4, FOXA3, IL17A, FOXA2, IHH, ETS1, NR3C2, LOXL2, EOMES, CCNE1, TCF7, HTRA1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, MXD1, FBN1, PLEK, HMGB2, ARHGEF10L, LYL1, MYBL2, MYBL1, MYOCD, DDX58, ETV1, GREM1, ELF3, IRF7, IRF8, ZMYND11, FBP1, CREB5, TAF9, AURKB, TBX21, MAPK14, SOD2, TNIP3, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, PRKCB, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB6, HOXB5, PRKDC, NEDD4L, RAD21, PRDM16, HMOX1, ELANE, NKX2-3, FZD1, NFE2, FZD5, PLK1, FZD8, FOSL2, FOSL1, SNAI2, CDKN1A, BTG2, ZNF367, HAVCR2, TCF19, BRD2, PAWR, PAX5, PAX2, AES, ZEB1, TAL1, RARA, HCLS1, ENG, NR1I2, ASCL2, EPCAM, NR1H2, NR1H4, GTF2H1, ELP4, SULF1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, NACC2, WFS1, HOPX, COPS5, MAFB, BCL6, MAFF, BCL3, CDK2, CYR61, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, RBBP8, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, DNAJA3, PPIL4, GFI1, ZNF608, EDNRB, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, IL23A, PFN1, NBL1, BEX1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, LIF, TOP2A, AHCTF1, PRL, XPO1, HBZ, EDN1, PARP9, TFEC, TLR4, TLR2, SP100, PURA, APBB1, CDX2, CDX1, LILRB1, GRHL2, LILRB4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, PTTG1, LMO2, TIMELESS, ADRB2, NLRP3, TGFB2, TGFB1, CBX4, NR4A2, NFKBIA, NR4A1, NR4A3, FEV, JMY, NFKBID, CREBZF, KDM5D, SLC40A1, TMEM100, KLF12, KLF13, CKAP2, DCN, TGFBR3, IFNG, CAMK2D, LEF1, DLL1, HSPD1, HLX, SNCA, LUM, MEIS2, MEIS1, RBMX]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[CXCL13, SLC8A1, EDNRA, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, TGM2, PDGFRA, PRKCE, F2R, ADCYAP1, AGTR1, CALCA, C5AR1, FPR1, FPR3, ITPR3, FPR2, THY1, CD19, HRH4, PLCG2, PLCG1, CCR10, CCR1, CAV1, CXCL10, CXCL11, PTPRC, CALM3, CD24, GPR18, CXCL9, FASLG, ADM, JPH2, CCR9, CD38, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, CD52, PTGIR, EDN1, TRPC3, GPR35, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, PTGER2, CXCR5, CXCR4, CXCR6, GNA15, CXCR1, CXCR3, CXCR2, S1PR3, CCL1, CCL19, GPR157, SNCA, CCL21, GPR6, P2RX5, CD4, FKBP1B, F2RL1, F2RL3]
GO:0051598;meiotic recombination checkpoint;9.0;1.0;0.896240625180289;9.628524252492122;404.9258988516973;8.390779266560578;0.01355250542491682;0.8253454670833372;[TRIP13, BRCA2]
GO:0006349;regulation of gene expression by genetic imprinting;7.0;0.8933024483968273;0.7975705894556142;9.577230958104572;130.9317736178294;6.8867018697843045;0.004382168632042727;0.7031056191423581;[KCNQ1, ARID4A, ARID4B, BRCA1]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CX3CR1, CXCL6, CCL13, CXCL9, CXCR5, MPL, CXCR4, CXCL1, CXCR6, CXCL13, CXCL3, CXCL2, CXCL5, CCL8, CXCR1, CCL7, CCL5, CXCR3, CXCR2, CCRL2, CCL4, CCR9, CCL2, CCL1, CCR7, CCR6, CCL19, CCR5, CCL18, CCR10, CCR3, CCR2, CCR1, CCL23, CCL21, CCL20, GPR35, PPBP, CXCL10, CXCL11, CXCL12, XCL2, XCL1, PF4]
GO:0051593;response to folic acid;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;113.95729645358138;7.379178354882098;0.003814048157392989;0.728290889492758;[GSN, TYMS]
GO:0045409;negative regulation of interleukin-6 biosynthetic process;8.0;1.0;0.875;9.628524252492122;835.4451311618078;8.16763571524637;0.027961596688182013;0.7926932703116032;[GHSR, NLRP12, INPP5D]
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[SMARCAL1, CCNH, SMC3, CHEK1, TRIM25, WDHD1, ESCO2, NEIL3, DNA2, PRKDC, CDCA5, BRIP1, RAD21, BARD1, CDC7, POLA1, FEN1, BTG2, BRCA1, BRCA2, CHAF1B, CHAF1A, ACTL6A, PARP9, SIRT1, RAD51C, PCNA, UNG, RAD54B, USP1, RAD54L, APBB1, PMS1, GINS2, GINS4, RPA1, RPA2, GTF2H1, MLH1, RPA3, TRIP13, DCLRE1A, PTTG1, RUVBL2, RUVBL1, MEN1, LIG1, MSH6, MSH2, FANCD2, TIMELESS, BLM, RNASEH2A, PSMD14, RAD51AP1, CLSPN, FANCI, FANCL, HMGA1, ISG15, FANCG, COPS5, UBE2T, JMY, CDK2, CDK1, MCM8, FOXM1, EXO1, TOPBP1, RFC5, RFC3, RFC4, RFC1, RFC2, H2AFX, SMC1A, DTL, UHRF1, POLD3, CDC45, POLD1, RBBP8, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, POLQ, MND1, RAD50, RAD51, POLE2]
GO:0006284;base-excision repair;8.0;0.9326813400603323;0.8413406700301662;9.584072489921288;183.0506323445446;5.69953618377475;0.006126539929698291;0.6664745454937787;[UNG, POLQ, LIG1, HMGA1, RPA1, RPA2, NEIL3, RPA3, DNA2]
GO:0007131;reciprocal meiotic recombination;9.0;1.0;0.896240625180289;9.628524252492122;175.07189671554147;6.343086423195323;0.005859498828591432;0.7206263598461826;[MND1, RAD54B, RAD50, RAD51, RAD51C, RAD21, TRIP13]
GO:0032570;response to progesterone;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;105.99106082751567;6.166155715036245;0.0035474254201351726;0.6384578026126634;[YAP1, GABRB1, TGFB2, TGFB1, CAV1, PTGER2, FOS, TYMS, THBS1, FOSL1, CLDN4, FOSB, CD38, TLR2]
GO:0006283;transcription-coupled nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;5.486614186532078;0.006172937954381027;0.676826329833192;[CCNH, RFC5, RFC3, RFC4, RFC1, LIG1, RFC2, PCNA, POLD3, POLD1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, RPA1, RPA2, GTF2H1, COPS5, RPA3]
GO:0007130;synaptonemal complex assembly;6.0;1.0;0.8231203125901445;9.628524252492122;88.07517101545795;6.781341354126479;0.0029477967113796214;0.6699184248047958;[TRIP13]
GO:0045401;positive regulation of interleukin-3 biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.777073627680469;0.027900220892599446;0.875;[SYK]
GO:0006289;nucleotide-excision repair;8.0;0.8436909121759173;0.7968454560879586;9.461470167828956;183.0506323445446;5.132682728539097;0.006126539929698291;0.6374856334316459;[CCNH, BRCA2, RFC5, RFC3, RFC4, RFC1, LIG1, RFC2, SIRT1, NEIL3, PCNA, POLD3, BRIP1, POLD1, RBBP8, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, RPA1, RPA2, GTF2H1, COPS5, RPA3]
GO:0000733;DNA strand renaturation;7.0;0.9326813400603323;0.8172600352873667;9.584072489921288;172.76820112826425;7.57984905034425;0.005782396210476689;0.738553198190834;[SMARCAL1, BLM, RAD54L]
GO:0000731;DNA synthesis involved in DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.369013057007038;574.6870345922199;5.8067817141283475;0.019234257863048946;0.6719590869034888;[BLM, PCNA, BRCA2, POLD3, POLD1, TRIM25, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA2, ISG15, SIRT1, POLA1, POLE2, RPA3, DTL]
GO:0045647;negative regulation of erythrocyte differentiation;8.0;0.9326813400603323;0.8413406700301662;9.582004236857228;359.6763559852469;7.697632086000634;0.012038043947121413;0.7686572628545723;[KLF13, MAFB, HOXA5]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, CLU, ICAM1, PYCARD, TNFSF11, TRIM25, PRKCH, PRKCB, BTK, PRKCQ, ADAM8, S100A9, S100A8, CARD11, TNFRSF11A, PRKCZ, NLRP3, S100A12, TGFB1, EIF2AK2, NFKB1, NFKB2, MYD88, CD40, ITGB2, CD36, CHUK, RIPK2, IL18, IRAK3, TRAF1, GREM1, PSMA6, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0044314;protein K27-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;8.16763571524637;0.00527474598481953;0.8501222226412654;[UBE2S, UBE2T, RNF6]
GO:0045646;regulation of erythrocyte differentiation;7.0;0.7980440201809971;0.7499413753476991;9.34084218004034;77.59787612007705;5.9928839937622085;0.002597131080184449;0.6573957313958061;[SPI1, HMGB2, GATA1, ETS1, INPP5D, NCKAP1L, HOXA5, LYN, MED1, KLF13, STAT1, ISG15, INHBA, MAPK14, MAFB, CDK6, TAL1]
GO:0051090;regulation of DNA binding transcription factor activity;10.0;0.7192862368539868;0.7748841302879137;9.223059144383958;255.33763090554476;3.793137346993279;0.00854592071745993;0.6092222321850824;[GFI1, PHB2, ICAM1, AKT1, TNFSF11, CYP1B1, TRIM25, PRKCH, PRKCB, SFRP4, BTK, SIK1, PRKCQ, TRIB1, BEX1, TWIST1, PRKCZ, PKHD1, NHLH2, S100A12, HMOX1, FZD1, JUN, FZD2, JUP, EIF2AK2, FOSL1, ID1, EZH2, CD40, CD36, HAVCR2, IL10, EDN1, SYK, ANXA3, RIPK2, NFAM1, IL18, FOS, SIRT1, PSMA6, HCK, IL1B, KIT, HCLS1, TLR6, SGK1, TLR4, TLR2, SP100, FLNA, NR1H4, POU4F1, NLRP12, CD40LG, FOXA2, CSF3, TNF, CLU, PYCARD, MEN1, FANCD2, ADAM8, S100A9, S100A8, CARD11, TNFRSF11A, G3BP2, NLRP3, TGFB1, WFS1, NFKB1, NFKB2, NFKBIA, IL6, COPS5, JMY, CCDC22, NFKBID, MYD88, CREBZF, ITGB2, TNFAIP3, ARRB1, ARRB2, MYOCD, CHUK, DDX58, IRAK3, TRAF1, GREM1, XCL1, LTF, HDAC2, NLRC3, NLRC4, NOD2, KLF4]
GO:0045404;positive regulation of interleukin-4 biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.083926447120524;0.027900220892599446;0.839552420951524;[CD86]
GO:0110032;positive regulation of G2/MI transition of meiotic cell cycle;9.0;1.0;0.896240625180289;9.628524252492122;414.4836470731219;8.67846133901236;0.013872394656472954;0.8400575416471059;[CDC25C, CDC25A]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[SPI1, EHMT2, SLA2, PHB2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, FZD1, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, HELLS, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, ZEB1, TAL1, RARA, HCLS1, PLCB1, NR1I2, ASCL2, BTAF1, FLNA, STAT1, NR1H2, NR1H4, POU4F1, CENPF, FOSB, LGR4, GMNN, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, FOXO1, SBNO2, NACC2, ZNF423, WFS1, NFKB1, NFKB2, DAB2, BCL6, BCL3, CDK2, CIITA, FHL2, FASLG, FOXM1, HHEX, EMILIN1, RFC1, PEG3, XCL1, BIRC5, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, E2F8, PRRX1, KLF4, PML, KLF8, KLF5, DNAJA3, GFI1, IKZF1, UXT, ZNF608, EDNRB, DPF3, SOX7, SOX4, HNF1B, RUNX2, EREG, SFRP2, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H2, SUV39H1, IFNA2, PTPRK, BRCA1, BMI1, XPO1, CD38, CD36, HBZ, EDN1, PARP9, CBFA2T3, MDFIC, IL1B, DEPDC1, SP100, SATB2, RELB, PURA, RXRA, APBB1, CDX2, LILRB4, NEDD4, ARID4A, LOXL2, CHCHD3, BASP1, EOMES, CCNE1, TIMELESS, CALCA, TCF7, TGFB1, CBX4, VDR, CAV1, HMGA1, NR4A2, BMP2, NR4A3, UBA3, MXD1, CREBZF, HMGB2, MYOCD, KLF12, H2AFX, GREM1, IFNG, ELF3, IRF7, IRF8, FBP1, PFDN5, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, GATA1, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, DLGAP5, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, STAT4, SPP1, STAT1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, RUVBL2, ADCYAP1, BLM, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, ARRB1, FOXM1, HHEX, PPP1R12A, PEG3, UHRF1, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, POU2AF1, CCNH, CCNC, IKZF1, TNFSF11, HNF1B, SFRP2, EGR1, EGR2, EGR3, IGF1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3D, HNF4A, CD38, IL10, IL18, RGMA, IL1A, IL1B, YAP1, SATB2, RELB, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, EOMES, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL2, MYBL1, YWHAH, MYOCD, DDX58, ETV1, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, RNF6, TBX21, EGF, MAPK14, CD4, TNIP3, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, PRKDC, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD2, FZD5, FZD8, FOSL2, FOSL1, TGFB1I1, PAX5, PAX2, ZEB1, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, EPCAM, NR1H2, NR1H4, GTF2H1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, DAB2, COPS5, MAFB, MAFF, BCL3, CDK2, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR4, TLR2, SP100, APBB1, CDX2, CDX1, LILRB1, GRHL2, CAMK4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, CKS1B, KLF13, CKAP2, DCN, DNM2, LEF1, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:0044320;cellular response to leptin stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;109.38485831558611;7.379178354882098;0.003661012767841448;0.7004918368257019;[CCNA2, PID1, NR4A3]
GO:0034501;protein localization to kinetochore;8.0;0.8436909121759173;0.7968454560879586;9.292052015870908;35.81813124301707;7.212124270218933;0.0011988006184784857;0.7438283705770736;[MIS12, CDK1, BUB1B, TTK, AURKB]
GO:0071930;negative regulation of transcription involved in G1/S transition of mitotic cell cycle;11.0;1.0;0.9324289523296623;9.628524252492122;1849.0626671205805;8.67846133901236;0.061886463420164586;0.8762458687964789;[E2F1, E2F7]
GO:0018279;protein N-linked glycosylation via asparagine;9.0;0.8653626801206646;0.8289219652406215;9.4949928598676;334.83267440717236;6.113511981550823;0.011206548282565083;0.7088859122241795;[ST6GALNAC2, ASGR1, ASGR2, ST3GAL6]
GO:1904172;positive regulation of bleb assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;9.083926447120524;0.006704083591926775;0.8607930461318132;[ANLN]
GO:0071932;replication fork reversal;9.0;1.0;0.896240625180289;9.628524252492122;151.34471233918515;9.777073627680469;0.005065371320594365;0.896240625180289;[DNA2]
GO:0070839;divalent metal ion export;8.0;0.8933024483968273;0.8216512241984136;9.427853557029971;35.67391733828006;9.083926447120524;0.001193973908871026;0.839552420951524;[SLC11A1, SLC40A1]
GO:1903096;protein localization to meiotic spindle midzone;9.0;1.0;0.896240625180289;9.628524252492122;35.99248463016168;9.777073627680469;0.0012046360694383546;0.896240625180289;[TTK]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[, NUP107, PRKACB, CLDN3, PADI4, PDGFC, ABCA1, MCTS1, JUP, FN1, COL1A1, COL1A2, HLA-DRB1, ACHE, DPYS, ARHGAP6, CHAF1B, CHAF1A, KCND2, ARG1, F5, SLC7A7, SLC7A9, KCNA5, CENPA, HLA-DMA, HLA-DMB, DMD, CENPW, CENPE, CENPF, CENPH, CENPI, CENPK, CENPL, CENPM, GOPC, CENPN, CENPO, KCNG2, NCF1, GMNN, RUVBL2, RUVBL1, OLFM4, BLM, UQCRB, LIN7A, ACAT1, G3BP2, CXCL12, DMXL2, HLA-DRA, LRRK2, ALAD, VBP1, NDUFC2, ACPP, BDP1, BIRC2, BIRC3, NDUFB7, NDUFB6, HM13, NDUFB4, NDUFB3, NDUFB2, NDUFB1, CDC45, CCL5, EIF4H, NDUFA8, NDUFA7, NDUFA6, NDUFA3, NDUFA2, IL2RB, CD247, EIF3D, CCNH, PRF1, IKZF1, TCL1A, SNRPD2, SNRPD1, TNFSF11, FBXO5, SNRPD3, HNF1B, MIF, KCTD12, KCTD15, TGFA, PTK2, ANLN, CD40, CTSZ, CD3G, CD3E, CD3D, CCT3, CCT2, FCER1G, YAP1, NAPA, MIS12, CAPG, RXRA, CCT8, CD74, GCH1, RPA1, RPA2, RPA3, NDUFAB1, TGM2, NDUFB10, NDUFB11, TCF7, RASGRP1, CCNB1, LPXN, H1FX, ECT2, CAV2, UBE2C, CAV1, HMGA1, VIL1, NASP, UBE2S, TCF4, HMGB2, TNFAIP3, LAMC1, NUP62, GREM1, NDUFS8, NDUFS7, NDUFS6, NDUFS4, NDUFS3, NUP54, FBP1, TAF9, SAMHD1, RRM1, EGF, MX2, SOD2, TTC19, TEK, CDA, BIN2, ASF1B, NUP205, PRKCZ, ACMSD, HMOX1, NCKAP1L, EHD3, SERPINA1, CLINT1, TK1, BRD2, HCLS1, GSN, GTF2H1, HJURP, TNF, CLU, DACH1, OIP5, MEN1, TLE4, SNRPG, SNRPE, SNRPF, ITPR3, NACC2, LSM3, HOPX, SYNJ1, CDK1, PIK3C2A, EMILIN1, ADSL, VWF, TRAF1, PTBP2, MCM2, NLGN1, NLRC4, NOD2, PLN, WASF3, PML, MARCKS, RAD51, P2RX1, IMPDH2, PPP2R1A, MCCC2, COX7A2L, TLN1, MGST1, CD79B, CD79A, VASP, CDT1, AHCTF1, HBZ, RAD51C, UQCR10, AIF1, CTNNA1, NDUFA11, KNTC1, CHRNB4, NCF1C, ADRB2, NLRP3, MYH11, TGFB1, EIF2S1, H2AFX, AXIN2, CKAP5, DNM2, TGFBR3, COL6A2, COL6A1, COLEC12, CAMK2D, HIST1H2BK, LEF1, HSPD1, REPS2, POLQ, RBMX]
GO:0006296;nucleotide-excision repair, DNA incision, 5'-to lesion;8.0;1.0;0.875;9.628524252492122;115.13879119899096;6.166155715036245;0.0038535917232456105;0.6903374900225189;[PCNA, POLD3, POLD1, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA2, GTF2H1, RPA3]
GO:0007140;male meiotic nuclear division;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;65.96656019186406;6.015873511986907;0.0022078414035718876;0.6585714164269392;[BRCA2, KIF18A, RAD51C, FIGNL1, TRIP13, MYBL1]
GO:0007141;male meiosis I;8.0;1.0;0.875;9.628524252492122;140.0657740590801;6.641579411751319;0.004687875406744682;0.7146506799819907;[RAD51C, TRIP13, BRCA2, MYBL1]
GO:0046985;positive regulation of hemoglobin biosynthetic process;8.0;1.0;0.875;9.628524252492122;545.056182040423;8.67846133901236;0.018242539894176294;0.8188169164668168;[KLF4]
GO:0006297;nucleotide-excision repair, DNA gap filling;7.0;1.0;0.8509193652572005;9.628524252492122;149.0421272461911;6.641579411751319;0.0049883058697239;0.6905700452391912;[RFC5, RFC3, PCNA, RFC4, RFC1, LIG1, RFC2, RPA1, RPA2, POLD3, POLD1, RPA3]
GO:0045410;positive regulation of interleukin-6 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.3044735649636;7.8311634786251565;0.02792341990494083;0.7754860644832351;[TLR1, IL1B, PTAFR, TLR6, EREG]
GO:0007144;female meiosis I;8.0;1.0;0.875;9.628524252492122;140.0657740590801;8.16763571524637;0.004687875406744682;0.7926932703116032;[TRIP13]
GO:0006298;mismatch repair;8.0;0.8259837884571596;0.7879918942285797;9.500690880982237;183.0506323445446;6.375876246018314;0.006126539929698291;0.701062607729944;[PCNA, RNASEH2A, LIG1, RPA1, RPA2, MLH1, MSH6, POLD3, MSH2, EXO1, RPA3, PMS1]
GO:0045416;positive regulation of interleukin-8 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.474488534686424;0.027942676825076673;0.7572456912631272;[TLR8, TLR7, TLR4, TNF, ELANE]
GO:0042148;strand invasion;7.0;0.8436909121759173;0.7727648213451592;9.456673995565463;149.0421272461911;7.8311634786251565;0.0049883058697239;0.7514054297404357;[RAD51, RAD51C]
GO:0045415;negative regulation of interleukin-8 biosynthetic process;8.0;1.0;0.875;9.628524252492122;836.0204953067102;8.390779266560578;0.027980853608317785;0.8041048419030481;[BCL3, KLF4, ELANE]
GO:1990776;response to angiotensin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;7.138016298065211;0.0024778305216419678;0.7159578506919597;[BRIP1, PRKCD, CYBB, CDC6, PTGS2, SLC30A10, NFKB1]
GO:0043242;negative regulation of protein complex disassembly;6.0;0.7248374789738407;0.6855390520770648;8.83001655627435;65.72942481560547;5.572381008289503;0.002199904695936496;0.6080921364962873;[LMOD1, CAPG, TNF, EPS8, SPTA1, SPTAN1, TMOD1, GSN, CKAP2, IRAK3, SPTB, VIL1]
GO:0070830;bicellular tight junction assembly;6.0;1.0;0.8231203125901445;9.628524252492122;56.140948375987016;6.280566066213989;0.001878987018571015;0.6443087532925187;[ACTN4, F11R, GRHL2, CLDN3, POF1B, ECT2]
GO:0014902;myotube differentiation;6.0;0.8653626801206646;0.7558016526504768;9.377209824211215;22.452520143917486;7.379178354882098;7.514656432606705E-4;0.7004918368257019;[MEF2C, SORT1, AVPR1A]
GO:0001837;epithelial to mesenchymal transition;5.0;0.7508913569872202;0.6656866903545304;8.647694999480395;23.145667324477426;5.618190544320798;7.746646556020492E-4;0.5775555375700647;[LEF1, LOXL2, TMEM100, EPB41L5, FAM83D, EOMES, TGFB2, TGFB1, TGFBR3, BMP2, SNAI2, ENG]
GO:0010543;regulation of platelet activation;8.0;0.7866048967936545;0.7683024483968273;9.510741216835738;81.8829764000265;6.343086423195323;0.0027405495302144796;0.6993857346658935;[LYN, PDGFRA, FCER1G, SYK, TXK, PRKCD, PLEK, PDGFA, ALOX12, SELP, THBD, CEACAM1, PDPN, CD9, PRKCQ, TLR4]
GO:0071922;regulation of cohesin loading;9.0;0.7586651285174919;0.775573189439035;9.446202695698167;97.41872309218135;8.16763571524637;0.0032605169907366205;0.8139338954918922;[CDCA5]
GO:0043009;chordate embryonic development;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;22.496195207419138;4.623782033182691;7.529274083310655E-4;0.5595807407949613;[IHH, EDNRA, PDGFRA, TPM1, MSH2, TWIST1, GATA3, GATA1, EPB41L5, CCNB2, CCNB1, PLCG1, MYH10, STIL, EIF2S2, FOSL1, BMP2, MAFF, BCL2L1, PTPRR, BRCA1, TMEM100, HHEX, EDN1, DUSP3, RXRA, TIE1]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[ITGB2, PTGS2, TNF, CLU, AIF1, ICAM1, KLRK1, AKT1, CD36, EDN1, AGXT2, KLF4, DNM2, IFNG, IL1B, PTX3, TLR6, TLR4]
GO:0090435;protein localization to nuclear envelope;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;34.85305034697331;7.697632086000634;0.0011665002294043187;0.7445766281117727;[NUP155, PLK1, NUP54]
GO:1905049;negative regulation of metallopeptidase activity;10.0;0.8933024483968273;0.861892236059334;9.59573442966913;499.6307270806722;7.9853141584524145;0.016722190796928726;0.8236103492792612;[TIMP2, TIMP3, TIMP1]
GO:0006260;DNA replication;7.0;0.7307253602413294;0.7162820453778652;9.271849308553389;254.20053156235352;4.77312732173501;0.008507863025766288;0.5950173184638491;[DSCC1, CHEK1, WDHD1, DNA2, SLBP, BLM, RNASEH2A, BRIP1, CLSPN, BARD1, CDT1, CDC7, CDC6, POLA1, POLA2, NASP, CDK2, CDK1, ACHE, FEN1, MCM7, MCM8, MCM10, BRCA1, CHAF1B, CHAF1A, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, RMI1, DBF4, MCM3, MCM4, MCM5, MCM6, DTL, MCM2, CDC45, POLD1, RBBP8, POLQ, RRM1, RRM2, RPA1, DONSON, RPA2, RAD50, POLE2, RPA3, DNAJA3, SSBP1]
GO:0006261;DNA-dependent DNA replication;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;254.89367874291247;6.250713103064308;0.008531062038107634;0.6946617587785947;[SLBP, POLD1, RFC5, WDHD1, POLQ, RFC3, RFC4, RFC1, RFC2, RPA1, DONSON, POLE2, DNAJA3, SSBP1, DNA2]
GO:0006266;DNA ligation;7.0;0.7763722522362496;0.7391054913753253;9.35659053700848;149.0421272461911;7.004484905440688;0.0049883058697239;0.7091290490632969;[TOP2A, LIG1, HMGB2]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, FCER1G, CHUK, SYK, FOS, GAB2, VAV1, LAT2, BTK, PRKCQ, LCP2, CARD11, PAK1, IGKC, IGLV1-44, PLCG2, PLCG1, LYN, JUN, NFKB1, NR4A3, IGKV3-20, LAT]
GO:0008203;cholesterol metabolic process;6.0;0.7980440201809971;0.722142322680643;9.223059144383958;82.64786032185484;5.058574756385375;0.0027661495067272364;0.581816060879476;[CUBN, CH25H, NPC2, CFTR, CEBPA, RXRA, ABCA1, DHCR24, SNX17]
GO:0045665;negative regulation of neuron differentiation;8.0;0.6162540371078848;0.6831270185539424;8.732436227935485;338.1488864638422;4.401795219996305;0.011317538915704735;0.6001080122550225;[SEMA5B, GFI1, EDNRB, LGALS1, ARHGDIA, TNR, HOXA2, EPHB2, MED1, SEMA6A, PAQR3, THY1, JAG1, PLK2, PTK2, ID1, ITM2C, NRP1, LRRK2, CTSZ, ARHGAP4, CD38, YWHAH, DCC, RGMA, ASPM, IL1B, NLGN1, HDAC2, LRP1, RNF6, DLL1, SPP1, LINGO1, SEMA4A, SEMA4B, IRX3, MEIS1, PMP22]
GO:0000712;resolution of meiotic recombination intermediates;5.0;1.0;0.7902410118609202;9.628524252492122;26.252913020668647;6.8867018697843045;8.786613727139965E-4;0.6424272657460779;[TOP2A, BLM, MLH1]
GO:0045666;positive regulation of neuron differentiation;8.0;0.6181399273706679;0.684069963685334;8.712233520617966;337.32148776029015;3.9481280100702625;0.011289846625707336;0.576907450041722;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, MEF2C, ADCYAP1, MAP1B, S100A9, NBL1, EPHA3, NEDD4L, SOCS2, ECT2, LYN, FZD1, SYT2, FN1, BMP2, CXCL12, LIN28A, BCL6, FES, BCL2, PLXNB2, TCF4, EZH2, ROBO2, NRP1, TIMP2, NME1, ZEB1, RARA, SHANK3, NLGN1, RAB21, PAK1, CNR1, FYN, APBB1, IRX3, FKBP1B, CAMK1]
GO:0038094;Fc-gamma receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.857092701852345;0.002626513627734276;0.6233919466506386;[CYFIP1, CD3G, IGHG1, FCGR3A, FCGRT, FCER1G, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, CLEC4D, CLEC4E, PAK1, IGKC, IGLV1-44, PLCG2, NCKAP1L, FYN, PLCG1, FCGR1A, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0043001;Golgi to plasma membrane protein transport;8.0;0.9326813400603323;0.8413406700301662;9.589303539338841;211.1766051690936;6.481236761676141;0.00706789092840378;0.7064507494004503;[GOLPH3L, RAB31]
GO:0006267;pre-replicative complex assembly involved in nuclear cell cycle DNA replication;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;77.92043580405796;8.67846133901236;0.0026079268625224215;0.8400575416471059;[CDC45]
GO:0043488;regulation of mRNA stability;9.0;0.7436939687323844;0.7680876095464813;9.240758721483358;282.23354693635815;4.989581884898423;0.009446102822258332;0.6514080748132811;[FMR1, XPO1, AKT1, SLC11A1, PRKCD, AXIN2, E2F1, RBM38, TNFSF13, MAPK14, MYD88]
GO:0006264;mitochondrial DNA replication;9.0;1.0;0.896240625180289;9.628524252492122;406.93153826265655;7.697632086000634;0.013619632371043343;0.7898978880348613;[DNAJA3, SSBP1, DNA2]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP1, CD3G, IGHG1, FCGR3A, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, PLCG2, NCKAP1L, FYN, PLCG1, FCGR1A, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0006265;DNA topological change;7.0;1.0;0.8509193652572005;9.628524252492122;171.38190676714436;7.57984905034425;0.005735998185793931;0.738553198190834;[TOP2A, HMGB2]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[CEBPA, CEBPB, IFITM1, CYR61, IL6R, CTHRC1, MEF2C, JAG1, IGF1, RUNX2, IL6, BMP2, SFRP2, FAM20C, LTF]
GO:0045425;positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.083926447120524;0.027900220892599446;0.839552420951524;[SYK, CD80]
GO:0006268;DNA unwinding involved in DNA replication;8.0;0.8259837884571596;0.7879918942285797;9.34084218004034;24.41922106263308;7.57984905034425;8.172893530941673E-4;0.7626338329336335;[PURA, RAD51, MCM7, HMGA1, RPA1, MCM4, MCM6, MCM2]
GO:0038093;Fc receptor signaling pathway;7.0;0.8436909121759173;0.7727648213451592;9.474373572664863;77.78262967477835;4.556717802602145;0.0026033146153928975;0.5839501255913225;[CYFIP1, IGHG1, FCGRT, GRAP2, PRKCE, PRKCD, CLEC4D, BTK, PRKCQ, CLEC4E, CARD11, IGLV1-44, PLCG2, NCKAP1L, PLCG1, LYN, JUN, PTK2, NFKB1, NR4A3, IGKV3-20, LAT, ITK, CD3G, FCGR3A, FCER1A, FCER1G, CHUK, SYK, FOS, GAB2, VAV1, LAT2, FGR, HCK, KIT, LCP2, PAK1, IGKC, FYN, FCGR1A, FCGR1B, FCGR2A, CD247, FCGR2B]
GO:0006269;DNA replication, synthesis of RNA primer;8.0;0.8259837884571596;0.7879918942285797;9.523163736834295;624.5843169808977;8.16763571524637;0.020904274999959296;0.7926932703116032;[POLA1, PRIM2, PRIM1]
GO:0006027;glycosaminoglycan catabolic process;6.0;0.7866048967936545;0.7164227609869718;9.245532000236016;234.16675596998346;5.618190544320798;0.00783735058591714;0.610434838299289;[SDC2, HMMR, GNS, PKHD1, PGLYRP1, TGFB1, LUM, FUCA1, OMD, BGN, HSPG2, DCN, VCAN, OGN, SDC1, CSPG4, HPSE]
GO:0097067;cellular response to thyroid hormone stimulus;6.0;0.8933024483968273;0.7697715367885581;9.485423408851448;110.48347060425422;7.004484905440688;0.003697782332456301;0.6813299963962409;[GHSR, MED1, KIT, LMO2, CTSH, GAS2L1, GATA1, CTSS, CTSB]
GO:0045672;positive regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;840.7838216260375;6.599019797332524;0.0281402778535103;0.7337148045016781;[CCR1, TMEM64, FOS, TNF, POU4F1, IFNG, IL23A, CA2, TNFSF11, IL17A]
GO:0043011;myeloid dendritic cell differentiation;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;91.1712242271392;6.8867018697843045;0.003051418826107602;0.6753065664753021;[TGFB1, SPI1, RELB, CAMK4, LTBR]
GO:0045671;negative regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;842.5336305879634;6.481236761676141;0.028198842384740134;0.7276913745807394;[LILRB1, LILRB3, LILRB4, MAFB, INPP5D, TLR4, LTF, FBN1]
GO:0010759;positive regulation of macrophage chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;998.0472698001994;7.292166977892469;0.033403743935984914;0.7881627702307852;[CCL5, C5AR1, C3AR1, MAPK14, THBS1]
GO:0001805;positive regulation of type III hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1205.6585476054483;9.083926447120524;0.04035230656610712;0.8969813732811862;[FCER1G, BTK]
GO:0033630;positive regulation of cell adhesion mediated by integrin;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.61675044652454;6.943860283624253;0.0011585914843924019;0.6453503496879909;[TGFB2, SFRP2, SYK, CCL21, CCL5, ADAM9, NCKAP1L, PTPN6, CXCL13]
GO:0010994;free ubiquitin chain polymerization;7.0;1.0;0.8509193652572005;9.628524252492122;46.126504921393284;8.16763571524637;0.0015438126085597365;0.7686126355688037;[UBE2C, UBE2S]
GO:0006270;DNA replication initiation;7.0;0.7980440201809971;0.7499413753476991;9.405380701177911;149.0421272461911;6.343086423195323;0.0049883058697239;0.6753050999230941;[GINS2, MCM7, MCM8, GINS4, MCM10, CDC7, CDC6, POLA1, PURA, POLA2, CDC34, CDC45, CCNE2, CCNE1, MCM3, MCM4, MCM5, MCM6, TOPBP1, MCM2]
GO:0000729;DNA double-strand break processing;7.0;0.811012628672052;0.7564256795932265;9.35659053700848;149.0421272461911;6.599019797332524;0.0049883058697239;0.6883935445785896;[BARD1, BLM, RAD50, BRIP1, EXO1, RBBP8, BRCA1, DNA2]
GO:0008210;estrogen metabolic process;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;78.56989776551285;6.599019797332524;0.002629663769894499;0.6605944919115335;[PDGFRA, HSD17B4, CYP1B1]
GO:0006273;lagging strand elongation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;265.91551950056737;7.9853141584524145;0.008899953129253659;0.8046099625986299;[POLA1, LIG1]
GO:0000727;double-strand break repair via break-induced replication;10.0;1.0;0.9152410118609203;9.628524252492122;521.7226431472901;8.16763571524637;0.01746158734624478;0.8329342821725234;[GINS2, CDC45, GINS4, CDC7]
GO:0006271;DNA strand elongation involved in DNA replication;8.0;0.7763722522362496;0.7631861261181248;9.417215158824915;149.73527442675106;7.069023426578259;0.005011504882065279;0.7365101867784198;[GINS1, POLA1, GINS2, RFC3, PCNA, RFC4, LIG1, GINS4]
GO:0006272;leading strand elongation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;265.91551950056737;8.67846133901236;0.008899953129253659;0.8400575416471059;[POLA1, PCNA]
GO:0090200;positive regulation of release of cytochrome c from mitochondria;9.0;1.0;0.896240625180289;9.628524252492122;472.23248408711356;6.409777797693995;0.015805196260752157;0.7240369598395108;[BIK, PLAUR, MMP9, PYCARD]
GO:0000724;double-strand break repair via homologous recombination;9.0;0.8653626801206646;0.8289219652406215;9.515195567185119;520.6240308586224;5.299736813202263;0.01742481778162994;0.6672694122704188;[BLM, FEN1, PSMD14, MCM8, BRCA1, BRCA2, RAD54B, RAD51AP1, CDC45, RBBP8, RAD54L, GINS2, POLQ, H2AFX, GINS4, RPA1, RPA2, CDC7, RAD50, RAD51, RAD51C, RPA3]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[BLK, ITK, TXK, SLA, SLA2, GRAP2, FYN, CSK, JAK3, LYN, SYK, MATK, BMX, PTK2, FGR, ZAP70, HCK, LCK, FES, BTK]
GO:0043254;regulation of protein complex assembly;5.0;0.5023590972498763;0.5414205604858584;6.876988939450173;27.318252308649967;3.6656062881777913;9.14317319939619E-4;0.4777002879064576;[CYFIP1, ICAM1, EPS8, TCL1A, STMN1, ARFIP1, PRKCE, PRKCD, HNF1B, CLDN7, PFN1, TWIST1, PRKCZ, NCKAP1L, ABCA1, VASP, CDT1, JUN, EIF2AK2, FOSL1, KIF14, CCR7, CD36, SPTAN1, HCK, TAL1, HCLS1, TLR6, TLR4, NAPA, CAPG, PAK1, GSN, CCL21, BIK, NR1H2, RPA1, RPA2, GTF2H1, PSMC6, RPA3, PSMC2, CSF3, HJURP, CXCL13, TNF, CLU, PYCARD, TMOD1, CORO1A, SPTA1, TMEM27, TGFB1, SELP, VIL1, FES, JMY, PLEK, LMOD1, MMP1, SPTB, PSRC1, IFNG, IRF8, LCP1, CDH17, BIRC2, NLRC3, EPS8L1, EPS8L3, SNCA, VPS41]
GO:0000723;telomere maintenance;7.0;0.7307253602413294;0.7162820453778652;9.292052015870908;183.01793442924338;5.266214121163619;0.006125445559899373;0.6202338003175094;[DCLRE1A, FEN1, BRCA2, RFC5, RFC3, RFC4, RFC1, RFC2, RAD51C, CCNE2, CCNE1, DNA2, PRIM2, BLM, SP100, PCNA, PRKDC, PRIM1, POLD3, POLD1, RPA1, RPA2, POLA1, POLA2, RAD50, RAD51, RPA3]
GO:0042167;heme catabolic process;7.0;0.8259837884571596;0.7639112594857803;9.464221201200845;638.5210787907555;7.8311634786251565;0.02137072587546392;0.7514054297404357;[BLVRB, HMOX1]
GO:0000722;telomere maintenance via recombination;9.0;0.9326813400603323;0.8625812952104552;9.593432932680852;337.7230221555657;7.212124270218933;0.011303285620559713;0.7650689957573628;[RAD50, RAD51, RAD51C, BRCA2]
GO:0043017;positive regulation of lymphotoxin A biosynthetic process;8.0;1.0;0.875;9.628524252492122;856.0759792352393;9.777073627680469;0.028652092606641942;0.875;[CD86]
GO:0007129;synapsis;6.0;1.0;0.8231203125901445;9.628524252492122;47.18392532465019;6.686031174322154;0.0015792035178401665;0.665044257777226;[CCNE2, CCNE1, FANCD2, MLH1]
GO:0007127;meiosis I;7.0;0.8653626801206646;0.7836007053175329;9.405380701177911;72.30745439798314;6.343086423195323;0.0024200654262164006;0.6753050999230941;[BRCA2, RAD51C, CKS2, TRIP13, MYBL1]
GO:0033629;negative regulation of cell adhesion mediated by integrin;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;51.31823397956752;7.474488534686424;0.0017175751078840245;0.7053660038532718;[SERPINE1, CYP1B1, SNAI2]
GO:1990314;cellular response to insulin-like growth factor stimulus;8.0;1.0;0.875;9.628524252492122;388.66587636398185;7.57984905034425;0.013008297105323164;0.7626338329336335;[CCNA2, GHSR, TGFB1, FBN1]
GO:0010529;negative regulation of transposition;5.0;0.8653626801206646;0.7229223519212526;9.271849308553389;41.7579727432223;6.781341354126479;0.0013976017679800644;0.6370391240755715;[MYBL1, APOBEC3A, APOBEC3B]
GO:0001812;positive regulation of type I hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1109.5695898802176;9.083926447120524;0.0371362956254912;0.8969813732811862;[FCER1G, BTK]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[CD74, FCER1G, PRKCD, EXO1, INPP5D, BCL3, IRF7, TLR8, CD27, FCGR2B, IL13RA2, HLA-DQB1]
GO:0031442;positive regulation of mRNA 3'-end processing;10.0;0.9326813400603323;0.8815816818910864;9.590783924509275;630.6357977915417;7.57984905034425;0.021106812616712402;0.8028748447945538;[CCNB1, NCBP2]
GO:0002903;negative regulation of B cell apoptotic process;10.0;0.8436909121759173;0.837086467948879;9.466005322994347;155.02018656046687;7.292166977892469;0.00518838613506862;0.7881627702307852;[CD74, BCL6, MIF, AURKB]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, IL1RN, CSF3R, C5AR1, ITGB2, PIK3CD, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, S100A12, CCL1, NCKAP1L, CCL19, CCL18, CCL23, TGFB2, CXADR, FCER1G, SYK, CCL21, CCL20, PDE4D, PPBP, VAV1, CXCL10, CXCL11, IL1B, XCL2, XCL1, S100A9, S100A8, PF4]
GO:0010767;regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage;12.0;0.9326813400603323;0.9144609826203107;9.60185600540996;631.9844254116175;8.67846133901236;0.02115194996947028;0.8919372290569614;[NEDD4, CHEK1]
GO:0001818;negative regulation of cytokine production;5.0;0.5133656128089943;0.5469238182654175;7.031139619277432;44.35819177106142;4.304802954008995;0.0014846287587966433;0.5103888351227501;[CD83, TNF, PYCARD, HERC5, CDH3, DHX58, TRIM25, HOMER3, PGLYRP1, GHSR, CD96, LAG3, IL1R2, SLC11A1, IL23A, BTK, CD274, TWIST1, GATA3, INPP5D, NLRP3, HMOX1, NCKAP1L, ELANE, SLAMF1, TGFB2, TGFB1, PRG2, FN1, ISG15, INHBA, NFKB1, IL6, BCL6, BCL3, CD24, GPR18, ORM1, IFNA2, TNFAIP3, PTPN22, ARRB1, ARRB2, LRRC32, IFIH1, CD34, JAK3, HAVCR2, IL10, ANXA1, ARG1, DDX58, IRAK3, PDCD1LG2, CEACAM1, IFNG, BANK1, RARA, TLR8, XCL1, BPI, TLR6, TLR4, LTF, LEF1, NLRC3, DLL1, THBS1, RELB, GPNMB, TBX21, CSK, TIGIT, IL33, NR1H4, LILRB1, KLF4, PML, NLRP12, F2RL1, FCGR2B, LGR4]
GO:0033624;negative regulation of integrin activation;7.0;1.0;0.8509193652572005;9.628524252492122;113.99365377889563;9.083926447120524;0.0038152650043517884;0.8154717862087246;[KIF14]
GO:0090656;t-circle formation;8.0;1.0;0.875;9.628524252492122;168.69220570471313;7.379178354882098;0.005645976311808157;0.7523715242355574;[SMARCAL1, BLM, EXO1, DNA2]
GO:1905463;negative regulation of DNA duplex unwinding;8.0;0.8933024483968273;0.8216512241984136;9.5544162803384;116.67017030639651;9.083926447120524;0.003904845603818755;0.839552420951524;[TOP2A, MCM2]
GO:0045605;negative regulation of epidermal cell differentiation;7.0;0.8436909121759173;0.7727648213451592;9.517298617381897;259.1625201531526;7.212124270218933;0.008673936318400527;0.7197477358342742;[HOXA7, DLL1, GRHL2, EZH2]
GO:0030194;positive regulation of blood coagulation;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;205.4468638594546;6.518977089658987;0.006876121643202558;0.7083807915285978;[F2R, SERPINE1, PLEK, THBS1, F3, SELP, THBD, PDPN, CD36, HPSE, TLR4, S100A9]
GO:0061098;positive regulation of protein tyrosine kinase activity;11.0;0.8436909121759173;0.8542744084176208;9.55953138100517;2154.6219316186807;5.8650506222523235;0.07211325701743153;0.7323679139043926;[CSF1R, NCF1, TGFA, GRM5, CCL5, STAP1, FYN, ACE, EGF, EREG, GREM1, CD24]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[TGFA, SLC30A10, PIK3C2A, EPS8, EFEMP1, REPS2, AKT1, PLCG1, TGFB1, EGF, GAB1, PTK2, EREG, BTC, VIL1, KIF16B, FES, HBEGF]
GO:0042572;retinol metabolic process;9.0;1.0;0.896240625180289;9.628524252492122;118.00963323224862;6.375876246018314;0.003949676222508656;0.722303232910233;[DGAT2, TTR, ALDH1A1, CYP1B1]
GO:0043420;anthranilate metabolic process;8.0;0.8933024483968273;0.8216512241984136;9.533214072687796;223.03738466346266;9.777073627680469;0.0074648605440717835;0.875;[KYNU]
GO:0045842;positive regulation of mitotic metaphase/anaphase transition;11.0;0.9326813400603323;0.8987696223598284;9.60254876608886;1435.6381372244598;7.57984905034425;0.04804951646246229;0.8200627852632958;[CDT1, ESPL1, DLGAP5]
GO:0042573;retinoic acid metabolic process;9.0;0.8259837884571596;0.8092325194088689;9.500690880982237;139.55611397069308;6.7325511899570465;0.0046708175422506696;0.740543606130341;[SCPEP1]
GO:0045600;positive regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;5.71663061713405;0.00382428925936973;0.6154690682008903;[CEBPA, CEBPB, PTGS2, FRZB, PRDM16, AKT1, TMEM64, MAPK14, BMP2, KLF5, SFRP2]
GO:0051294;establishment of spindle orientation;7.0;0.8653626801206646;0.7836007053175329;9.517298617381897;88.53546790794914;6.343086423195323;0.002963202434130993;0.6753050999230941;[GPSM2, SPAG5, CENPA, NDC80, LLGL2]
GO:0042574;retinal metabolic process;9.0;1.0;0.896240625180289;9.628524252492122;79.50217411028933;7.212124270218933;0.0026608662201599294;0.7650689957573628;[CYP1B1]
GO:0009113;purine nucleobase biosynthetic process;8.0;0.7763722522362496;0.7631861261181248;9.474373572664863;934.1877806379209;7.138016298065211;0.03126642430353244;0.7400384854347593;[MTHFD1, GMPS, PAICS, GART, PRTFDC1]
GO:0045840;positive regulation of mitotic nuclear division;8.0;0.7140352122741334;0.7320176061370667;9.138976027173417;276.06341799230654;5.75172193694532;0.009239594159256459;0.6691433273378073;[CDCA5, TGFA, PHB2, AURKA, NUP62, NUSAP1, DLGAP5, SH2B1, PDGFRB, RANBP2, RANBP1, CDT1, EDN1, TGFB1, EGF, UBE2C, IGF1, EREG, BTC, IL1A, ESPL1, IL1B, CD28]
GO:0051290;protein heterotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;6.444869117505266;0.002859955186148837;0.6805102716434839;[CD74, NLGN1, RRM1, NUP54]
GO:0097053;L-kynurenine catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;764.3846786597122;9.083926447120524;0.025583267293192123;0.8797934328124444;[KYNU]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[CDA, DPYS, TK1, ACPP, FBP1, HM13, SAMHD1, CD79A, RXRA, VASP, SOD2, IMPDH2, CD247]
GO:0051045;negative regulation of membrane protein ectodomain proteolysis;9.0;1.0;0.896240625180289;9.628524252492122;966.2736676900156;7.697632086000634;0.032340310067742455;0.7898978880348613;[IL10, TIMP2, TIMP3, TIMP1]
GO:0001867;complement activation, lectin pathway;8.0;1.0;0.875;9.628524252492122;200.06168254027287;7.292166977892469;0.006695884470798082;0.747921758369865;[FCN1, C1S]
GO:0010575;positive regulation of vascular endothelial growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;64.54350789155374;6.481236761676141;0.002160213123744424;0.6545710619905948;[TGFB1, C5AR1, RORA, BRCA1, PTGS2, SULF1, SULF2, C3, IL1A, IL1B, C3AR1, CYP1B1, HPSE, NOX1]
GO:0008272;sulfate transport;7.0;0.8653626801206646;0.7836007053175329;9.405380701177911;30.347012514884874;6.8867018697843045;0.0010156871983350835;0.7031056191423581;[SLC13A1, RACGAP1, SLC26A8, SLC26A7, SLC26A11, SLC26A3]
GO:0033690;positive regulation of osteoblast proliferation;6.0;1.0;0.8231203125901445;9.628524252492122;63.05258358394898;7.379178354882098;0.0021103132289136558;0.7004918368257019;[BMP2, HPSE, GATA1, CYR61, LTF, CTHRC1]
GO:1904385;cellular response to angiotensin;8.0;1.0;0.875;9.628524252492122;462.69925393661634;7.379178354882098;0.015486127626965131;0.7523715242355574;[BRIP1, PRKCD, CDC6, SLC30A10, NFKB1]
GO:0010594;regulation of endothelial cell migration;8.0;0.7307253602413294;0.7403626801206646;9.253830803050711;53.61991368545132;4.793467005972133;0.0017946102562627052;0.620138125604427;[NRP1, NRP2, CD40, SPARC, ITGB3, CXCL13, PIK3C2A, ETS1, AKT1, MEF2C, EDN1, ANXA1, ANXA3, EMP2, SIRT1, DCN, CEACAM1, EPHA2, SP100, GATA3, PTGS2, THBS1, HMOX1, PLCG1, SEMA4A, TGFB1, JUP, PLK2, NR2F2, KLF4, PTK2, TEK]
GO:0045859;regulation of protein kinase activity;9.0;0.5608425510848448;0.6766619007227115;8.333797084897721;159.5555227474585;3.0974744418360864;0.005340179755709658;0.5546456121830788;[, ADARB1, AKT1, PROK2, PRKACB, PRKCD, PRKAR1B, FPR1, PDGFA, THY1, IQGAP3, PRKCZ, FLRT2, PRKAR2B, PDGFD, PDGFC, S100A12, SFN, NCKAP1L, ELANE, LYN, ACE, FZD5, PLK1, FZD8, EIF2AK2, CDC6, AZU1, NR2F2, NOX4, PKIG, EZH2, CDKN1A, LRRC4, DUSP2, DUSP3, DUSP1, RIPK2, BGN, EMP2, SIRT1, DUSP6, CKS2, LRRC19, NTF3, CCL19, CDKN2C, CCL21, GTF2H1, ELP4, CENPE, PKN1, CDKN3, CCNT2, NCF1, TNF, CLU, PYCARD, MAP3K8, MEN1, MAP2K2, CISH, F2R, CDC25C, CDC25A, ADCYAP1, ADAM9, ADAM8, CSF1R, BLM, TNFRSF11A, PKMYT1, SOCS2, DRD4, MAP2K6, TNFRSF10B, CXCL10, PTPRC, CDK6, CDK1, CSPG4, LAT, LRRK2, ITGB3, PTPN22, ARRB1, CYR61, HHEX, DUSP10, LCP2, CEBPA, NOD2, CCL5, FYN, CSK, PTPN6, IL1RN, CCNH, CCNF, CCNC, HERC5, TCL1A, PPP2R1A, TNFSF11, EPHB2, ACSL1, SLC11A1, PAQR3, MIF, EREG, SFRP2, IL23A, TRIB1, TGFA, PIK3R5, EGR1, GADD45B, IGF1, PTK2, TPX2, CALM3, CD24, CD40, KIF14, RAC2, CCR7, MAP4K1, EDN1, SYK, STRADB, IL18, GP1BA, CEACAM1, MDFIC, IL1B, KIT, TLR6, TLR4, CXCR4, PAK1, CD74, PODN, CD40LG, CAMK1, IL6R, PDGFRB, TSC2, CCNE2, HGS, CCNE1, CALCA, C5AR1, ADRB2, RASGRP1, CCNB2, CCNB1, STAP1, CLSPN, ECT2, TGFB2, TGFB1, CAV1, GH1, BMP2, GNAQ, TNFAIP3, CKS1B, GHR, GRM5, LRRTM4, NUP62, MYOCD, IRAK3, DCN, FGR, CCNA2, GREM1, PSRC1, IFNG, CHI3L1, PDE5A, LTF, THBS1, SNCA, EGF, MAPK14, CD4]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRA, EDNRB, GPR171, C3AR1, AKT1, PROK2, HOMER3, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, TIAM2, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, PIK3R5, C3, GNG10, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD2, FZD5, OR2J2, FZD8, AZU1, NMBR, PPBP, GNG11, MARCO, PNOC, CALM3, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, ADM, CD3E, AKAP12, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR3, CCR2, EDN1, GPR37, ANXA1, GPR35, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, PLCB1, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR3, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, F2RL1, RAMP1, LGR4, F2RL3, PF4, CHRM2, FCN1, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, CISH, SPNS3, APLP2, F2R, NPY1R, DGKZ, PDGFRL, ADCYAP1, SPNS1, OR2C3, GNAZ, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, ITPR3, GPR84, ADRB2, GPR82, HRH4, PSAP, ECT2, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, GNAQ, OR7E24, TAS2R7, CXCL6, GPSM2, CXCL9, OR1G1, PLEK, CXCL1, ARRB1, ARRB2, CXCL3, CXCL2, CXCL5, LTB4R, GRM5, CA2, PDE4B, PTGIR, ARHGEF12, PDE4D, GLP2R, OR2H1, XCL2, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, GNA15, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0031032;actomyosin structure organization;6.0;0.7192862368539868;0.682763431017138;8.763526815005518;32.01253927882412;5.16195311083921;0.001071430880247358;0.5871028347338303;[ITGB5, LMOD1, ARRB1, F11R, EPB41L5, CNN1, EPB41L4B, RACGAP1, EPB41L3, MYH14, MYOZ2, MYH10, PDGFRB, MEF2A, TMOD1, PDGFRA, TPM1, KIF23, SORBS1, ANLN, KRT19, ZYX]
GO:0007187;G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;6.0;0.6997970393407541;0.6730188322605215;8.578702127993445;26.976932752798508;4.347727998726029;9.028936615729279E-4;0.5454633246350222;[CHRM2, CHRM1, GRIK3, ADM, LTB4R, AKAP12, GRM5, EDNRA, RGS1, PRKACB, CCR3, PTGDR, LHCGR, PTGIR, EDN1, GPR37, ANXA1, PDE4D, GLP2R, NPY1R, MC3R, ADCYAP1, ADCY9, GNAZ, CALCA, CALCRL, PTGER2, FPR1, FPR2, GPR84, ADRB2, GNAI1, GNAI2, GNA15, PLN, CNR1, NPY, HRH4, PSAP, FLNA, CCL2, S1PR3, DRD4, CCR1, ABCA1, GABBR1, HTR1E, TSHR, MARCO, GNAQ, RAMP1, LGR4]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IL10, IFNA4, IFNA7, MEF2C, CR2, CD40, IFNA14, IFNA16, IFNA2, CD180, PRKCD, LEF1, IFNA8, HSPD1, CD79A, CD40LG, PTPRC, BCL2, IL7R, MS4A1, CARD11, IFNA21, IFNA10]
GO:0007188;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;7.0;0.7090535922965819;0.7054461614054914;8.712233520617966;27.67007993335845;4.535326612620827;9.260926739143067E-4;0.5828561791408859;[CHRM2, CHRM1, GRIK3, ADM, LTB4R, AKAP12, GRM5, EDNRA, RGS1, PRKACB, CCR3, PTGDR, LHCGR, PTGIR, EDN1, GPR37, PDE4D, GLP2R, NPY1R, MC3R, ADCYAP1, ADCY9, GNAZ, CALCA, CALCRL, PTGER2, FPR1, FPR2, GPR84, ADRB2, GNAI1, GNAI2, GNA15, PLN, CNR1, HRH4, PSAP, FLNA, S1PR3, DRD4, ABCA1, GABBR1, HTR1E, TSHR, MARCO, GNAQ, RAMP1, LGR4]
GO:0043433;negative regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.468181602416943;278.0076986152632;4.753193106834193;0.00930466748196786;0.6755074688592472;[GFI1, TNFAIP3, ARRB1, ARRB2, PHB2, PYCARD, CYP1B1, HAVCR2, MEN1, IL10, CHUK, IRAK3, SIRT1, SFRP4, XCL1, SIK1, TRIB1, SP100, HDAC2, TWIST1, NLRC3, PKHD1, G3BP2, FLNA, NLRP3, HMOX1, WFS1, NR1H4, KLF4, NFKBIA, NLRP12, ID1, CCDC22, NFKBID, EZH2, FOXA2]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, JAK3, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, RIPK2, IL15, IL18, PDCD1LG2, HLA-E, ZAP70, IL23A, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, EBI3, CD1D, CORO1A, AIF1, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, VCAM1, LILRB2, IGF1, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, CD28, HLA-DPB1, CD24]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[CD40, TNFRSF13B, TNF, TNFSF13B, PYCARD, TNFSF11, CHUK, TNFRSF1B, LTA, LTB, BIRC2, BIRC3, TNFRSF11A, TNFRSF17, TNFSF14, STAT1, TNFSF12, TNFSF13, TNFRSF10C, TNFRSF10B, NFKBIA, CD40LG, CD27, LTBR]
GO:0042590;antigen processing and presentation of exogenous peptide antigen via MHC class I;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;32.556158890958;6.409777797693995;0.0010896253394395913;0.618037346520142;[ITGB5, IFI30, CD36, FCGR1A, FCGR1B, FCER1G, CHUK, HLA-B, TAP1, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E]
GO:0051056;regulation of small GTPase mediated signal transduction;7.0;0.6799073451904818;0.6908730378524415;8.647694999480395;45.070113835906206;4.018171853803189;0.001508456149618737;0.5564088607247961;[EPS8, ARHGDIA, STMN1, ARHGDIB, EPHB2, PDGFRB, F2R, TSC2, TIAM2, DEPDC1B, ARHGAP19, RASAL2, ARHGAP15, RASGRP1, RASGRP4, RACGAP1, ECT2, A2M, ABCA1, TGFB2, IGF1, ARHGAP25, ARHGAP30, BCL6, GPR18, ARHGAP9, ARHGAP11A, NRP1, KIF14, ARHGEF10L, ARRB1, FOXM1, ARHGAP6, ARHGAP4, NUP62, PSD3, TAGAP, RAC2, TIMP2, RALGPS2, PLEKHG1, ARHGEF12, GPR35, RHOG, ARAP3, RHOH, ARAP1, GMIP, VAV1, DNM2, RHOU, FBP1, FGD3, FGD4, EPS8L1, EPS8L3, COL3A1, DLC1, F2RL1, SIPA1, F2RL3]
GO:0045860;positive regulation of protein kinase activity;10.0;0.6281612110245125;0.7293216173731766;9.003430535177193;1094.9224192180604;3.5309668621989068;0.03664606800502658;0.5958148214005239;[, IL1RN, CCNH, CCNC, TCL1A, AKT1, PROK2, TNFSF11, PRKACB, ACSL1, SLC11A1, PRKCD, MIF, EREG, PRKAR1B, IL23A, FPR1, TGFA, PDGFA, IQGAP3, PRKCZ, PIK3R5, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, EGR1, ACE, FZD5, GADD45B, FZD8, EIF2AK2, CDC6, AZU1, IGF1, PTK2, TPX2, NOX4, CALM3, CD24, EZH2, CDKN1A, CD40, KIF14, CCR7, MAP4K1, EDN1, SYK, RIPK2, STRADB, IL18, EMP2, SIRT1, DUSP6, MDFIC, IL1B, KIT, CKS2, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD74, CCL21, CENPE, CD40LG, PKN1, CAMK1, CCNT2, NCF1, TNF, CLU, MAP3K8, IL6R, PDGFRB, MAP2K2, F2R, ADCYAP1, ADAM9, ADAM8, CSF1R, CALCA, C5AR1, TNFRSF11A, ADRB2, RASGRP1, CCNB1, STAP1, CLSPN, ECT2, DRD4, MAP2K6, TGFB2, TGFB1, TNFRSF10B, GH1, BMP2, PTPRC, CDK1, CSPG4, LAT, LRRK2, ITGB3, ARRB1, CYR61, CKS1B, GHR, GRM5, GREM1, PSRC1, IFNG, CHI3L1, LCP2, PDE5A, LTF, NOD2, THBS1, CCL5, FYN, CSK, SNCA, EGF, MAPK14, CD4]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[IHH, BRCA2, ETS1, CTGF, RUVBL2, CD38, PDGFRB, IL10, GHSR, POSTN, ANXA1, DUSP1, TACR3, CCNA2, IL1B, RARA, PCNA, ABCB4, PTGS2, SOCS2, CST3, RBBP8, TGFB1, NR2F2, POU4F1, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:0030177;positive regulation of Wnt signaling pathway;7.0;0.7307253602413294;0.7162820453778652;9.040737587590003;188.4547261984632;4.948759890378168;0.006307410087620234;0.6039991761920099;[LRRK2, TNFAIP3, HHEX, RUVBL1, SOX4, WLS, AXIN2, SFRP4, ASPM, DEPDC1B, SFRP2, DAAM2, NAIP, TLR2, YAP1, JUP, EGF, CAV1, SULF1, NFKB1, SULF2, COL1A1, BMP2, DAB2, LGR4]
GO:0044539;long-chain fatty acid import;11.0;1.0;0.9324289523296623;9.628524252492122;75.02792930111643;7.474488534686424;0.0025111172729558144;0.8146746435927894;[RPS6KB1, ACSL1, CD36, SLC27A2]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, F11R, ICAM1, ANPEP, CLEC5A, ITGB7, ITGB6, HAVCR1, CTSB, CR2, CR1, CXADR, EPHA2, GYPA, SELPLG, DPP4, NCAM1, SLAMF1, GPR15, CDK1]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[CXCL13, RASGRP1, NTF3, CCR7, ECT2, EVI5, CCL21, RHOG, TBC1D8, TBC1D9, TBCK, EPHA2]
GO:0070829;heterochromatin maintenance;5.0;0.8933024483968273;0.736892236059334;9.510741216835738;53.15674682346314;9.083926447120524;0.0017791084782150738;0.7547934328124444;[WDHD1]
GO:0030174;regulation of DNA-dependent DNA replication initiation;9.0;0.7508913569872202;0.7716863036738992;9.326243380619188;154.23465726608282;7.9853141584524145;0.005162095176516053;0.8046099625986299;[CDT1, CDK2]
GO:0006068;ethanol catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;292.83912655610527;7.292166977892469;0.009801062027729285;0.7238411236270654;[ALDH2]
GO:0044772;mitotic cell cycle phase transition;4.0;0.8436909121759173;0.6718454560879586;9.040737587590003;28.43277148921302;4.321752512322768;9.516192739109223E-4;0.4710146244622313;[GMNN, BUB1B, EPS8, PPP2R1A, NEK2, SKP2, CDC25C, CDC25A, MELK, CDC34, CCNE2, CCNE1, CUL5, PKMYT1, IQGAP3, GSPT1, CCNB2, CCNB1, PRKAR2B, CEP72, CEP76, PLK4, CDT1, UBE2C, PLK2, PLK1, CDC7, CDC6, INHBA, POLA1, POLA2, CDK6, NASP, UBE2S, CDK2, CDK1, CDK14, CDKN1A, MCM7, MCM8, MCM10, FOXM1, TUBG1, MASTL, CKAP5, CIT, DNM2, CCNA2, DBF4, MCM3, CKS2, MCM4, RHOU, MCM5, MCM6, BCAT1, PLCB1, MCM2, PRIM2, PRIM1, AURKA, CDC45, RBBP8, RANBP2, RANBP1, CDKN2C, CEP152, RPA1, RPA2, WEE1, RPS6KB1, POLE2, RPA3, TACC3, CDKN3]
GO:0006069;ethanol oxidation;7.0;1.0;0.8509193652572005;9.628524252492122;86.80492924435106;7.292166977892469;0.0029052828624440484;0.7238411236270654;[ALDH2, ALDH1A1]
GO:0044774;mitotic DNA integrity checkpoint;8.0;0.8259837884571596;0.7879918942285797;9.405380701177911;188.74061193661657;5.769740442447999;0.006316978425995768;0.6700647945471605;[TOP2A, BLM, TOPBP1, NAE1, CLSPN, FANCI, TIPIN, DONSON, RPA2, CDC6, MSH6, MSH2, CDK2, CDK1]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[CCNF, LGALS1, PSMD3, SKP2, ESCO2, MXRA8, SPARCL1, SDC2, C3, FN1, TF, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FAM20C, FSTL1, CST3, SPP1, PSMC6, PSMC2, NUCB1, DSCC1, TNC, MEN1, IGFBP5, CISH, APLP2, IGFBP3, FBXW2, PSMD14, CUL5, SOCS2, IGFBP7, NAE1, WFS1, IL6, COPS5, UBA3, CCDC22, UBE2M, FBN1, LAMC1, CYR61, VCAN, DTL, LAMB1]
GO:0097267;omega-hydroxylase P450 pathway;10.0;1.0;0.9152410118609203;9.628524252492122;253.27491700286936;7.57984905034425;0.008476883539459374;0.8028748447945538;[CYP4F2, CYP4A11, CYP1B1]
GO:0045870;positive regulation of single stranded viral RNA replication via double stranded DNA intermediate;9.0;1.0;0.896240625180289;9.628524252492122;106.55819935642852;9.777073627680469;0.003566407036306347;0.896240625180289;[TOP2A]
GO:0097028;dendritic cell differentiation;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;22.452520143917486;6.343086423195323;7.514656432606705E-4;0.6146267465268138;[LYN, TGFB1, SPI1, TREM2, LILRB1, GATA1, RELB, CAMK4, F2RL1, PRTN3, CCR7, LTBR, CCL19]
GO:0034765;regulation of ion transmembrane transport;6.0;0.45556283921517005;0.5509017321977295;6.676594601596523;33.03735142972539;3.697140432584879;0.0011057304206669666;0.512192246247148;[, KCNG2, FMR1, SLC8A1, AKT1, EPHB2, SCN1A, KCNH1, KCNH2, MEF2C, DAPK1, PRKCE, F2R, CACNA2D3, CYBB, ACTN4, ATP1B2, PDZK1, ATP1B1, GEM, KCNQ1, CFTR, KCNE3, KCNE4, HVCN1, TWIST1, NEDD4L, ADRB2, THY1, CACNA1F, CORO1A, CD19, PLCG2, PLCG1, SCN3A, DRD4, LYN, TGFB1, CAV1, CXCL10, CXCL11, EHD3, FXYD2, FXYD6, CALM3, NOX1, KCNK5, CXCL9, CLIC3, CTSS, GRM5, JPH2, PDE4B, YWHAH, KCND2, GPR35, TRPC1, PDE4D, MMP9, DNM2, TMEM37, XCL1, SHANK3, NLGN1, CAMK2D, PTAFR, KCNA5, THBS1, PLN, FLNA, DMD, FYN, SNCA, SLC31A2, KCNIP4, KCNJ15, KCNJ16, TSPAN13, NEDD4, FKBP1B, GOPC, PTPN6, F2RL3]
GO:0010572;positive regulation of platelet activation;9.0;0.8933024483968273;0.8428918493787028;9.592156608321247;334.5200598726648;8.16763571524637;0.011196085355429928;0.8139338954918922;[SELP, PDPN, PLEK, TLR4]
GO:0010571;positive regulation of nuclear cell cycle DNA replication;10.0;0.8436909121759173;0.837086467948879;9.54628615425515;1141.0186722643214;7.9853141584524145;0.038188868110550556;0.8236103492792612;[CDC7]
GO:0045639;positive regulation of myeloid cell differentiation;7.0;0.7307253602413294;0.7162820453778652;9.186691500213083;278.20784311065285;5.311165509025885;0.0093113661381102;0.622532616383239;[CSF3, HMGB2, MPL, TNF, ETS1, CA2, TNFSF11, HOXA5, MED1, FOS, IFNG, IL23A, TAL1, HCLS1, TRIB1, LEF1, GATA1, INPP5D, NCKAP1L, CCR1, CD74, JUN, JAG1, STAT1, LIF, ISG15, INHBA, TMEM64, MAPK14, POU4F1, CD4, FES, ACIN1, EVI2B, PF4, IL17A]
GO:0007162;negative regulation of cell adhesion;5.0;0.5651597194614189;0.5728208715916296;7.400047131651798;38.26822196421712;4.255612709818223;0.001280802949978559;0.5078732437472537;[, CD86, IL1RN, PLXND1, CD80, SERPINE1, TNC, IHH, SPINT2, LGALS3, LGALS1, CDH1, ARHGDIA, ARHGDIB, TNR, CYP1B1, HOXA7, MEN1, LAG3, POSTN, SEMA6A, PRKCD, ACTN4, HLA-G, CLDN7, MAD1L1, CD274, TACSTD2, FBLN1, ALOX12, EPB41L5, LPXN, PAG1, TGFB1, JAG1, PTK2, COL1A1, BMP2, CXCL12, PTPRC, BCL6, PLXNB2, SNAI2, TGFBI, NFKBID, IFNA2, PTPN22, LRRC32, ARHGAP6, CTLA4, JAK3, HAVCR2, IL10, ANXA1, DUSP3, ARG1, PAWR, PDCD1LG2, CEACAM1, XCL1, PDE5A, CEBPB, THBS1, GPNMB, EPCAM, HLX, TBX21, TIGIT, JAM2, CD74, CCL21, LILRB1, LILRB2, KLF4, DLC1, CD9, PTPN6, FCGR2B, SIPA1]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB2, EPHB1, EREG, BTC, BTK, EPHA3, EPHA2, SDC2, SH2D2A, TXK, TGFA, PDGFA, PIK3R3, SLC30A10, PRKCZ, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, PILRA, IGF1, PTK2, COL1A1, NRP1, ITK, PTPRR, NRP2, CD3E, SYK, GAB1, GAB2, VAV1, HCK, KIT, PLCB1, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF1, SULF2, NCF1, NCF2, NCF4, SLA, CTGF, FGF5, EFEMP1, GRAP2, AP2M1, PDGFRB, PDGFRA, MATK, TSC2, CYBB, PDGFRL, DOK2, COL4A2, CD8B, KIF16B, COL4A1, CD8A, BLK, CSF1R, CUL5, RASGRP4, FOXO1, SOCS2, STAP1, TGFB1, CAV2, CRIM1, BMX, VIL1, GH1, NR4A3, FES, CSPG4, ITGB3, PIK3C2A, GHR, BLNK, NCBP2, MMP2, MMP9, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, SHCBP1, CD4, CD7, TEK]
GO:0009104;lipopolysaccharide catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;699.2048752589922;9.777073627680469;0.023401757931384683;0.8509193652572005;[AOAH]
GO:0051085;chaperone cofactor-dependent protein refolding;5.0;1.0;0.7902410118609202;9.628524252492122;21.14140270213274;6.409777797693995;7.075837224132252E-4;0.618037346520142;[CD74, HSPA6, HSPE1]
GO:0045875;negative regulation of sister chromatid cohesion;9.0;0.7369933605727446;0.7647373054666613;9.305750860229072;314.67461185837936;8.16763571524637;0.010531876070135456;0.8139338954918922;[ESPL1]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[, SLA2, F11R, TRBC1, C3AR1, AKT1, PRKACB, WLS, MEF2C, ZFYVE16, HHLA2, FPR1, PDGFA, FPR3, FPR2, GATA3, THY1, SLC30A10, KLRK1, PDGFD, PDGFC, LYN, ABCA1, JUN, JAG1, HLA-DRB4, FN1, VANGL1, COL1A1, COL1A2, HLA-DRB1, SIGLEC9, LRRC4, CTLA4, JAK3, HLA-DPA1, GPR35, RIPK2, BGN, PTH2R, FOS, SIRT1, F3, LRRC19, PTAFR, KCNA5, PTGS2, FSTL1, NRAS, FRZB, NTF3, STAT4, FLNA, IL12RB1, IL12RB2, P2RY13, CASP8AP2, STAT1, P2RY14, USP9Y, TMEM64, COL3A1, HLA-DPB1, LGR4, NCF1, NCF2, NCF4, F13A1, SLA, RORA, CXCL13, CTGF, EFEMP1, MAP3K8, AP2M1, LAG3, IFNA14, CISH, IFNA16, IFNA10, BLK, CD274, GPR87, TACSTD2, LY96, TNFRSF11A, CORO1A, FOXO1, SOCS2, TNFRSF17, ZNF423, IFNA21, GRIA4, GPR98, TNFRSF10C, TNFRSF10B, BMX, NFKB1, CXCL10, CXCL11, CXCL12, PTPRC, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, ITGB5, ITGB4, LRRK2, ITGB3, ITGB2, PIK3CD, FASLG, ARRB2, ITGAL, TNFSF13B, HHEX, FCGR3A, ITGAX, ITGB8, ITGB7, ITGB6, ITGA4, TNFRSF1B, ITGA7, BIRC5, LCP2, LCP1, BIRC2, BIRC3, IL2RG, TSPAN33, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1A, FCGR1B, CTHRC1, TSPAN15, TSPAN13, FCGR2A, IL2RB, PTPN6, CD247, FCGR2B, ICAM2, ICAM3, IFI30, ICAM1, TNFSF11, TRIM25, EPHB2, EPHB1, RSAD2, HNF1B, MIF, EREG, BTC, SFRP4, SFRP2, IFI27, BTK, EPHA3, EPHA2, SDC2, TGFA, PIK3R3, TSPAN8, CD19, TSPAN5, TSPAN2, CD14, PAG1, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, PPBP, PILRA, IGF1, PTK2, ID1, CD28, SDC1, CD27, CD24, IGHM, NRP1, PTPRR, NRP2, CD40, TNFRSF13B, GRIK3, CD3G, PTPRK, CD3E, CD3D, CCR9, FCER1A, MUC13, CD38, CD37, CCR7, CCR6, MUC15, CD36, CCR5, CCR3, CCR2, IL10, CD53, FCER1G, SYK, IL15, GAB1, IL18, GAB2, RGMA, LAT2, IL1A, IL1B, KIT, IGHD, GNAI2, RELB, PAK1, IGKC, PERP, IL32, CD74, IL33, SORT1, OSM, IL18R1, IL17A, CD86, CD80, TRAC, MPL, IHH, CELSR1, CCRL2, IL6R, PDGFRB, CD97, PDGFRA, THEMIS, CYBB, GEM, MUC3B, PDGFRL, OSCAR, DOK2, TYROBP, CD8B, CCNE1, CD8A, CARD11, TCF7, PSEN2, KIR2DL1, RASGRP4, VCAM1, CAV2, CRIM1, ISG15, INHBA, VIL1, GH1, IL6, BMP2, GNAQ, IL7R, IGKV3-20, PLEK, SIRPB1, LMNB1, GHR, GRM5, NUP62, MMP1, NCBP2, MMP2, IRAK3, MMP9, IRF7, IRF8, BCL2A1, SAMHD1, EGF, MX2, MAPK14, SOD2, CD2, CD4, CD6, CD7, CD9, TEK, CDA, CYFIP1, CLEC10A, EPS8, STMN1, GPR171, HOMER3, JUNB, DAPK1, PRKCB, PRKCE, PRKCD, HOXB9, DAAM2, PRKCQ, MAML3, PRKCZ, FLRT2, PLCG2, HMOX1, NCKAP1L, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, FZD1, FZD2, FZD5, FZD8, GP6, SNAI2, CDK14, DENND1B, ITK, CDKN1A, TGFB1I1, ASGR2, TIMP1, ANXA1, SERPINB2, IFNGR1, NFAM1, IFNGR2, AES, FCER2, ZEB1, PLCB1, HBEGF, ENG, HLA-DQB1, CCL13, ALOX5, CCL19, CCL18, GPR157, CCL23, CCL21, CCL20, IL10RA, CARD9, NR1H4, G0S2, SULF1, SULF2, ZYX, PLP1, PF4, SEMA5B, CSF3, CSF3R, PLXND1, FMR1, ITGA2B, IL5RA, TNF, FGF5, PYCARD, CDH5, IGHG1, CDH3, FCGRT, GRAP2, IL13RA2, IL13RA1, TLE4, RNF43, SEMA6A, CLEC4A, CLEC4D, ADAM9, CLEC4E, CSF1R, CD151, CALCRL, CUL5, IGLV1-44, CD300LF, EIF2B3, DAB2, BCL6, BCL2, PLXNB2, CSPG4, LAT, BCL2L1, PTPN22, PIK3C2A, ADAMTS1, CR2, CR1, CHUK, LCK, ESRP1, IL3RA, XCL2, XCL1, CX3CR1, CEBPA, CEBPD, NOD2, P2RY6, PLN, P2RY2, POLR2E, IL21R, CSK, POLR2I, POLR2J, POLR2K, POLR2L, SEMA4A, SEMA4B, KLF4, PML, P2RX5, KLF6, P2RX1, MNDA, CLEC2D, IL1RN, IFITM1, IFIT1, IFIT3, IFIT2, EDNRB, ICOSLG, SOX4, ACSL1, IL1R1, IL1R2, HLA-B, FLT3LG, HLA-C, HLA-A, HLA-F, HLA-G, RUNX2, HLA-E, IL23A, TLN1, PFN1, IGSF6, SH2D2A, TXK, EBI3, TWIST1, APCDD1, CD79B, CD79A, INPP5D, CCR10, LIF, NMBR, MARCO, IFNA5, ROBO2, IFNA4, IFNA7, IFNA2, PRL, IFNA8, FFAR2, EDN1, GP1BB, GPBAR1, GP1BA, PDCD1LG2, LIME1, IL17RB, VAV1, HCK, CEACAM1, RHOU, TLR4, TLR2, GUCY2C, SP100, CXCR5, IFI6, CXCR4, CXCR6, LILRA1, LILRA2, CXCR1, CXCR3, CXCR2, LILRB1, LILRB2, SORBS1, LILRB3, PODN, KRT19, CD40LG, FCN1, IL18RAP, ARHGDIA, MATK, TSC2, COL4A2, KIF16B, COL4A1, KLRF1, PRTN3, KLRB1, C5AR1, CSF2RB, LTBP2, ADRB2, DTX3, CSF2RA, STAP1, KLRC1, BTNL8, TGFB2, STIL, TGFB1, NR4A2, NFKBIA, NR4A3, FES, KLRD1, NFKBID, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, TMEM100, LRRTM4, BLNK, PDE4B, CASP2, DCC, PDE4D, GLP2R, PLAUR, AXIN2, DCN, TGFBR3, FGR, ZAP70, IFNG, OAS1, OAS3, LTA, LTB, CDH17, CAMK2D, CLEC12B, LEF1, DLL1, GMDS, REPS2, S1PR3, NCAM1, TRAT1, SHCBP1, TSHR, LTBR]
GO:0045630;positive regulation of T-helper 2 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2538.1941708228874;7.8311634786251565;0.08495107467099283;0.8630410292508717;[CD86, RARA, IL18, NLRP3, PRKCZ]
GO:0045637;regulation of myeloid cell differentiation;6.0;0.620063164412167;0.633151894796228;8.465373442686442;67.16582126229967;4.39257856489138;0.002247979592334476;0.5477569846744829;[CSF3, CSF3R, SPI1, ITGA2B, MPL, TNF, ETS1, LGALS3, HOXA9, GPR171, TNFSF11, HOXA7, HOXA5, MED1, LHCGR, MEF2C, PRKCB, TYROBP, IL23A, PRKCQ, TRIB1, MYL9, GATA1, INPP5D, NCKAP1L, LYN, CCR1, NFE2, JUN, JAG1, LIF, ISG15, INHBA, NFKBIA, NR4A3, MAFB, CDK6, FES, FBN1, HMGB2, CA2, KLF13, GP1BA, FOS, NME1, CEACAM1, IFNG, TAL1, RARA, IRF7, HCLS1, TLR4, LTF, CEBPB, LEF1, DLL1, THBS1, CD74, STAT1, LILRB1, TMEM64, LILRB3, MAPK14, MEIS2, POU4F1, LILRB4, CD4, MEIS1, CAMK4, ACIN1, EVI2B, PF4, IL17A, C1QC]
GO:0045876;positive regulation of sister chromatid cohesion;9.0;0.7436939687323844;0.7680876095464813;9.292052015870908;259.00348872071737;7.474488534686424;0.008668613679475917;0.7784863164434164;[FEN1, RAD21]
GO:0019371;cyclooxygenase pathway;10.0;1.0;0.9152410118609203;9.628524252492122;253.27491700286936;7.379178354882098;0.008476883539459374;0.7926125360964777;[TBXAS1, PTGS2, PTGS1]
GO:0019370;leukotriene biosynthetic process;8.0;0.8653626801206646;0.8076813400603323;9.488762310116963;324.40599840797483;6.781341354126479;0.010857576820271119;0.7217981122146513;[SYK, ALOX5]
GO:0019373;epoxygenase P450 pathway;10.0;1.0;0.9152410118609203;9.628524252492122;253.27491700286936;6.686031174322154;0.008476883539459374;0.7571649570480019;[CYP4F2, CYP4A11, CYP1B1, CYP4F12]
GO:0035606;peptidyl-cysteine S-trans-nitrosylation;10.0;1.0;0.9152410118609203;9.628524252492122;309.9752588804085;9.083926447120524;0.010374592955105871;0.8797934328124444;[S100A9]
GO:0019372;lipoxygenase pathway;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;153.6575605806622;7.138016298065211;0.005142780269808322;0.7400384854347593;[GPX1, ALOX5, ALOX12, PTGS2]
GO:0042130;negative regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;581.9323154417883;5.734022359845919;0.01947675089275457;0.6894787953221185;[CD86, CD274, CEBPB, CD80, IHH, LRRC32, GPNMB, CTLA4, HAVCR2, IL10, TGFB1, ARG1, PAWR, LILRB1, PDCD1LG2, LILRB2, HLA-G, XCL1, PTPN6, PDE5A, MAD1L1]
GO:0010569;regulation of double-strand break repair via homologous recombination;9.0;0.8436909121759173;0.8180860812682478;9.523163736834295;184.48234756552796;6.221725566191056;0.00617445814968456;0.7144199599751273;[POLQ, BLM, RPA2, RAD51AP1, RAD51, FIGNL1, CHEK1]
GO:0034516;response to vitamin B6;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;87.04156493882871;9.777073627680469;0.002913202846179917;0.8509193652572005;[KYNU]
GO:0071902;positive regulation of protein serine/threonine kinase activity;11.0;0.6763753087927167;0.7706166067260205;9.206529842432747;1260.5827351979337;3.9422628906178643;0.04219056969626795;0.6340364598898325;[, IL1RN, CCNH, CCNC, TCL1A, AKT1, PROK2, TNFSF11, ACSL1, MIF, FPR1, TGFA, PDGFA, IQGAP3, PIK3R5, PDGFD, PDGFC, S100A12, ELANE, FZD5, GADD45B, FZD8, EIF2AK2, CDC6, IGF1, NOX4, CALM3, CD24, EZH2, CD40, MAP4K1, EDN1, SYK, RIPK2, SIRT1, DUSP6, MDFIC, IL1B, KIT, CKS2, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD74, CD40LG, PKN1, CAMK1, CCNT2, TNF, MAP3K8, PDGFRB, MAP2K2, F2R, ADAM9, ADAM8, CSF1R, C5AR1, TNFRSF11A, ADRB2, RASGRP1, CCNB1, DRD4, MAP2K6, TGFB1, GH1, BMP2, CDK1, CSPG4, LRRK2, ARRB1, CKS1B, GHR, PSRC1, IFNG, PDE5A, LTF, NOD2, THBS1, CSK, SNCA, EGF, MAPK14]
GO:0033260;nuclear DNA replication;10.0;0.8653626801206646;0.8479223519212526;9.551563211355994;268.92620209745564;8.67846133901236;0.009000717966333083;0.8590579283277371;[SLBP, DONSON]
GO:0014740;negative regulation of muscle hyperplasia;8.0;1.0;0.875;9.628524252492122;117.88012497015305;9.083926447120524;0.003945341697526185;0.839552420951524;[KLF4]
GO:0033262;regulation of nuclear cell cycle DNA replication;9.0;0.7140352122741334;0.7532582313173557;9.240758721483358;171.6907107923128;7.212124270218933;0.00574633357861074;0.7650689957573628;[CDT1, TIPIN, DACH1, BCL6, CDC7]
GO:0034351;negative regulation of glial cell apoptotic process;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;104.32654737607098;7.697632086000634;0.003491715652880169;0.7686572628545723;[PRKCH, PRKCD, CCL2, DLL1]
GO:0051928;positive regulation of calcium ion transport;8.0;0.7043150770688792;0.7271575385344395;8.848365694942547;69.31158403183679;5.085725745451326;0.002319796341169766;0.6350842511328143;[CXCL9, ARRB2, MYLK, LGALS3, JPH2, PDGFRB, TRPC3, TRPC1, F2R, ATP1B1, XCL1, KCNE3, THY1, CD19, CCL5, CCL4, PLCG2, CCL2, PLCG1, SNCA, CCR1, WFS1, CAV1, CXCL10, P2RX5, CD4, CXCL11, EHD3, CXCL12, CALM3, F2RL3]
GO:0046578;regulation of Ras protein signal transduction;8.0;0.6954798709641801;0.72273993548209;8.712233520617966;46.45640819702609;4.388001897863968;0.0015548541743014947;0.5994026211197198;[EPS8, ARHGDIA, STMN1, ARHGDIB, EPHB2, PDGFRB, F2R, TIAM2, RASAL2, RASGRP1, RASGRP4, ECT2, ABCA1, TGFB2, IGF1, BCL6, GPR18, NRP1, KIF14, ARHGEF10L, ARRB1, FOXM1, NUP62, PSD3, TIMP2, RALGPS2, PLEKHG1, ARHGEF12, GPR35, ARAP3, VAV1, DNM2, FBP1, FGD3, FGD4, EPS8L1, EPS8L3, COL3A1, DLC1, F2RL1, F2RL3]
GO:0009157;deoxyribonucleoside monophosphate biosynthetic process;9.0;0.7763722522362496;0.7844267512984139;9.478992518521158;899.5024035803052;7.379178354882098;0.030105535948226757;0.7736121494158466;[TK1, TYMS, DCK]
GO:0048754;branching morphogenesis of an epithelial tube;6.0;0.7436939687323844;0.6949672969563367;8.8813098506619;51.7127811195946;4.956792062075433;0.0017307802455913577;0.5766108891590862;[NRP1, PLXND1, CTSZ, IHH, PHB2, HOXA11, HHEX, EDNRA, HOXA5, MED1, EDN1, HNF1B, PAX2, GREM1, SFRP2, COL4A1, TIMELESS, ENG, EPHA2, LEF1, PAK1, TGFB1, EGF, VDR, PML, PPP1CA, BMP2, BCL2]
GO:0000578;embryonic axis specification;4.0;0.7866048967936545;0.6433024483968273;8.753055515138222;24.589985525707924;6.409777797693995;8.230046859952432E-4;0.5777963346592216;[EPB41L5, STIL, FZD5, PCSK6]
GO:0090050;positive regulation of cell migration involved in sprouting angiogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;645.2358217485536;6.7325511899570465;0.021595462279385098;0.7767319332797141;[NRP1, ANXA1, PLK2, HMOX1, PTGS2, PIK3C2A]
GO:0090051;negative regulation of cell migration involved in sprouting angiogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;662.774530299232;7.069023426578259;0.02218246707076338;0.7939391391080821;[KLF4, THBS1]
GO:0002752;cell surface pattern recognition receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;1037.7692336294238;9.083926447120524;0.03473320231790253;0.8969813732811862;[FCN1, FFAR2]
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.5544162803384;412.6549923027037;6.280566066213989;0.013811191226989502;0.7693087532925187;[LY96, HSPD1, CD36, CD14, IRAK3, TLR1, BTK, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, MYD88, TLR2]
GO:0046580;negative regulation of Ras protein signal transduction;9.0;0.8259837884571596;0.8092325194088689;9.394909401310617;288.24654468039586;5.885253329569843;0.009647352445404638;0.6972127541467594;[RASAL2, STMN1, NUP62, TIMP2, EPHB2, TGFB2, ARAP3, BCL6, DLC1, FBP1]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, RORA, PHB2, ETS1, SLC8A1, LOXL2, AQP1, ICAM1, EDNRA, PLAU, MYB, AKT1, POSTN, PRKCE, ACTN4, ATP1B1, CLDN3, ADAM8, ABCB4, PSEN2, TWIST1, DPP4, CCNB1, BRIP1, HMOX1, EGR1, TGFB2, TGFB1, VCAM1, CAV1, NR4A2, BMP2, CXCL12, BCL2, NOX4, CD24, SUV39H2, ALAS2, SUV39H1, ADM, ALAD, CD38, MYOCD, ADSL, EDN1, KCND2, MMP2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, CCNA2, IL1B, LTA, BIRC2, TLR2, CXCR4, KCNA5, PTGS2, THBS1, ASCL2, CST3, PAK1, E2F1, PML, FABP1, TEK]
GO:0002758;innate immune response-activating signal transduction;9.0;0.6324783794010864;0.7124798148808322;8.79372655486915;406.8866713069129;4.647174912757396;0.013618130714412242;0.6338973663344365;[FCN1, CLEC10A, ICAM2, ICAM3, PGLYRP1, PRKACB, PRKCE, CD180, PRKCD, MUC3B, CLEC4A, CLEC4D, BTK, CLEC4E, S100A9, S100A8, CARD11, LY96, KLRK1, CLEC7A, PLCG2, S100A14, CD14, CD300LF, MAP2K6, LYN, NFKB1, NFKBIA, MARCO, MYD88, ITGAM, ITGB2, TNFAIP3, CTSS, IFIH1, MUC13, FFAR2, MUC15, CD36, HAVCR2, FCER1G, CHUK, SYK, DDX58, RIPK2, IRAK3, TLR1, HCK, IRF7, TLR8, TLR10, TLR7, PIK3C3, TLR6, TLR5, TLR4, TLR2, COLEC12, UNC93B1, NOD2, LILRA2, HSPD1, RELB, PAK1, NRAS, FYN, CARD9, NR1H4, TNIP3]
GO:0014739;positive regulation of muscle hyperplasia;8.0;1.0;0.875;9.628524252492122;117.65934785475751;9.777073627680469;0.003937952486160401;0.875;[AIF1]
GO:2000753;positive regulation of glucosylceramide catabolic process;8.0;1.0;0.875;9.628524252492122;623.5788865307586;9.777073627680469;0.0208706241476218;0.875;[PRKCD]
GO:0051926;negative regulation of calcium ion transport;8.0;0.7140352122741334;0.7320176061370667;8.890925309361343;69.46225493434336;5.666199763507158;0.0023248391606816524;0.6647697194109919;[FMR1, PTGS2, ICAM1, PLN, DRD4, TGFB1, GPR35, LILRB1, LILRB2, GEM, FKBP1B, BCL2, CALM3]
GO:0031077;post-embryonic camera-type eye development;7.0;1.0;0.8509193652572005;9.628524252492122;36.784493016758105;8.390779266560578;0.0012311438773764656;0.7800242071602487;[BCL11B, FZD5, KLF4]
GO:2000755;positive regulation of sphingomyelin catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;1040.6474307865747;9.777073627680469;0.034829532986543094;0.9152410118609203;[PRKCD]
GO:0050832;defense response to fungus;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;69.94032091756767;6.193554689224359;0.002340839598908718;0.6398589874268261;[TGFB1, DEFA4, DEFA1, MPO, GNLY, S100A12, CTSG, S100A9, S100A8, LTF, IL17A]
GO:0035434;copper ion transmembrane transport;9.0;0.8259837884571596;0.8092325194088689;9.434368238051164;100.43308211951074;7.9853141584524145;0.003361404874634337;0.8046099625986299;[ATP7B, SLC31A2]
GO:0071539;protein localization to centrosome;9.0;0.9326813400603323;0.8625812952104552;9.541512875502493;37.378778991281564;6.781341354126479;0.0012510340941211122;0.7430387373949403;[STIL, SPAG5, AURKA]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[SEH1L, HIST1H2BK, C5AR1, HMGB2, TNF, KLRK1, NLRP3, CD36, PGLYRP1, CAMP, HAVCR2, RIPK2, DEFA4, CARD9, RNASE6, RNASE3, DEFA1, LYZ, HLA-E, FGR, IL6, LTA, MYD88, TLR2]
GO:0010390;histone monoubiquitination;11.0;0.8933024483968273;0.8790801765280758;9.589303539338841;498.95626046972137;6.375876246018314;0.016699617006440744;0.7584915600596062;[UHRF1, BMI1]
GO:0009165;nucleotide biosynthetic process;8.0;0.5302988655260388;0.6401494327630194;8.295339716686179;725.1038699111774;4.326035174114769;0.024268573974811393;0.5962336399854383;[SLC35B3, PANK3, ENO2, AQP1, KMO, ATP5J2, ADCY9, MTHFD1, GMPS, ATP5J, ATP5I, ATP5H, ATP5O, ATP5L, ACAT1, CYC1, TGFB1, PAICS, ADM, PFAS, HK3, ATIC, KYNU, UPP1, TK1, ADSL, CAD, BPGM, PARP9, DCK, NME1, GART, PRTFDC1, GUCY2C, DTYMK, PTGS2, COX5B, TYMS, RRM1, RRM2, IMPDH2]
GO:1902600;proton transmembrane transport;8.0;0.7586651285174919;0.754332564258746;9.117698628726131;95.86613314633948;4.835431205071165;0.0032085532024895276;0.6222841766978864;[COX7B, COX6A1, COX7C, SLC2A6, SLC36A1, COX8A, ATP5J2, COX6B1, COX7A2L, NDUFS7, HVCN1, ATP5J, ATP5I, ATP5H, ATP5O, COX5B, COX5A, ATP5L, CYC1, SLC15A3, NDUFA4, COX6C]
GO:0046104;thymidine metabolic process;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;399.2486070631531;8.390779266560578;0.013362491577985136;0.8253454670833372;[DPYD, TK1]
GO:0002764;immune response-regulating signaling pathway;5.0;0.5860072649471136;0.5832446443344771;7.893923197104016;48.795248251786205;3.532906727016733;0.0016331330461149228;0.4709140261775204;[, CYFIP1, CLEC10A, ICAM2, ICAM3, SLA2, TRBC1, C3AR1, PGLYRP1, PRKACB, ICOSLG, MEF2C, PRKCB, PRKCE, PRKCD, HLA-G, BTK, PRKCQ, HHLA2, TXK, FPR1, FPR3, FPR2, GATA3, THY1, CD79B, CD79A, KLRK1, CD19, INPP5D, PLCG2, NCKAP1L, S100A14, PLCG1, CD14, IGHA1, HLA-DQA2, HLA-DQA1, PAG1, LYN, JUN, HLA-DRB4, PTK2, MARCO, CD28, CD24, HLA-DRB1, IGHM, DENND1B, ITK, CD40, CD3G, CD3E, CD3D, CTSS, IFIH1, FCER1A, CTSH, CTLA4, MUC13, CD38, FFAR2, MUC15, CD36, HLA-DPA1, HAVCR2, FCER1G, SYK, RIPK2, FOS, GAB2, LIME1, VAV1, LAT2, TLR1, HCK, KIT, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, HLA-DQB1, TLR2, LILRA2, RELB, PAK1, NRAS, IGKC, CARD9, NR1H4, LILRB1, LILRB2, HLA-DPB1, FCN1, TRAC, IGHG1, FCGRT, GRAP2, CD180, THEMIS, MUC3B, CLEC4A, CLEC4D, CLEC4E, S100A9, S100A8, CARD11, BLK, C5AR1, LY96, KIR2DL1, CLEC7A, IGLV1-44, CD300LF, MAP2K6, BTNL8, EIF2B3, BMX, NFKB1, NFKBIA, PTPRC, NR4A3, BCL2, HLA-DRA, NFKBID, IGKV3-20, LAT, MYD88, ITGAM, ITGB2, TNFAIP3, PIK3CD, PTPN22, FCGR3A, PDE4B, CR2, CR1, CHUK, DDX58, PDE4D, IRAK3, FGR, ZAP70, LCK, IRF7, LCP2, PIK3C3, COLEC12, UNC93B1, CLEC12B, NOD2, HSPD1, FYN, CSK, FCGR1A, FCGR1B, TRAT1, CD4, FCGR2A, TNIP3, PTPN6, MNDA, CD247, FCGR2B]
GO:0002522;leukocyte migration involved in immune response;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;38.08781428465786;9.083926447120524;0.0012747648673000812;0.7876727335416686;[HCK, FUT7]
GO:0002523;leukocyte migration involved in inflammatory response;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;29.137022145890857;7.379178354882098;9.751899096054872E-4;0.7004918368257019;[ITGB2, FFAR2, ADAM8, CCR6, SELE, S100A9, ELANE, S100A8, JAM3]
GO:0046597;negative regulation of viral entry into host cell;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;84.95196338807416;6.832634648514029;0.002843265762795464;0.7244212536750128;[FCN1, IFITM1, GSN, IFNA2, TRIM25, PTX3, TRIM10]
GO:0070431;nucleotide-binding oligomerization domain containing 2 signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;488.61025226297863;7.8311634786251565;0.01635334542256394;0.8630410292508717;[NFKBIA, RIPK2, NOD2]
GO:0033004;negative regulation of mast cell activation;7.0;0.8653626801206646;0.7836007053175329;9.5544162803384;126.92306413003195;7.379178354882098;0.00424800073309046;0.728290889492758;[CNR1, HMOX1, IL13RA2, CD300LF]
GO:0035666;TRIF-dependent toll-like receptor signaling pathway;13.0;0.9326813400603323;0.9288956347978027;9.592156608321247;413.3481394832653;6.599019797332524;0.013834390239330937;0.8000291440890255;[CHUK, LY96, IRF7, TLR6, CD14, CD300LF, TLR4]
GO:0010389;regulation of G2/M transition of mitotic cell cycle;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;58.92720908338202;4.74012102526684;0.001972240656975688;0.6174100096703167;[PPP2R1A, NEK2, CDC25C, CDC25A, MSH6, BLM, HMMR, CCNB1, PRKAR2B, RAD21, CEP72, NAE1, CLSPN, CEP76, FANCI, PLK4, PLK1, CDC7, CDC6, TPX2, CDK6, CDK2, CDK1, KIF14, BRCA1, TOPBP1, TUBG1, CKAP5, RAD51C, DTL, SMARCD3, VPS4B, AURKB, AURKA, CEP152, DONSON, CENPF]
GO:0071526;semaphorin-plexin signaling pathway;6.0;0.811012628672052;0.7286266269261705;9.089527751759436;26.50247477320489;6.166155715036245;8.87013979980389E-4;0.6384578026126634;[NRP1, SEMA5B, SEMA4A, NRP2, SEMA6A, PLXND1, SEMA4B, ARHGDIA, FLNA, PLXNB2]
GO:1902850;microtubule cytoskeleton organization involved in mitosis;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;48.697023367814154;5.202362649177086;0.0016298455476450346;0.5891693804036648;[GPSM2, KIF11, CDC20, STMN1, NUF2, NUSAP1, NEK2, MYBL2, TUBG1, ESPL1, KIFC1, BIRC5, BIRC2, BIRC3, TTK, CENPA, AURKB, AURKA, CCNB1, POC1A, FLNA, STIL, PLK2, NDC80, CENPE, TPX2, KIF4A, TACC3, RAN, SPC25]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[IFITM1, SPARC, LST1, SPINT2, ADARB1, PHB2, IFIT3, CYP1B1, EPHB1, SOX7, SOX4, MED1, MEF2C, HLA-G, EREG, SFRP4, SFRP2, SPINT1, BTK, TRIB1, GATA3, GATA1, BRIP1, INPP5D, HMOX1, SFN, S100A11, LYN, JUN, BCL11B, FZD5, LIF, EIF2AK2, CDC6, NR2F2, FOSL1, NOX4, SNAI2, SRPX, CDKN1A, BTG2, TNFRSF13B, TGFB1I1, ADM, PRL, PTPRK, BRCA2, LRRC32, HNF4A, TIMP2, CTLA4, CD33, HAVCR2, IL10, DUSP1, ARG1, IL15, PAWR, PDCD1LG2, CBFA2T3, NME1, IL1A, CEACAM1, ZEB1, IL1B, RARA, TLR2, PTGS2, ASCL2, AIF1, PAK1, GPNMB, FRZB, PDPN, CTNNA1, CCL23, CDKN2C, STAT1, OSM, LILRB1, LILRB2, PODN, SULF1, FAP, FABP7, DLC1, PKN1, CDKN3, CD86, CD80, SIRPG, IHH, TNF, ETS1, CDH5, DACH1, MEN1, IGFBP5, IGFBP3, F2R, TPM1, TSC2, ADCYAP1, HGS, MAD1L1, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, CDK6, BCL6, OGN, BCL2, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, KLF13, AXIN2, TGFBR3, GREM1, TFDP1, IFNG, ASPH, LTA, XCL1, PDE5A, CEBPA, CEBPB, NLRC3, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, SOD2, PML, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MED1, MEF2C, PRKCH, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PRKDC, PDGFA, IQGAP3, GATA1, PRKCZ, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, MCTS1, JUN, FN1, CDC7, CDC6, FOSL2, FOSL1, NOX1, CDKN1A, ADM, HOXC10, TIMP1, JAK3, HLA-DPA1, HAVCR2, ANXA1, ARG1, RIPK2, FCRL3, EMP2, SIRT1, F3, PAX2, MMP12, RARA, HCLS1, HBEGF, PTAFR, KCNA5, PTGS2, NRAS, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, STAT1, LRG1, HLA-DPB1, CSF3, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, PPP1R16B, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, DNMT1, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, CDK6, BCL6, CDK2, CDK1, BCL2, HPSE, BCL2L1, ITGB3, FASLG, ARRB1, FOXM1, CYR61, TNFSF13B, LBH, ITGA4, ASPM, XCL1, BIRC5, CX3CR1, HDAC2, SMARCD3, TTK, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, PML, KLF5, PRC1, DNAJA3, PTPN6, CCNF, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, TIPIN, FLT3LG, MIF, RUNX2, EREG, HLA-E, BTC, SFRP2, IL23A, KIF20B, EBI3, TGFA, TWIST1, CD1D, PKHD1, SLAMF1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, IGF1, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, KIF14, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CD38, CCR3, CCR2, IL10, EDN1, SYK, IL15, RHOG, IL18, PDCD1LG2, AVPR1A, GAB2, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, AIF1, GNAI2, CST3, PURA, PAK1, CXCR2, CD74, CDX2, OSM, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, ETS1, IL6R, TGM2, PDGFRB, GHSR, PDGFRA, MATK, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, HTRA1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, IL7R, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, TBC1D8, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, LEF1, DLL1, THBS1, HLX, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, RPS6KB1, TEK]
GO:1901522;positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus;12.0;0.7140352122741334;0.8051379187272112;9.260799472366804;1467.8987330058965;6.641579411751319;0.04912924957061573;0.7877709925721352;[RUNX2, BMP2, RXRA]
GO:0046599;regulation of centriole replication;10.0;0.8259837884571596;0.8282329060895002;9.503361109538115;89.11396308082499;6.943860283624253;0.002982564146955293;0.7703503496879909;[PLK4, STIL, PLK2, VPS4B, NUP62, BRCA1, CEP76]
GO:0001890;placenta development;4.0;1.0;0.75;9.628524252492122;49.86610466882393;6.193554689224359;0.0016689736466849693;0.5667386748366816;[ABCB4, CCNF, HTRA1, MAPK14, ASCL2, PTK2, DCN, PHLDA2, E2F7, BIRC2, E2F8]
GO:0001892;embryonic placenta development;5.0;1.0;0.7902410118609202;9.628524252492122;37.179255381886215;6.832634648514029;0.0012443562184742403;0.639662265535933;[MED1, CEBPA, CEBPB]
GO:0001893;maternal placenta development;4.0;1.0;0.75;9.628524252492122;43.252245699280884;7.379178354882098;0.001447613739060994;0.6273715242355574;[RXRA, AKT1, NR2F2]
GO:0002740;negative regulation of cytokine secretion involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;981.2960148552594;7.9853141584524145;0.03284309450812846;0.8236103492792612;[IL10, LILRB1, TNF]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[SLC46A2, PRKDC, GATA3, CCNB2, HOXA3, BCL11B, MAFB, BCL2, MAD1L1]
GO:0050850;positive regulation of calcium-mediated signaling;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;239.92176968958296;6.039404009397101;0.008029965715936047;0.6838554019015759;[TREM2, CD3E, TNF, JPH2, CCL4, SYK, TRAT1, IGF1, ZAP70, P2RX5, CD4, CALM3]
GO:0002732;positive regulation of dendritic cell cytokine production;8.0;0.8933024483968273;0.8216512241984136;9.54514264355307;385.4233449309147;9.777073627680469;0.012899772496347238;0.875;[NOD2]
GO:0043097;pyrimidine nucleoside salvage;9.0;0.811012628672052;0.801746939516315;9.507896264703508;2649.2611103990594;7.292166977892469;0.08866838518485125;0.769162383550154;[CDA, UPP1, TK1, DCK, TYMP]
GO:2000778;positive regulation of interleukin-6 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;618.0674169630446;6.599019797332524;0.02068616022119099;0.7527151911823093;[DDX58, F2R, TWIST1, PYCARD, IFIH1, IL1B, TLR8, F2RL1, IL17A]
GO:0071314;cellular response to cocaine;7.0;1.0;0.8509193652572005;9.628524252492122;537.09778937307;8.67846133901236;0.017976179653688387;0.7947362817240173;[CCNA2]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[TNC, IHH, FHL2, CYR61, FBL, AKT1, JUNB, MEF2C, TPM4, IGFBP5, IGFBP3, RUNX2, VCAN, COL6A1, EPHA2, LEF1, HSD17B4, TWIST1, GPNMB, FIGNL1, SPP1, HSPE1, COL1A1, BMP2, PSMC2, ALPL, SNAI2, RBMX, LGR4]
GO:0032388;positive regulation of intracellular transport;6.0;0.6073376606709605;0.6267891429256247;8.04155919591008;60.38198030770418;4.449197458890889;0.00202093054064465;0.5506524775466656;[, CHRM1, CDH3, CDH1, MED1, PRKCD, PDZK1, KIF20B, SFN, ECT2, TGFB1, JUP, FZD5, IGF1, DAB2, CDK1, ITGAM, LRRK2, ITGB2, RAC2, FCER1G, SYK, NCBP2, GAB2, FGR, IFNG, IL1B, HCLS1, RHOU, NLGN1, PTGS2, RAB21, PAK1, ABLIM3, FYN, SPAG5, MAPK14, NEDD4, CAMK1]
GO:0032147;activation of protein kinase activity;11.0;0.6799073451904818;0.7723826249249031;9.164951513576677;1096.8683293671154;4.034070439870987;0.03671119586651001;0.6387315022281249;[, TNF, AKT1, PROK2, TNFSF11, MAP3K8, PRKACB, MAP2K2, SLC11A1, F2R, PRKCD, PRKAR1B, ADAM9, CALCA, C5AR1, FPR1, TGFA, ADRB2, IQGAP3, PRKCZ, PRKAR2B, PDGFC, NCKAP1L, CLSPN, ECT2, DRD4, MAP2K6, TGFB2, GADD45B, TNFRSF10B, EIF2AK2, IGF1, TPX2, BMP2, CDK1, CSPG4, LRRK2, ITGB3, KIF14, ARRB1, GHR, MAP4K1, SYK, RIPK2, STRADB, IL18, EMP2, DUSP6, GREM1, MDFIC, IL1B, KIT, CHI3L1, TLR6, TLR4, CXCR4, NOD2, THBS1, PAK1, NTF3, CCL19, CD74, EGF, MAPK14, CD40LG, PKN1]
GO:0071315;cellular response to morphine;8.0;1.0;0.875;9.628524252492122;528.974071528598;8.390779266560578;0.017704286128305307;0.8041048419030481;[AIF1]
GO:2000775;histone H3-S10 phosphorylation involved in chromosome condensation;12.0;1.0;0.9481203125901445;9.628524252492122;711.4828594708514;9.777073627680469;0.023812691013487215;0.9481203125901445;[CCNB1]
GO:0031297;replication fork processing;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;150.6515651586252;6.375876246018314;0.005042172308252987;0.701062607729944;[SMARCAL1, BLM, PCNA, BRCA2, RAD51, DNA2]
GO:0072643;interferon-gamma secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;7.8311634786251565;0.004587596526932657;0.8157270763441555;[F2RL1, LILRB1, GATA3]
GO:0035655;interleukin-18-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.8311634786251565;0.00101047745553359;0.7514054297404357;[IL18RAP, ALOX5, IL18, AKT1, IL18R1]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[, BLK, IGHM, ITK, TXK, PIK3CD, CD79B, CD79A, IGHG1, IGKC, CD19, TRBC1, PLCG2, CTLA4, CD38, NCKAP1L, IGHA1, LYN, MEF2C, SYK, PRKCB, BMX, LIME1, LAT2, PTPRC, LCK, BTK, IGHD, BCL2, PTPN6, MNDA]
GO:0031291;Ran protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;8.67846133901236;9.9090025448413E-4;0.8188169164668168;[GPSM2]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, LGALS1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, MAP3K8, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD5, CD28, PTPN6, CD24, CARD11]
GO:0001660;fever generation;7.0;1.0;0.8509193652572005;9.628524252492122;35.726156595412796;8.16763571524637;0.0011957223097949796;0.7686126355688037;[IL1A, IL1RN, IL1B]
GO:0046135;pyrimidine nucleoside catabolic process;8.0;0.7307253602413294;0.7403626801206646;9.333724712271477;1255.5710096994353;6.686031174322154;0.04202283175409332;0.7169239451870815;[CDA, DPYS, UPB1, TYMP, NT5E, DPYD, UPP1, APOBEC3A]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[LYN, ABCA1, YAP1, HDAC2, TNC, KLF4, PHB2, PAX2, AQP1, COL1A1, MYB, RARA, HOXA2, EPHA3]
GO:0035404;histone-serine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.405380701177911;709.5369493217947;7.292166977892469;0.023747563152003725;0.7881627702307852;[CCNB1, VRK1, AURKB, AURKA]
GO:0051714;positive regulation of cytolysis in other organism;6.0;0.8653626801206646;0.7558016526504768;9.503361109538115;151.20928208599747;8.67846133901236;0.005060838591899488;0.7669372290569613;[PGLYRP1]
GO:0035407;histone H3-T11 phosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;710.1813063381824;9.083926447120524;0.02376912920145855;0.8969813732811862;[CHEK1, PKN1]
GO:0030199;collagen fibril organization;5.0;1.0;0.7902410118609202;9.628524252492122;53.964823970696955;5.9928839937622085;0.0018061540931107725;0.5967173779995258;[TGFB2, COL14A1, LUM, COL11A1, COL12A1, LOXL2, COL1A1, GREM1, COL3A1, SFRP2, COL1A2, COL5A1, LOX, COL5A2, CYP1B1]
GO:2000304;positive regulation of ceramide biosynthetic process;9.0;0.9326813400603323;0.8625812952104552;9.59573442966913;909.7864372675522;7.57984905034425;0.03044973330070948;0.7838744581139225;[PRKCD, TNF, CYR61]
GO:2000781;positive regulation of double-strand break repair;9.0;0.8933024483968273;0.8428918493787028;9.55953138100517;610.2987732095577;6.943860283624253;0.020426150706087248;0.7513499630073597;[BLM, TIMELESS, PARP9, FOXM1]
GO:0071548;response to dexamethasone;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;124.89021324540595;6.015873511986907;0.004179963043429046;0.6826520511697386;[PCNA, FECH, ABCB4, PTAFR, FOXO1, AQP1, ICAM1, GHSR, EDN1, TGFB1, ARG1, RPS6KB1, IL1B]
GO:0034394;protein localization to cell surface;5.0;1.0;0.7902410118609202;9.628524252492122;29.829169826127035;6.686031174322154;9.983554695705216E-4;0.6321649570480018;[FCN1, FLNA, EMP2, PTPRK, VCL, CD177]
GO:0034395;regulation of transcription from RNA polymerase II promoter in response to iron;11.0;0.8933024483968273;0.8790801765280758;9.533214072687796;252.6466751378032;9.083926447120524;0.00845585684961658;0.8969813732811862;[SLC40A1, HMOX1]
GO:0055012;ventricular cardiac muscle cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;47.302935560632505;8.16763571524637;0.001583186683336236;0.7686126355688037;[MEF2C, MYOCD, RXRA, RARA]
GO:0042176;regulation of protein catabolic process;6.0;0.5945822691631375;0.6204114471717133;8.214830917184116;56.791667214012804;3.8826707934156186;0.001900765992470805;0.5216802775280761;[PSMD3, AKT1, TRIB1, NEDD4L, BARD1, PLK2, TNFSF12, PLK1, PTK2, XPO1, TIMP2, PBK, TIMP3, TIMP1, IL10, CBFA2T3, RNF144A, RNF144B, IL1B, CST3, FLNA, IL33, PSMC6, NEDD4, PSMC2, MAD2L1, FMR1, TNF, CLU, LAMP3, HGS, ADAM9, ADAM8, PSMD14, FOXO1, FAM83D, OSBPL7, CAV1, DAB2, CCDC22, LRRK2, TNFAIP3, ALAD, GPX1, IRAK3, TNFRSF1B, IFNG, DTL, CEBPA, LRP1, TAF9, LRP2, AURKA, FYN, SNCA, EGF, PML]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SLA, SLA2, GRAP2, AKT1, NEK2, EPHB1, PDGFRB, PDGFRA, MAP2K2, DAPK1, MATK, VRK1, MELK, BTK, SIK1, BLK, CSF1R, TXK, THY1, LYN, EIF2AK2, BMX, EIF2S1, CLK4, PTK2, CLK1, FES, ITK, LRRK2, JAK3, MAP4K1, SYK, CAD, IRAK3, FGR, ZAP70, HCK, LCK, KIT, CAMK2D, TTK, AURKB, AURKA, PAK1, FYN, CSK, CAMK4, TEK]
GO:0042177;negative regulation of protein catabolic process;7.0;0.7140352122741334;0.7079369713942671;9.105276108727574;231.8232476428224;5.040875179285974;0.007758915471227624;0.6087099563505541;[ALAD, LAMP3, TIMP2, PBK, TIMP3, TIMP1, IL10, IRAK3, TAF9, CST3, FLNA, FYN, SNCA, PML, MAD2L1]
GO:0060603;mammary gland duct morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;32.20947323359611;8.16763571524637;0.0010780220824845236;0.7408135829017477;[CSF1R]
GO:0045444;fat cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[STEAP4, FFAR2, MED1, GPX1, SIRT1, PLCB1, CEBPA, CEBPB, RETN, ADRB2, PTGS2, FOXO1, PRDM16, EGR2, LAMB3, NOC3L, KLF4, NR4A2, NR4A1, ALDH6A1, LRG1, NR4A3]
GO:0002320;lymphoid progenitor cell differentiation;5.0;0.8653626801206646;0.7229223519212526;9.223059144383958;22.164838071467113;7.379178354882098;7.418371831928127E-4;0.6676125360964777;[SPI1, PRKDC, KIT, BCL2, GATA3, SOX4]
GO:0048714;positive regulation of oligodendrocyte differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;471.693664190925;6.943860283624253;0.01578716244373315;0.7703503496879909;[HDAC2, CXCR4, ASPA, TLR2]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[TGFB1, SLC46A2, TNFSF14, RIPK2, CACNA1F, CORO1A, CCNB2, SIT1, BCL2, NCKAP1L, JAK3]
GO:0002554;serotonin secretion by platelet;10.0;1.0;0.9152410118609203;9.628524252492122;131.6544252072528;8.67846133901236;0.0044063551303965215;0.8590579283277371;[FCER1G, SYK, P2RX1]
GO:0023021;termination of signal transduction;7.0;0.8653626801206646;0.7836007053175329;9.434368238051164;144.8699869040881;8.67846133901236;0.004848668087156246;0.7947362817240173;[PRKCD]
GO:0006914;autophagy;4.0;0.6729672293956388;0.5864836146978194;8.39638057119949;37.75222312160081;4.39717627414001;0.001263532933085;0.4748717991491287;[LAMP2, HGS, WDFY3, S100A9, S100A8, FOXO1, PLEKHF2, SRPX, PLEKHF1, ITGB4, LRRK2, PTPN22, CTSD, PIK3C3, VPS4B, DRAM1, VPS41]
GO:0043032;positive regulation of macrophage activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.59742726208806;6.641579411751319;0.004237101960174532;0.6905700452391912;[IL10, IL33, ITGAM, LRRK2, ITGB2, THBS1, HSPD1, STAP1, TLR6, TLR4, HAVCR2]
GO:0071732;cellular response to nitric oxide;6.0;1.0;0.8231203125901445;9.628524252492122;346.50110413771324;7.004484905440688;0.011597080124741305;0.6813299963962409;[CCNA2, CDK2, FOXO1, DNM2, AQP1]
GO:2000310;regulation of NMDA receptor activity;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;200.74624271324296;6.8867018697843045;0.006718796083723233;0.7484268790654467;[MEF2C, NLGN1, DAPK1, EPHB2]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[FASLG, TNF, PYCARD, CTSH, F2R, F3, IFI27, LCK, S100A9, S100A8, NLRC4, HSPD1, NLRP3, SNCA, CASP8AP2, TNFRSF10B, HSPE1, PML, NLRP12, P2RX1, DLC1]
GO:0071727;cellular response to triacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;168.80270344913424;8.67846133901236;0.005649674571872418;0.8188169164668168;[TLR1, CD14, TLR2]
GO:0090267;positive regulation of mitotic cell cycle spindle assembly checkpoint;13.0;0.9326813400603323;0.9288956347978027;9.597752593825367;471.1536740716433;7.8311634786251565;0.015769089460400346;0.8630410292508717;[NDC80, MAD2L1]
GO:0090026;positive regulation of monocyte chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;859.35541097108;6.8867018697843045;0.028761852235543582;0.7674272657460779;[CCR1, CXCL10, CXCL12, CCL5, SERPINE1, CCL1, FPR2, S100A14, PLA2G7, AIF1, CCR2]
GO:0034144;negative regulation of toll-like receptor 4 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;7.697632086000634;0.011871713162238609;0.7898978880348613;[LYN, TNFAIP3, LILRA2]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, CD74, EDN1, CCL21, C5AR1, CXCL1, PPBP, CXCL3, CXCL2, CXCL5, IL23A, IL1B, CXCR2, C3AR1, RAC2, XCL1, CCR7, NCKAP1L, CCL19, PF4]
GO:0034142;toll-like receptor 4 signaling pathway;12.0;0.8436909121759173;0.8699657686781033;9.485423408851448;412.6549923027037;6.943860283624253;0.013811191226989502;0.8032296504172152;[ITGAM, RIPK2, PRKCE, ITGB2, NR1H4, LY96, NFKBIA, TNIP3, S100A14, CD14, TLR4]
GO:0090266;regulation of mitotic cell cycle spindle assembly checkpoint;12.0;0.8653626801206646;0.8808016526504769;9.548481544818586;280.44081179639056;7.138016298065211;0.009386101590480495;0.8131587980249038;[CDT1, CCNB1, DUSP1, NDC80, MAD2L1]
GO:0043277;apoptotic cell clearance;7.0;1.0;0.8509193652572005;9.628524252492122;28.437470009997963;6.8867018697843045;9.517765291732001E-4;0.7031056191423581;[LRP1, ITGB3, MARCO, RARA, CD36, TGM2]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[YAP1, LRRK2, RUVBL1, SOX4, WLS, JUP, EGF, CAV1, AXIN2, NFKB1, SULF2, COL1A1, SFRP4, ASPM, SFRP2, DAAM2, LGR4, NAIP]
GO:0046785;microtubule polymerization;7.0;1.0;0.8509193652572005;9.628524252492122;97.26999823215544;7.292166977892469;0.0032555393035152377;0.7238411236270654;[FBXO5, CKAP5]
GO:0045454;cell redox homeostasis;5.0;1.0;0.7902410118609202;9.628524252492122;31.944097044200298;5.572381008289503;0.0010691401802485107;0.5752128357670632;[TXNDC15, GPX1, SLC11A1, TMX1]
GO:0045217;cell-cell junction maintenance;5.0;0.8653626801206646;0.7229223519212526;9.310070521373587;51.610367046990525;7.474488534686424;0.0017273525387479806;0.6724867031240476;[CSF1R, F2R, F2RL1, PRTN3, CD177]
GO:0043280;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.811012628672052;0.8536266269261705;9.556203590912496;733.386781063286;4.956792062075433;0.024545795556936395;0.7016108891590862;[FASLG, ARRB1, TNF, CYR61, CTGF, PYCARD, CTSH, SOX7, DAPK1, F2R, SIRT1, F3, IFI27, LCK, S100A9, S100A8, NLRC4, HSPD1, NLRP3, SNCA, CASP8AP2, GSN, TNFRSF10B, HSPE1, PML, NLRP12, P2RX1, DLC1]
GO:0044130;negative regulation of growth of symbiont in host;7.0;1.0;0.8509193652572005;9.628524252492122;102.69207226600344;7.212124270218933;0.0034370112418783067;0.7197477358342742;[IL10, LTA, IRF8, CTSG, CD36, TNF, MPO, ELANE]
GO:0055015;ventricular cardiac muscle cell development;7.0;1.0;0.8509193652572005;9.628524252492122;69.56390858866273;7.379178354882098;0.002328241417009372;0.728290889492758;[CCNB1, CDK1, FHL2, MYH10]
GO:0071726;cellular response to diacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;168.80270344913424;8.390779266560578;0.005649674571872418;0.8041048419030481;[CD36, TLR6, CD14, TLR2]
GO:0090237;regulation of arachidonic acid secretion;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;83.13942816732954;7.9853141584524145;0.0027826018401329354;0.8046099625986299;[SYK, MIF]
GO:0034134;toll-like receptor 2 signaling pathway;12.0;0.9326813400603323;0.9144609826203107;9.590783924509275;412.6549923027037;8.16763571524637;0.013811191226989502;0.8658135829017477;[RIPK2, TLR2]
GO:0008089;anterograde axonal transport;9.0;0.8259837884571596;0.8092325194088689;9.405380701177911;71.1020239957658;6.113511981550823;0.0023797207554711163;0.7088859122241795;[FMR1, RAB21, KIF4A]
GO:0090235;regulation of metaphase plate congression;6.0;0.8259837884571596;0.7361122068187242;9.427853557029971;45.24164634670696;7.8311634786251565;0.001514197188386001;0.7236063770733796;[SPAG5, MAD1L1]
GO:0001695;histamine catabolic process;8.0;1.0;0.875;9.628524252492122;799.2000283083077;9.777073627680469;0.02674850571415016;0.875;[HNMT]
GO:0060623;regulation of chromosome condensation;7.0;0.8259837884571596;0.7639112594857803;9.377209824211215;21.750886949199476;8.390779266560578;7.279826116623381E-4;0.7800242071602487;[CCNB1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, ZEB1, TAL1, RARA, HCLS1, ASCL2, STAT1, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CDK2, CIITA, FHL2, FASLG, FOXM1, HHEX, RFC1, PEG3, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, E2F8, PRRX1, KLF4, KLF8, KLF5, DNAJA3, GFI1, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H2, SUV39H1, BMI1, XPO1, CD36, HBZ, EDN1, PARP9, IL1B, SP100, SATB2, RELB, RXRA, APBB1, CDX2, LILRB4, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TIMELESS, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, IRF8, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0002774;Fc receptor mediated inhibitory signaling pathway;8.0;1.0;0.875;9.628524252492122;130.16139686502353;8.67846133901236;0.004356384815420379;0.8188169164668168;[LYN, LILRB1, LILRB2]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[CSF3, SPI1, SPARC, TNC, ICAM1, EEF1B2, ALAD, PRKCE, CYBB, ADCYAP1, CLDN3, IL1B, CLDN7, RARA, S100A8, BIRC2, PSMD14, FECH, GATA3, TYMS, CCL7, CNR1, FYN, CD14, GSN, VCAM1, GGH, RPS6KB1, CDK1, CD27]
GO:1902808;positive regulation of cell cycle G1/S phase transition;8.0;0.8933024483968273;0.8216512241984136;9.5544162803384;106.07932343249502;6.113511981550823;0.003550379490092644;0.6876452870438905;[, ANXA1, KCNA5, CDC6, PHB2, AIF1, CDC45, PLCB1, FAM83D]
GO:0034125;negative regulation of MyD88-dependent toll-like receptor signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;9.083926447120524;0.011871713162238609;0.8607930461318132;[CD300LF]
GO:0034128;negative regulation of MyD88-independent toll-like receptor signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;7.8311634786251565;0.011871713162238609;0.7967266896635242;[LY96, CD14, TLR4]
GO:2000334;positive regulation of blood microparticle formation;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;107.44151918580685;9.083926447120524;0.0035959709560594052;0.7876727335416686;[CD36, TNF]
GO:1905098;negative regulation of guanyl-nucleotide exchange factor activity;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;99.11376152007192;8.16763571524637;0.003317248401482572;0.7408135829017477;[STMN1, EIF2S1]
GO:0050829;defense response to Gram-negative bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.407625775213448;0.0023911797157970473;0.627465598881932;[IGHM, HIST1H2BK, SERPINE1, HMGB2, PYCARD, CTSG, IL6R, CAMP, DEFA4, SLC11A1, RNASE6, RNASE3, AZU1, DEFA1, LYZ, SELP, CD4, IL6, IL23A, BPI, TLR4, LTF]
GO:0034123;positive regulation of toll-like receptor signaling pathway;8.0;0.7140352122741334;0.7320176061370667;9.09300601613576;411.4409909120541;6.781341354126479;0.013770559692974778;0.7217981122146513;[RSAD2, CAV1, PTPN22, TLR1, F2RL1, TLR5, LTF, TLR2]
GO:0034122;negative regulation of toll-like receptor signaling pathway;8.0;0.7140352122741334;0.7320176061370667;9.0094850440859;260.8137256220838;6.166155715036245;0.00872920067945721;0.6903374900225189;[LYN, LY96, TNFAIP3, IRAK3, ARRB2, LILRA2, F2RL1, TLR6, CD14, CD300LF, TLR4, LGR4]
GO:0034121;regulation of toll-like receptor signaling pathway;7.0;0.609056648853049;0.655447689683725;8.322272599045768;87.36499042264505;5.666199763507158;0.002924027606059212;0.6406890846681925;[GFI1, LY96, TNFAIP3, PTPN22, ARRB2, LILRA2, CD36, CD14, CD300LF, LYN, RSAD2, FCRL3, CAV1, IRAK3, TLR1, IRF7, F2RL1, TLR6, TLR5, TLR4, LGR4, BIRC2, LTF, TLR2, BIRC3]
GO:0090241;negative regulation of histone H4 acetylation;12.0;0.9326813400603323;0.9144609826203107;9.60254876608886;1490.3225296813393;8.16763571524637;0.049879753865236;0.8658135829017477;[SPI1, SIRT1]
GO:0043299;leukocyte degranulation;8.0;0.811012628672052;0.780506314336026;9.223059144383958;48.80626136022181;3.5624655292582776;0.0016335016449431083;0.5571846528378576;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PGLYRP1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, NRAS, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, CORO1A, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, LAT, ITGAM, ITGB2, PIK3CD, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, NPC2, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CTSD, CAMP, CD33, CTSB, CD53, CCT2, FCER1G, MME, GAA, RHOG, LAT2, HCK, CEACAM1, CEACAM6, KIT, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, RASGRP1, MGAM, HSPA6, GGH, NR4A3, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, DOCK2, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0046323;glucose import;10.0;0.8933024483968273;0.861892236059334;9.461470167828956;38.205824888540654;7.212124270218933;0.00127871457600939;0.7840693824379941;[SORT1, SLC2A6]
GO:0002793;positive regulation of peptide secretion;7.0;0.6162540371078848;0.6590463838111429;8.05612761173837;82.41339311992232;4.224114042758852;0.002758302100485337;0.56694075384528;[FCN1, TNF, PYCARD, CLEC5A, TNFSF11, SOX4, WLS, POSTN, PRKCE, F2R, GOLPH3L, MIF, HLA-E, ADCYAP1, ADAM9, ADAM8, CLEC4E, S100A9, S100A8, CFTR, BLK, CD274, CSF1R, TWIST1, GATA3, PRKCZ, RASGRP1, TMEM27, NLRP3, CD14, MYH10, TGFB2, TGFB1, FZD5, CRTAM, IGF1, IL6, ACHE, ORM1, LRRK2, PTPN22, ARRB1, IFIH1, CD38, FFAR2, CD34, HAVCR2, IL10, CHUK, SYK, DDX58, RIPK2, IL17RB, MMP12, TLR1, FGR, IL1A, IL1B, IGHD, TLR8, TLR4, TLR2, EXOC1, NOD2, CD58, CCL19, APBB1, IL33, NR1H2, NR1H4, MAPK14, CD2, NLRP12, F2RL1, CD244, IL17A]
GO:0000132;establishment of mitotic spindle orientation;8.0;0.9326813400603323;0.8413406700301662;9.582004236857228;227.84740072539455;6.641579411751319;0.007625847452931234;0.7146506799819907;[GPSM2, CENPA, NDC80]
GO:0002548;monocyte chemotaxis;7.0;1.0;0.8509193652572005;9.628524252492122;125.46101547564297;6.039404009397101;0.004199067280386423;0.6597747671587765;[CCL13, CCL23, CALCA, ANXA1, CCL21, CCL20, TNFRSF11A, LGALS3, IL6, CCL8, CCL7, CCL5, CCL4, XCL2, TNFSF11, CCL2, XCL1, S100A12, CCL1, CCL19, CCL18, IL6R, CCR2]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, PRKDC, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, HCLS1, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, DNMT1, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, GPX1, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, IGF1, PTK2, VNN1, ID1, CD28, CD27, NRP1, KIF14, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, CASP2, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, AURKA, SNCA, SOD2, RPS6KB1, TEK, NAA15]
GO:0046330;positive regulation of JNK cascade;12.0;0.8436909121759173;0.8699657686781033;9.567899630675686;1762.0380321839782;4.909539177224887;0.058973827205923174;0.6991943744303455;[IL1RN, NCF1, TNF, CTGF, PYCARD, TNFSF11, CCR7, MAP4K1, EDN1, SYK, RIPK2, MDFIC, IL1B, TLR6, PLCB1, TNFRSF11A, NOD2, RASGRP1, PAK1, CCL19, SLAMF1, FZD5, CCL21, GADD45B, CARD9, FZD8, CD40LG, CD27, F2RL1, PKN1, LTBR, FCGR2B, NOX1]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, PRKDC, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, FOSL1, NOX4, NOX1, SRPX, ADM, CTLA4, TIMP3, ANXA1, DUSP1, RIPK2, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, POU4F1, TNF, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A9, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, BCL2, BCL2L1, PLEKHF1, PIK3CD, FASLG, ARRB1, ARRB2, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, GZMA, GZMB, PML, P2RX1, MNDA, IFIT2, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, GADD45B, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, IL10, VAV1, IL1B, CXCR2, CTNNA1, APBB1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, TGM2, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, NFKBID, UBE2M, TNFAIP8, CASP2, MYBL2, YWHAH, ARHGEF12, PLAUR, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
GO:0002309;T cell proliferation involved in immune response;7.0;0.8653626801206646;0.7836007053175329;9.517298617381897;137.0826054799011;8.390779266560578;0.004588031439076979;0.7800242071602487;[SLC11A1, LILRB1]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[NCF2, ITGB3, NCF4, ICAM3, ITGAL, CD36, TGM2, ANXA1, CD93, ANXA3, SLC11A1, DNM2, PECAM1, RARA, IRF8, PRTN3, CD302, LRP1, CEBPE, PLD4, CORO1A, CD14, ELANE, SLAMF1, CDC7, MARCO]
GO:0034115;negative regulation of heterotypic cell-cell adhesion;8.0;1.0;0.875;9.628524252492122;130.132988179366;7.57984905034425;0.004355434002277579;0.7626338329336335;[IL10, IL1RN, KLF4]
GO:0033026;negative regulation of mast cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;301.33162323320204;9.777073627680469;0.010085298248760914;0.896240625180289;[FCER1G]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[NCF1, ETS1, AQP1, IL18RAP, MYB, AKT1, CYP1B1, PDGFRA, DAPK1, TPM1, PRKCD, CYBB, FANCD2, BTK, MGST1, FOXO1, PDGFD, ECT2, JUN, EIF2S1, NR4A2, IL6, CDK2, CDK1, NOX4, EZH2, LRRK2, TNFAIP3, PTPRK, CD36, GPX2, ANXA1, GPX1, CHUK, ARG1, FOS, MMP9, SIRT1, PAX2, DNM2, CCNA2, HDAC2, PCNA, AIF1, CST3, SNCA, KLF4, SOD2, MAPK13, FABP1]
GO:2000342;negative regulation of chemokine (C-X-C motif) ligand 2 production;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;89.04410360278419;9.083926447120524;0.002980226013094716;0.8154717862087246;[KLF4]
GO:2000348;regulation of CD40 signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;41.8512380110395;7.9853141584524145;0.0014007232725606145;0.7314896500084853;[FANCD2, TNFAIP3, TREM2, SLAMF1]
GO:2000105;positive regulation of DNA-dependent DNA replication;9.0;0.7763722522362496;0.7844267512984139;9.440472020989182;901.5417397663175;7.379178354882098;0.03017379069508918;0.7736121494158466;[CDT1, CDK2, CDC7, E2F7, E2F8]
GO:2000104;negative regulation of DNA-dependent DNA replication;9.0;0.7140352122741334;0.7532582313173557;9.245532000236016;982.5781715052054;6.558197802812269;0.03288600713733608;0.7316271658034954;[SMARCAL1, BLM, TIPIN, GMNN, DONSON, SMC1A, BRCA2, SMC3, MSH6, STAG2, MSH2, BCL6, TIMELESS]
